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Iridium(I)-catalyzed olefin isomerization in bis(allyl) ethers was integrated into a generally 
applicable strategy for affecting highly stereoselective Claisen rearrangements. Catalyzed alkene 
isomerization afforded allyl vinyl ethers from easily prepared di(allyl) ethers; direct thermolysis 
of these reaction mixtures led to highly diastereoselective [3,3] sigmatropic rearrangements 
affording syn-2,3-dialkyl-4-pentenal derivatives.  
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Merging the catalytic asymmetric synthesis of di(allyl) ethers with ensuing olefin 
isomerization-Claisen rearrangement (ICR) reactions provided a convenient, two-step route to 
asymmetric aliphatic Claisen rearrangements from easily obtained starting materials. These 
reactions delivered the 2,3-disubstituted 4-pentenal derivatives characteristic of aliphatic Claisen 
rearrangements with excellent relative and absolute stereocontrol. A catalytic enantioselective 
synthesis of the (+)-calopin dimethyl ether demonstrated the utility of this reaction technology in 
asymmetric synthesis enterprises. 
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Stereoselective quaternary all-carbon stereocenter construction was often not easily 
achieved from methodologies developed primarily for accessing less substituted stereogenic 
carbons. Olefin isomerization-Claisen rearrangement (ICR) reactions offered a strategy for 
recruiting the Claisen rearrangement for asymmetric quaternary carbon construction. Several 
complementary strategies for enantioselective quaternary carbon synthesis derived directly from 
the ICR reaction design. 
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1.0  CLAISEN REARRANGEMENT-INTRODUCTION 
The Claisen rearrangement stands as one of the most powerful methods for introducing 
molecular complexity from easily obtained starting materials.1 Originally disclosed as the [3,3]- 
sigmatropic reorganization of allyl-aryl or allyl-vinyl ethers, the term Claisen rearrangement has 
subsequently expanded to include any such process involving a 1,5-diene possessing a 
heteroatom in the 3-position (Figure 1). Thus, in addition to the traditional formulation in which 
X = O, aza-Claisen (X = N),2 thio-Claisen (X = S),3 and even metallo-Claisen (X = metal)4 
rearrangements are well known. 
 
 
1 Recent reviews of Claisen rearrangement, see: (a) Ziegler, F. E. Chem. Rev. 1988, 88, 1423. (b) Nubbemeyer, U. Synthesis 2003, 
961. (c) Hiersemann, M.; Abraham, L. Eur. J. Org. Chem. 2002, 1461-1471. (d) Wipf, P. In Comprehensive Organic Synthesis, 
Trost, B. M.; Fleming, I., Eds.; Pergamon: Oxford, 1991; Vol. 5, p 827-873. (e) Castro, A. M. M. Chem. Rev. 2004, 104, 2939-
3002. 
2 (a) Tsunoda, T.; Sasaki, O.; Ito, S. Tetrahedron Lett. 1990, 31, 727. (b) Kurth, M. J.; Brown, E. J. Synthesis 1988, 362. (c) 
Kurth, M. J.; Soares, C. J. Tetrahedron Lett. 1987, 28, 1031. (d) Kurth, M. J.; Decker, O. H. W. J. Org. Chem. 1986, 51, 1377. (e) 
Kurth, M. J.; Decker, O. H. W.; Hope, H.; Yanuck, M. D. J. Am. Chem. Soc. 1985, 107, 443. (f) Hill, R. K.; Khatri, H. N. 
Tetrahedron Lett. 1978, 19, 4337. (g) Jolidon, S.; Hansen, H.-J. Helv. Chim. Acta 1977, 60, 978.
3  (a) Tubery, F.; Grierson, D. S.; Husson, H. P. Tetrahedron Lett. 1990, 31, 523. (b) Beslin, P.; Perrio, S. J. Chem. Soc., Chem. 
Comm. 1989, 414. (c) Plate, R.; Theunisse, A. W. G.; Ottenheijm, H. C. J. J. Org. Chem. 1987, 52, 370. (d) Takahata, H.; Banba, 
Y.; Mozumi, M.; Yamazaki, T. Heterocycles 1986, 24, 3347. (e) Kwart, H.; Miles, W. H.; Horgan, A. G.; Kwart, L. D. J. Am. 
Chem. Soc. 1981, 103, 1757. (f) Kwart, H.; Johnson, N. A.; Eggersichs, T.; George, T. J. Org. Chem. 1977, 42, 172. (g) Kwart, 
H.; Schwartz, J. L. J. Org. Chem. 1974, 39, 1575. 
4  (a) Knochel, P.; Normant, J. F. Tetrahedron Lett. 1986, 27, 1039, 1043, 4427, 4431. (b) Dewar, M. J. S.; Merz, K. M. J. Am. 
Chem. Soc. 1987, 109, 6553. (c) Normant, J. F.; Quirion, J. C. Tetrahedron Lett. 1989, 30, 3959. 
X [3,3]-sigmatropic rearrangement
X
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Figure 1. The Claisen rearrangement 
1.1 CLAISEN VARIANTS 
1.1.1 Preparation of allyl vinyl ether 
One of the earliest reported methods for preparing of allyl vinyl ether Claisen substrates was the 
mercury(II) ion 5  or acid-catalyzed 6  interchange of allylic alcohols with alkyl vinyl ethers 
(Scheme 1). The formed allyl vinyl ethers typically required elVated temperatures for the [3,3] 
sigmatropic rearrangement. Though it allowed for a straightforward method to the preparation of 
allyl vinyl ethers, the toxicity and low yields associated with the mercury transetherification have 
limited the use of this procedure. 
OEt
cat. Hg(OAc)2
O
OEt
AcOHg O OOH
R
R
eimination R
[3,3]
R
H  
Scheme 1. Mercury (II)-catalyzed preparation of Claisen substrate 
                                                 
5 Hg2+ catalyzed: Watanabe, W. H.; Conlon, L. E. J. Am. Chem. Soc. 1957, 79, 2828-2833.  
 2
6 H+ catalyzed: (a) Marbet, R.; Saucy, G. Helv. Chim. Acta. 1967, 50, 2091-2095. (b) Marbet, R.; Saucy, G. Helv. Chim. Acta. 
1967, 50, 2095. 
Nakai has reported a new version of the transetherification catalyzed by 2,6-
dimethylphenol (DMP)- or palladium(II). 7  The Pd(II)-catalyzed cascade transetherification 
followed by Claisen rearrangement at ambient temperature gave a high syn- diastereoselectivity, 
while the DMP-catalyzed transetherification followed by thermal Claisen rearrangement 
afforded anti- diastereomers (Scheme 2). 
tBu
OH
Me
OMe
MeO
MeO
O
Me
tBu
+
catalyst
*
*
PdCl2(PhCN)2      23 oC  anti : syn = < 2 : > 98
DMP                    100 oC  anti : syn = > 98 : < 2
O
MeO
tBu
Me
[3,3]
 
Scheme 2. Palladium (II) or DMP-catalyzed transetherfication followed by Claisen rearrangement 
A methylidenation of allyl esters to allyl vinyl ethers was a useful protocol to prepare 
vinyl ethers. The Tebbe’s reagent and similar reagents were used widely in the methylidenation 
(Scheme 3).8 However the strong Lewis acidic residue had limited its application. 
O
O
Ph Cl
AlTi
Cp
Cp
Me
Me O
Ph
O
Ph
[3,3]
 
Scheme 3. Tebbe’s reaction for Claisen substrates 
                                                 
7 (a) Mikami, K.; Takahasi, K.; Nakai, T. Tetrahedron Lett. 1987, 47, 5879. For a most recent  example of Pd(II)-catalyzed 
tandem vinyl ether exchange-Claisen rearrangement, see: (b) Wei, X.; Lorenz, J. C.; Kapadia, S.; Saha, A.; Haddad, N.; Busacca, 
C. A.; Senanayake, C. H. J. Org, Chem. 2007, 72, 4250-4253. 
 3
8 (a) Pine, S. H.; Zahler, R.; Vans, D. A.; Grubbs, R. H. J. Am. Chem. Soc. 1980, 102, 3270. (b) Hartley, R. C.; McKiernan, G. J. 
J. Chem. Soc., Perkin Trans. 1, 2002, 2763 and references therein. 
An elimination reaction was a common protocol to prepare vinyl ethers. Many 
elimination precedents have been reported. Two examples are described here: the first reaction is 
a selenium oxidative elimination (Scheme 4);9 the second example is a NIS-assisted allyl alcohol 
attacking vinyl silyl ether following base-mediated elimination (Scheme 5).10
OMe
OMe ArSe
OH
PPTS
O
OMe
SeAr
1. mCPBA
2. heat
O
OMe
 
Scheme 4. Selenium oxidative elimination 
OH
Ph
+ OTBS
NIS, -78 oC O
Ph
OTBS
I n-BuLi
-78 oC
O
Ph  
Scheme 5. NIS-assisted allyl alcohol attacking vinyl silyl ether following elimination 
A novel protocol for preparing vinyl ethers reported by Stoltz was a tandem Rh-catalyzed 
Bamford-Stevens/Clasien rearrangement sequence (Scheme 6).11 The protocol entailed a tandem 
process in which α-allyloxy N-aziridinyl imines 1 were converted via rhodium-catalyzed 
Bamford-Stevens reaction to allyl vinyl ethers 2, which subsequently underwent the thermal 
Claisen rearrangement to furnish aldehyde products 3. Importantly, the Bamford-Stevens 
reaction provided an access for (Z)-enol ethers, which were not easily afforded from other 
source, with high stereoselectivity.  
                                                 
9 Coates, R. M.; Rogers, B. D.; Hobbs, S. J.; Peck, D. R.; Curran, D. P. J. Am Chem. Soc. 1987, 109, 1160 
10 Maeda, K.; Shinokubo, H.; Oshima, K.; Utimoto, K. J. Org. Chem. 1996, 61, 2262. 
 4
11 May, J. A.; Stoltz, B. M. J. Am. Chem. Soc. 2002, 124, 12426-12427. 
N
O
N
Ph
Ph
Ph O Ph
Ph
O
H
Ph
Ph1 mol % Rh2(OAc)4,
DCE.
130 oC, 2-4 h
87 %, anti: syn > 20 : 1
1 2 3
 
Scheme 6. Tandem Rh-catalyzed Bamford-Stevens/Clasien rearrangement 
Ullmann coupling reaction is a straightforward idea to prepare allyl vinyl ethers from 
allyl alcohols and vinyl halides. Recently, Buchwald has reported a copper (I) iodide and 
tetramethyl-1,10-phenanthroline-catalyzed domino C-O coupling/Claisen rearrangement process 
with moderate yield and high diastereoselection (Scheme 7).12 To avoid the strong epimerization 
of the formed aldehyde (4) under basic reaction conditions, one limitation of this protocol was 
that the starting material vinyl iodide was 2,2-disubstituted-1-iodoethenes. As a result, an all 
carbon α-quaternary center was introduced into the Claisen adduct. 
Me OH
Me
MeMe
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Me H
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Me
Me
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Me
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Scheme 7. Domino Cu(I)-catalyzed coupling/Claisen rearrangement 
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12 (a) Nordmann, G.; Buchwald, S. L. J. Am. Chem. Soc. 2003, 125, 4978. A Ir-catalyzed etherification of allyl alcohols with 
vinyl or isopropenyl acetates has been reported recently, see: (b) Morita, M.; Sakaguchi, S.; Ishii, Y. J. Org. Chem. 2006, 71, 
6285-6286. 
1.1.2 Activated Claisen variants 
Although the parent aliphatic Claisen rearrangement is a very useful reaction, a common feature 
of these simple allyl vinyl ether Claisen rearrangements is the relatively high temperatures 
required. This fact, coupled with the difficulty in accessing these substrates has led to a less 
widespread reliance on these traditional Claisen variants as compared to certain other activated 
protocols.  
Most of organic synthesis contributions of the Claisen rearrangement were obtained from 
a series of activated variants, including the Carroll’s allyic β-ketoesters rearrangement (Scheme 
8),13 the Eschenmoser’s N,O-ketene acetals rearrangement from amide acetals (Scheme 9)14 and 
Johnson’s ketene acetals rearrangement from ortho ester (Scheme 10).15 In these processes, the 
preparation of vinyl components of the Claisen rearrangement was simplified. 
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Me OMe
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OMe
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Me
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Scheme 8. Carroll’s Claisen rearrangement 
OH
Xylene, 150 oC
MeO OMe
Me NEt2 Me O
MeO NEt2
O
NEt2
O
NEt2
 
Scheme 9. Eschenmoser’s Claisen rearrangement 
                                                 
13 (a) Carroll, M. F.; J. Chem. Soc. 1940, 704; (b) Carroll, M. F.; J. Chem. Soc. 1940, 1266. (c) Carroll, M. F.; J. Chem. Soc. 1941, 
507. (d) Kimel, W.; Cope, A. C. J. Am. Chem. Soc. 1943, 65, 1992. 
14 (a) Wick, A. E.; Felix, D.; Steen, K.; Eschenmoser, A.; Helv. Chim. Acta. 1964, 47, 2425. (b) Wick, A. E.; Felix, D.; Steen, K.; 
Eschenmoser, A.; Helv. Chim. Acta. 1969, 52, 1030. 
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15 Johnson, W. S.; Werthemann, L.; Bartlett, W. R.; Brocksom, T. J.; Li, T. –T.; Faulkner, D. J.; Petersen, M. R. J. Am. Chem. 
Soc. 1970, 92, 741. 
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Scheme 10. Johnson’s Claisen rearrangement 
The most significant advancement in the field of the activated Claisen rearrangement has 
been reported by Ireland, in which silyl ketene acetals readily rearranged at or below room 
temperature (Scheme 11).16 The silyl ketene acetals are typically generated at low temperatures 
(–78 °C) by enolization of allylic esters with amide bases followed by silyl trapping. A simple 
warming of these intermediates to ambient temperature was often enough to facilitate 
rearrangement. The utility of this protocol lied in the fact that silyl ketene acetal olefin geometry, 
and thus relative product stereochemistry, was dictated by judicious choice of enolization 
conditions. 
O
O
Me
Me
1. LDA
2. TMSCl
O
OTMS
Me
Me
HO
O
Me
Me
syn: anti = 87: 13  
Scheme 11. Ireland’s enolate Claisen rearrangement 
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16 Ireland, R. E.; Mueller, R. H.; Willard, A. K. J. Am Chem. Soc. 1976, 98, 2868. 
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1.2 TRANSITION METAL-CATALYZED ALLYL ETHER ISOMERIZATION 
REACTION  
Although activated Claisen variants are broadly used, they produce carboxylic acids, esters or 
amides. The original Claisen rearrangement affords aldehydes, which have more transformations 
in organic synthesis. But methods for preparing allyl vinyl ethers lack substrate generality or 
operational simplicity. As a result, the discovery of new protocols for making allyl vinyl ethers 
with both substrate generality and operational simplicity is desired.  
Analysed from the structure, the allyl vinyl ether can be derived from the di(allyl) ether 
with a selective olefin isomerization process (Figure 2). Discovery of a useful olefin 
isomerization methodology followed by Claisen rearrangement with substrate generality and 
operational simplicity is a specific aim of my research. In this dissertation, we describe an 
isomerization procedure from allyl ethers to vinyl ethers that enable the Claisen rearrangement 
with substrate generality and operational simplicities. We named the procedure ICR 
(Isomerization Claisen Rearrangement) reaction. For this specific aim, a stereoselective allyl 
ether isomerization reaction was desired.  
OR1 R2
H
R1 R2
O
difficulty prepared
vinyl ether
useful
aldehyde functionalities
O
R1 R2
R3
R3
R3
O
R1 R2
R3
catalyzed isomerization
easily prepared
allyl ether
1) R1-M
2) base or catalyst
X R3
O
H R2
chair-like transition states
[3,3]H
 
Figure 2. Olefin isomerization-Claisen rearrangement (ICR) reactions 
Several kinds of chemical compounds have been reported with ability to isomerize 
olefins. One example is strong bases (e. g. sodium, potassium hydroxide, potassium amide/liquid 
ammonia, sodium methoxide and lithium diethylamide),17 which had been used as catalysts for 
the allyl ether isomerization at high temperatures. The base-induced isomerization afforded 
highly stereoselective cis-propenyl ethers via a five-member ring transition state (95-100 %, 
Figure 3).  
RO
-H+
O
MR
+H+
MeRO
 
Figure 3. Base-catalyzed olefin isomerization reaction 
In the base-promoted ICR reaction, which has been rarely reported,18 the isomerization of 
the 3,3-disubstituted allyl ether is more favorable (Scheme 12). Its chemoselectivity is different 
from that of the transition metal-catalyzed ICR reaction, in which the unsubstituted allyl ether 
                                                 
17  (a) Prosser, T. J.; Price, C. C.; Snyder, W. M. J. Am. Chem. Soc. 1961, 83, 1701-1704. (b) Price, C. C.; Snyder, W. M. J. Am. 
Chem. Soc. 1961, 83, 1773-1774. 
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18  Vyglazov, O. G.; Chuiko, V. A.; Izotova, L. V. Russ. J. Gen. Chem. 2003, 73, 933-939. 
was more favorable for isomerization. These base-promoted ICR reactions are of narrow utility, 
limited by strongly basic conditions, tedious workups and moderate yields. As a result, most 
useful isomerization catalysts are transition metal complexes. 
O Me
Me
Me
KOH, DMSO
120 oC, 4 h
O
H
Me
Me
Me [3,3] O
Me
Me
MeH  
Scheme 12. Strong base-promoted ICR reaction 
The transition metal-catalyzed allyl ether isomerization process involves three steps: 1) 
an oxidative addition (or C-H insertion); 2) an allyl migration and 3) a reductive elimination. The 
overall reaction affordes vinyl ether from an allyl ether. First, the transition metal complex [M] 
coordinates an olefin (5); then the complex [M] insertes into the allyl C-H bond to form a new C-
M-H bond intermediate (6); next, the allyl M-H bond isomerizes to the other allyl position to 
form a vinyl ether (7); finally, the reductive elimination of complex 7 affordes a more stable 
vinyl double bond (8) and startes a new catalytic cycle (Figure 4). 
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Figure 4. Transition metal-catalyzed allyl ether isomerization reactions 
 10
 11
                                                
There is good chemoselectivity for the isomerization of di(allyl) ethers (9, Figure 5). 
Both  kinetic and thermodynamic factors lead to the formation of the least sterically hindered C-
M σ bond intermediate: The intermediate c is more favorable than intermediates a, b and d. The 
kinetic preference is caused by the activation barrier to the σ-complex (6) formation is lower 
for the less sterically hindered C-H bond. So in di(allyl) ether 9, The Ha is more favable to be 
inserted than Hb. The thermodynamic preference is the stronger C-M bond formation, because 
the more substituents (6b) formed the weaker C-M bond.19 As a result, it is difficult to isomerize 
1-substituted allyl ethers (5b, Figure 4) because it is difficult to insert a metal complex into a 
3osp3 C-H bond, especially for those complexes with large cone angle ligands. 20  This 
chemoselectivity ensures that the Claisen rearrangement precursor allyl vinyl ether (10) is 
obtained through only one isomerization process from the monosubstituted di(allyl) ether (9). 
The analysis also suggests that the kineticallyl favorable E-vinyl ether is formed from 
isomerization of the allyl ether. 
 
19 Arndtsen, B. A.; Bergman, R. G.; Mobley, T. A.; Peterson, T. H. Acc. Chem. Res. 1995, 28, 154. 
20 The Complexes with small cone angle can insert the secondary allyl ethers, see: Ohmura, T.; Yamamoto Y.; Miyaura, N. 
Organometallics 1999, 18, 413. 
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Figure 5. Chemoselectivity of isomerizatioon 
The transition metal-catalyzed isomerization of allyl ethers is a convenient and 
straightforward method for preparing enol ethers, which are useful in synthetic transformations. 
In one application, allyl or but-3-en-2-yl moieties were introduced as stable protecting groups for 
carbohydrates. They were easily removed via a transition metal-catalyzed isomerization 
following an acid-promoted hydrolysis (Scheme 13).21  
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21 (a) Boons, G.-J.; Burton, A.; Isles, S. J. Chem. Soc., Chem. Comm. 1996, 141. (b) Corey, E. J.; Suggs, J. W. J. Org. Chem. 
1973, 38, 3224. 
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Scheme 13.  Transition metal-catalyzed deprotection of allyl or but-3-en-2-yl ether 
Recently, many metal complexes have been reported to be effective catalysts for the 
isomerization of allyl ethers. For example, a complex H2Ru(PPh3)4 catalyzed isomerization gave 
an equibrium mixture with the (Z)-enol ether predominating (Z = 55-68%).22  The complex 
NiCl2(dppb)/LiBHEt3 catalyzed isomerization of allyl ethers yielded (Z)-enol ethers under mild 
condition (Z > 95-99%).23 In contrast, various cationic iridium(I) complexes stereospecifically 
produced (E)-enol ethers (E = 88-99%). The iridium(I) complex [Ir(PR3)2Sol2]PF6 prepared in 
situ by treating [Ir(COD)(PMePh2)2]PF6 or [Ir(COD)2]PF6/2PR3 with hydrogen or metal hydrides 
was found to be an excellent catalyst for achieving high yields and high stereoselectivity in the 
isomerization of various allyl ethers under mild conditions (Figure 6).24  
                                                 
22 Suzuki, H.; Koyama, Y.; Moro-oka, Y.; Ikawa, T. Tetrahedron Lett. 1979, 20, 1415. 
23 Wille, A.; Tomm, S.; Frauenrath, H. Synthesis 1998, 305. 
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24(a) Baudry, D.; Ephritikhine, M.; Felkin, H. J. Chem. Soc., Chem. Commun.1978, 694. (b) Ohmura, T.; Yamamoto Y.; Miyaura, 
N. Organometallics 1999, 18, 413. (c) Ohmura, T.; Shirai, Y.; Yamamoto Y.; Miyaura, N. Chem. Commun. 1998, 1337. (d) 
Yamamoto, Y.; Miyairi, T.; Ohmura, T.; Miyaura, N. J. Org. Chem. 1999, 64, 296. (e) Swenton, J. S.; Bradin, D.; Gates, B. D. J. 
Org. Chem. 1991, 56, 6156. Solid-supported catalyst, see: (f) Baxendale, I. R.; Lee, A. –L.; Ley, S. V. J. Chem. Soc., Perkin 
Trans. 1, 2002, 1850. 
OR
NiCl2(dppb), LiBHEt3
Ir(I)+
H2Ru(PPh3)4
Me
OROR
Me
Me
OR
 
Figure 6. Different transition metal-catalyzed isomerization of allyl ethers 
1.3 OLEFIN ISOMERIZATION-CLAISEN REARRANGEMENT  
1.3.1 Precedents of ICR reaction 
The chemoselective isomerization of the di(allyl) ether (9) would afford the allyl vinyl ether 
(10), the precursor of the Claisen rearrangement. Miyaura has reported the iridium complex 11 
(R = PMePh2) as a stereoselective catalyst for a series of isomerizations of di(allyl) ethers 
(Figure 7).25 The order of isomerization reactivity was allyl > methallyl > crotyl > cinnamyl >> 
prenyl > 2-cyclohexenyl, which experimently indicated that the less substituted allyl group had 
more tendency to be isomerized.  
                                                 
25 Yamamoto, Y.; Fujikawa, R.; Miyaura, N. Synth. Comm. 2000, 30, 2383. 
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Figure 7. Relative isomerization rate of different allyl ether 
Some cascade allyl ether isomerization/Claisen rearrangement reaction precedents have 
been reported. Salomon found that 0.1 mol% RuCl2(PPh3)3 catalyzed the rearrangement of 
di(allyl) ethers bearing cycle for a synthesis of  γ,δ -unsaturated aldehydes and ketones at 200 oC 
without solvent in sealed Pyrex tubes in 1-4 h. No diastereoselectivity was reported in this 
reaction (eq 1). 26  It is believed that this high temperature was required for the Claisen 
rearrangement.  
O
O
Me
Me O
H0.1 mol % RuCl2(PPh3)3
200 oC. 71 %
(1)
 
Ishii has reported that a catalyst system containing [Ir(COD)Cl]2, 
tricyclohexanephosphine (PCy3) and cesium carbonate, isomerized an allyl homoallyl ether to 
afford an allyl vinyl ether. The reaction was performed at 100 oC to yield a 1: 1 diastereomeric 
                                                 
26  Salomon, R. G.; Reuter, J. M. J. Org. Chem. 1977, 42, 3360. 
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mixture (eq 2).27 It is suggested that this iridium-catalyzed isomerization reaction is difficult or 
impossible at ambient temperature because the Claisen rearrangement of the allyl vinyl ether 
(12) did not require high temperature. Another factor eroding the reaction was that the 
isomerization of the homoallyl ether was much more difficult than that of the allyl ether. 
O
R
O
R
Me
Me
O
R Me
Me
H1 mol % [Ir(COD)Cl]2,
2 mol % PCy3,
1 mol % Cs2CO3.
Toluene, 100 oC. 81 %
12
(2)
 
Olefin isomerization with ruthenium carbene catalysts in conjunction with RCM 
reactions has been reported by several groups.28 Dixneuf has reported a three component catalyst 
Ru3(CO)12/1,3-bis(2,6-diisopropylphenyl) imidazolinium chloride/Cs2CO3 (molar ratio 1:3:6) 
successively promotes both isomerization from the allyl ether to the vinyl ether and the Claisen 
rearrangement to afford the γ,δ-unsaturated aldehyde.29 Schmidt utilized a combination of the 
first generation Grubbs catalyst and ethyl vinyl ether to perform tandem isomerization-Claisen 
rearrangements (eq 3).30 Better diastereoselective products were obtained as a mixture of 2: 1 
diastereomers. All these reports indicated that the allyl ether isomerization leading to the Claisen 
rearrangement. Unfortunately, very poor diastereoselections were observed in all of these 
precedents, so their applications in organic synthesis were rarely reported.31
                                                 
27 Higashino, T.; Sakaguchi, S.; Ishii, Y. Org. Lett. 2000, 2, 4193-4196. 
28 (a) Arisawa, M.; Terada, Y.; Nakagawa, M.; Nishida, A. Angew. Chem. Int. Ed. 2002, 41, 4732-4734. (b) Hanessian, S.; 
Giroux, S.; Larsson, A. Org. Lett. 2006, 8, 5481-5484. 
29  (a) Notre, J. L.; Brissieux, L.; Semeril, D.; Bruneau, C.; Dixneuf, P. H. Chem. Chemmun. 2002, 1772-1773. (b) Ammar, H. B.; 
Le Notre, J.; Salem, M.; Kaddachi, M. T.; Dixneuf, P. H. J. Organomet. Chem. 2002, 662, 63-69. 
30  (a) Schmidt, B. Synlett 2004, 1541-1544. The second generation Grubbs catalyst was used in Nelson group for isomerization 
of allyl amines, see: (b) Nihar, S.; Nelson, S. G. unpublished result.  
31 One application is a synthesis of pyrrole derives, see: Iyer, R. S.; Kobierski, M. E.; Salomon, R. G. J. Org. Chem. 1994, 59, 
6038. 
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1.3.2 Requirements for good ICR reaction 
Some factors are beliVed to cause poor chemoselectivity. First, the E/Z ratio of the vinyl ether 
perhaps is poor. As noted earlier, the Claisen rearrangements proceed via a highly ordered six-
member chair like transition state to produce two stereocenters, often with high lVels of 
stereoselectivity. The E isomer afforded the 2,3-syn adduct and the Z isomer afforded the 2,3-
anti adduct after [3,3] sigmatropic rearrangement. So the poor E/Z ratio causes poor 
diastereoselectivity (Figure 8).  
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R1 R2
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R2
Me
2,3-syn
2,3-anti  
Figure 8. Stereochemical consequence of ICR reaction 
Second, the epimerization of the formed aldehydes (13, except an α-quaternary aldehyde) 
sometimes is the most essential reason for the poor diastereoselectivity. The aldehyde generated 
from the ICR process contains an α-chiral center, which is easily epimerized under basic or 
Lewis acidic conditions via enol or enolate intermediates (Figure 9). As a result, bases, acids or 
Lewis acids should be avoided in good ICR reaction. 
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Figure 9. Epimerization of α-chiral aldehyde under base or Lewis acid 
Finally, high reaction temperatures erode stereoselectivity. The [3,3] sigmatropic 
rearrangement of the good stereodefined allyl vinyl ether via different transition states affords 
different enantiomers, diastereomers and E/Z isomers. The (E,E)-allyl vinyl ether affords the 2,3-
syn-4-E Claisen adduct via the chair transition state with the  R1 in a pseudo equatorial position, 
which is the most favorable transition state with the lowest energy. Three other isomers, 2,3-syn-
4-Z, 2,3-anti-4-E and 2,3-anti-4-Z are afforded as minor products in other transition states, in 
which boat transition state and/or R1 in a pseudo axial position are taken (Figure 10). The lower 
temperature favors the better stereoselectivity according to the Bolzman rule. So the higher 
temperature will afford poorer chemoselectivity in the Claisen rearrangement. Moreover, the 
high temperature promotes many side reactions. For example, the epimerization is accelerated 
significantly in high temperatures. 
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Figure 10. Stereochemical consequence for different transition states 
Based on the above discussion, our research focused on the discovery of a convenient and 
highly stereoselective process concerning the cascade olefin isomerization/Claisen 
rearrangement (ICR reactions, Figure 11). Our requirements for a good ICR reaction were good 
isomerization regio- and stereoselectivities, neutral reaction conditions, relatively low reaction 
temperatures, substrate generality and operational simplicity. This transformation from simple 
starting materials to complex, important functionality is a main goal of synthetic chemistry. 
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Figure 11. Requirements for good ICR protocol 
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2.0  IRIDIUM-CATALYZED OLEFIN ISOMERIZATION LEADING TO HIGHLY 
STEREOSELECTIVE CLAISEN REARRANGEMENTS OF ALIPHATIC ALLYL 
VINYL ETHERS 
2.1 REACTION DEVELOPMENT 
One major focus in developing successful ICR reactions is an olefin isomerization catalyst that 
would render di(allyl) ethers (9) effective precursors to highly stereoselective Claisen 
rearrangement. The catalyst would necessarily achieve both chemo- and stereoselective 
isomerization of one of the allyl residues and would not interfere with the ensuing thermal 
Claisen rearrangement nor accelerate epimerization of the aldehyde (13) product. Successfully 
developing catalysts satisfying these criteria would allow thermolysis of allyl vinyl ethers (10) in 
the presence of the catalyst complex to afford direct access to diastereomerically enriched 2,3-
dialkyl-4-pentenal derivatives (13) (Figure 12). 
O
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R1 catalyzedisomerization. O
Req R2
R1
Claisen
 Rearrangement
OHC
Req R2
R1
O
R2
R1
Reqvia
good regioselectivity no epimerization
9 10 13
 
Figure 12. Olefin isomerization-Claisen rearrangement (ICR) reaction 
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2.1.1 Selection of precatalyst 
Many cationic iridium(I) complexes used as isomerization catalysts are prepared from one 
equivalent of commercially available precatalyst [Ir(COD)Cl]2 (COD: 1,5-cyclooctadiene), four 
equivalents of phosphine ligand and two equivalents of halide abstractor. These catalysts are 
activated via hydrogenation or hydrometalation by molecular hydrogen or metallic (aluminum or 
boron) hydride to remove the COD ligand before they become catalytically active (Figure 13). 
These aluminum or boron residues generated from metallic hydrides are strong Lewis acids, 
which were harmful for the ICR. 
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Sol
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Cl
Cl
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4 PR3
2 AgPF6
H2
or metallic (aluminum or 
boron) hydride
Leave Lewis Acid Residue
catalystprecatalyst
+ AgCl  
Figure 13. Activation of precatalyst [Ir(COD)Cl]2
Based on the above discussion, a novel iridium-based olefin isomerization catalyst 
without metallic hydride activation should be discovered. The desired catalyst should not 
produce Lewis acid. Complexes of Ir(I) with cycloctene (COE) instead of COD are potential 
good precatalysts in the olefin isomerizaion. The cycloctene is easily displaced by phosphine 
ligand or solvent. This advantage makes the easily prepared dimer [Ir(COE)2Cl]2 (14) a useful 
potential olefin isomerization precatalyst. 32  Treatment of the iridium dimer complex 14 with 4, 
6 or 8 equivalents of phosphine ligand and 2 equivalents of halide abstractor afforded di-, tri- or 
                                                 
32 Onderdelinden, A. L.; Ent der Ent A. Inorg. Chim. Acta.1972, 6, 420. 
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tetra- coordination iridium complexes (Figure 14). 33 These complexes were investigated for the 
ICR reaction of di(allyl) ether. 
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Figure 14. Isomerization catalyst based on iridium complex with COE ligand 
2.1.2 Results and discussions 
Choosing a suitable ligand is very important for reactivity. The isomerization of di(allyl) ether 9a 
was investigated to screen the reactivity of different iridium complexes. Treated the 9a to the 10 
mol% complexes Ir(Ligand)2SbF6 (15a-c), which were prepared from 1 equivalent of 
[Ir(COE)2Cl]2 (14), 4 equivalents of phosphine ligands (Ligand = PCy3, PPh3 and PPh2Me) and 2 
equivalents of halide abstractor AgSbF6, at ambient temperature for 12 h. The result indicated 
that the reaction with ligand PCy3 (5a) gave the superior result: a mixture of aldehydes (13a and 
13a′. Both of them had poor diastereoselectivity) was obtained. The other two complexes (15b,c) 
afforded poorer yields of the isomerization-Claisen rearrangement products (Scheme 14). The 
ligand PCy3 is a σ-basic phosphorus ligand that accelerates oxidative addition by stabilizing the 
iridium complex. Conversely, because the larger complex has more tendencies to shift from 2o 
                                                 
33 These complexes are formulated on the basis of reaction stoichiometry and are not necessarily intended to present the reactive 
catalyst complex that may be accessed by revrsible phosphine dissociation. 
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sp3 C-Ir bond to 1o sp3 C-Ir bond to avoid steric bulk, the steric bulk of PCy3 accelerates the 
isomerization and the reductive elimination. In conclusion, the PCy3 is the superior ligand for 
olefin isomerization. 
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PR3: PCy3 (Ir complex 15a) 50: 50 (both dr = 50: 50)
PPh3 and PPh2Me (Ir complex 15b,c) starting material and by products
H H
9a 13a 13a'
 
Scheme 14. Ligands of olefin isomerization catalyst 
The isomerization of 9a afforded a mixture of allyl vinyl ethers (10a and 10a′) in 1 h in 
the presence of  10 mol% Ir(PCy3)2SbF6 (15a) catalyst at 0 oC (Scheme 15). The result indicated 
that the reaction afforded allyl vinyl ethers first, which subsequently rearranged to the Claisen 
adducts at relative higher temperature. The poor diastereo- and regioslectivity suggested the 
complex 15a was not suitable for ICR.  
10a
10a'
O
MePh
9a
5 mol % [Ir(COE)2Cl]2
20 mol % PCy3
10 mol % AgSbF6
0 oC, 1 h
O
Me
Me
Ph
O
Ph
Me
Me
allyl migration
O
PhMe
allyl migration
isomerization
 
Scheme 15. Isomerization at relative lower temperature 
Based on the above investigation, the ligand PCy3 was chosen as the superior ligand. But 
the 10 mol% expensive catalyst loading is too much for a synthetic reaction. Another experiment 
indicated that 1 mol% catalyst 15a loading afforded a mixture of 13a and 13a′ (50: 50. Both of 
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them have poor diastereoselectivity. syn: anti = 50: 50). Next, we examined the effect of the 
different coordination number of the ligands PCy3. A triphosphine complex Ir(PCy3)3SbF6 (16) 
and a tetraphosphine complex Ir(PCy3)4SbF6(17) are prepared in situ for mediating ICR reaction. 
The result indicated that the 1 mol% triphosphine complex 16 is a better catalyst than the 
diphosphine complex 15a to afford a mixture of aldehydes nearly 100 % conversion. The 
tetraphosphine complex 17 gave no isomerization products or aldehydes. Monitored by TLC and 
GC-MS trace, the isomerization of di(allyl) ether 9a with 1 mol% diphosphine complex (15a) 
required 1-2 h, but required only 5-10 min with the triphosphine complex 16 (eq 4). As a result, 
the tris(phosphine) complex 16 was preferred for the ICR reaction. 
O
Ph Me
Me O
Me Ph
Me
+
O
MePh
0.5 mol %  [Ir(COE)2Cl]2
13a, 50 %, 
syn:anti = 1:1
13aa, 50 %
syn:anti = 1:1
3 mol % PCy3
1 mol % AgSbF6
23 oC, 5-10 min for 
isomerization
9a
H H
(4)
 
2.1.3 Halide abstractor 
The iridium complex (16)-catalyzed ICR reaction generated a mixture of aldehydes. Besides the 
desired [3,3] sigmatropic rearrangement product 13a, a [1,3] sigmatropic rearrangement product 
13a' was generated from Lewis acid-catalyzed allyl ether migration, followed by [3,3] 
sigmatropic rearrangement (Figure 15). Considering that the conjugated di(allyl) ether 9a' was 
more stable than the unconjugated di(allyl) ether 9a; and the allyl ether migration was easily 
mediated by Lewis acid. We concluded that there is some Lewis acidic character in the iridium(I) 
catalyst 16. 
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Figure 15. Lewis acid-catalyzed allyl ether migration followed by ICR reaction 
 A halide abstractor in the preparation of the cationic Ir(I) catalyst was critical in defining 
the efficiency of the reaction.34 The complex 16 catalyzed allyl ether isomerization. However, 
the reaction generated poor regio- and stereoselectivity products. In general, Lewis acidic 
contaminants presented during the thermal Claisen rearrangements, whether they were derived 
from Lewis acidic Ir(I)-phosphine sepecies or Ag(I) salt by-products, led to poor 
diastereoselection in the putative Claisen adducts. The catalyst preparation employing AgSbF6 is 
harmful for the ICR reaction because Ag+ contaminants mediated side reactions. For example, 
the competing allyl ether migration and the epimerization of the Claisen adduct. Upon treatment 
of di(allyl) ether 9a with 1 mol% AgSbF6 in CH2Cl2 at ambient temperature overnight, a very 
complex mixture was observed. Among non-silver halide abstractors, both NaSbF6 and NaBPh4 
afforded Claisen adduct with good diastereoselection (93 : 7 and 95 : 5 respective, Table 1) and 
high conversion when 1 mol% catalyst was used in 50/1 CH2Cl2/acetone, where acetone was 
used for increasing solubility of the sodium salt and stabilizing the Ir(I) catalyst by coordination. 
                                                 
34  Lightfoot, A.; Schnider, P.; Pfaltz, A. Angew. Chem. Int. Ed. 1998, 37, 2897. 
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These results indicated that the complex [Ir(PCy3)3]BPh4 (18) was the optimized catalyst for the 
ICR reaction. 
Table 1. Effect of different halide abstractor and solvent 
O
Ph Me
Me
O
MePh
0.5 mol %  [Ir(COE)2Cl]2
13a
3 mol % PCy3
1 mol % X
23 oC,24 h
9a
H
 
entry halide abstractor (X) solvent syn: anti 
a AgSbF6 CH2Cl2 50:50 
b NaSbF6 CH2Cl2 no reaction 
c NaSbF6 CH2Cl2/acetone = 50/1 93:7 
d NaBPh4 CH2Cl2/acetone = 50/1 95:5 
2.1.4 Optimization of ICR reaction 
The [3,3] sigmatropic rearrangement of allyl vinyl ether 10a was slow at ambient temperature, so 
high reaction temperatures were required for most thermal Claisen rearrangements. In the ICR of 
9a, the isomerization step was completed in 30 min with 1 mol% Ir(PCy3)3BPh4 (18) from GC-
MS trace and TLC, but the Claisen rearrangement required 24 h or longer at ambient 
temperature. Refluxing the crude isomerization reaction mixture in CH2Cl2 accelerated the rate; 
but the diastereoselection was eroded to syn : anti = 85 : 15. Refluxing the purified allyl vinyl 
ether (E)-10a in CH2Cl2 (The allyl vinyl ether was purified with short silica gel column 
chromatography using pentane as an eluent. The yield is 78 %) afforded 95: 5 diastereoselection. 
The result indicated that the iridium’s Lewis acidic character eroded the diastereoselection. 
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Considering that the tetraphosphine complex [Ir(PCy)4]SbF6 (17) had no isomerization 
reactivity, so additional phosphine ligand would saturate the metal’s coordination sphere prior to 
thermolysis. The inactivated complex 18 will passivate any residual Lewis acidic character in the 
Ir catalyst (Figure 16). For realizing this idea, more 3 mol% PPh3 or PCy3 were added into the 
reaction after the isomerization. After refluxing 12 h in dichloromethane, the reaction affored 
product with good diastereoselection (syn : anti = 94 : 6) for both additives. Including these two 
choices, PPh3 is more convenient than PCy3 (Table 2).  
Table 2. Conditions for ICR optimization 
Me
O
Ph
O
Ph
Me
Me
H
O
Ph Me
Me1 mol % Ir(PCy3)BPh4
9a 10a        13a
23 oC, 30 min
conditions
 
entry conditions temperature (oC) additive time (h) syn: anti 
a crude 10a 23 no 24 95:5 
b crude 10a 39 no 4 85:15 
c purified 10a 39 no 4 95:5 
d crude 10a 23 3 mol% PPh3 4 94:6 
e crude 10a 23 3 mol% PCy3 4 94:6 
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Figure 16. Additional ligands inactive the catalyst 
In conclusion, an optimized ICR procedure was discovered. A series of Ir(I) complexes 
and conditions were investigated and found complex Ir(PCy3)3BPh4 was the superior one. 
Additional 3 mol% PPh3 after isomerization was necessary for obtaining product with good 
diastereoselectivity. 
2.2 ICR REACTIONS OF SUBSTITUTED DI(ALLYL) ETHERS 
2.2.1 Preparation of substrates and the summary of ICR result 
Based on the good ICR result of the model di(allyl) ether, more di(allyl) ether substrates with 
general structures (9) were examined in order to determine the scope and efficiency of this novel 
ICR reaction. Generally, the substrates 9 were easily prepared by RM-enal 1,2-addition (M = Mg 
or Li), followed by O-allylation (Figure 17). 
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OH R2
1. ReqLi or ReqMgBr
2. O-allylation.
O
Req R2
R1
R1 = H, Me, Cy, CH2CH2Ph, CH2CH2OBn...;
R2 = Me, nPr, iPr, Ph, TMS, OCH2Bn...;
Req = Et, Ph, tBu, nBu, TMSCH2....
9  
Figure 17. Preparation of di(allyl) ether substrates 
Three major O-allylation reactions were used in this dissertation. First, a base 
deprontonation of the allyl alcohol followed by a SN2 reaction with an allyl or substituted allyl 
bromide afforded di(allyl) ether (9a) (eq 5). Second, an acid-catalyzed allylation was more 
convenient for (E)-1,3-diphenylprop-2-en-1-ol (entry e), (E)-2-methyl-1,3-diphenylprop-2-en-1-
ol (entry f) or similar structures coupling with allyl alcohols (eq 6).35 This reaction was also 
useful for etherification of lots of alcohols with 1,3-diphenyl alcohols. Third, a palladium(0)-
catalyzed allylic etherification of the bis(alkoxy)zinc with allyl acetate was used for alcohols 
containing functionalities that were not tolerated strong basic conditions, such as, (E)-4-phenyl-
1-(trimethylsilyl)but-3-en-2-ol (eq 7).36   
Ph
OH
Me Ph
O
Me
1. NaH, THF, reflux, 30 min;
2. Allyl bromide, THF, reflux,
    5 h.
9a91 %
(5)
 
Ph
OH
Ph Ph
O
Ph
cat. H2SO4, allyl alcohol,
THF, 23 oC.
9e84 %
(6)
 
OH
Ph
O
Ph
1. 0.5 eq. Et2Zn, THF, 23 oC;
2. 5 mol % Pd(PPh3)4
allyl acetate,THF, 23 oC.
TMS TMS (7)
 
                                                 
35 Doering, W. von E.; Birladeanu, L.; Sarma, K.; Blaschke, G.; Scheidemantel, U.; Boese, R.; Benet-Bucholz, J.; Klarner, F. -G.; 
Gehrke, J. –S.; Zimny, B. U.; Sustmann, R.; Korth, H. –G. J. Am. Chem. Soc. 2000, 122, 193. 
36 Kim, H.; Lee, C. Org. Lett. 2002, 4, 4369-4372. In this paper, Pd(PPh3)4 was used,  but Pd(OAc)2 and 5 eq PPh3 obtain same 
result. 
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The summary of ICR results of di(allyl) ethers 9 is listed in Table 3. The di(allyl) ethers 9 
were subjected to 1-2 mol% catalyst Ir(PCy3)3BPh4 (18) in a solvent mixture (CH2Cl2 or 1,2-
dichloroethane (DCE)/acetone = 50:1) at ambient temperature to afford the allyl vinyl ethers 10. 
After isomerization (10-150 min), the Ir catalyst was deactivatd with 3-6 mol% PPh3 following 
thermolysis at different conditions afforded the syn-2,3-disubstituted γ,δ-unsaturated pentenals 
13 with good yield and diastereoselectivity. 
Table 3. ICR reactions of substituted di(allyl) ethers (9) 
O
Req R2
R1 O
Req R2
R1
O
Req R2
R1
H
HO
Req R2
R1
1-2 mol % 18,10-150 min,
CH2Cl2 or DCE/acetone 50/1, 
then PPh3, 23 oC,9
10
23-80 oC.
13
DIBAL-H,
CH2Cl2, -78 oC.
13'
HO
R2
R1
Req
13'-(Z)-isomers
Ir(PCy3)3BPh4
       18
OReq
R2
R1
 
entry R1 R2 Req temp 
(o C) 
syn: anti 
(13) 
% yield 
(13′) 
13′-(Z)-
isomer (%) 
a H Me Ph 39 94: 6 80 0 
b H nPr Ph 39 97: 3 70 0 
c H iPr Ph 39 95: 5 93 0 
d H TMS Ph 39 97: 3 87 0 
e H Ph Ph 23 98: 2 92 0 
fa H Ph Ph 60 94: 6 92 7 
g H iPr nBu 80 94: 6 76 12 
h Me Me nBu 80 92: 8 85 12 
i H Ph nBu 80 96: 4 62 0 
j Me Me tBu 80 93: 7 62 0 
k Cy Ph Et 80 95: 5 61 0 
l CH2CH2Ph Ph Et 80 96: 4 77 0 
m CH2CH2OBn Ph Et 80 96: 4 74 0 
n CH2CH2OBn Ph Ph 23 97: 3 71 0 
The substrate is (E)-3-(allyloxy)-2-methyl-1,3-diphenylprop-1-ene (9f, eq 8) .  
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Ph
Me
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Ph Ph
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13f'
Me
ICR O
Ph Ph
Me
13f
Me
H
reduction (8)
 
2.2.2 Isomerization reaction 
In Table 3, substrates (9) were subjected to 1-2 mol% Ir(PCy3)3BPh4 (18) in CH2Cl2 or 1,2-
DCE /acetone 50/1 at 23 oC for 5 min to 2.5 h to afford the high yield of corresponding (E)-
propenyl ethers (10). In all these entries, the isomerization of unsubstituted allyl ethers (R1 = 
H, entry a-g, i) required 1 mol% Ir(PCy3)3BPh4 to afford 100 % the (E)-propenyl ethers in 10 
min at ambient temperature (eq 9). A longer reaction time afforded a mixture of (E)- and (Z)- 
isomers.  
O
Req R2
O
Req R2
Me
1 mol % 18,10 min,
CH2Cl2 or DCE/acetone 50/1, 
then PPh3, 23 oC,9 10
(9)
 
But the isomerization of the 3-substituted allyl ethers (R1 = alkyl group, entry h, j-n) was 
more difficult than that of unsubstituted allyl ethers (R1 = H). According the GC-MS data, the 
conversion of the 1 mol% Ir(PCy3)3BPh4 catalyzed isomerization of the crotyl ether (entry h) 
was 41 % in 30 min and 59 % in 1 h. This result indicated that the isomerization of the crotyl 
ether was much slower than that of the allyl ether. Because methyl is a larger group than a proton 
to hinder the coordination of iridium complex with olefin, the isomerization was slower in the 
substituted allyl ether case. The slower isomerization also could be an electronic effect, the more 
substituted allyl metallics are less stable. Futhermore, the ratio of (E) : (Z)-vinyl ether (10h) is 
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different with time. According the data from crude proton NMR spectra, the E : Z ratio was 88 : 
12 in 2 h, 81 : 19 in 6 h and 74 : 26 in 12 h (eq 10).  
nBu
O Me
Me nBu
O
Et
Me
 1 mol % Ir(PPh3)3,
12 h, 23 oC, 
100 % conv.
9h 10h
nBu
O
Me
Et
74 26
:
+ (10)
 
The decreased (E) : (Z) ratio of vinyl ether with time suggested that there is a 
transformation from the (E)-vinyl ether to the (Z)-vinyl ether. This transformation is a slower 
process than the isomerization of the crotyl ether. So at the first step, the isomerization of the 
crotyl ether produced the kinetically favorable (E)-isomer. The iridium complex coordinates the 
olefin from the back side of the RO group to avoid the non-bonding interaction to afford the E-
vinyl ether (Figure 18).  
L2Ir
H
OR1
H OR1
L2Ir H
Et
OR1
L2Ir
H
H
R1O
L2Ir
Et
H
OR1 OR1
(E)-vinyl ether
(Z)-vinyl ether
Me
Me
Me
Me
 
Figure 18. Formation of kinetic E vinyl ether 
Next, the transformation from the (E)-isomer to the (Z)-isomer via π-allyliridium 
intermediate gave the (Z)-isomer as the thermodynamically favorable product, which perhaps 
had lower energy because of O-Ir coordination (Figure 19).  
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Figure 19. Transformation from (Z)- to (E)-vinyl ethers 
For optimizing the isomerization of substituted allyl ether (entry h), more catalyst loading 
was used to make the isomerization time shorter to avoid this E-Z transformation. When 2 mol% 
catalyst Ir(PCy3)3BPh4 was used, the conversion to the allyl vinyl ether is 62 % in 30 min, 75 % 
in 1 h. After catalyst quenching in 1.5 h, the by-product (Z)-10h was not observed from the crude 
proton NMR. The desired product (E)-10h was obtained with 90 % yield after flash 
chromatography or was used for Claisen rearrangement directly without further purification (eq 
11). When the R1 group was larger, the isomerization reaction was more difficult and the 
conversion was poorer at the same reaction condition. With 2 mol% catalyst at ambient 
temperature followed by quenching in 150 min, the conversion for different substrates were: R1 
cyclohexyl (entry k, 78% conversion from crude proton NMR spectra), CH2CH2Ph (entry l, 85% 
conversion) and CH2CH2OBn (entry m, n, 85% conversion). These isomerization products were 
fine for the Claisen rearrangement without further purification. 
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nBu
O Me
Me nBu
O
Et
Me
 2 mol % Ir(PPh3)3,
90 min, 23 oC, 
90 %9h 10h
(11)
 
In addition to the isomerization from allyl ethers to vinyl ethers, the iridium complex 
Ir(PCy3)3BPh4 (18) also coordinated other olefins and mediated their allyl isomerization.37 For 
example, some by-products were detected from the isomerization of substrate 9b (R2 = nPr). 
When substrate 9b was treated with 1 mol% catalyst Ir(PCy3)3BPh4 followed by quenching in 1 
h, the crude NMR spectra indicated a mixture of products in the reaction. After thermolysis, 40 
% yield of the Claisen adduct (13b) and 38 % yield of by-products as a mixture of 1-((3E)-1-
((E)-prop-1-enyloxy)hex-3-enyl)benzene (10ba) and 1-((4E)-1-((E)-prop-1-enyloxy) hex-4-
enyl)benzene (10bb) were afforded (Scheme 16). This result indicated a side reaction, in which 
the catalyst Ir(PCy3)3BPh4 isomerized the double bond in nonbranched alkyl group. Because the 
desired isomerization reaction was faster than the side isomerization reaction, the shorter 
isomerization time would cut the by-products down. However, very short time (5 min) would 
erode the conversion of the desired product. Therefore, after screening different conditions, the 
optimized result indicated that the reaction with 2 mol% catalyst and quenched in 10 min 
afforded the best result, only trace of by-products 10ba, 10bb and starting material 9b were 
afforded.  
                                                 
37  Shen, X. in Nelson group used the catalyst 18 to transform the terminal olefin to internal olefin in the total synthesis of (-)-
Pironetin. See: Shen, X.; Wasmuth, A. S.; Zhao, J.; Zhu, C.; Nelson, S. G. J. Am. Chem. Soc. 2006, 128, 7438-7439.
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1 mol % 18
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CH2Cl2, 23 oC
+
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10bb
13b, 40 %
Optimized condition: 2 mol % 18
10 min, then 6 mol % PPh3
obtain trace 10bb and 10ba and 
starting material. total 38 %
no reaction  
Scheme 16. ICR of di(allyl) ether 9b 
2.2.3 Thermal Claisen rearrangement of different substrates 
With a good isomerization procedure established to (E)-allyl vinyl ethers 10a-n, we investigated 
the thermal Claisen rearrangement of substrates listed in Table 1 and found that the structure 
impacted the Claisen rearrangement rate. When Req group is ethyl, n-butyl or tert-butyl, reflux of 
the crude allyl vinyl ethers (entry g-j, k-m) in 1,2-DCE (83 oC) was recommended; when Req 
group is phenyl or TMSCH2 and R2 group is methyl, n-propyl, iso-propyl or TMS, reflux of the 
crude allyl vinyl ethers (entry a-d) in CH2Cl2 (39 oC) was good; when Req is phenyl or TMSCH2 
and R2 is phenyl (entry e,n), stirring the allyl vinyl ethers 6e, n at ambient temperature was 
sufficient. Because the phenyl and TMSCH2 group stabilized the forming positive charge with 
conjugation or hyperconjugation, the adjacent C-O σ-bond was cleavge easily to favor the 
Claisen rearrangement under mild conditions (Figure 20).38  
                                                 
38 Wilson S. R.; Price, M. F. J. Am. Chem. Soc, 1982, 104, 1124. 
 35 
O
Me
R
O
Me
R
Me3Si
conjugation hyperconjugation  
Figure 20. The Ph and TMSCH2 activate the Claisen rearrangement 
Claisen product α-chiral aldehyde (13a-n) was subjected to a significant epimerization of 
the α-stereocenter during the attempted general silica gel chromatographic purification because 
of the weak acidity of silica gel. Diastereomer ratios were determined for the crude aldehyde by 
intergrating the aldehyde CHO resonances in the 1H NMR spectra. Then the aldehyde was 
directly reduced by DIBAL-H at -78 oC in CH2Cl2 to afford corresponding alcohol (13a-n′), the 
yields of ICR reactions were based on alcohol 13a-n′. All these reactions exhibited high 
diastereoselection (syn : anti = 91 : 9 to 98 : 2) and moderate to high yields in three steps (Table 
1). A neutral silica gel, Introbeads (pH = 7.0), was good enough to purify α-chiral aldehyde with 
little epimerization.  
If the Req lies in the pseudoequatorial position in the chair-like transition state, only the (E)-
isomer of the Claisen adduct forms. But some (Z)-isomers were observed in the ICR reaction of 
substrates 9g, h, (Table 1) which had small alkyl Req and R2 groups. These (Z)-isomers were 
formed via higher energy chair transition state with pesudoaxial Req group (Figure 21). 39   
                                                 
39 Nonoshita, K.; Maruoka, K.; Yamamoto, H. Bull. Chem. Soc. Jpn. 1992, 65, 541. 
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Figure 21. Formation of (Z)- and (E)-isomer of aldehydes 
2.2.4 ICR of other di(allyl) ethers 
Besides the good ICR result of substatres 9a-n, some di(allyl) ethers with different structures 
were prepared for observing the ICR reactivity. The ICR of di(allyl) ether 9o, which has two 
isomerization positions and the bulky TBDPS group as protection group of the hydroxyl, 
afforded no regioselective isomerization: the desired allyl vinyl ether 10o and by-product 10o′ 
were observed as a 1:1 mixture from crude proton NMR spectra. After thermolysis and DIBAL-
H reduction, 37 % yield of an alcohol 13o′ and 31 % by-product vinyl ether 10o′ were obtained 
(Scheme 17).  
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Scheme 17. Competing isomerization pathways of di(allyl) ether 9o 
Treatment of a 3,3-disubstituted allyl ether (9p) under same conditions afforded no 
isomerization, even in microwave oven at 120 oC (eq 12). As a result, it is difficult to prepare 
Claisen adducts bearing α-iPr or other branched alkyl groups with this simple ICR strategy. 
 
O
Ph Ph
Me
Me
9p
O
Ph Ph
Me
Me
[3,3] O
Ph
Me
MeH
Phheating
10p
no isomerization
13p
(12)Ir(PCy3)3
 
The more electron-donor alkyl substituents adjacent to the oxygen atom in the di(allyl) 
ethers stable the positive charge developed during the Claisen. As a result, the ICR reaction of 
the di(allyl) ether with quaternary carbinol center (9q/r) afforded trisubstituted enals (13q/r) 
with good diastereoselectivity and yields at relatively low temperatures (Scheme 18).  
O
Me
Me
R
1) 1 mol % 18, 10 min
2) PPh3, heating
Me
Me R
Me
O
H
R                 Product  Temp (oC)  yield, syn: anti
Ph (9q)       13q           60               92      95: 5
Me (9r)       13r            83                81      91: 9
9 13
 
Scheme 18. ICR of  di(allyl) ether with quaternary carbinol center 
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The ICR reaction of di(allyl) ethers (19) with conjugated dienes was interesting because 
it affords non-conjugated dienals. Substrates (19a-d) were treated under ICR conditions to afford 
Claisen products with good yields and diastereoselectivities (20a-d, Table 4). Diene groups 
activated the Claisen rearrangement at relatively low temperature. It is worthy of note that 
changing R and Req each other afforded a pair of diastereomers, such as, aldehydes 20a and 20b. 
 
Table 4. ICR reactions of di(allyl) ethers with conjugated diene 
O
Req
O
Req
Me
H1.1 mol % 18, 30 min,
then PPh3, 23 oC,
2. heat
19 20
R R
 
entry R Req T (o C) syn: anti % yield(alcohol) 
a H Ph 23 97: 3 80 
b Ph H 39 95: 5 70 
c H Me, Me 39 95: 5 93 
d Ph Et 39 95: 5 87 
 
In conclusion, the ICR reaction of di(allyl) ethers (9a-q and 19a-d) are described in this 
section, along with details for preparation of these substrates. The isomerization followed by the 
Claisen rearrangement of di(allyl) ethers affords Claisen adducts with high diastereoselection 
and moderate to high yields. 
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2.3 ICR REACTION OF ALLYL HOMOALLYL ETHERS  
2.3.1 ICR reactions of allyl homoallyl ethers 
Allyl-homoallyl ethers, which are easily prepared from an allyl metal (Sn, Mg, Zn) or non-metal 
(B, Si) reagent-aldehyde addition followed by O-allylation, are progenitors of allyl vinyl ethers 
after two isomerizations (Figure 22). The allyl-homoallyl ether 1-allyl-1-(allyloxy)cyclohexane 
(21a) was subjected to 2 mol% catalyst at ambient temperature and stirred overnight to afford 77 
% of allyl vinyl ether (22a) and 23 % of by-product homoallyl vinyl ether (22a′). The result 
indicated that the isomerization of terminal homoallyl ether is slower than that of allyl ether. 
Then the thermolysis of this mixture afforded Claisen adduct (23a) in 64 % yield (Scheme 19).  
O
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R Me
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Figure 22. ICR of allyl homoallyl ether 
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+
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Scheme 19. ICR of quaternary allyl homoallyl ether 
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The ICR reaction of allyl homoallyl ethers (21b/c) afforded Claisen adducts (23b/c) with  
modest to good yields and good diastereoselectivity (Scheme 20). In these two reactions, no 
homoallyl vinyl ethers (22b/c′) were observed. The result indicated that the quaternary carbinol 
center in 21a hindered the isomerization of the homoallyl ether. However, the ICR reaction of 
allyl homoallyl ethers afforded syn-2,3-dimethyl enals with convenience.  
O
CHO
Me
1). 2 mol % 18,12 h, then PPh3
2). DCE, reflux, 12 h
21 23
yield, diastereomers
70%, syn : anti : Z = 88 : 5: 7
48%, syn : anti : Z = 92 : 4: 4
R
entry
b
c
R
PhCH2CH2
TBDPSOCH2
R
Me
 
Scheme 20. ICR of allyl homoallyl ether 21b/c 
2.3.2 Preparation of dienals with ICR protocol 
The preparation of the 2,3-syn-disubstituted-4-enal with the ICR protocol from di(allyl) ether or 
allyl homoallyl ether was discussed in previous sections. Here we described a ICR methodology 
for preparing aldehydes containing a conjugated diene; then dieneophiles would be introduced 
into these dienals for a type I intramolecular Diels-Alder reaction (IMDA, Figure 23) to afford 
bicycle products.  
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Figure 23. Design of conjugated diene from ICR following IMDA reaction 
Based on the discussion in previous sections, the isomerization of terminal homoallyl 
ethers produces E-allyl ethers. So the easily prepared triene ether (E)-4-(allyloxy)hepta-1,5-diene 
(25a) was treated with 2 mol% catalyst 18 at ambient temperature to afford vinyl ether 26a,  
which subsequently rearranged quickly to dienal 27a with good yield and diastereoselectivity 
(syn: anti = 94: 6, Scheme 21) at ambient temperature. 
O
Me
O
MeMe
Me
O
MeMe
Me
H
2 mol % 18
 12 h, 23 oC
25a 26a 27a, syn: anti =94: 6
68 % ( based on alcohol)  
Scheme 21. ICR reaction  of triene ether 25a 
However, poor chemoselectivities were obtained in the ICR of similar substrates 25b 
(Scheme 22) and 25c (Scheme 23). In these two reactions, two sides in triene ethers 26b/c are 
different. In Scheme 22, the phenyl side is more favorable for rearrangement (to afford dienal 
27ba) than the methyl side (to afford dienal 27bb); but in Scheme 23, due to the methyl 
substitution hindering the Claisen rearrangement, the phenyl side is less favorable (to afford 
dienal 27ca) than the methyl side (to afford dienal 27cb) for the Claisen rearrangement.  
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Scheme 22. ICR reaction  of triene ether 25b 
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Scheme 23. ICR reaction  of triene ether 25c 
This double isomerization-Claisen rearrangement procedure caused some problems, such 
as the poor chemoselectivity in Scheme 22 and Scheme 23. For overcoming theses challenges, a 
new strategy, which was based on the fact that the isomerization of the homoallyl ether was 
much slower than that of the allyl ether, was designed. When the substrate 25b was subjected to  
2 mol% catalyst followed by quenching in 15 min, the stable allyl vinyl ether (28b) was 
obtained. After thermolysis, the Claisen adduct (29b) with a non-conjugated diene was obtained, 
which was subsequently isomerized to the conjugated dienal (27ba) with good 
diastereoselectivity after the second Ir(I)-catalyzed isomerization (Scheme 24).  
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Scheme 24. Alternative route for preparing dienal 
 
In this chapter, the iridium(I)-catalyzed olefin isomerization of di(allyl) ethers is 
integrated into a generally applicable strategy for affecting highly stereoselective Claisen 
rearrangements. Catalyzed alkene isomerization affords allyl vinyl ethers from easily prepared 
di(allyl) ethers; direct thermolysis of these reaction mixtures leads to highly diastereoselective 
[3,3] sigmatropic rearrangements affording syn-2,3-dialkyl-4-pentenal derivatives. 
2.4 EXPERIMENTAL SECTION 
General Information: Unless otherwise stated, all reactions were performed in dry glassware 
under an atmosphere of oxygen-free nitrogen using standard inert atmosphere techniques for the 
manipulation of solvents and reagents. Anhydrous solvents were obtained by passage through 
successive alumina- and Q5 reagent-packed columns on a solvent purification system. Acetone 
was used as purchased. Sodium hydride (60 % dispersion in mineral oil) was washed with 
pentanes (3x) and dried under vacuum before use.  Crotyl bromide, allyl bromide, and allyl 
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acetate were distilled form CaH2. [(cC8H14)2IrCl]2 40and PCy3 were stored and weighed out in a 
nitrogen filled glove box.  Infrared spectra were recorded on a Nicolet Avatar 360 FT-IR 
spectrometer. Proton and carbon NMR spectra were recorded on a Bruker DPX 301 and DPX 
302 (300 MHz for proton) spectrometers with chemical shifts reported in relative to residual 
CHCl3 (7.27 ppm) for 1H and CDCl3 (77 ppm) for 13C NMR spectra. Low-resolution mass 
spectra were obtained on a Fiseons Autospec in EI mode at 70 V and are reported in m/z. 
Analytical thin layer chromatography was performed on EM Reagent 0.25 mm silica gel 60-F 
plates. Flash chromatography was performed as previously described on EM silica gel 60 (230-
240 mesh) or Introbeads (PH = 7.0). Analytical high performance liquid chromatography 
(HPLC) was performed on a Hewlett Packard 1100 liquid chromatograph equipped with a 
variable wavelength UV detector (deuterium lamp, 190-600 nm), using a Daicel ChiracelTM OD-
H column (250 x 4.6 mm) (Daicel Inc.).  HPLC grade isopropanol and hexanes were used as the 
eluting solvents. Analytical gas liquid chromatography (GLC) was performed on a Varian 3900 
gas chromatography with a flame ionization detector and split mode capillary injection system 
using Varian CP Wax 52CB column (30 m x 0.25 mm). 
2.4.1 Experiment of section 2.2 
Preparation of substituted di(allyl) ethers. General Procedure A: A solution of the alcohol 
(1.0 equiv.) in anhydrous THF (0.5 M) was added to a suspension of pre-washed NaH (2.0 
equiv.) in anhydrous THF (1.0 M). The resulting suspension (0.25 M) was heated at reflux for 30 
min whereupon allyl bromide or crotyl bromide (2.0 equiv.) was added and the resulting 
                                                 
40 Onderdelinden, A. L.; Ent der Ent A. Inorg. Chim. Acta.1972, 6, 420. 
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suspension heated at reflux for a further 2 h. The reaction mixture was then cooled to ambient 
temperature and poured into ice. The THF was removed in vacuo and the aqueous residue was 
extracted with Et2O (3x) and the combined organic extracts were dried over anhydrous MgSO4. 
The solvent was removed in vacuo and the residue purified as indicated. 
 
General Procedure B: A solution of the Et2Zn (1.0 M in hexanes, 0.65 equiv.) was added to a 
solution of the allyl alcohol (1.0 equiv.) in anhydrous THF (1.8 M) at ambient temperature. The 
resulting solution was stirred for 30 min then added via syringe to a solution of Pd(PPh3)4 (5 
mol%) and allyl acetate (1.5 equiv.) in anhydrous THF (0.09 M). The final concentration was 0.8 
M.  The reaction was stirred for 2 d at ambient temperature whereupon the solvent was removed 
in vacuo, and the residue purified as indicated. 
 
General Procedure C: Five drops of concentrated H2SO4 were added to a solution of (E)-1,3-
diphenyl-2-propen-1-ol (1.0 equiv.) and allyl alcohol or crotyl alcohol (1.1 equiv.) in anhydrous 
THF (1.0 M).  The resulting solution was stirred for 1 h at ambient temperature whereupon H2O 
(10 ml) was added and the resulting mixture was extracted with Et2O (3x). The combined 
organic extracts were washed with brine, dried over anhydrous MgSO4, The solvent was 
removed in vacuo and the residue purified as indicated. 
 
(E)-(1-Allyloxybut-2-enyl)benzene (9a): General Procedure A was followed 
employing 14.4 g of (E)-1-phenylbut-2-en-1-ol41 (97.0 mmol), 4.7 g NaH (194.0 
4 ml allyl bromide (194.0 mmol).  Purification by vacuum distillation gave 16.6 g 
O
Ph Me
mmol) and 16.
                                                 
41 Pocker, Y.; Hill, M. J. J. Am. Chem. Soc. 1969, 91, 3243.  
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(91 %) of the title compound as a colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.16-7.27 (m, 
5H), 5.80-5.93 (m, 1H), 5.49-5.68 (m, 2H), 5.20 (dd, J = 19, 1.6 Hz, 1H), 5.10 (dd, J = 10, 1.4, 
1H), 4.68 (d, J = 6.7 Hz, 1H), 3.92 (ddt, J = 12.8, 5.5, 1.4 Hz, 1H), 3.86 (ddt, J = 12.8, 5.5, 1.4 
Hz, 1H), 1.64 (d, J = 5.6 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 141.6, 134.9, 132.1, 
128.3, 128.2, 127.3, 126.7, 116.6, 81.8, 68.9, 17.7 ppm; MS (EI, 70 V): m/z 187 (M+.-H), 147, 
131, 115, 105, 91, 77, 69; HRMS m/z calcd for C13H16O (M+.): 188.1201; found: 188.1197. 
 
(E)-(1-Allyloxyhex-2-enyl)benzene (9b): General Procedure A was followed 
(E)-(1-Allyloxypent-4-methyl-2-enyl)benzene (9c): General Procedure A was 
                                                
employing 5.54 g of (E)-1-phenylhex-2-en-1-ol 42  (31.0 mmol), 1.45 g NaH 
d 5.3 ml allyl bromide (62.0 mmol). Purification by flash chromatography (2 % 
EtOAc/hexanes) gave 5.96 g (90 %) of the title compound as a colorless oil. 
(62.0 mmol) an
1H NMR (300 MHz, 
CDCl3): δ 7.16-7.27 (m, 5H), 5.79-5.93 (m, 1H), 5.61 (dt, J= 15.4, 6.4 Hz, 1H), 5.48 (ddt, J= 
15.4, 7.0, 0.9 Hz, 1H), 5.20 (dq, J = 17.2, 1.7 Hz, 1H), 5.09 (dq, J = 10.4, 1.4, 1H), 4.68 (d, J = 
7.1 Hz, 1H), 3.92 (ddt, J = 12.8, 5.5, 1.4 Hz, 1H), 3.86 (ddt, J = 12.8, 5.5, 1.4 Hz, 1H), 1.95 (q, J 
= 6.8 Hz, 2H), 1.33 (hex, J = 7.4 Hz, 2H), 0.81 (t, J = 7.4 Hz, 3H), ppm; 13C NMR (75 MHz, 
CDCl3): δ 141.7, 134.9, 133.3, 130.8, 128.2, 127.2, 126.6, 116.5, 81.7, 68.8, 34.2, 22.2, 13.6 
ppm; MS (EI, 70 V): m/z 216 (M+.), 173, 159, 145, 129, 117, 105, 91, 84, 77, 71; HRMS m/z 
calcd for C15H20O (M+.): 216.1514; found: 216.1518. 
 
followed employing 1.75 g of (E)-1-phenyl-4-methylpent-2-en-1-ol 43  (10.0 
 NaH (20.0 mmol) and 1.7 ml allyl bromide (20.0 mmol).  Purification by flash mmol), 480 mg
 
42 Wang, D.; Chen, D.; Haberman, J. X.; Li, C. Tetrahedron 1988, 54, 5129-5142. 
l.  
O
43 Prepared in quantitative yield by addition of phenyllithium to 4-methyl-2-pentena
Ph nPr
O
Ph iPr
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chromatography (2 % EtOAc/hexanes) gave 1.99 g (92 %) of the title compound as colorless oil. 
IR (liquid film): 2961, 1724, 1451, 1267, 1069, 973, 924, 739, 700 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.16-7.26 (m, 5H), 5.79-5.92 (m, 1H), 5.59 (dd, J = 15.5, 6.3 Hz, 1H), 5.45 (ddd, J = 
15.5, 7.2, 1.0 Hz, 1H), 5.20 (dq, J = 17.2, 1.7 Hz, 1H), 5.09 (dq, J = 10.4, 1.5 Hz, 1H), 4.67 (d, J 
= 7.2 Hz, 1H), 3.90 (ddt, J = 12.8, 5.5, 1.5 Hz, 1H), 3.84 (ddt, J = 12.8, 5.5, 1.5 Hz, 1H), 2.18-
2.25 (m, 1H), 0.91 (d, J = 6.7 Hz, 3H), 0.89 (d, J = 6.7 Hz, 3H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 141.8, 140.6, 135.0, 128.3, 127.7, 126.7, 116.7, 81.9, 68.9, 30.7, 22.2 (overlap of 2C) 
ppm; IR(liquid film) vmax: 2961, 1724, 1451, 1267, 1069, 973, 924, 739, 700 cm-1; (MS (EI, 70 
V): m/z 216 (M+.), 173, 159, 143, 131, 117, 105, 97, 91, 77; HRMS m/z calcd for C15H20O (M+.): 
216.1514; found: 216.1507. 
 
((E)-3-(Allyloxy)-3-phenylprop-1-enyl)trimethylsilane (9d): General 
1
for C15H21OSi (M+.-H): 245.1362; found 245.1371. 
                                                
O
Procedure B was followed employing 2.06 g of (E)-3-(trimethylsilyl)-1-
-olphenylprop-2-en- 44 (10.0 mmol), 6.5 ml Et Zn (1.0 M in hexanes), 578 mg Pd(PPh )  (0.5 
mmol) and 1.6 ml allyl acetate (15.0 mmol).  Purification by flash chromatography (2 % 
EtOAc/hexanes) gave 1.97 g (80 %) of the title compound as colorless oil. IR (liquid film): 2955, 
1617, 1452, 1248, 1070, 990, 838, 699 cm
2 3 4
-1; 1H NMR (300 MHz, CDCl ): δ 7.34-7.43 (m, 5H), 
6.23 (dd, J = 18.6, 5.7 Hz, 1H), 6.03 (ddt, J = 17.1, 10.4, 5.4 Hz, 1H), 5.37 (d, J = 17.1, Hz, 1H), 
5.26 (d, J = 10.4 Hz, 1H), 4.90 (d, J = 5.7 Hz, 1H), 4.06 (d, J = 5.4 Hz, 2H), 0.16 (s, 9H) ppm; 
3
13C NMR (75 MHz, CDCl ): δ 145.7, 140.8, 134.7, 131.4, 128.3, 127.4, 126.9, 116.8, 83.7, 69.1, 
-1.4 ppm; MS (EI, 70 V) m/z: 245 (M
3
+.-H), 205, 189, 159, 147, 131, 115, 105. HRMS m/z calcd 
 
Ph TMS
44 Kitano, Y.; Matsumoto, T.; Sato, F. Tetrahedron 1988, 44, 4073. 
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 (E)-3-Allyloxy-1,3-diphenylpropene (9e): General Procedure C was followed 
employing 3.67 g of (E)-1,3-diphenyl-2-propen-1-ol 45  (17.5 mmol), 1.4 ml 
(
chromatography
oxy)-2-methyl-1,3-diphenylprop-1-ene (9f) : General Procedure C 
was followed employing 3.15 g of (E)-2-methyl-1,3-diphenylprop-2-en-1-ol46 
u
the title compou
                                                
allyllic alcohol 20.3 mmol) and five drops of concentrated sulfuric acid.  Purification by flash 
 (5 % EtOAc/hexanes) gave 3.65 g (84 %) of the title compound as colorless oil. 
IR (liquid film): 3060, 3027, 2857, 1950, 1879, 1647, 1500, 1494, 1450, 1301, 1069, 967, 923, 
746, 698 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.20-7.41 (m, 10H), 6.61 (d, J = 15.9 Hz, 1H), 
6.30 (dd, J = 15.9, 7.0 Hz, 1H), 5.97 (ddt, J = 17.1, 10.4, 5.5 Hz, 1H), 5.31 (dq, J = 17.2, 1.6 Hz, 
1H), 5.20 (dq, J = 10.5, 1.3, 1H), 4.97 (d, J = 7.0 Hz, 1H), 4.06 (ddt, J = 12.8, 5.4, 1.3 Hz, 1H), 
4.00 (ddt, J = 12.8, 5.6, 1.4 Hz, 1H) ppm; 13C NMR (75 MHz, CDCl3): δ 141.0, 136.4, 134.7, 
131.2, 130.1, 128.3, 127.5, 126.7, 126.4, 116.7, 81.5, 69.0 ppm; MS (EI, 70 V): m/z 250 (M+.), 
220, 207, 193, 181, 165, 145, 131, 115, 105, 91, 77, 65; HRMS m/z calcd for C18H18O (M+.): 
250.1358; found: 250.1368. 
 
(E)-3-(Allyl
(14.0 mmol), 1.1 ml allyllic alcohol (15.4 mmol) and five drops of concentrated 
rification by flash chromatography (5 % EtOAc/hexanes) gave 3.05 g (82 %) of 
nd as a colorless oil. 
sulfuric acid. P
1H NMR (300 MHz, CDCl3):  δ 7.11-7.37 (m, 10H), 6.62 
(s, 1H), 5.97 (ddt, J = 17.1, 10.6, 5.4 Hz, 1H), 5.27 (dq, J = 17.2, 1.7 Hz, 1H), 5.13 (dq, J = 10.4, 
1.5, 1H), 4.83 (s, 1H), 4.02 (ddt, J = 13.0, 5.2, 1.5 Hz, 1H), 3.93 (ddt, J = 13.0, 5.6, 1.5 Hz, 1H), 
1.64 (d, J = 1.3 Hz, 1H); 13C NMR (75 MHz, CDCl3): δ 140.8, 138.0, 137.5, 134.9, 129.1, 128.2, 
 
O
45 Huang, W. –S.; Hu, Q. –S.; Pu, L. J. Org. Chem. 1999, 64, 7940. 
46 Nudelman, N. S.; Garcia, G. V. J. Org. Chem. 2001, 66, 1387. 
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128.1, 127.7, 126.6, 126.5, 116.6, 86.1, 69.2, 13.5 ppm. MS (EI, 70 V): m/z 264 (M+.), 249, 234, 
223, 206, 191, 178, 158, 129, 105, 91, 77. HRMS m/z calcd for C19H20O (M+.): 264.1514; found: 
264.1525. 
 
(E)-5-Allyloxy-2-methyl-non-3-ene (9g): General Procedure A was followed 
employing 4.68 g of (E)-2-methyl-non-3-en-5-ol47  (30.0 mmol), 1.44 g NaH 
n
EtOAc/hexanes
 was followed 
employing 3.84 g of (E)-oct-2-en-4-ol 48  (30.0 mmol), 1.44 g NaH (60.0 
l
EtOAc/hexanes) ga
                                                
(60.0 mmol) a d 5.1 ml allyl bromide (60.0 mmol)..  Purification by flash chromatography (2 % 
) gave 5.09 g (87 %) of the title compound as colorless oil.  1H NMR (300 MHz, 
CDCl3): δ 5.90 (dddd, J = 17.2, 10.3, 6.0, 5.2 Hz, 1H), 5.55 (dd, J = 15.5, 6.5 Hz, 1H), 5.23 (dq, J 
= 17.2, 1.7 Hz, 1H), 5.21 (ddd, J = 15.5, 8.3, 1.3 Hz, 1H), 5.13 (dq, J = 10.3, 1.5 Hz, 1H), 4.02 
(ddt, J = 12.8, 5.1, 1.5 Hz, 1H), 3.79 (ddt, J = 12.8, 6.0, 1.3 Hz, 1H), 3.61 (dt, J = 8.1, 6.6 Hz, 
1H), 2.30 (m, 1H), 1.28-1.60 (m, 6H), 1.00 (d, J = 6.7 Hz, 3H), 0.99 (d, J = 6.7 Hz, 3H), 0.88 (t, J 
= 7.0 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 141.0, 135.5, 127.7, 116.3, 80.4, 68.6, 35.5, 
30.8, 27.7, 22.6, 22.4 (overlap of 2C), 14.0 ppm; MS (EI, 70 V): m/z 195 (M+.-H), 179, 139, 97, 
81, 69, 55; HRMS m/z calcd for C13H23O (M+.-H): 195.1749; found: 195.1746. 
 
(E)-4-But-2-enyloxyoct-2-ene (9h): General Procedure A
mmol) and 6.2 m  crotyl bromide (60.0 mmol).  Purification by flash chromatography (2 % 
ve 4.63 g (85 %) of the title compound as colorless oil. 1H NMR (300 MHz, 
CDCl3): δ 5.50-5.71 (m, 3H), 5.27 (ddq, J = 15.3, 8.1, 1.6 Hz, 1H), 3.92 (dd, J = 11.7, 5.7 Hz, 
1H), 3.68 (dd, J = 11.5, 6.4 Hz, 1H), 3.58 (q, J = 7.0 Hz, 1H), 1.66-1.69 (m, 6H), 1.48-1.63 (m, 
 
O
nBu iPr
47 Prepared in quantitative yield by addition of n-butyllithium to 4-methyl-2-pentenal. 
48 Chamberlin, A, R.; Mulholland, R. L. Jr. Tetrahedron 1984, 40, 2297-2302.  
O
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2H), 1.22-1.29 (m, 4H), 0.86 (t, J = 6.7 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 132.3, 128.6, 
128.1, 128.0, 80.0, 68.4, 35.3, 27.6, 22.6, 17.6, 17.5, 13.9 ppm; MS (EI, 70 V): m/z 125 (M+.-
nBu), 111, 97, 85, 81, 71, 69, 55; HRMS m/z calcd for C12H22O (M+.-nBu): 125.0966; found: 
125.0970. 
 
(E)-(3-Allyloxyhept-1-enyl)benzene (9i): General Procedure A was followed 
employing 5.13 g of (E)-1-phenylhept-1-en-3-ol 49  (27.0 mmol), 1.30 g NaH 
n
EtOAc/hexanes
yloxy)-5,5-dimethylhex-2-ene (9j): General Procedure A 
was followed employing 1.28 g of (E)-2,2-dimethylhex-4-en-3-ol 50  (10.0 
chromatography (2
                                                
(54.0 mmol) a d 4.6 ml allyl bromide (54.0 mmol).  Purification by flash chromatography (2 % 
) gave 5.41 g (87 %) of the title compound as colorless oil. IR (liquid film): 2957, 
2860, 1727, 1454, 1266, 1071, 969, 920, 739, 699 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.27-
7.45 (m, 5H), 6.54 (d, J = 16.0 Hz, 1H), 6.11 (dd, J = 16.0, 8.0 Hz, 1H), 5.90-6.04 (m, 1H), 5.31 
(dq, J = 17.2, 1.6 Hz, 1H), 5.20 (dm, J = 17.2 Hz, 1H), 4.13 (ddt, J = 12.8, 5.2, 1.5 Hz, 1H), 3.74-
3.84 (m, 2H), 1.36-1.82 (m, 6H), 0.94 (t, J = 7.0 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 
136.6, 135.2, 131.9, 130.7, 128.5, 127.5, 126.4, 116.5, 80.2, 69.1, 35.5, 27.6, 22.6, 14.0 ppm; 
MS (EI, 70 V): m/z 230 (M+.), 189, 173, 145, 131, 117, 105, 91; HRMS m/z calcd for C16H22O 
(M+.): 230.1671, found: 230.1670. 
 
(2E)-4-(But-2-en
mmol), 480 mg NaH (20.0 mmol) and 1.7 ml crotyl bromide (20.0 mmol).  Purification by flash 
 % EtOAc/hexanes) gave 1.66 g (91 %) of the title compound as colorless oil.  
1H NMR (300 MHz, CDCl3): δ 5.49-5.73 (m, 3H), 5.34 (dd, J = 15.3, 8.4 Hz, 1H), 3.83-4.06 (m, 
 
49 Trost, B. M.; Kulawiec, R. J. J. Am. Chem. Soc., 1993, 115, 2027. 
50 Chamberlin, A. R.; Mulholland, R. L. Tetrahedron Lett., 1984, 25, 2297. 
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1H), 3.67 (dd, J = 12.2, 6.2 Hz, 1H), 3.19 (d, J = 8.4 Hz, 1H), 1.63-1.76 (m, 6H), 0.88 (s, 9H) 
ppm; 13C NMR51 (75 MHz, CDCl3): δ ppm; MS (EI, 70 V): m/z 182 (M+), 125, 111, 95, 71, 55; 
HRMS m/z calcd for C12H22O (M+.): 182.1671; found: 182.1670. m/z calcd for C8H13O (M+.-
tBu): 125.0966; found: 125.0967. 
 
1-((S,1E)-3-((E)-3-Cyclohexylallyloxy)pent-1-enyl)benzene (9k): 
General procedure A was followed employing 1-phenyl-pent-1-en-3-ol 
l
Purification by flash c
3E)-5-((E)-1-Phenylpent-1-en-3-yloxy)pent-3-enyl)benzene (9l): 
Genera A  was followed employing (E)-1-phenylpent-1-en-3-
                                                
O
(162 mg, 1.0 mmo ) and ((E)-3-bromoprop-1-enyl)cyclohexane 52  (306 mg, 1.5 mmol). 
hromatograph on silical gel (2 % EtOAc in hexanes) to yield 210 mg (74 
%) of the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.26-7.43 (m, 5H), 6.53 
(d, J = 16.0 Hz, 1H), 6.09 (d, J = 16.0, 7.9 Hz, 1H), 5.66 (dd, J = 15.5, 6.2 Hz, 1H), 5.53 (dt, J = 
15.5, 5.6 Hz, 1H), 4.06 (dd, J = 11.7, 5.5 Hz, 1H), 3.85 (dd, J = 11.7, 6.3 Hz, 1H), 3.80 (q, J = 
7.4 Hz, 1H), 1.94-2.01 (m, 1H), 1.54-1.80 (m, 6H), 1.01-1.34 (m, 6H), 0.96 (t, J = 7.4 Hz, 3H) 
ppm; 13C NMR (75 MHz, CDCl3): δ 140.03, 136.75, 132.03, 130.72, 128.52, 127.53, 126.40, 
124.02, 81.34, 69.33, 40.33, 32.73, 32,69, 28.61, 26.15, 26.00, 9.92 ppm; MS (EI, 70 V): m/z 284 
(M+.), 255, 212, 162, 145, 133, 117, 104, 91, 81, 67, 57; HRMS m/z calcd for C20H28O (M+.): 
284.2140; found 284.2136. 
 
1-((
l Procedure 
 
51 Due to a mixture of E/Z isomers, 13C NMR had not been assigned clearly. 
52 Adam, J. M.; Fays, L. D.; Laguerre, M.; Ghosez, L.; Tetrahedron 2004, 60, 7325-7344. 
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ol (288 mg, 2.0 mmol) and a mixture of (E)-(5-bromopent-3-enyl) benzene and (3-bromopent-4-
enyl)benzene53 (about 4: 1, 672 mg, 3.0 mmol). Purification by flash chromatograph on silical 
gel (2.5 % ethyl acetate in hexanes) afford 428 mg (70 %) of the title compound as colorless oil. 
1H NMR (300 MHz, CDCl3): δ 7.19-7.43 (m, 10H), 6.51 (d, J = 16.0 Hz, 1H), 6.08 (d, J = 16.0, 
7.9 Hz, 1H), 5.75 (dt, J = 15.4, 6.2 Hz, 1H), 6.63 (dt, J = 15.4, 6.1 Hz, 1H), 4.06 (dd, J = 11.8, 
5.4 Hz, 1H), 3.85 (dd, J = 11.8, 6.3 Hz, 1H), 3.77 (q, J = 7.0, 1H), 2.74 (t, J = 7.8 Hz, 2H), 2.40 
(q, J = 7.2 Hz, 1H), 1.54-1.82 (m, 2H), 0.96 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 141.77, 136.68, 133.20, 132.09, 130.58, 128.53, 128.37, 128.26, 127.56, 127.30, 
126.39, 125.77, 81.33, 68.88, 35.45, 34.06, 28.60, 9.88 ppm; MS (EI, 70 V): m/z 306 (M+.), 288, 
277, 248, 234, 161, 144, 129, 115, 91; HRMS m/z calcd for C22H26O (M+.): 306.1984; found 
306.1981. 
 
                                                
1-(((3E)-5- ((E)-1-Phenylpent-1-en-3-yloxy)pent-3-enyloxy)methyl) 
benzene (9m): General Procedure A was followed employing (E)-1-
phenylpent-1-en-3-ol (288 mg, 2.0 mmol) and (E)-((5-bromopent-3-enyloxy)methyl)benzene54 
(765 mg, 3.0 mmol). Purification by flash chromatograph on silical gel (2.5 % ethyl acetate in 
hexanes) afford 544 mg (81 %) of the title compound as colorless oil. 1H NMR (300 MHz, 
CDCl3): δ 7.28-7.46 (m, 10H), 6.56 (d, J = 16.0 Hz, 1H), 6.11 (dd, J = 16.0, 7.9 Hz, 1H), 5.67-
5.83 (m, 2H), 4.56 (s, 2H), 4.10 (dd, J = 11.0, 5.3 Hz, 1H), 3.90 (dd, J = 11.0, 5.8 Hz, 1H), 3.83 
(q, J = 7.1 Hz, 1H), 3.57 (t, J = 6.8 Hz, 2H), 2.44 (q, J = 6.8 Hz, 2H), 1.62-1.83 (m, 2H), 1.00 (t, 
J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 138.32, 136.60, 132.05, 130.49, 130.10, 
O
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53 Bandini, M.; Cozzi, P. G.; Licciulli, S.; Umani-Ronchi, A. Synthesis 2004, 409-414. 
54 Tonn, C. E.; Palazon, J. M.; Ruiz-perez, C.; Rodriguez, M. L.; Martin, V. S. Tetrahedron Lett. 1988, 29, 3149-3152. 
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128.62, 128.46, 128.25, 127.54, 127.50, 127.44, 126.34, 81.42, 72.78, 69.58, 68.81, 32.71, 28.55, 
9.83 ppm; MS (EI, 70 V): m/z 336 (M+.), 307, 264, 245, 223, 187, 175, 161, 145, 131, 117, 104, 
92; HRMS m/z calcd for C23H28O2 (M+.): 336.2089; found 336.2086. 
 
((E)-3- ((E)-5-(Benzyloxy)pent-2-enyloxy)prop-1-ene-1,3-diyl)dibe 
nzene (9n): General Procedure C was followed employing (E)-1,3-
diphenylprop-2-en-1-ol (420 mg, 2.0 mmol) and (E)-5-(benzyloxy)pent-2-en-1-ol (384 mg, 2.0 
mmol). Purification by flash chromatograph on silical gel (2.5 % EtOAc in hexanes) afford 
691mg (90 %) of the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.27-7.49 
(m, 15H), 6.67 (d, J = 15.9 Hz, 1H), 6.37 (dd, J = 15.9, 7.1 Hz, 1H), 5.72-5.87 (m, 2H), 5.04 (d, J 
= 7.1 Hz, 1H), 4.58 (s, 2H), 4.09 (dd, J = 12.6, 5.0 Hz, 1H), 4.04 (dd, J = 12.6, 3.7 Hz, 1H), 3.59 
(t, J = 6.8 Hz, 2H), 2.47 (td, J = 6.8, 4.9 Hz, 2H) ppm; 13C NMR (75 MHz, CDCl3): δ 141.14, 
138.32, 136.51, 131.29, 130.61, 130.28, 128.44, 128.31, 127.59, 127.50, 126.88, 126.51, 81.47, 
72.83, 69.57, 68.86, 32.76 ppm; MS (EI, 70 V): m/z 384 (M+.), 368, 277, 293, 178, 115; HRMS 
m/z calcd for C27H30O2 (M+.): 384.2089. found 384.2089. 
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ICR reactions of substituted di(allyl) ethers. 
General Procedure D for ICR reactions: A solution of [(cC8H14)2IrCl]2 (Ir dimmer, 0.5 mol%, 
0.01 equiv Ir, or indicated amount) and PCy3 (0.03 equiv, or 3 equiv per Ir) in anhydrous CH2Cl2 
or 1,2-dichloroethane (1,2-DCE) (1.5 ml) was added to a solution of NaBPh4 (0.01 equiv, or 1 
equiv per Ir) in CH2Cl2/acetone (25:1) or 1,2-DCE/acetone (25:1) (1.5 ml, 0.67 M final 
concentration in substrate 1) and the resulting yellow solution stirred for 5 min at ambient 
temperature. The di(allyl) ether (1.0 equiv) was added and the reaction stirred for 30 min (or 
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indicated time) at ambient temperature whereupon PPh3 (0.03 equiv, or 3 equiv per Ir) was added 
and the resulting solution heated at reflux (39 oC or 80 oC) for the indicated time. The solvent 
was removed in vacuo and the diastereomer ratio of the aldehyde product 3 was determined by 
integration of the aldehyde proton resonances (-CHO) in the 1H NMR spectrum of the crude 
product mixture. The crude product mixture was dissolved in anhydrous CH2Cl2 and cooled to –
78 oC and 1 M hexanes solution of Diisobutylaluminum hydride (3.0 equiv) was added dropwise 
via syringe and the resulting solution was stirred for 5 min at –78 oC. The reaction mixture was 
warmed to ambient temperature and poured into 10 ml saturated Rochelle’s salt solution in water 
and Et2O (10 ml) was added and stirred until homogeneous, the solution was extracted with Et2O 
(3x). The combined organic extracts were dried over anhydrous MgSO4 and the solvent removed 
in vacuo. The resulting residue was purified by flash chromatography on silica gel using the 
solvents indicated.   
 
(E)-syn-2,3-Dimethyl-5-phenylpent-4-en-1-ol (13a′): 
General Procedure D (CH2Cl2) was followed employing 
515 mg ether 9a (2.74 mmol), 12.3 mg Ir dimer (0.014 
mmol), 23.0 mg PCy3 (0.082 mmol), 9.6 mg NaBPh4 (0.028 mmol), quenched with 21.5 mg 
PPh3 (0.082 mmol) and refluxed 6 h to afford (E)-syn-2,3-dimethyl-5-phenylpent-4-en-1-al (13a) 
(syn: anti = 94: 6). 5.5 ml Diisobutylaluminum hydride (1.0 M in hexanes, 5.5 mmol) reduction 
of 13a followed by purification by flash chromatography (25 % EtOAc/hexanes) gave 415 mg 
(80 %) of the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.20-7.40 (m, 5H), 
6.41 (d, J = 16 Hz, 1H), 6.18 (dd, J = 16, 8.1 Hz, 1H), 3.67 (dd, J = 11, 5.7 Hz, 1H), 3.52 (dd, J = 
11, 6.4 Hz, 1H), 2.39 (m, 1H), 1.72 (m, 1H), 1.10 (d, J = 6.8 Hz, 3H), 0.98 (d, J = 6.9 Hz, 3H) 
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ppm; 13C NMR (75 MHz, CDCl3): δ 137.6, 135.3, 128.8, 128.4, 126.9, 125.9, 66.5, 40.8, 39.1, 
16.6, 13.7 ppm; MS (EI, 70 V): m/z 190 (M+.), 131, 91; HRMS m/z calcd for C13H18O (M+.): 
190.1358, found: 190.1363. 
 
employing 216 mg of 9c (1.00 mmol
(E)-syn-2- Methyl-3-n-propyl-5-phenylpent-4-en-1-ol 
(13b′): General Procedure D (2 mol% catalyst loading, 
CH2Cl2) was followed employing 216 mg of 9b (1.00 mmol), 4.5 mg Ir dimer (0.005 mmol), 8.4 
mg PCy3 (0.03 mmol), 3.4 mg NaBPh4 (0.01 mmol) and an initial reaction time of 10 min 
(instead of 30 min) , quenched with 7.9 mg PPh3 (0.03 mmol) prior to heating the reaction at 
reflux for 12 h to afford (E)-syn-2-methyl-3-npropyl-5-phenylpent-4-en-1-al (13b) (syn : anti = 
97 : 3). Diisobutylaluminum hydride (2.0 ml, 1.0 M in hexanes, 2.0 mmol) reduction of 13b 
followed by purification by flash chromatography (20 % EtOAc/hexanes) gave 152 mg (70 %) of 
the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.20-7.39 (m, 5H), 6.38 (d, J 
= 15.8 Hz, 1H), 6.04 (dd, J = 15.8, 9.5 Hz, 1H), 3.67 (dd, J = 10.7, 5.1 Hz, 1H), 3.46 (dd, J = 
10.7, 6.8 Hz, 1H), 2.09-2.19 (m, 1H), 1.93 (s, 1H), 1.52-1.75 (m, 1H), 1.25-1.39 (m, 4H), 1.01 
(d, J = 6.8 Hz, 3H), 0.92 (t, J = 7.0 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 137.5, 133.5, 
130.4, 128.4, 126.8, 125.9, 66.2, 45.9, 40.1, 33.8, 20.6, 14.7, 14.1 ppm; MS (EI, 70 V): m/z 218 
(M+.), 159, 143, 129, 117, 104, 91; HRMS m/z calcd for C15H22O (M+.): 218.1671, found: 
218.1670.  
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(E)-syn- 2-Methyl-3-iso-propyl-5-phenylpent-4-en-1-ol 
(13c′): General Procedure D (CH2Cl2) was followed 
), 4.5 mg Ir dimer (0.005 mmol), 8.4 mg PCy3 (0.03 mmol), 
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3.4 mg NaBPh4 (0.01 mmol), quenched with 7.9 mg PPh3 (0.03 mmol) and reflux 12 h to afford 
(E)-syn-2-methyl-3-iso-propyl-5-phenylpent-4-en-1-al 13c (syn : anti = 95 : 5). 1H NMR (300 
MHz, CDCl3): δ 9.75 (d, J = 2.8 Hz, 1H), 6.47 (d, J = 15.8 Hz, 1H), 6.13 (dd, J = 15.8, 9.9 Hz, 
1H), 2.69 (dqd, J = 6.9, 6.9, 2.8 Hz, 1H), 2.25 (dt, J = 9.9, 6.9 Hz, 1H), 1.99-2.05 (m, 1H), 1.18 
(d, J = 6.9 Hz, 3H), 1.05 (d, J = 6.7 Hz, 3H), 0.97 (d, J = 6.7 Hz, 3H) ppm. Diisobutylaluminum 
hydride (2.0 ml, 1.0 M in hexanes, 2.0 mmol) reduction of 13c followed by purification by flash 
chromatography (20 % EtOAc/hexanes) gave 201 mg (93 %) of the title compound as colorless 
oil. 1H NMR (300 MHz, CDCl3): δ 7.22-7.47 (m, 5H), 6.38 (d, J = 15.8 Hz, 1H), 6.06 (dd, J = 
15.7, 9.4 Hz, 1H), 3.71 (dd, J = 10.7, 3.3 Hz, 1H), 3.46 (dd, J = 10.7, 6.1 Hz, 1H), 1.86-2.08 (m, 
3H), 1.78 (m, 1H), 1.06 (d, J = 6.8 Hz, 3H), 0.96 (d, J= 6.7 Hz, 3H), 0.90 (d, J = 6.8 Hz, 3H) 
ppm; 13C NMR (75 MHz, CDCl3): δ 137.5, 132.0, 128.4, 126.9, 126.0, 66.6, 52.7, 37.0, 28.2, 
21.9, 17.4, 15.6 ppm; IR (liquid film): 3355, 2959, 1494, 1385, 1030, 974, 747, 693 cm-1. MS 
(EI, 70 V): m/z 218 (M+.), 175, 157, 129, 117, 104, 91; HRMS m/z calcd for C15H22O (M+.): 
218.1671, found: 218.1673. 
 
(E)-syn- 2-Methyl-3-(trimethylsilyl)-5-phenylpent-4-
en-1-ol (13d′): General Procedure D (CH2Cl2) was 
followed employing 246 mg of 9d (1.00 mmol), 4.5 mg 
Ir dimer (0.005 mmol), 8.4 mg PCy3 (0.03 mmol), 3.4 mg NaBPh4 (0.01 mmol), quenched with 
7.9 mg PPh3 (0.03 mmol) and reflux 32 h to afford (E)-syn-2-methyl-3-(trimethylsilyl)-5-
phenylpent-4-en-1-al 13d (syn : anti = 97 : 3). 1H NMR (300 MHz, CDCl3): δ 9.76 (d, J = 1.6 
Hz, 1H), 7,46-7.22 (m, 5H), 6.39 (d, J = 15.7 Hz, 1H), 6.22 (dd, J = 15.7, 10.2 Hz, 1H), 2.77 
(qdd, J = 7.0, 7.0, 1.8 Hz, 1H), 2.12 (dd, J = 10.2, 6.9 Hz, 1H), 1.27 (d, J = 7.0 Hz, 3H), 0.21 (s, 
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9H) ppm; 13C NMR (75 MHz, CDCl3): δ 204.6, 137.4, 129.7, 128.8, 128.3, 126.6, 125.6, 47.0, 
36.5, 14.2, -1.7 ppm. Diisobutylaluminum hydride (2.0 ml, 1.0 M in hexanes, 2.0 mmol) 
reduction of 13d followed by purification by flash chromatography (20 % EtOAc/hexanes) gave 
215 mg (87 %) of the title compound as colorless oil. IR (liquid film): 3367, 2954, 1635, 1598, 
1496, 1447, 1248, 1028, 967, 835, 744, 692 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.18-7.38 (m, 
5H), 6.30 (d, J = 15.7 Hz, 1H), 6.16 (dd, J = 15.7, 10.6 Hz, 1H), 3.72 (dd, J = 10.6, 4.2 Hz, 1H), 
3.51 (dd, J = 10.6, 7.0 Hz, 1H), 1.95-2.07 (m, 1H), 1.79 (s, 1H), 1.74 (dd, J = 10.6, 8.0 Hz, 1H), 
1.11 (d, J = 6.8 Hz, 3H), 0.12 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3): δ 138.0, 131.1, 128.7, 
126.4, 125.6, 67.6, 38.6, 36.8, 8.0, -1.3 ppm; MS (EI, 70 V) m/z: 248 (M+.), 233, 205, 194, 173, 
158, 143, 129, 91, 73. HRMS m/z Calcd for C15H24OSi (M+.): 248.1596; found 248.1591. 
 
(E)-syn- 2-Methyl-3-phenyl-5-phenylpent-4-en-1-ol 
(13e′): General Procedure D (CH2Cl2) was followed 
employing 500 mg of 9e (2.00 mmol), 9.0 mg Ir dimer (0.01 mmol), 16.8 mg PCy3 (0.06 mmol), 
6.8 mg NaBPh4 (0.02 mmol), quenched with 15.8 mg PPh3 (0.06 mmol) and a reaction was 
stirred 12 h at ambient temperature (instead of reflux) to afford (E)-syn-2-methyl-3-phenyl-5-
phenylpent-4-en-1-al 13e (syn : anti = 98 : 2). 1H NMR (300 MHz, CDCl3): δ 9.68 (d, J = 2.8 
Hz, 1H), 7.15-7.32 (m, 10H), 6.43 (d, J = 15.8 Hz, 1H), 6.35 (dd, J = 15.8, 7.3 Hz, 1H), 3.64 (t, J 
= 8.3 Hz, 1H), 2.84 (qdd, J = 6.8, 6.8, 2.8 Hz, 1H), 0.92 (d, J = 6.9 Hz, 3H) ppm; 13C NMR (75 
MHz, CDCl3): δ 204.3, 140.9, 136.6, 131.3, 130.4, 128.6, 128.3, 127.9, 127.4, 126.7, 126.1, 
50.7, 50.6, 12.5 ppm. Diisobutylaluminum hydride (4.0 ml, 1.0 M in hexanes, 4.0 mmol) 
reduction of 13e followed by purification by flash chromatography (20 % EtOAc/hexanes) gave 
461 mg (92 %) of the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.23-7.38 
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(m, 10H), 6.40-6.52 (m, 2H), 3.73 (dd, J= 10.4, 4.2 Hz, 1H), 3.59 (dd, J = 9.5, 4.9 Hz, 1H), 3.36 
(dd, J = 8.3, 7.9 Hz, 1H), 2.10-2.20 (m, 1H), 1.92 (s, 1H), 0.87 (d, J = 6.8 Hz, 3H) ppm; 13C 
NMR (75 MHz, CDCl3): δ 142.9, 137.2, 132.7, 130.2, 128.5, 128.4, 128.0, 127.1, 126.2, 126.1, 
66.2, 52.8, 40.4, 15.1 ppm; MS (EI, 70 V): m/z 252 (M+.), 193, 178, 165, 115, 91, 77, 65; HRMS 
m/z calcd for C18H20O (M+.): 252.1514, found: 252.1514.  
 
(E)-syn-2,4-Dimethyl-3,5-diphenylpent-4-en-1-ol (13f′): 
General Procedure D (1,2-DCE) was followed employing 
264 mg of 9f (1.00 mmol), 4.5 mg Ir dimer (0.005 mmol), 
8.4 mg PCy3 (0.03 mmol), 3.4 mg NaBPh4 (0.01 mmol), quenched with 7.9 mg PPh3 (0.03 
mmol) and warm the reaction at 60 oC 70 h to afford (E)-syn-2,4-dimethyl-3,5-diphenylpent-4-
en-1-al (13f) (2, 3-syn, 4E: 2,3-anti, 4E: 4Z = 87: 6: 7). 1H NMR (300 MHz, CDCl3): δ 9.78 (d, J 
= 3.7 Hz, 1H), 7.21-7.45 (m, 10H), 6.68 (s, 1H), 3.65 (d, J = 11.3 Hz, 1H), 3.10-3.26 (m, 1H), 
1.86 (s, 3H), 1.05 (d, J = 6.8 Hz, 3H) ppm. Diisobutylaluminum hydride (2.0 ml, 1.0 M in 
hexanes, 2.0 mmol) reduction of 13f followed by purification by flash chromatography (20 % 
EtOAc/hexanes) gave 230 mg (92 %) of the title compound as colorless oil. 1H NMR (300 MHz, 
CDCl3): δ 7.18-7.55 (m, 10H), 6.62 (s, 1H), 3.79 (dd, J= 10.7, 4.0 Hz, 1H), 3.58 (dd, J = 10.6, 
6.4 Hz, 1H), 3.30 (d, J = 11.0 Hz, 1H), 2.40-2.60 (m, 1H), 1.77 (d, J= 1.2 Hz, 3H), 0.94 (d, J = 
6.6 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 141.7, 140.4, 137.8, 128.8, 128.4, 128.1, 127.9, 
126.1, 126.0, 125.7, 66.5, 59.2, 35.5, 15.7, 15.0 ppm; MS (EI, 70 V): m/z 267 (M+.+H), 249, 234, 
219, 207, 191, 175, 129, 117; HRMS m/z calcd for C19H22O (M+.): 266.1671; found: 266.1676.  
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(E)-syn-3-iso-Propyl-2-methylnon-4-en-1-ol (13g′): 
General Procedure D (1,2-DCE) was followed employing 
377 mg of 9g (1.92 mmol), 9.0 mg Ir dimer (0.01 mmol), 16.8 mg PCy3 (0.06 mmol), 6.8 mg 
NaBPh4 (0.02 mmol), quenched with 15.8 mg PPh3 (0.06 mmol) and reflux 14 h to afford (E)-
syn-3-iso-propyl-2-methylnon-4-en-1-al 13g. 1H NMR (300 MHz, CDCl3): δ 9.60 (d, J = 3.0 Hz, 
1H), 5.42 (dt, J = 15.3, 6.7 Hz, 1H), 5.21 (ddt, J = 15.2, 9.7, 1.2 Hz, 1H), 2.44-2.50 (m, 1H), 
1.94-2.05 (m, 3H), 1.81-1.87 (m, 1H), 1.30-1.33 (m, 4H), 1.04 (d, J = 6.9 Hz, 3H), 0.91 (d, J = 
6.7 Hz, 3H), 0.88 (t, J = 7.0 Hz, 3H), 0.81 (d, J = 6.7 Hz, 3H) ppm. Diisobutylaluminum hydride 
(4.0 mmol, 1.0 M in hexanes, 4.0 mmol) reduction of 13g followed by purification by flash 
chromatography (20 % EtOAc/hexanes) gave 288 mg (76 %) of the title compound as colorless 
oil (13 % Z-isomers from NMR). Separation of the isomers by GLC [Varian CP Wax 52CB 
column (30 m x 0.25 mm), flow rate 0.6 mL/min, method: 80 oC for 2.00 min, ramp at 5.00 
oC/min to 250 oC, hold for 20 min, Tr = 25.9 (2,3-syn, 4E), 26.3 (2,3-anti, 4E) and 26.8 (2,3-syn, 
4Z) min] provided the isomer ratio: 83: 5: 12.  1H NMR (300 MHz, CDCl3): δ 5.35 (dt, 15.3, 6.6 
Hz, 1H), 5.16 (ddt, J= 15.3, 9.6, 1.1 Hz, 1H), 3.60 (dd, J= 10.7, 4.0 Hz, 1H), 3.34 (dd, J= 10.7, 
6.5 Hz, 1H), 2.00 (qd, J= 6.6, 0.9 Hz, 2H), 1.90 (s, 1H), 1.73-1.86 (m, 1H), 1.63-1.71 (m, 1H), 
1.53-1.61 (m, 1H), 1.29-1.32 (m, 4H), 0.93 (d, J = 6.5 Hz, 3H), 0.87 (t, J= 6.8 Hz, 3H), 0.83 (d, 
J= 6.7 Hz, 3H), 0.75 (d, J = 6.8 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 132.0, 129.3, 66.6, 
52.3, 36.7, 32.2, 31.8, 27.6, 22.1, 21.7, 17.1, 15.5, 13.7 ppm; MS (EI, 70 V): m/z 198 (M+.), 167, 
155, 139, 137, 123, 111, 95, 83, 69; HRMS m/z calcd for C13H26O (M+.): 198.1984; found: 
198.1976.  
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(E)-syn-2-Ethyl-3-methylnon-4-en-1-ol (13h′): General 
Procedure D (2 mol% catalyst loading, 1,2-DCE) was 
followed employing 182 mg of 9h (1.00 mmol), 9.0 mg Ir 
dimer (0.01 mmol), 16.8 mg PCy3 (0.06 mmol), 6.8 mg NaBPh4 (0.02 mmol) and an initial 
reaction time of 90 min (instead of 30 min), then quenched with 15.8 mg PPh3 (0.06 mmol) and 
reflux 14 h to afford (E)-syn-2-ethyl-3-methylnon-4-en-1-al 13h. 1H NMR (300 MHz, CDCl3): δ 
9.59 (d, J = 3.6 Hz, 1H), 5.46 (dt, J = 15.3, 6.3 Hz, 1H), 5.33 (dd, J = 15.3, 7.7 Hz, 1H), 2.44-
2.53 (m, 1H), 1.91-2.10 (m, 3H), 1.28-1.74 (m, 6H), 0.96 (t, J = 6.9 Hz, 3H), 0.80-0.88 (m, 6H) 
ppm. Diisobutylaluminum hydride (2.0 ml, 1.0 M in hexanes, 2.0 mmol) reduction of 13h 
followed by purification by flash chromatography (15 % EtOAc/hexanes) gave 155 mg (85 %) of 
the title compound as colorless oil. Separation of the isomers by GLC [Varian CP Wax 52CB 
column (30 m x 0.25 mm), flow rate 0.6 mL/min, method: 80 oC for 2.00 min, ramp at 5.00 
oC/min to 250 oC, hold for 20 min, Tr = 25.1 (2,3-anti, 4E), 25.3 (2,3-syn, 4E) and 25.5 (2,3-syn, 
4Z) min] provided the isomer ratio: 7: 80: 12. 1H NMR (300 MHz, CDCl3): δ 5.42 (dt, 15.4, 5.7 
Hz, 1H), 5.35 (dd, J= 15.4, 6.6 Hz, 1H), 3.59 (s, 1H), 3.58 (s, 1H), 2.16-2.30 (m, 1H), 1.96 (q, J 
= 6.5 Hz, 2H), 1.61 (s, 1H), 1.24-1.38 (m, 6H), 0.99 (d, J = 6.9 Hz, 3H), 0.91 (t, J = 7.1 Hz, 3H), 
0.88 (t, J = 6.9 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 134.4, 129.7, 63.3, 47.5, 37.2, 32.2, 
31.7, 22.1, 20.9, 17.8, 13.8, 11.6; MS (EI, 70 V): m/z 184 (M+.), 166, 153, 137, 123, 111, 95, 81, 
69, 55 ppm; HRMS m/z calcd for C12H24O (M+.): 184.1827; found: 184.1831. 
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(E)-syn-2-Methyl-3-phenylnon-4-en-1-ol (13i′) General 
Procedure D (1,2-DCE) was followed employing 460 mg of 
9i (2.00 mmol), 9.0 mg Ir dimer (0.01 mmol), 16.8 mg PCy3 
O
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(0.06 mmol), 6.8 mg NaBPh4 (0.02 mmol), quenched with 15.8 mg PPh3 (0.06 mmol) and reflux 
14 h to afford aldehyde 13i (syn : anti = 96 : 4). Diisobutylaluminum hydride (4.0 ml, 1.0 M in 
hexanes, 4.0 mmol) reduction of (E)-syn-2-methyl-3-phenylnon-4-en-1-al 13i followed by 
purification by flash chromatography (20 % EtOAc/hexanes) gave 284 mg (62 %) of the title 
compound as a colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.17-7.34 (m, 5H), 5.68 (ddt, J= 
15.2, 9.0, 1.1 Hz), 5.54(dt, J= 15.2, 6.3 Hz), 3.70 (dd, J= 10.9, 5.0 Hz, 1H), 3.57 (dd, J= 10.9, 5.8 
Hz, 2H), 3.11 (t, J= 9.1 Hz, 1H), 1.94-2.08 (m, 3H), 1.63 (s, 1H), 1.26-1.40 (m, 4H), 0.89 (t, J= 
7.0 Hz, 3H), 0.79 (d, J = 6.9 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 143.9, 132.6, 131.4, 
128.4, 127.8, 126.0, 66.7, 53.1, 40.5, 32.2, 31.5, 22.2, 15.3, 13.9 ppm; MS (EI, 70 V): m/z 232 
(M+.), 173, 131, 117, 105, 91, 69, 55; HRMS m/z calcd for C16H24O (M+.): 232.1827; found: 
232.1833.  
 
(E)-syn-2-Ethyl-3,6,6-trimethylhept-4-en-1-ol (13j′): 
General Procedure D (2 mol% catalyst loading, 1,2-DCE) 
was followed employing 127 mg of 9j (0.70 mmol), 3.2 mg Ir dimer (0.0035 mmol), 5.9 mg 
PCy3 (0.021 mmol), 2.4 mg NaBPh4 (0.007 mmol) and an initial reaction time of 90 min (instead 
of 30 min) before quenched with 5.5 mg PPh3 (0.021 mmol) and reflux 14 h to afford (E)-syn-2-
ethyl-3,6,6-trimethylhept-4-en-1-al 13j (syn : anti = 93 : 7). Diisobutylaluminum hydride (1.4 
ml, 1.0 M in hexanes, 1.4 mmol) reduction of 13j followed by purification by flash 
chromatography (15 % EtOAc/hexanes) gave 80 mg (62 %) of the title compound as colorless 
viscous oil. Separation of the diastereomers by GLC [Varian CP Wax 52CB column (30 m x 
0.25 mm), flow rate 0.6 mL/min, method: 80 oC for 2.00 min, ramp at 5.00 oC/min to 250 oC, 
hold for 20 min, Tr = 21.0 (2,3-syn, 4E) and 21.3 (2,3-anti, 4E) min] provided the diastereomer 
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ratio: 93: 7. 1H NMR (300 MHz, CDCl3): δ 5.47 (dd, J = 15.7, 0.6 Hz, 1H), 5.28 (dd, J = 15.7, 
8.1 Hz, 1H), 3.60 (m, 2H), 2.19 (s, 1H), 1.61 (s, 1H), 1.26-1.49 (m, 3H), 1.00 (d, J = 6.8 Hz, 3H), 
1.00 (s, 9H), 0.92 (t, J = 7.2 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 140.9, 129.1, 63.5, 
47.7, 37.6, 31.6, 29.8, 21.1, 18.2, 11.6 ppm; MS (EI, 70 V): m/z 184 (M+.), 151, 128, 111, 97, 84, 
69, 58; HRMS m/z calcd for C12H24O (M+.): 184.1827; found: 184.1829. 
 
cyclohexylallyloxy) pe
syn-(E)-2-(Cyclohexylmethyl)-3-phenylhept-4-enal (13k): General 
Procedure D was followed employing 1-((S,1E)-3-((E)-3-
nt-1-enyl)benzene (9k, 210 mg, 0.74 mmol) and 2 mol% catalyst (6.7 mg 
Ir-dimer, 12.4 mg PCy3, 5.1 mg NaBPh4), stirred 6 h at dichloromethane whereupon the solvent 
was removed in vacuo. Hexane was added and the resulting suspension was loaded onto a 6 x 2 
cm plug of Florisil and eluted with hexanes. Removal of the solvent in vacuo affored 1-((1E)-3-
((E)-3-cyclohexylprop-1-enyloxy)pent-1-enyl)benzene (10k). Then added 5 ml dichloroethane 
and refluxed in oil bath for 16 h. Purification by flash chromatograph on Iatrobeads neutral 
(pH7) silica gel (2.5 % ethyl ether in hexanes) to yield 128 mg (61 %) of the title compound as a 
colorless oil. (syn : anti = 95 : 5). 1H NMR (300 MHz, CDCl3): δ 9.53 (d, J = 4.5 Hz, 1H), 7.16-
7.37 (m, 5H), 5.53-5.60 (m, 2H), 3.40-3.48 (m, 1H), 2.72-2.81 (m, 1H), 1.95-2.11 (m, 2H), 0.96 
(t, J = 7.2 Hz, 3H), 0.57-1.72 (m, 13 H) ppm; 13C NMR (75 MHz, CDCl3): δ 205.0, 142.1, 134.2, 
129.8, 127.9, 126.6, 54.0, 50.2, 35.4, 35.1, 34.1, 32.3, 26.4, 26.1, 25.9, 25.4, 13.5 ppm; MS (EI, 
70 V): m/z 284 (M+.), 255, 226, 212, 162, 145; HRMS m/z calcd for C20H28O (M+.): 284.2140. 
found 284.2144. 
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syn-(E)-2-(cyclohexylmethyl)-3-phenylhept-4-en-1-ol (13k′): 
Diisobutylaluminum hydride (1.4 ml, 1.0 M in hexanes, 1.4 mmol) 
reduction of 13k (142 mg, 0.5 mmol) followed purification by flash chromatograph on silical gel 
(16 % ethyl acetate in hexanes) afford 128 mg (90 %) of the title compound as colorless oil. 1H 
NMR (300 MHz, CDCl3): δ  7.17-7.33 (m, 5H), 5.68 (dd, J = 15.3, 7.9 Hz, 1H), 5.61 (dt, J = 
15.3, 5.3 Hz, 1H), 3.74 (dd, J = 11.3, 3.6 Hz, 1H), 3.62 (dd, J = 11.3, 5.0 Hz, 1H), 3.23 (t, J = 8.7 
Hz, 1H), 1.90-2.08 (m, 3H), 0.86-1.70 (m, 14H), 0.98 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 
MHz, CDCl3): δ 144.1, 133.0, 131.6, 128.4, 127.9, 126.0, 63.5, 52.2, 42.4, 36.4, 35.0, 34.4, 32.6, 
26.5, 26.4, 26.2, 25.5, 13.7 ppm; MS (EI, 70 V): m/z 286 (M+.), 268, 243, 214, 199, 172, 143, 
130; HRMS m/z calcd for C20H28O (M+.): 286.2297. found 286.2292. 
HO
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3-yloxy)pent-3-enyl)ben
syn-(E)-3-Phenyl-2-(3-phenylpropyl)hept-4-enal (13l): General 
Procedure D was followed employing 1-((3E)-5-((E)-1-phenylpent-1-en-
zene (9l, 306 mg, 1.0 mmol) and 2 mol% catalyst (9.0 mg Ir-dimer, 16.8 
mg PCy3, 6.8 mg NaBPh4) in dichloroethane for 6 h, and then refux 16 h. Purification by flash 
chromatograph on Iatrobeads neutral (pH7) silica gel (2.5 % EtOAc in hexanes) afford 236 mg 
(77 %) (syn : anti = 96 : 4) of the title compound as colorless oil.  1H NMR (300 MHz, CDCl3): δ 
9.71 (d, J = 4.2 Hz, 1H), 7.19-7.50 (m, 10H), 5.68-5.72 (m, 2H), 3.60-3.66 (m, 1H), 2.52-2.84 
(m, 4H), 2.09-2.17 (m, 2H), 1.41-1.72 (m, 3H), 1.08 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 
MHz, CDCl3): δ 204.84, 134.30, 141.88, 141.75, 129.48, 128.72, 128.24, 127.86, 126.66, 
125.72, 56.42, 49.71, 35.52, 28.60, 27.27, 25.45, 13.50 ppm; MS (EI, 70 V): m/z 306 (M+.), 288, 
277, 199, 187, 145, 91; HRMS m/z calcd for C22H26O (M+.): 306.1984. found 306.1982. 
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syn-(E)-3-Phenyl-2-(3-phenylpropyl)hept-4-en-1-ol (13l′): 
m
syn-(E)-2-(3-(Benzyloxy)propyl)-3-phenylhept-4-enal (13m): 
6.8 mg NaBPh4) in dichl
Diisobutylaluminum hydride (1.4 ml, 1.0 M in hexanes, 1.4 mmol) 
g, 0.77) followed purification by flash chromatograph on silical gel (16 
% EtOAc in hexanes) afford 216 mg (90 %) of the title compound as colorless oil.
reduction of 13l (236 
 1H NMR (300 
MHz, CDCl3): δ 7.08-7.34 (m, 10H), 5.66 (dd, J = 15.4, 8.3 Hz, 1H), 5.58 (dt, J = 15.4, 5.7 Hz, 
1H), 3.73 (dd, J = 11.3, 4.5 Hz, 1H), 3.68 (dd, J = 11.3, 4.7 Hz, 1H), 3.25 (t, J = 8.8 Hz, 1H), 
2.35-2.61 (m, 2H), 1.98-2.11 (m, 2H), 1.82-1.93 (m, 1H), 1.44-1.74 (m, 3H), 1.23-1.33 (m, 2H), 
0.98 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 144.01, 142.48, 133.12, 131.34, 
128.49, 128.26, 128.19, 127.81, 126.06, 125.58, 63.20, 51.57, 45.28, 36.01, 28.81, 28.34, 25.49, 
13.68 ppm; IR(liquid film): 3373, 3026, 2931, 1601, 1494, 1453, 1030, 969, 748, 699 cm-1; MS 
(EI, 70 V): m/z 308 (M+.), 290, 261, 233, 199, 186, 145, 117, 91; HRMS m/z calcd for C22H28O 
(M+.): 308.2140. found 308.2142.  
 
General Procedure D was followed employing di(allyl) ether (9m, 336 
mg, 1.0 mmol) and 2 mol% catalyst (9.0 mg Ir-dimer, 16.8 mg PCy3, 
oroethane for 6 h, then refuxed 16 h after 15.2 mg PPh3 was added. 
Purification by flash chromatograph on Iatrobeads neutral (pH7) silica gel (2.5 % ethyl acetate in 
hexanes) afford 249 mg (74 %) of the title compound as colorless oil, (syn : anti = 96 : 4). 1H 
NMR (300 MHz, CDCl3): δ 9.59 (d, J = 4.1 Hz, 1H), 7.18-7.34 (m, 10H), 5.43-5.63 (m, 2H), 
4.16 (s, 2H), 3.45-3.54 (m, 1H), 3.37 (t, J = 5.8 Hz, 1H), 2.64-2.72 (m, 1H), 1.97-2.13 (m, 2H), 
1.28-1.72 (m, 4H), 0.96 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 204.75, 141.92, 
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138.45, 134.34, 129.49, 128.70, 128.28, 127.90, 127.53, 127.46, 126.64, 72.70, 69.67, 56.26, 
49.83, 27.04, 25.45, 24.43, 13.50 ppm. 
 
syn- (E)-2-(3-(Benzyloxy)propyl)-
3,5-diphenylpent-4-en-1-ol (13n′): 
General Procedure D was followed 
employing ((E)-3-((E)-5-(benzyloxy)pent-2-enyloxy)prop-1-ene-1,3-diyl)dibenzene (9n, 384 
mg, 1.0 mmol) and 2 mol% catalyst (9.0 mg Ir-dimer, 16.8 mg PCy3, 6.8 mg NaBPh4) in 
dichloromethane for 6 h, and stirred overnight after 15.2 mg (0.06 mmol) PPh3 was added o 
afford syn-(E)-2-(3-(benzyloxy)propyl)-3,5-diphenylpent-4-en-1-ol 13n (syn : anti = 97 : 3). 
Diisobutylaluminum hydride (2.0 ml, 1.0 M in hexanes, 2.0 mmol) reduction of 13n followed by 
purification by flash chromatography (16 % EtOAc/hexanes) gave 274 mg (71 %) of the title 
compound as a colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.19-7.36 (m, 15H), 6.49 (d, J = 
15.6 Hz, 1H), 6.41 (dd, J = 15.6, 8.0 Hz, 1H), 4.45 (s, 2H), 3.76 (d, J = 4.5 Hz, 2H), 3.50 (t, J = 
8.6 Hz, 1H), 3.39 (t, J = 6.4 Hz, 2H), 1.96-2.05 (m, 1H), 1.30-1.77 (m, 4H) ppm; 13C NMR (75 
MHz, CDCl3): δ 143.20, 138.35, 137.22, 132.53, 130.42, 128.60, 128.44, 128.30, 127.95, 
127.60, 127.49, 127.16, 126.28, 126.15, 72.81, 70.45, 62.64, 51.62, 45.10, 26.81, 25.00 ppm. 
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tert-Butyl((Z)-4-((E)-oct-2-en-4-yloxy)but-2-enyloxy)diphenylsilane (9o): 
General procedure A was followed employing (E)-oct-2-en-4-ol (640 mg, 5.0 
mmol) and (Z)-(4-bromobut-2-enyloxy)(tert-butyl)diphenylsilane (2.910 g, 7.5 
O
Bu Me
TBDPSO
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mmol)55. Purification by flash chromatograph on silical gel (2 % EtOAc in hexanes) to yield  
1443 mg (66 %) of the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.69-7.72 
(m, 4H), 7.38-7.46 (m, 6H), 5.76 (dt, J = 11.2, 6.0 Hz, 1H), 5.58 (dt, J = 11.2, 6.6 Hz, 1H), 5.51 
(dq, J = 15.3, 6.4 Hz, 1H), 5.23 (dd, J = 15.3, 8.2 Hz, 1H), 4.27 (d, J = 6.0 Hz, 2H), 3.91 (dd, J = 
12.7, 5.6 Hz, 1H), 3.74 (dd, J = 12.7, 6.9 Hz, 1H), 3.50 (q, J = 7.0 Hz, 1H), 1.65 (d, J = 6.3 Hz, 
3H), 1.20-1.45 (m, 6H), 1.07 (s, 9H), 0.89 (t, J = 7.4 Hz, 3H) ppm. 
 
syn- (E)-2-(2-(tert-Butyldiphenlilyl 
oxyethyl) -3-methylnon-4-en-1-ol 
(13o′): General Procedure D was 
followed employing di(allyl) ether (9o, 436 mg, 1.0 mmol) and 2 mol% catalyst (9.0 mg Ir-
dimer, 16.8 mg PCy3 and 6.8 mg NaBPh4) in dichloroethane for 6 h, and refluxed overnight to 
afford syn-(E)-2-(2-(tert-butyldiphenylsilyloxy)ethyl)-3-methylnon-4-en-1-al 13o. Then DIBAL-
H (1.0 M in hexanes, 2.0 ml, 2.0 mmol) was added at -78 oC. Purification by flash 
chromatograph on silical gel (5-16 % EtOAc in hexanes) afford 162 mg (37 %) of the title 
compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.67-7.77 (m, 4H), 7.35-7.50 (m, 6H), 
5.40 (dt, J = 15.2, 6.2 Hz, 1H), 5.32 (dd, J = 15.2, 6.7 Hz, 1H), 3.54-3.83 (m, 4H), 2.74 (brs, 1H), 
2.14-2.38 (m, 1H), 1.97-2.01 (m, 1H), 1.45-1.72 (m, 3H), 1.31-1.35 (m, 4H), 1.08 (s, 9H), 0.97 
(d, J = 6.9 Hz, 3H), 0.92 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 135.56, 134.06, 
133.27, 129.98, 129.73, 127.70, 64.57, 63.28, 44.36, 38.38, 32.26, 31.75, 26.77, 22.17, 19.07, 
17.48, 13.92 ppm; MS (EI, 70 V): m/z 381 (M+.-C4H9), 363, 351, 303, 255, 229, 199; HRMS m/z 
calcd for C24H33O2Si (M+.-C4H9): 381.2250. found 381.2255. 
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55 LeStrat, F.; Murphy, J. A.; Hughes, M. Org. Lett. 2004, 4, 2735-2738. 
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 tert- Butyl((E)-4-((E)-oct-2-en-4-yloxy)but-1-enyloxy)diphenylsil 
ane (10o′): The compound was isolated with the 13o’ as the by 
product. yield 135 mg (31 %). 1H NMR (300 MHz, CDCl3): δ 7.67-7.77 (m, 4H), 7.35-7.50 (m, 
6H), 6.34 (d, J = 11.9 Hz, 1H), 5.59 (dq, J = 15.3, 6.4 Hz, 1H), 5.28 (dd, J = 15.3, 8.1 Hz, 1H), 
5.14 (dt, J = 11.9, 7.5 Hz, 1H), 3.53 (q, J = 7.0 Hz, 1H), 3.41 (dt, J = 9.3, 6.9 Hz, 1H), 3.15 (dt, J 
= 9.3, 7.2 Hz, 1H), 2.10 (q, J = 7.0 Hz, 2H), 1.72 (dd, J = 6.4, 1.5 Hz, 3H), 1.25-1.47 (m, 6H), 
1.11 (s, 9H), 0.91 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ141.57, 135.46, 132.99, 
132.58, 129.79, 127.68, 108.14, 80.86, 68.54, 35.38, 28.02, 27.65, 26.85, 26.55, 22.66, 19.23, 
17.64, 14.05, 1.02 ppm. 
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(E)-3-(3-Methylbut-2-enyloxy)-1,3-diphenylprop-1-ene (9p): General 
Procedure C was followed employing 2.61 g of (E)-1,3-diphenyl-2-propen-
1-ol (12.4 mmol) and 3-methylbut-2-en-1-ol (2.09 g, 24.8 mmol). 
Purification by flash chromatography (5 % EtOAc/hexanes) gave 2.58 g (75 %) of the title 
compound as colorless oil. IR (liquid film): 3027, 1600, 1494, 1449, 1377, 1059, 967, 745, 698. 
cm-1; 1H NMR (300 MHz, CDCl3): δ 7.27-7.54 (m, 10H), 6.70 (d, J = 15.9 Hz, 1H), 6.44 (dd, J = 
15.9, 7.0 Hz, 1H), 5.54 (t, J = 6.8 Hz, 1H), 5.06 (d, J = 7.0 Hz, 1H), 4.06-4.18 (m, 2H), 1.86 (s, 
3H), 1.72 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 144.3, 136.9, 136.5, 131.1, 130.5, 128.4, 
127.5, 126.9, 126.5, 121.1, 81.5, 64.8, 25.8, 18.0 ppm; MS (EI, 70 V) m/z: 278 (M+.), 209, 193, 
181, 158, 131, 115, 105, 91, 77, 69; HRMS m/z calcd for C20H22O (M+.): 278.1671; found 
278.1683. 
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(E)-(3-(Allyloxy)-3-methylbut-1-enyl)benzene (9q): General Procedure A was 
followed employing (E)-2-methyl-4-phenylbut-3-en-2-ol56 (810 mg, 5.0 mmol), 
allyl bromide (908 mg, 7.5 mmol). Purification by flash chromatograph on silical gel (2.5 % 
EtOAc in hexanes) afford 1008 mg (99 %) of the title compound as colorless oil. 1H NMR (300 
MHz, CDCl3): δ 7.27-7.46 (m, 5H), 6.56 (d, J = 16.4 Hz, 1H), 6.29 (d, J = 16.4 Hz, 1H), 5.99 
(ddt, J = 17.2, 10.4, 5.3 Hz, 1H), 5.35 (d, J = 17.2 Hz, 1H), 5.19 (d, J = 10.4 Hz, 1H), 3.96 (d, J = 
5.3 Hz, 2H), 1.47 (s, 6H) ppm; 13C NMR (75 MHz, CDCl3): δ 136.76, 135.90, 135.31, 128.87, 
127.43, 126.30, 115.78, 75.32, 64.08, 26.39 ppm. MS (EI, 70 V): m/z 187 (M+.-Me), 161, 145, 
129, 117, 105, 91, 77, 67; HRMS m/z calcd for C13H15O (M+.-Me) 187.1123; found 187.1122. 
O
Me
Me
Ph
 
 
                                                
syn-2,5-Dimethyl-3-phenylhex-4-enal (13q): General Procedure D was 
followed employing (E)-(3-(Allyloxy)-3-methylbut-1-enyl)benzene (9q, 
404 mg, 2.0mmol) and 1 mol% catalyst (9.0 mg Ir-dimer, 16.8 mg PCy3 and 6.8 mg NaBPh4) in 
dichloroethane for 10 min, after 15.8 mg PPh3 was added, heated the mixture to 60 oC and stirred 
6 h. Purification by flash chromatograph on Introbeads silica gel (PH = 7.0, 2.5 % ethyl acetate 
in hexanes) afford 372 mg (92 %) of the title compound as colorless oil, (syn: anti = 95: 5). 1H 
NMR (300 MHz, CDCl3): δ 9.68 (d, J = 3.0 Hz, 1H), 7.21-7.37 (m, 5H), 5.44 (d, J = 9.9 Hz, 1H), 
3.70 (t, J = 9.7 Hz, 1H), 2.68-2.79 (m, 1H), 1.73 (s, 3H), 1.69 (s, 3H), 0.94 (d, J = 6.9 Hz, 3H) 
ppm. 
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(E)-4-(Allyloxy)-4-methylpent-2-ene (9r): General Procedure A was followed 
employing (E)-2-methylpent-3-en-2-ol57 (1.0 g, 10 mmol), allyl bromide (1.8 g, 
O
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56 Kohler, H.; Am. Chem. J. 1905, 33, 28. 
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15 mmol). Purification by flash chromatograph on silical gel (2.5 % EtOAc in hexanes) afford 
1.26 g (90 %) of the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 5.91 (ddt, J 
= 17.3, 10.4, 5.4 Hz, 1H), 5.61 (dq, J = 16.4 Hz, 6.0 Hz, 1H), 5.46 (d, J = 16.4 Hz, 1H), 5.25 (d, J 
= 17.3 Hz, 1H), 5.11 (d, J = 10.4 Hz, 1H), 3.83(d, J = 5.4 Hz, 1H), 1.71 (d, J = 6.0 Hz, 3H), 1.28 
(s, 6H) ppm; 13C NMR (75 MHz, CDCl3): δ 136.6, 136.0, 124.4, 115.2, 74.7, 63.6, 26.1, 17.5 
ppm; MS (EI, 70 V): m/z 125 (M+.-Me), 109, 91; HRMS m/z calcd for C8H13O (M+.-
Me)125.0966, found 125.0961. 
 
syn-2,3,5-Trimethylhex-4-en-1-ol (13r′): 
General Procedure D was followed 
employing di(allyl) ether (9r, 280 mg, 2.0mmol) and 1 mol% catalyst (9.0 mg Ir-dimer, 16.8 mg 
PCy3 and 6.8 mg NaBPh4) in dichloroethane for 10 min, after 15.8 mg PPh3 was added, heated 
the mixture to 83 oC and stirred 6 h to afford syn-2,3,5-trimethylhex-4-en-1-al 13r, (syn : anti = 
91 : 9). 1H NMR (300 MHz, CDCl3): δ 9.63 (d, J = 2.1 Hz, 1H), 5.02 (d, J = 9.8 Hz, 1H), 2.70 
(dqd, J = 9.8, 6.9, 6.9 Hz, 1H), 2.24 (dqd, J = 6.9, 6.9, 2.1 Hz, 1H), 1.70 (s, 3H), 1.64 (s, 3H), 
1.05 (d, J = 6.9 Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H) ppm. Diisobutylaluminum hydride (4.0 ml, 1.0 
M in hexanes, 4.0 mmol) reduction of 13r followed by purification by flash chromatography (16 
% EtOAc/hexanes) gave 230 mg (81 %) of the title compound as a colorless oil. 1H NMR (300 
MHz, CDCl3): δ 4.99 (d, J = 9.7 Hz, 1H), 3.56 (dd, J = 10.7, 5.5 Hz, 1H), 3.34 (dd, J = 10.7, 6.6 
Hz, 1H), 2.25 (dqd, J = 9.7, 6.7, 6.7 Hz, 1H), 2.00 (brs, 1H), 1.67 (s, 3H), 1.60 (s, 3H), 1.39-1.55 
(m, 1H), 0.89 (d, J = 6.7 Hz, 3H), 0.88 (d, J = 6.7 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 
Me
Me Me
Me
O
H
Me
Me Me
Me
OH
                                                                                                                                                             
57 Collins, S.; Hong, Y.; Hoover, G. J.; Veit, J. R. J. Org. Chem. 1990, 55, 3565-3568. 
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130.5, 129.9, 67.0, 41.4, 34.8, 25.8, 18.3, 17.9, 14.2 ppm; MS (EI, 70 V): m/z 142 (M+.), 109, 96, 
83, 66, 53; HRMS m/z calcd for C9H18O (M+.): 142.1358. found 142.1354. 
 
                                                
(E)-1- Phenyl-5-(piperidin-1-
yl)pent-2-en-1-ol (19a′): A solution of 
1-(but-3-ynyl)piperidine 58  (1.37 g, 
10.0 mmol) in dry THF was added n-BuLi (1.6 M in hexanes, 6.3 ml, 10.0 mmol) at -78 oC and 
stirred 30 min, then benzealdehyde (1.06 g, 10.0 mmol) in THF was added dropwise, stirred 
overnight with warm to ambient temperature. Saturated NH4Cl solution was added to quench the 
reaction, exatracted with ethyl ether. After solvent Vaporation, the crude oil was purified by 
column chromatography on silical gel (16 % ethyl acetate in hexanes) to yield 1.85 g (82 %) of 
1-phenyl-5-(piperidin-1-yl)pent-2-yn-1-ol (19a′′) as light yellow oil. The compound was solved 
in dry THF, then sodium bis(2-methoxyethoxy)aluminum hydride (Red-Al, 65 % in toluene, 3.33 
M, 1.8 equiv, 4.5 ml, 14.8 mmol in 20 ml THF) was added dropwise at 0 oC, warmed to reflux 
for 3h, cool it to 0 oC, add water following saturated sodium tartrate solution slowly to quench 
the reaction and extracted with ethyl ether, After solvent Vaporation, the crude oil was purified 
by column chromatography on silical gel (20 % methanol in dichloromethane) to yield 1.76 g (95 
%) of the title compound  as light yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.23-7.40 (m, 5H), 
5.66-5.79 (m, 2H), 5.15 (d, J = 5.0 Hz, 1H), 2.34-2.40 (m, 6H), 2.23-2.34 (m, 2H), 1.55-.162 (m, 
4H), 1.43-1.47 (m, 2H) ppm; 13C NMR (75 MHz, CDCl3): δ 143.40, 133.71, 129.87, 128.36, 
127.35, 126.15, 74.83, 58.60, 54.36, 29.56, 25.68, 24.30 ppm; MS (EI, 70 V): m/z 227 (M+.-
OH
Ph NN
OH
Ph
 
58 Turner, S. C.; Esbenshade, T. A.; Bennani, Y. L.; Hancock, A. A. Bioorg. Med. Chem. Lett. 2003, 13, 2131-2136. 
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H2O), 198, 158, 129, 115, 98, 84, 77; HRMS m/z calcd for C16H21N (M+.-H2O): 227.1674. found 
227.1673.  
 
(E)-(1-(Allyloxy)penta-2,4-dienyl)benzene (19a): The general procedure A  
was applied to (E)-1-phenyl-5-(piperidin-1-yl)pent-2-en-1-ol (19a′, 1.76 g, 7.8 
mmol). The crude product was purified by column chromatography on silical gel (2 % ethyl 
acetate in hexanes) to yield 1.25 g (80 %) of the title compound as light yellow oil. 1H NMR 
(300 MHz, CDCl3): δ 7.29-7.40 (m, 5H), 6.23-6.42 (m, 2H), 5.90-6.02 (m, 1H), 5.83 (dd, j = 
14.4, 7.0 Hz, 1H), 5.11-5.35 (m, 4H), 4.88 (d, J = 7.1 Hz, 1H), 4.02 (dd, J = 13.8, 5.5 Hz, 1H), 
3.98 (dd, J = 13.8, 5.5 Hz, 1H) ppm; 13C NMR (75 MHz, CDCl3): δ 141.00, 136.28, 134.73, 
134.29, 132.11, 128.46, 127.64, 126.83, 117.83, 116.91, 81.22, 69.18 ppm; MS (EI, 70 V): m/z 
200 (M+.), 187, 173, 159, 143, 131, 115, 105, 91, 77, 65, 55; HRMS m/z calcd for C14H16O (M+.): 
200.1201. found 200.1205. 
O
Ph
 
(allyloxy)penta-2,4-dienyl)benzene (
syn-(E)-2-Methyl-5-phenyl-3-vinylpent-4-enol (20a′): 
General Procedure D was followed employing (E)-(1-
19a, 200 mg, 1.0 mmol) with 1 mol% catalyst (4.5 mg Ir-
dimer, 8.4 mg PCy3 and 3.4 mg NaBPh4) and stirred 30 min at dichloromethane. Then added 
PPh3 (7.8 mg, 0.03 mmol) and keep ambient temperature for 12 h to afford syn-(E)-2-methyl-5-
phenyl-3-vinylpent-4-enal 20a (syn : anti = 94 : 6). 1H NMR (300 MHz, CDCl3): δ 9.73 (d, J = 
2.0 Hz, 1H), 6.49 (d, J = 15.9 Hz, 1H), 6.20 (dd, J = 7.8 Hz, 1H), 5.91 (ddd, J = 16.6, 10.8, 7.4 
Hz, 1H), 5.26 (ddd, J = 10.8, 1.3, 0.9 Hz, 1H), 5.25 (ddd, J = 16.6, 1.3, 1.3 Hz, 1H), 3.37 (q, J = 
7.4 Hz, 1H), 2.65 (qdd, J = 7.0, 7.0, 2.0 Hz, 1H), 1.20 (d, J = 7.0 Hz, 3H) ppm. 
O
Ph
Me
HO
Ph
Me
H
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Diisobutylaluminum hydride (2.0 ml, 1.0 M in hexanes, 2.0 mmol) reduction of 20a followed by 
purification by flash chromatograph on silical gel (16 % ethyl acetate in hexanes) to yield 160 
mg (80 %) of the title compound as colorless oil. IR (liquid film): 3373, 2961, 2877, 1635, 1494, 
1449, 1030, 969, 915, 749, 694 cm-1.1H NMR (300 MHz, CDCl3): δ 7.23-7.41 (m, 5H), 6.35 (d, J 
= 15.9 Hz, 1H), 5.98 (dd, J = 15.9, 7.9 Hz, 1H), 5.73-5.85 (m, 1H), 5.06 (d, J = 11.6 Hz, 1H), 
5.05 (d, J = 15.6 Hz, 1H), 3.58 (dd, J = 10.6, 6.0 Hz, 1H), 3.46 (dd, J = 10.6, 6.0 Hz, 1H), 2.90 
(q, J = 7.4 Hz, 1H), 1.62-1.85 (m, 1H), 1.73 (s, 1H), 0.90 (d, J = 6.9 Hz, 1H) ppm; 13C NMR (75 
MHz, CDCl3): δ 138.49, 137.39, 131.55, 130.43, 128.48, 127.13, 126.07, 116.10, 66.29, 49.87, 
39.88, 13.87 ppm; MS (EI, 70 V): m/z 202 (M+.), 184, 169, 155, 143, 128, 115, 91; HRMS m/z 
calcd for C14H16 (M+.-H2O): 184.1252. found 184.1244.  
 
                                                
((1E,3E)-5-(Allyloxy)penta-1,3-dienyl)benzene(19b): The general procedure 
A was applied to (2E,4E)-5-phenylpenta-2,4-dien-1-ol59 (1.6 g, 10.0 mmol). 
The crude product was purified by column chromatography on silical gel (2 % ethyl acetate in 
hexanes) to yield 1.91 g (95 %) of the title compound as light yellow oil. 1H NMR (300 MHz, 
CDCl3): δ 7.21-7.40 (m, 5H), 6.79 (dd, J = 15.6, 10.4 Hz, 1H), 6.54 (d, J = 15.6 Hz, 1H), 6.41 
(dd, J = 15.1, 10.5 Hz, 1H), 5.84-6.00 (m, 2H), 5.30 (d, J = 17.3 Hz, 1H), 5.20 (d, J = 10.4 Hz, 
1H), 4.08 (d, J = 6.2 Hz, 2H), 4.01 (d, J = 5.6 Hz, 2H); 13C NMR (75 MHz, CDCl3): δ 136.98, 
134.61, 132.61, 132.49, 129.95, 128.42, 128.08, 127.40, 126.22, 116.80, 70.89, 70.19 ppm. MS 
(EI, 70 V): m/z 200 (M+.), 187, 173, 159, 143, 131, 115, 105, 91, 77, 65, 55; HRMS m/z calcd for 
C14H16O (M+.): 200.1201; found 200.1205. 
O
Ph
 
 
59 Kim, D. D.; Lee, S. J.; Beak, P. J. Org. Chem. 2005, 70, 5376-5386. 
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anti-(E)-2-Methyl-5-phenyl-3-vinylpent-4-enol (20b′): 
The general procedure D was followed employing 
((1E,3E)-5-(Allyloxy)penta-1,3-dienyl)benzene (19b, 200 
mg, 1.0 mmol) with 1 mol% catalyst (4.5 mg Ir-dimer, 8.4 mg PCy3 and 3.4 mg NaBPh4) and 
stirred 30 min at dichloroethane. Then added PPh3 (7.8 mg, 0.03 mmol) and warm to 80 oC for 
12 h to afford anti-(E)-2-methyl-5-phenyl-3-vinylpent-4-enal 20b (syn : anti = 92 : 8). 
Diisobutylaluminum hydride (2.0 ml, 1.0 M in hexanes, 2.0 mmol) reduction of 20b followed by 
purification by flash chromatograph on silical gel (16 % ethyl acetate in hexanes) to yield 160 
mg (80 %) of the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.23-7.41 (m, 
5H), 6.45 (d, J = 15.9 Hz, 1H), 6.19 (dd, J = 15.9, 8.5 Hz, 1H), 5.91 (ddd, J = 16.9, 10.5, 7.6 Hz, 
1H), 5.14 (d, J = 16.9 Hz, 1H), 5.12 (d, J = 10.5 Hz, 1H), 3.65 (dd, J = 10.8, 6.1 Hz, 1H), 3.54 
(dd, J = 10.8, 6.0 Hz, 1H), 3.00 (q, J = 7.4 Hz, 1H), 1.79-1.93 (m, 1H), 1.73 (s, 1H), 0.98 (d, J = 
6.9 Hz, 1H) ppm; 13C NMR (75 MHz, CDCl3): δ 139.97, 137.41, 131.18, 130.03, 128.44, 
127.09, 126.06, 115.31, 66.23, 49.67, 39.90, 13.76 ppm. MS (EI, 70 V): m/z 202 (M+.), 184, 169, 
155, 143, 128, 115, 91; HRMS m/z calcd for C14H16 (M+.-H2O): 184.1252; found 184.1244. 
O
Me
Ph
HO
Me
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((1E,3E)-5-(Allyloxy)-5-methylhexa-1,3-dienyl)benzene (19c): The 
general procedure A  was applied to (3E,5E)-2-methyl-6-phenylhexa-3,5-
dien-2-ol60 (1.88 g, 10.0 mmol). The crude product was purified by column chromatography on 
silical gel (2 % ethyl acetate in hexanes) to yield 2.17 g (95 %) of the title compound as light 
yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.21-7.44 (m, 5H), 6.81 (dd, J = 15.6, 10.3 Hz, 1H), 
6.58 (d, J = 15.6 Hz, 1H), 6.35 (dd, J = 15.3, 10.3 Hz, 1H), 5.95 (ddt, J = 17.2. 10.3, 5.4 Hz, 1H), 
O
Ph
Me
Me
 
60 Gallagher, W. P.; Terstiege, I.; Maleczka, R. E. J. Am. Chem. Soc. 2001, 123, 3194-3204. 
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5.84 (d, J = 11.6 Hz, 1H), 5.31 (d, J = 17.2 Hz, 1H), 5.15 (d, J = 10.3 Hz, 1H), 3.90 (d, J = 5.4 
Hz, 2H), 1.39 (s, 6H) ppm; 13C NMR (75 MHz, CDCl3): δ 139.76, 137.19, 135.99, 132.23, 
129.53, 128.55, 127.45, 126.25, 115.77, 75.23, 64.12, 26.38 ppm. 
 
syn-(E)-2,5-Dimethyl-3-styrylhex-4-enal (20c): General Procedure D was 
followed employing di(allyl) ether (19c, 228 mg, 1.0 mmol) with 1 mol% 
catalyst (4.5 mg Ir-dimer, 8.4 mg PCy3 and 3.4 mg NaBPh4) and stirred 30 
min at dichloroethane. Then added PPh3 (7.8 mg, 0.03 mmol) and warm to 80 oC for 12 h (syn : 
anti  = 92: 8). The crude product was purified by column chromatography on Iatrobeads neutral 
(pH7) silica gel (2 % ethyl acetate in hexanes) to yield 176 mg (77 %) of the title compound as 
light yellow oil.1H NMR (300 MHz, CDCl3): δ 9.66 (d, J = 2.3 Hz, 1H), 6.40 (d, J = 15.9 Hz, 
1H), 6.06 (dd, J = 15.9, 7.7 Hz, 1H), 5.15 (d, J = 8.3 Hz, 1H), 3.39 (q, J = 8.2 Hz, 1H), 2.44-2.50 
(m, 1H), 1.75 (s, 3H), 1.68 (s, 3H), 1.10 (d, J = 6.9 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 
204.82, 137.16, 134.17, 130.61, 129.81, 128.47, 127.24, 126.12, 123.39, 50.93, 43.48, 25.88, 
18.21, 11.62 ppm. 
Me
Ph
Me
Me
O
H
2.4.2 Experiment of section 2.3. 
2.4.2.1 ICR reaction of allyl homoallyl ether 
syn- 4-Cyclohexylidene-2,3-dimethylbutan-1-ol 
(23a′): General procedure D was followed 
employing 180 mg of 1-allyl-1-Me
Me
O H
Me
Me
HO
 75 
(allyloxy)cyclohexane61 (21a, 180 mg, 1.0 mmol) and 2 mol% catalyst (9.0 mg Ir-dimer, 0.01 
mmol, 16.8 mg PCy3, 0.06 mmol, 6.8 mg NaBPh4, 0.02 mmol) in dichloroethane and an initial 
reaction time of 12 h before quenched with 15.8 mg PPh3 (0.06 mmol) and reflux 12 h to afford 
syn-4-cyclohexylidene-2,3-dimethylbutan-1-al 23a (syn: anti = 94: 6). 1H NMR (300 MHz, 
CDCl3): δ 9.62 (d, J = 2.3 Hz, 1H), 4.96 (d, J = 9.8 Hz, 1H), 2.72 (ddq, J = 9.8, 6.8, 6.8 Hz, 1H), 
2.22 (qdd, J = 6.9, 6.9, 2.3 Hz, 1H), 2.10-2.18 (m, 2H), 2.00-2.10 (m, 2H), 1.46-1.59 (m, 6H), 
1.04 (d, J = 6.9 Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 205.1, 
139.8, 124.0, 51.6, 37.0, 32.5, 28.8, 28.4, 27.6, 26.6, 18.1, 10.5 ppm. Diisobutylaluminum 
hydride (2.0 ml, 1.0 M in hexanes, 2.0 mmol) reduction of 23a followed by purification by flash 
chromatography (15 % EtOAc/hexanes) gave 115 mg (64 %) of the title compound as colorless 
oil. IR (liquid film): 3349, 2927, 2853, 1667, 1448, 1376, 1019, 851 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 4.95 (d, 1H), 3.58 (dd, J = 10.3, 5.5 Hz, 1H), 3.39-3.41 (m, 1H), 2.24-2.36 (m, 1H), 
2.06-2.17 (m, 4H), 1.41-1.65 (m, 6H), 0.91 (d, J = 6.7 Hz, 1H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 138.8, 126.7, 67.2, 41.5, 37.3, 34.0, 29.1, 28.7, 27.9, 26.9, 18.6, 14.4 ppm. 
 
                                                
(3-(Allyloxy)hex-5-enyl)benzene (21b): General Procedure A was followed 
employing 1.76 g of 1-phenylhex-5-en-3-ol62  (10.0 mmol), 480 mg NaH 
(20.0 mmol) and 1.4 ml allyl bromide (20.0 mmol).  Purification by flash chromatography (2 % 
ethyl acetate/hexanes) gave 1.94 g (90 %) of the title compound as colorless oil. 1H NMR (300 
MHz, CDCl3): δ 7.32-7.58 (m, 5H), 5.85-6.16 (m, 2H), 5.45 (dq, J = 17.1, 1.5 Hz, 1H), 5.20-5.33 
(m, 3H), 4.21 (ddt, J = 12.6, 5.3, 1.2 Hz, 1H), 4.11 (ddt, J = 12.6, 5.6, 1.2 Hz, 1H), 3.54 (tt, J = 
5.9, 5.9 Hz, 1H), 2.75-2.97 (m, 4H), 1.94-1.98 (m, 2H) ppm; 13C NMR (75 MHz, CDCl3): δ 
O
Ph
 
61 Higashino, T.; Sakaguchi, S.; Ishii, Y. Org. Lett., 2000, 2, 4193. 
62 Schmidt, B. J. Org. Chem. 2004, 69, 7672-7687. 
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142.14, 135.10, 134.52, 128.26, 128.17, 125.57, 116.94, 116.47, 77.59, 69.83, 38.11, 35.47, 
31.48 ppm. 
 
syn-(E)-2,3-Dimethyl-7-phenylhept-4-enal (23b): General procedure D 
was followed employing 216 mg of (3-(allyloxy)hex-5-enyl)benzene (21b, 
 catalyst (9.0 mg Ir-dimer, 0.01 mmol, 16.8 mg PCy
O
Ph Me
Me
H
1.0 mmol) and 2 mol%
                                                
3, 0.06 mmol, 6.8 mg 
NaBPh4, 0.02 mmol) in dichloroethane and an initial reaction time of 12 h before quenched with 
15.8 mg PPh3 (0.06 mmol) and reflux 12 h. Purification by flash chromatograph on Iatrobeads 
neutral (pH7) silica gel (2.5 % EtOAc in hexanes) afford 150 mg (70 %) of the title compound as 
colorless oil, (syn : anti : Z- isomer = 88 : 5 : 7). 1H NMR (300 MHz, CDCl3): δ 9.75 (d, J = 2.1 
Hz, 1H), 7.30-7.63 (m, 5H), 5.65 (dt, J = 15.3, 6.3 Hz, 1H), 5.30 (ddt, J = 15.3, 7.3, 1.0 Hz, 1H), 
2.83 (t, J = 7.7 Hz, 2H), 2.64-2.75 (m, 1H), 2.48 (q, J = 7.6 Hz, 1H), 2.38-2.47 (m, 1H), 1.13 (d, 
J = 7.0 Hz, 1H), 1.13 (d, J = 6.9 Hz, 1H) ppm; 13C NMR (75 MHz, CDCl3): δ 205.45, 141.71, 
133.38, 129.91, 128.43, 128.21, 125.74, 51.10, 37.36, 35.86, 34.24, 16.78, 10.06 ppm; MS (EI, 
70 V): m/z 216 (M+.), 175, 158, 131, 117, 105, 91; HRMS m/z calcd for C15H20O (M+.): 
216.1514. found 216.1518. 
 
(2-(Allyloxy)pent-4-enyloxy)(tert-butyl)diphenylsilane (21c): General 
Procedure A was followed employing 1.02 g of 1-(tert-butyl-
diphenylsiloxy)pent-4-en-2-ol 63  (3.00 mmol). Purification by flash chromatography (5 % 
EtOAc/hexanes) gave 841 mg (74 %) of the title compound as colorless oil. IR (liquid film): 
3072, 2930, 2858, 2360, 1428, 1113, 917, 823, 702 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.72-
TBDPSO
O
 
63 Roush, W. R.; Hoong, L. K.; Palmer, Ma. A. J. Straub, J. A.; Palkowitz, A. D. J. Org. Chem.1990, 55, 4117-4126. 
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7.76 (m, 4H), 7.41-7.50 (m, 6H), 5.81-6.01 (m, 2H), 5.30 (dq, J = 17.2, 1.5 Hz, 1H), 5.19 (d, J = 
10.4 Hz, 1H), 5.13 (d, J = 18.0 Hz, 1H), 5.08 (d, J = 10.2 Hz, 1H), 4.15 (dd, J = 12.7, 5.5 Hz, 
1H), 4.06 (dd, J = 12.7, 5.7 Hz, 1H), 3.76 (dd, J = 10.6, 5.7 Hz, 1H), 3.69 (dd, J = 10.6, 4.9 Hz, 
1H), 3.50-3.58 (m, 1H), 2.30-2.48 (m, 2H), 1.12 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3): δ 
135.6, 135.3, 134.8, 133.5, 129.6, 127.6, 116.9, 116.5, 79.2, 71.0, 65.4, 36.1, 26.8, 19.2 ppm; 
MS (EI, 70 V) m/z: 323 (M+.-tBu), 283, 267, 239, 221, 205, 177, 163, 135, 117. HRMS m/z calcd 
for C20H23O2Si (M+.-tBu): 323.1467; found 323.1469. 
 
syn-(E)- 6-(tert-Butyl-diphenylsiloxy)-2,3-dimethylhex-4-en-1-nal 
(23c): General Procedure D (2 mol% catalyst loading, 1,2-DCE) was 
followed employing 380 mg of ether 21c (1.00 mmol) and an initial 
reaction time of 12 h prior to heating the reaction time of 14 h to afford aldehyde (syn: anti = 96: 
4). Purification by flash chromatography on Iatrobeads neutral (pH = 7) silica gel (5 % 
EtOAc/hexanes) gave 184 mg (48 %) of the title compound (syn : anti = 95 : 5) as colorless oil. 
1H NMR (300 MHz, CDCl3): δ 9.67 (d, J = 1.8 Hz, 1H), 7.69-7.72 (m, 4H), 7.37-7.45 (m, 6H), 
5.69 (dd, J = 15.4, 6.6 Hz, 1H), 5.60 (dt, J = 15.4, 4.2 Hz, 1H), 4.22 (d, J = 4.2 Hz, 2 H), 2.59-
2.70 (m, 1H), 2.36 (qdd, J = 7.0, 6.9, 1.8 Hz, 1H), 1.09 (s, 9H), 1.05 (d, J = 7.1 Hz, 3H), 1.03 (d, 
J = 7.6 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 205.1, 135.5, 133.7, 132.9, 129.6, 129.3, 
127.6, 64.2, 50.9, 36.7, 26.8, 19.2, 16.3, 9.8 ppm; MS (EI, 70 V) m/z: 323 (M+.-tBu), 267, 245, 
239, 199, 183, 139. HRMS m/z calcd for C20H23O2Si (M+.-tBu): 323.1467, Found 323.1451. 
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syn- (E)-6-(tert-Butyl-diphenylsiloxy)-2,3-dimethylhex-4-en-1-ol 
(23c′): Diisobutylaluminum hydride reduction of 140 mg of 23c (0.37 
HO
TBDPSO
Me
Me
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mmol) followed by purification by flash chromatography (15 % EtOAc in hexanes) gave 127 mg 
(91 %) of the title compound as colorless oil. IR (liquid film): 3365, 3071, 2960, 2858, 1428, 
1380, 1265, 1112, 823, 739, 703 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.69-7.72 (m, 4H), 7.37-
7.46 (m, 6H), 5.65 (dd, J = 15.5, 6.9 Hz, 1H), 5.56 (dt, J = 15.5, 4.6 Hz, 1H), 4.20 (d, J = 4.6 Hz, 
2 H), 3.59 (dd, J = 10.6, 5.7 Hz, 1H), 3.44 (dd, J = 10.6, 6.4 Hz, 1H), 2.14-2.26 (m, 1H), 1.51-
1.65 (m, 1H), 1.45 (s, 1H), 1.08 (s, 9H), 0.98 (d, J = 6.8 Hz, 3H), 0.91 (d, J = 6.7 Hz, 3H) ppm; 
13C NMR (75 MHz, CDCl3): δ 135.6, 135.5, 133.8, 129.6, 127.9, 127.6, 66.6, 64.5, 40.6, 38.4, 
26.8, 19.2, 16.4, 13.6 ppm; MS (EI, 70 V) m/z: 325 (M+.-tBu), 229, 199, 181, 139, 109. HRMS 
m/z calcd for C20H25O2Si (M+.-tBu): 325.1624; found 325.1627. 
2.4.2.2 Preparation of dienal from ICR protocol 
(E)-4-(Allyloxy)hepta-1,5-diene (25a): General Procedure A was followed 
employing 5.41 g of (E)-hexa-1,5-dien-3-ol64 (48.3 mmol) and allyl bromide 
(8.7 g, 72 mmol) in THF. Purification by flash chromatography (2.5 % EtOAc/hexanes) gave 
5.273 g (72 %) of the title compound as colorless oil. IR (liquid film): 3078, 2980, 2919, 2857, 
1642, 1440, 1084, 969, 916 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.74-5.96 (m, 2H), 5.61 (dq, J 
= 15.3, 6.4 Hz, 1H), 5.00-5.37 (m, 5H), 4.03 (ddt, J = 12.9, 5.1, 1.5 Hz, 1H), 3.82 (ddt, J = 12.9, 
5.9, 1.4 Hz, 1H), 3.71 (dt, J = 8.0, 6.5 Hz, 1H), 2.38 (dtt, J = 14.1, 6.8, 1.3 Hz, 1H), 2.25 (dtt, J = 
14.1, 6.6, 1.3 Hz, 1H), 1.72 (dd, J = 6.4, 1.6 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 135.2, 
134.9, 131.4, 128.8, 116.5, 116.4, 79.6, 68.7, 40.2, 17.6 ppm; MS (EI, 70 V) m/z: 151 (M+.-H), 
111, 95, 69, 59. HRMS m/z calcd for C10H15O (M+.-H): 151.1123; found 151.1128. 
O
Me
 
                                                 
64 Viola, A.; Iorio, E. J.; Chen, K. K.; Glover, G. M.; Nayak, U.; Kocienski, P. J. J. Am. Chem. Soc., 1967, 3462. 
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1-((E)-3-(Allyloxy)hexa-1,5-dienyl)benzene (25b): General Procedure A was 
followed employing 3.13 g of (E)-1-phenylhexa-1,5-dien-3-ol65 (18.0 mmol) 
and allyl bromide (3.3 g, 27 mmol) in THF. Purification by flash chromatography (2.5 % 
EtOAc/hexanes) gave 3.51 g (91 %) of the title compound as colorless oil. IR (liquid film): 3078, 
2856, 1642, 1494, 1072, 750, 693 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.06-7.26 (m, 5H), 6.39 
(d, J = 16.0 Hz, 1H), 5.96 (dd, J = 16.0, 7.9 Hz, 1H), 5.66-5.86 (m, 2H), 4.93-5.19 (m, 4H), 3.97 
(dd, J = 12.9, 4.9 Hz, 1H), 3.73-3.84 (m, 2H), 2.21-2.41 (m, 2H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 136.3, 134.9, 134.3, 132.1, 129.7, 128.4, 127.5, 126.3, 116.9, 116.4, 79.5, 69.0, 40.2 
ppm; MS (EI, 70 V) m/z: 213 (M+.-H), 181, 173, 145, 131, 115, 103, 91, 77, 63. HRMS m/z calcd 
for C15H17O (M+.-H): 213.1279; found 213.1276. 
O
Ph
 
1-((E)-3-(Allyloxy)-2-methylhexa-1,5-dienyl)benzene (25c): General 
Procedure A was followed employing 3.38 g of (E)-2-methyl-1-phenylhexa-
1,5-dien-3-ol 66  (18.0 mmol) and allyl bromide (3.3 g, 27 mmol).  Purification by flash 
chromatography (2.5 % EtOAc/hexanes) gave 3.783 g (92 %) of the title compound as colorless 
oil. IR (liquid film): 3026, 2857, 1724, 1492, 1449, 1069, 743, 699 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.22-7.36 (m, 5H), 6.44 (s, 1H), 5.76-6.09 (m, 2H), 5.03-5.34 (m, 4H), 4.03 (ddt, J = 
12.8, 5.1, 1.5 Hz, 1H), 3.81-3.89 (m, 2H), 2.46-2.58 (m, 1H), 2.32-2.42 (m, 1H), 1.85 (d, J = 1.3 
Hz) ppm; 13C NMR (75 MHz, CDCl3): δ 137.3 (overlap of 2 C), 135.0, 134.9, 129.0, 128.2, 
128.1, 126.5, 116.7, 116.5, 84.9, 69.0, 38.5, 12.6 ppm; MS (EI, 70 V) m/z: 227 (M+.-H), 187, 
169, 145, 129, 117, 105, 91. HRMS m/z calcd for C16H19O (M+.-H): 227.1436; found 227.1439. 
O
Ph
Me
                                                 
65 Kelly, B. G.; Giheany, Tetrahedron Lett., 2002, 43, 887. 
66 Gordon, C. M.; McCluskey Chem. Comm., 1999, 1431. Prepared in quantitative yield by addition of allyl magnesium bromide 
to 3-phenyl-2-methyl-propenal. 
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 syn-(4
 
 
was followed employing 214 mg of 2
E,6E)-2,3-Dimethylocta-4,6-dien-1-ol (27a): 
General Procedure D was followed employing 304 
mg of 25a (2.00 mmol) and 2 mol% catalyst (18 mg 
iridium dimmer, 33.6 mg PCy3 and 13.6 mg NaBPh4), the initial reaction time of 17 h (no PPh3) 
at ambient temperature in CH2Cl2 to afford syn-(4E,6E)-2,3-dimethylocta-4,6-dien-1-al 26a (syn: 
anti = 94: 6). 1H NMR (300 MHz, CDCl3): δ 9.61 (d, J = 1.9 Hz, 1H), 5.93-6.04 (m, 2H), 5.53-
5.69 (m, 1H), 5.40-5.49 (m, 1H), 2.52-2.64 (m, 1H), 2.31 (m. 1H), 1.70 (d, J = 6.1 Hz, 3H), 1.00 
(d, J = 7.0 Hz, 3H), 0.98 (d, J = 7.0 Hz, 3H) ppm. Diisobutylaluminum hydride reduction of 26a 
followed by purification by flash chromatography (15 % EtOAc/hexanes) gave 207 mg (68 %) of 
the title compound as colorless oil. IR (liquid film): 3391, 2961, 1723, 1454, 1377, 1038, 989 
cm-1; 1H NMR (300 MHz, CDCl3): δ 5.95-6.08 (m, 2H), 5.56-5.66 (m, 1H), 5.46-5.55 (m, 1H), 
3.59 (dd, J = 10.7, 5.8 Hz, 1H), 3.44 (dd, J = 10.7, 6.4 Hz, 1H), 2.19 (m, 1H), 1.74 (d, J = 6.1 Hz, 
3H), 1.59 (m, 1H), 0.99 (d, J = 4.5 Hz, 3H), 0.90 (d, J = 6.9 Hz, 3H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 136.3, 131.6, 129.5, 127.3, 66.6, 40.9, 38.8, 17.9, 16.7, 13.7 ppm; MS (EI, 70 V) m/z: 
154 (M+.), 125, 109, 95, 81, 67, 55. HRMS m/z calcd for C10H18O (M+.): 154.1358, found 
154.1369. 
HO
Me
MeMe
O
Me
MeMe
H
syn-(E)-2-Methyl-3-phenylocta-4,7-dienal (29b): 
General Procedure D (2 mol% catalyst loading, CH2Cl2) 
5b (1.00 mmol) and an initial reaction time of 15 min 
(instead of 30 min), Purification by short column flash chromatography (2 % Et2O/hexanes) gave 
148 mg (70 %) of ether 28b as colorless oil; 1H NMR (300 MHz, CDCl3): δ 7.25-7.41 (m, 5H), 
O
H
Me
Ph
O
Ph
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6.56 (d, J = 16.0 Hz, 1H), 6.10-6.18 (m, 2H), 5.78-5.92 (m, 1H), 5.08-5.16 (m, 2H), 4.96 (dq, J = 
12.3, 6.7 Hz, 1H), 4.25 (q, J = 6.6 Hz, 1H), 2.37-2.57 (m, 2H), 1.53 (dd, J = 6.8, 1.5 Hz, 1H) 
ppm; 13C NMR (75 MHz, CDCl3): δ 145.0, 136.4, 133.7, 131.9, 129.1, 128.5, 127.7, 126.5, 
117.4, 101.3, 80.3, 39.8, 12.4 ppm. Then 3 mL 1,2-DCE was added into 148 mg of 28b (0.70 
mmol) and refluxed 12 h, remove the solvent to give aldehyde 29b (syn : anti = 97 : 3) as 
colorless oil. 1H NMR (300 MHz, CDCl3): δ 9.70 (d, J = 3.1 Hz, 1H), 7.19-7.36 (m, 5H), 5.66-
5.86 (m, 2H), 5.56 (dt, J = 15.4, 6.3 Hz, 1H), 4.98- 5.04 (m, 2H), 3.52 (t, J = 8.9 Hz, 1H), 2.72-
2.84 (m, 3H), 0.92 (d, J = 6.9 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 204.7, 141.4, 136.3, 
131.9, 129.9, 128.6, 127.9, 126.6, 115.4, 50.7, 36.4, 12.6 ppm; MS (EI, 70 V) m/z: 214 (M+.), 
199, 173, 157, 141, 129, 115, 103, 91, 77, 65. HRMS m/z calcd for C15H18O (M+.): 214.1358; 
found 214.1362. 
 
syn- (4E,6E)-2-Methyl-3-phenylocta-4,6-
dien-1-ol (27ba′): General Procedure D (2 
mol% catalyst loading, CH2Cl2) was followed 
employing 148 mg of 29b (0.70 mmol) and the initial reaction time 12 h at ambient temperature. 
Solvent was removed to afford the syn-(4E,6E)-2-methyl-3-phenylocta-4,6-dien-1-al 27ba (syn: 
anti = 97: 3). 1H NMR (300 MHz, CDCl3): δ 9.74 (d, J = 2.8 Hz, 1H), 7.41-7.23 (m, 5H), 6.17-
6.02 (m, 2H), 5.86-5.62 (m, 2H), 3.58 (t, J = 8.9 Hz, 1H), 2.89-2.76 (m, 1H), 1.78 (d, J = 7.5 Hz, 
3H), 0.97 (d, J = 6.9 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 204.5, 141.2, 131.8, 131.1, 
130.8, 129.1, 128.5, 127.8, 126.6, 50.8, 50.3, 17.9, 12.5 ppm. Diisobutylaluminum hydride 
reduction of 27ba followed by purification by flash chromatography (20 % EtOAc/hexanes) 
gave 127 mg (86 %) of the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.12-
O
Me
Ph
H
Me
HO
Me
PhMe
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7.29 (m, 5H), 6.05 (dd, J = 14.6, 10.3 Hz, 1H), 5.97 (ddq, J = 14.4, 10.2, 1.5 Hz 1H), 5.74 (dd, J 
= 14.1, 9.3 Hz, 1H), 5.58 (dq, J = 14.4, 6.7 Hz), 3.64 (dd, J = 10.6, 4.4 Hz, 1H), 3.47-3.58 (m, 
1H), 3.12 (t, J = 9.3 Hz, 1H), 1.97-2.06 (m, 1H), 1.68 (d, J = 6.5 Hz, 3 H), 1.46 (s, 1H), 0.75 (d, J 
= 6.8 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 143.4, 133.7, 131.2, 130.8, 128.5, 128.4, 
127.9, 126.2, 66.6, 52.7, 40.5, 18.0, 15.2 ppm; MS (EI, 70 V) m/z: 216 (M+.), 157, 141, 129, 117, 
105, 91, 84, 77, 65. HRMS m/z calcd for C15H20O (M+.): 216.1514; found 216.1511. 
 
(2 mol% catalyst loading, CH2Cl2) was followed em
syn-(4E,6E)-2,3-Dimethyl-7-phenylhepta-
4,6-dien-1-ol (27bb′): General Procedure D 
ploying 214 mg of 25b (1.00 mmol) and the 
initial reaction time 3 h (no PPh3, no heating). Solvent was removed to afford the a mixture of 
syn-(4E,6E)-2-methyl-3-phenylocta-4,6-dien-1-al 27ba and syn-(4E,6E)-2,3-dimethyl-7-
phenylhepta-4,6-dien-1-al 27bb (67: 33), Diisobutylaluminum hydride reduction of the mixtuure 
followed by purification by flash chromatography (20 % EtOAc/hexanes) gave 193 mg (90 %) of 
a mixture of the title compound 27ba′ and 27bb′ as colorless oil, including 28 mg pure 27bb′. 
1H NMR (300 MHz, CDCl3): δ 7.18-7.40 (m, 5H), 6.75 (dd, J = 15.6, 10.3 Hz, 1H), 6.47 (d, J = 
15.7 1H), 6.21 (dd, J = 15.2, 10.3 Hz), 5.78 (dd, J = 15.2, 8.2 Hz), 3.62 (dd, J = 10.6, 5.9 Hz, 
1H), 3.48 (dd, J = 10.6, 6.4 Hz, 1H), 2.25-2.37 (m, 1H), 1.61-1.72 (m, 1H), 1.32 (s, 1H), 1.03 (d, 
J = 6.8 Hz, 3H), 0.93 (d, J = 6.9 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 140.0, 137.5, 
130.5, 129.6, 129.2, 128.5, 127.2, 126.1, 66.6, 40.9, 38.9, 16.5, 13.7 ppm; MS (EI, 70 V) m/z: 
216 (M+.), 183, 169, 157, 142, 129, 115, 105, 91, 79, 65. HRMS m/z calcd for C15H20O (M+.): 
216.1514; found 216.1510. 
HO
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3.0  ENANTIOSELECTIVE CLAISEN REARRANGEMENTS ENABLED BY 
CATALYTIC ASYMMETRIC DI(ALLYL) ETHER SYNTHESES 
3.1 ICR REACTION WITH ENANTIOENRICHED SUBSTRATES 
The success of ICR reaction suggested an operationally simple one-step strategy for preparing an 
enantioenriched Claisen adduct from enantioenriched di(allyl) ether, whose chiral centers can be 
easily introduced from asymmetric nucleophilic addition. Rigorous translation of substrate 
chirality to the incipient stereogenic centers emerging from bond reorganization is among the 
defining characteristics of [3,3] sigmatropic rearrangements. Thermal Claisen rearrangements 
routinely prove via chair-like transition states that substituents residing at the carbinol 
stereocenter (Req) are oriented in pseudoequatorial positions. Considering that the ICR 
methodology makes the di(allyl) ether the immediate precursor to the allyl vinyl ether Claisen 
substrate, this analysis implicates an enantioenriched di(allyl) ether as a direct progenitor of an 
asymmetric aliphatic Claisen rearrangement. The enantioenriched (S)-(E)-1-phenyl-penten-3-ol 
(30a) was prepared by the an amino alcohol (N-methyl-α,α-diphenylprolinol, 33)-catalyzed 
addition of diethylzinc to cinnamaldehyde.67 Following the O-allylation, subjecting the resulting 
(S)-di(allyl) ether 31a (84% ee) to the optimized ICR conditions delivered an enantioenriched 
                                                 
67 The method for preparing the amino alcohol ligand and the procedure for diethyl zinc addition to aldehyde: Soai, K.; Okawa, 
A.; Kaba, T.; Ogawa, K. J. Am. Chem. Soc. 1987, 109, 7111-7115. The enantioselectivity in the diethyl zinc addition was not 
optimized. 
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pentenal (2S, 3R)-32a with good chairality transfer (84 % ee) and good diastereoselection (syn: 
anti = 95: 5, Scheme 25). 
O
H Ph
N
Me
O
Et Ph
Me
H
OH
Et Ph
1. NaH;
O
Et Ph
1. 1 mol % Ir(PCy3)3,
then 3 mol %PPh3
2. reflux, DCE
2 mol % 33
2. allyl bromide
84% ee
84% ee, syn : anti = 95 : 5
(S)-30a (S)-31a
33(2S, 3R)-32a
2.2 eq Et2Zn.
Ph
OH
Ph
84 % ee
 
Scheme 25. ICR reaction of enantioenriched di(allyl) ether 
3.2 ONE-POT REACTION FROM ALDEHYDE TO ENANTIOENRICHED 
DI(ALLYL) ETHER  
3.2.1  Reaction development 
Reaction design merging a catalytic asymmetric organometallic-aldehyde addition with an in situ 
O-allylation of the reaction intermediate metal alkoxide is attractive for preparing the 
enantioenriched di(allyl) ether in a single step. Combining this reaction sequence with a 
subsequent ICR reaction of enantioenriched di(allyl) ethers would provide the enantioenriched 
Claisen adducts in two steps from the easily obtained precursor (Figure 24).68  
                                                 
68 After our result has been published in J. Am. Chem. Soc. 2006, 128, 4232-4233, Trost reported a three-step strategy using 
Pd(0)-catalyzed asymmetric allylic alkylation-ICR reaction, see: Trost, B. M.; Zhang, T. Org. Lett. 2006, 8, 6007-6010.  
 85 
OH R
asymmetric addition
ReqM
O
Req R
M in situ allylation
X
O
Req R
Ir(PCy3)3BPh4 O
Req R
Me
isomerization
Claisen 
rearrangement O
Req R
Me
first step second step
H
 
Figure 24. Cascade addition/allylation reactions following ICR reaction 
With the goal of using a catalytic asymmetric transformation to establish substrate 
enantioenrichment, an amino alcohol-catalyzed diethylzinc-enal addition was selected to prepare 
the requisite enantioenriched di(allyl) ether ICR substrates for extensive data with readlly 
available reagent. 69  Nugent’s MIB ligand 70  had previously been demonstrated to be a 
satisfactory catalyst for the diethylzinc-enal addition. 71  However, little information existed 
regarding the potential for affecting the direct O-alkylation of the zinc alkoxide reaction 
intermediates. The covalent character of the Zn-O bonds and the highly aggregated nature of zinc 
alkoxides were expected to make direct O-alkylation difficult. For evaluating these reactions, 
cinnamaldehyde reacted with Et2Zn (1.0 equivalent) with 2 mol% (-)-MIB catalyst to afford the 
proposed intermediate enantioenriched zinc alkoxide S-30a′ in 93% ee, 72  whose direct O-
allylation with allyl bromide failed to afford any desired di(allyl) ether. A solution merging the 
                                                 
69 Review of dialkyl zinc addition to aldehyde, see: (a) Soai, K.; Shibata, T.; In Comprensive Asymmetric Catalysis; Jacobsen, E. 
N., Pfaltz, A., Yamamoto, H., Eds.; Springer: Berlin, 1999; pp 911-922. (b) Pu, L.; Yu, H. B. Chem. Rev. 2001, 101, 757-824. 
recent paper (c) Kang, S. W.; Ko, D. H,; Kim, K. H.; Ha, D. C.; Org. Lett. 2003, 5, 4517-4519. 
70 (a) Nugent, W. A. J. Chem. Soc., Chem. Commun. 1999, 1369. (b) Chen, Y. K.; Jeon, S. J.; Walsh, P. J.; Nugent, W. A.; 
Kendall, C.; Wipf, P.; Org. Synthese 2005, 82, 87. (c) (-)-MIB catalyzed diphenylzinc addition to aldehyde, including α,β-
unsaturated aldehyde, see: Kim, J. G.; Walsh, P. Angew. Chem. Int. Ed. 2006, 45, 4175-4178. 
71 Lurain, A. E.; Maestri, A.; Kelly, A. R.; Carroll, P. J.; Walsh, P. J.; J. Am. Chem. Soc. 2004, 126, 13608. 
72 The enantiomer excess is determined by HPLC separation of (S)-(E)-1-phenyl-penten-3-ol afforded after workup with water. 
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addition and allylation was suggested by Lee’s report that bis(alkoxy)zinc species undergo 
Pd(0)-catalyzed O-allylation (eq 12).73
PhCH2OH
1) 0.5 eq Et2Zn
2) 5 mol% Pd(PPh3)4
allyl acetate
OCH2Ph (12)
 
But subjecting the mixed ethylzinc alkoxide 30a′ to the Pd(0)-catalyzed allylation under 
the same condition afforded the alcohol 30a as the major product, with a mixture of ethers as 
minor (< 10 % yield) products. From the NMR spectra, the mixture includes the desired di(allyl) 
ether (31a) and by-product triene ether (34). The HPLC isolation of enantiomers indicated that 
the di(allyl) ether 31a was enantioenriched pure (93 % ee) but the triene ether 34 was racemic. 
The combined yield was improved to 40 % when 0.65 equivalent instead of 1.0 equivalent 
diethylzinc was used in this reaction (Scheme 26). 
O
H Ph
2 mol % (-)-MIB
Et Ph
O
Zn
Et
Br OH
Et R
5 mol % Pd(PPh3)4
AcO
Me
OH
N
Me Me O
(-)-MIB
1.0 eq Et2Zn, toluene, 0 oC
S-30a'
S-30a
O
Ph
O
Et Ph
+
racemic 3493 % ee 31a
combine< 10 %
0.65 equiv Et2Zn, combine 40 % yield
 
Scheme 26. Initial investigation for cascade addition/allylation process 
It has been reported that the transmetalation of diethyl zinc or ethyl zinc alkoxide with π-
allylpalladium complex afforded allyl zinc intermediates and EtPdOAc, which afforded Pd(0) 
catalyst and ethyl acetate after reductive elimination. The nucleophlic allylic zinc reagents 
                                                 
73 Kim, H.; Lee, C. Org. Lett. 2002, 4, 4369-4372. 
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caused the allylation of aldehydes, ketones and even esters in the absence of any catalyst (Figure 
25).74  
Zn
OR
EtPdOAc
Et2Zn
Zn
Et
O
R1 R2 OZnOR
R2
R1
ROZnEt
PdOAc
reductive elimination
Pd(0) + EtOAc
OZnEt
R2
R1
 
Figure 25. The Pd-Zn transmetalation and allylation 
Based on the above discussion, it is believed that the addition of unreacted 
cinnemaldehyde with formed allyl zinc reagent (35) afforded the asymmetric bis(alkoxy)zinc 
species (36). After the Pd(0)-catalyzed O-allylation, the enantioenriched di(allyl) ether 31a and 
the triene ether 34 were afforded (Figure 26). For blocking this Pd-Zn transmetalation process, 
the more basic ethyl ligand should be replaced by the less reactive oxygen ligand. 
O
Ph
Zn
O
Ph
O
Et Ph
O
H Ph
Et2Zn
cat. (-)-MIB Et Ph
OZnEt PdOAc
Et Ph
O
Zn
O
H Ph
O Et
Ph
PdOAc
+
racemic 34enantioenriched 31a 36
3530a' transmetalation
C-allylation
2 equiv.
O-allylation
 
Figure 26. Mechanism of the formation of by-product 34 
                                                 
74 Yasui, K.; Yajima, T.; Taniseki, Y.; Fugami, K.; Tanaka, A.; Tamaru, Y. Tetrahedron Lett. 1993, 34, 7619. 
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For removing this ethyl ligand, an active proton was required to react with ethylzinc 
alkoxide to release the ethane. The addition of one equivalent alcohol generated an asymmetric 
bis(alkoxy)zinc species, which consumed an additional equivalent electrophiles in the Pd(0)-
catalyzed allylation step (Scheme 27) to form a mixture of two allyl ethers.  
Et Ph
OZnEt
OiPr
Et Ph
O
Zn OiPr PdOAc
O
Et Ph
iPrOH
+
2 equiv
-C2H6  
Scheme 27. Alcohols as additive in one pot reaction 
Acetic acid was a good choice for this specific aim because the formed zinc acetate is less 
basic than the zinc alkoxide to ensure no side reactions. Treating the ethylzinc alkoxide S-30a′ 
with 1.0 equivalent acetic acid caused the more basic alkyl ligand to be selectively protonated to 
afford the alkoxyzinc carboxylate S-30a′′, which subsequently reacted with the π-allylpalladium 
complex75 to deliver the desired di(allyl) ether S-31a in 79 % yield (93 % ee). This Pd(0)-
catalyzed allylation procedure was slow at ambient temperature, the completion of the C-O 
coupling reaction required 5 days as monitored by TLC. But the reaction was much accelerated 
at warm conditions, the reaction was completed in 6 h at 55 oC in THF solvent. Enantioenriched 
di(allyl) ether in hand, it was subjected to the standard ICR condition to afford the 
enantioenriched 2,3-syn disubstituted heptenal Claisen rearrangement product ((2R,3S)-32a) 
with enantiomeric purity identical to that of the di(allyl) ether starting material (93 % ee, Scheme 
28). The successful execution of this reaction affirmed our original reaction design as an 
efficient, two-step approach to the enantioselective aliphatic Claisen rearrangement. 
                                                 
75 The in situ Pd(0) catalyst was produced from 5 mol % Pd(OAc)2 and 25 mol % PPh3 instead of the preformed Pd(PPh3)4 
catalyst in Lee’s precedent. Then adding 1.5 equivalent of allyl acetate provided a convenient condition for this C-O coupling 
reaction. 
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Scheme 28. Synthesis and ICR of enantioenriched di(allyl) ethers 
3.2.2 One-pot addition/allylation followed by ICR for the preparation of enantioenriched 
Claisen rearrangement products 
Merging this one-step enantioselective di(allyl) ether synthesis with a subsequent ICR reaction 
provided access to a variety of enantioenriched Claisen adducts from readily obtained diethylzinc 
and conjugated enal reaction partners (Table 5). The merged addition-allylation sequence 
afforded enantioenriched di(allyl) ether ICR substrates incorporating C3 aryl (entry a, b), alkenyl 
(entry c), aliphatic alkyl (entry d), or oxygen-substituted alkyl substituents (entry e) in good 
yields (73-87 %) and high enantioselectivies (88-98 % ee). Each of these di(allyl) ether 
substrates participated in the ICR reaction with faithful translation of chirality, delivering the 
pentenal derivatives with high absolute and relative stereocontrol. The ICR reaction of di(allyl) 
ether possessing trisubstituted allyl ether moiety (entry f) proceeds with a similarly high 
stereoselectivity albeit with some erosion of olefin stereochemistry due to high Claisen 
rearrangement temperatures. 
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Table 5. Synthesis and ICR of enantioenriched di(allyl) ethers 31a-f 
H R
O 1) Et2Zn, (-)-MIB
2) C3H5OAc, 
        Pd(0)
Et R
O 1 mol% Ir(PCy3)3+
PPh3, Δ
Me
REt
31a-e 32a-e
O
H
 
entry % yield 31 (% ee)a % yield 32 (syn:anti)b % ee 32c
31a (R = Ph)75 (93) 32a (R = Ph)82 (95:5) 92 a 
31b (R = 2-furyl)79 (96) 32b (R = 2-furyl)75 (95:5) 96 b 
31c (R = E-CHCHPh)87 (93) 32c (R = E-CHCHPh)77 (95:5) 93 c 
31d (R = nC5H11)80 (88) 32d (R = nC5H11)70 (97:3) 87 d 
31e (R = CH2OBn)73 (93) 32e (R = CH2OBn)60 (96:4) 92 e 
fc 31f 84 (98) 32f 81 (92:8)d 97 
a) Enantiomeric excess determined for allylic alcohol obtained by protonation of the zinc alkoxide prior to O-allylation.  b) 
Diastereomer ratios determined by 1H NMR of crude product mixtures.  c) Enantiomer ratios determined by chiral HPLC 
or GC.  d) The Claisen adduct 32f was obtained as an 83:17 E:Z mixture of olefin isomers. Enantiomer and diastereomer 
ratios are reported for the E isomer (eq  13). 
H Ph
O 1) Et2Zn, (-)-MIB
2) C3H5OAc, 
        Pd(0)
Et Ph
O 1 mol% Ir(PCy3)3+
PPh3, Δ
Me
PhEt
31f 32f (E/Z = 83: 17)
Me Me Me
H
O
(13)
 
A benzyloxy-substituted di(allyl) ether (31e) offered the potential for a competing allyl 
ether isomerization pathway. The isomerization process was required to be quenched in a short 
time (10 min) to ensure that not much side isomerization product formed. The desired product 
(32e) was obtained in a modest yield (eq 14). A longer reaction time increased the yield of by-
product homoallyl-vinyl ether (31e′) 
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Et
O 1 mol% Ir(PCy3)3+
PPh3, Δ
Me
Et
31e 32e
OBn OBn
60 %
+
Et
O
Me
31e'
OBn
O
H
(14)
 
The asymmetric di(allyl) ether synthesis was not limited to procedures employing only 
unsubstituted allyl acetate as the incipient electrophile. Some substituted allyl acetates worked as 
well. Compound (E)-3-(trimethylsilyl)allyl acetate provided the derived allyl Pd(0) complexes 
with a strong bias for regioselective nucleophilic addition because of the large size of the 
trimethylsilyl group. Because of this size, the isomerization of this substituted allyl ether was 
more difficult than that of other entries. Upon treatment of 2 mol% catalyst 18 and quenching in 
6 h at 50 oC, the thermolysis afforded a 50% yield Claisen product 38 plus recovered staring 
materials (Scheme 29). 
 
H Ph
O 1) Et2Zn, (-)-MIB
2) Pd(0) Et
O 2 mol% Ir(PCy3)3+
PhEt
37, 77 %, 93 % ee
38, 50 %,93 % ee, 
syn : anti = 95: 5
OAcTMS
TMS
TMSO
H
Ph
TMS
PdLn
Nu
Et
O TMS
Ph50 
oC, 6 h
PPh3
heating
 
Scheme 29. Preparation and ICR of TMS-substituted di(allyl) ether 
But (E)-but-2-enyl acetate provided a very poorly regioselective allylation (the branched 
product 39 : the non-branched product 40 = 2 : 1. The 40 was a mixture of syn- and anti- 
diastereomers and the 39 was a mixture of E- and Z- isomers). Upon treatment with the ICR 
conditions, the di(allyl) ether 39 afforded a very low yield of enal (41). No ICR was observed in 
the branched di(allyl) ether 40 (Scheme 30).  
 92 
H Ph
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2) Pd(0) Et Ph
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Scheme 30. Poor selectivity afforded in the reaction with crotyl acetate 
 
3.2.3 One-step reaction from alkenyl zinc addition 
Enantioenriched di(allyl) ether ICR substrates also were prepared from alkenyl zinc reagents76 
addition to aldehyde following the Pd(0)-catalyzed O-allylation. Alkenyl zinc reagents were 
readily obtained from hydroboration 77  or hydrozirconation 78  of alkynes followed by the 
transmetalation with a zinc species. The hydroboration was examined first for its cheap starting 
material. Walsh’s modified procedure79 was followed for the hydroboration. It was worthy of 
note that the solvents and borane source were important for the in situ Pd(0)-catalyzed allylation. 
The dimethylsulfide in the reagent BH3·Me2S deactivated the Pd(0) catalyst to cause the 
                                                 
76 The addition of the divinyl zinc reagent, see: (a) Oppolzer, W.; Radinov, R. N. Tetrahedron Lett. 1988, 29, 5645-5648. The 
addition of the diisopropenyl zinc reagent, see: (b) Soai, K. Inorganica Chimica Acta. 1999, 296, 33. The addition of the vinyl 
zinc halide reagent, see: (c) Oppolzer, W.; Radinov, R. N. Tetrahedron. Lett. 1991, 32, 5777-5780.  
77 Trivinylborane reagent, see: (a) Srebnik, M. Tetrahedron. Lett. 1991, 32, 2449-2452. Alkyl vinyl zinc, see: (b) Oppolzer, W.; 
Radinov, R. N. Helv. Chim. Acta. 1992, 75, 170-173. (c) Oppolzer, W.; Radinov, R. N. J. Am. Chem. Soc. 1993, 115, 1593-1594.  
78 Wipf, P.; Ribe, S.  J. Org. Chem. 1998, 63, 6454-6455. 
79 For (-)-MIB-catalyzed addition of in situ-generated vinyl zinc reagents to benzaldehyde, see: (a) Chen, Y. K.; Lurain, A. E.; 
Walsh, P. J. J. Am. Chem.. Soc. 2002, 124, 12225-12231. (b) Lurain, A. E.; Walsh, P. J. J. Am. Chem.. Soc. 2003, 125, 10677-
10683. For the paracyclophanes-catalyzed addition see: (d) Dahmen, S.; Brase, S. Org. Lett. 2001, 3, 4119-4122. 
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allylation to be impossible. The THF as ligand and solvent in the reagent BH3·THF was not a 
good solvent for the organozinc asymmetric addition to aldehydes. Considering these factors, the 
reagent BH3·THF was used first, then the solvent was changed from THF to pentane or toluene 
before transmetalation. Indeed this modified procedure worked, treatment of 2 equivalents of  
cyclohexene with BH3·THF afforded dicyclohexylborane in THF. Then 1-heptyne was added to 
prepare dicyclohexyl vinyl borane. After removal of the THF in vacuum and recharging pentane 
or toluene, diethylzinc (solution in hexanes) was added to afford ethyl vinylzinc reagent. The 
vinyl group was transfered to aldehydes in the presence of amino alcohol catalyst ((-)-MIB) to 
afford the enantioenriched ethylzinc alkoxide, which subsequently reacted with acetic acid. 
Finally species reacted with the π-allylpalladium complex to afford the enantioenriched di(allyl) 
ethers (42a) in 62 % yield (87 % ee) (Figure 27). Subjecting the di(allyl) ether 42a to the ICR 
condition provided the pentenal with optical purity matching that of the di(allyl) ether precursor 
(43a, 86 % ee, 80 % yield). A sterically hindered terminal alkyne 3,3-dimethyl-1-butyne was 
subjected to the same condition to afford 42b, which subsequently was treated under ICR 
conditions to afford the enantioenriched ICR adduct (43b, eq 15). 
C5H11 C5H11
EtZn
2 mol % (-)-MIB
PhCHO, 0 oC
O
Ph C5H11
1. HOAc
2.cat. Pd(0);  
allyl acetate
 55 oC, THF
Ph C5H11
O
Ph
O
C5H11
Me
H
Cy2BH, THF
23 oC C5H11
Cy2B
Et2Zn,pentane
Zn
Et
42a43a
H
-78 oC
ICR
 
Figure 27. One step reaction from alkenyl zinc reagent for preparing enantioenriched di(allyl) ether 
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63 %, 92 % ee 80 % 
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93 % ee  
In conclusion, an asymmetric di(allyl) ether synthesis-ICR reaction sequence provided a 
convenient access to enantioselective aliphatic Claisen rearrangement products from easily 
obtained starting materials. This methodology offered an operationally simple, two step 
procedure for realizing highly enantio- and diastereoselective [3,3] sigmatropic rearrangements 
of aliphatic allyl vinyl ethers. The potential of this reaction technology to simplify the execution 
of the enantioselective Claisen rearrangements should allow these reactions to be readily 
integrated into asymmetric synthesis activities. 
3.3 SYNTHESIS OF (+)-DI-O-METHYL CALOPIN 
To exploite this two step protocol consist of the asymmetric di(allyl) ether synthesis and ICR 
reaction in target-based synthesis, we undertook a synthesis of a lactone (+)-7,8-di-O-
methylcalopin (44). The calopins constitute a new class of mushroom metabolites, which are in 
part responsible for the bitter taste of Boletus calopus (German: Schönfussröhrling) and related 
mushrooms.80 Common to all compounds are a δ-lactone ring with three contiguous stereogenic 
centres. Two syntheses have been reported: Steglish used a highly stereoselective ene reaction;81 
Toste used a Re-oxo complex-catalyzed coupling of propargyl alcohols with enantioenriched 
                                                 
80 Hellwig, V.; Dasenbrock, J.; Gräf, C.; Kahner, L.; Schumann, S.; Steglich, W. Eur. J. Org. Chem. 2002, 17, 2895–2904. 
81 (a) Ebel, E.; Knör, S.; Steglich, W. Tetrahedron 2002, 59, 123-129. (b) Ebel, E.; Knör, S.; Steglich, W. Eur. J. Org. Chem. 
2002, 17, 2905-2912. 
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crotylsilanes.82  Two of its three stereocentres were easily set by the addition/allylation ICR 
protocols and the third one (tertiary alcohol) is obtained through stereoselective nucleophilic 
additions (Figure 28). 
O
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Me
Me
O
Me
OH
(+)-7,8-di-O-methyl calopin
PO
O
OMe
Me
Me
Me
OP
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PO
O
MeO
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Me
Me
O
MeO
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Me
Me
Et
O
MeO
OMe
Me
Et
O
MeO
OMe
Me
H
44
 
Figure 28. Retrosynthesis of (+)-7,8-di-O-methylcalopin 
For realizing our addition-allylation-ICR protocol, the α,β-unsaturated aldehyde was 
required to be prepared first. There were some methodologies to prepare enals from aldehydes. 
Compound 2,3-dimethoxy-4-methylbenzaldehyde (45), which was obtained from metalation and 
methylation of 2,3-dimethoxybenzaldehyde,83 was treated first with Wittig reagent Ph3PCHCHO 
at reflux in benzene. But the yield of enal 46 was low (50 %) and some dienal was produced as a 
by-product (Scheme 31).  The aldehyde 45 was treated with the Wittig reagent Ph3PCHCOOMe 
to afford unsaturated ester 47 in high yield. Then the ester 47 was reduced to allyl alcohol 48, 
which was oxidized to afford a 68 % yield of enal 46 in three steps. 
                                                 
82 Luzung, M. R.; Toste, F. D. J. Am. Chem. Soc. 2003, 125, 15760-15761. 
83 Comins, D. L.; Brown, J. D. J. Org. Chem. 1984, 49, 1078-1083. 
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Scheme 31. Preparation of unsaturated aldehyde with Wittig olefination 
This three steps strategy was not ideal for a concise synthesis. A superior method 
consisted of treating aldehyde 45 with Meyers’s lithium (Z)-tert-butyl(2-
(diethoxyphosphoryl)vinyl)amide (49), 84  which was prepared in situ by lithium tert-
butyl(vinyl)amide with (EtO)2P(O)Cl, to afford the unsaturated imine after elimination. The enal 
46 was formed only after acidic work up so that no dienal was observed. In this reaction, 65 % of 
unsaturated aldehyde 46 was formed in a single step (Scheme 32).  
Me
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tBu LDA
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Scheme 32. One step preparation from aldehyde to enal 
                                                 
84 Meyers, A. I.; Tomioka, K.; Fleming, M. P. J. Org. Chem. 1978, 43, 3788. 
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Then the one-pot diethylzinc-enal addition/Pd(0)-catalyzed O-allylation reaction afforded 
the enantioenriched di(allyl) ether 50 with good yield and enantiomer excess (90 %, 90 % ee). 
The enantioenriched di(allyl) ether 50 was treated with 1.0 mol% Ir(PCy3)3BPh4 and thermolysis 
at 80 oC to afford syn-2,3-disubstituted pentenal (51, syn : anti = 94 : 6 according to the crude 
proton NMR spectrum), which was reduced by DIBAL-H without further purification to alcohol 
(52) and protected by the benzyl group to yield 53. 80 % yield was afforded in three steps. Then 
OsO4-catalyzed dihydroxylation followed by NaIO4 cleavage transformed the olefin to the 
desired aldehyde (54, syn: anti= 93: 7) (Scheme 33). 85
Me
OMe
OMe
CHO
a
O
Et
MeO
OMe
Me
c
O
Et
MeO
OMe
Me
Me
e BnO
MeO
OMe
Me
Me
Et
BnO
OHC
MeO
OMe
Me
Me
46 50 51
5354
b
H
HO
Et
MeO
OMe
Me
Me
52
d
 
Reagent and conditions: (a) 1. 2 mol% (-)-MIB, Et2Zn, toluene, 0 oC, then 1.0 equiv. HOAc; 2. 5 mol% Pd(OAc)2, 25 mol% 
PPh3, 1.5 equiv allyl acetate, THF, 60 oC, 90 %, 90 % ee; (b) 1 mol% Ir(PCy3)3BPh4,DCE/acetone 50, ambient temperature, then 
3 mol% PPh3, 80 oC, 12 h, syn : anti = 94 : 6; (c) DIBAL-H, -78 oC; (d) NaH, BnBr, THF, 60 oC, 80 % in three steps; (e) 1. 5 
mol% OsO4, N-methyl-morpholine oxide, 2. NaIO4, 78 %, syn : anti = 93: 7. 
Scheme 33. One pot reaction followed by ICR 
For the next step, we investigated a Felkin favored nucleophilic addition to aldehyde 54 
to obtain desired diastereomer of the 3,4-anti secondary alcohol 55 (Figure 29). The vinyl 
                                                 
85 Ozonolysis afford aldehyde with worse diastereomer because of epimerization. 
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Grignard reagent afforded near 1 : 1 ratio of two diastereomers. The alkenyl zinc reagent, 86 
which was prepared from the terminal alkyne through hydrozirconination (Cp2ZrHCl) and 
transmetalation (Et2Zn), afforded a much better diastereomer ratio and the desired allyl alcohol 
55 was isolated with 67 % yield.  
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Me
OH
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MeO
OMe
Me
Me
C5H11
54 55
C5H11 ZnEt
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H
OH
Nu
H
Ar
R
H
Ar
H
R
Nu
OMe
OMe
 
Figure 29. Felkin favored nucleophilic addition 
The alcohol 55 was protected with a TBS group to provide 56 and the subsequent 
ozonolysis afforded the aldehyde 57. Benzyl group deprotection (10 % Pd/C, 1 atm H2) followed 
by the intramolecular cyclization afforded a δ-lactol (58) as a mixture of diastereomers, which 
was oxidized with 5 mol% tripropylamino perruthenate (TPAP) and excess NMO to afford a δ-
lactone (59). TBAF caused the decomposition of the substrate in the deprotection of the TBS 
ether. Finally, the much milder reagent tris(dimethylamino)sulfonium difluorotrimethylsilicate 
(Me2N)3S F2SiMe3 (TASF) 87  was used to afford a clean product 44 in DMF at ambient 
temperature. The product has same 1H NMR, 13C NMR and [α]D data as those in reference 
(Scheme 34).88  
                                                 
86 (a) Wipf, P.; Xu, W. Tetrahedron Lett. 1994, 35, 5197. 
87 Application of TASF, see: Scheidt, K. A.; Chen, H.; Follows, B. C.; Chemler, S. R.; Coffey, S.; Roush, W. R. J. Org. Chem. 
1998, 63, 6436-6437. 
88 Ref 82. 
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Reagents and conditions: (a) TBSCl, imidazole, DMF; (b) O3, CH2Cl2, -78 oC, then Me2S, -78-23 oC, 72 % in two steps; (c) 5 % 
Pd-C, H2, EtOAc; (d) 5 mol% TPAP, N-methyl-morpholine oxide, CH2Cl2; (e) (Me2N)3S F2SiMe3(TASF), DMF, 81 % in three 
steps. 
Scheme 34. Synthesis route-finish the synthesis 
The asymmetric Claisen reaction is still not a very popular process. This chapter 
describes clear solutions to this problem using an asymmetric alkyl zinc reaction. Claisen 
rearrangement proceeds quite smoothly in the presence of the Ir(I) complex as isomerization 
catalyst. The transformation from simple starting materials to complex, important functionality is 
a main goal of synthetic chemistry. We have described a method in which this is accomplished in 
a very efficient manner. All materials taken alone are very simple, standard reagents, but are 
creatively combined to generate important structures. The utility of this type of transformation is 
shown by the synthesis of (+)-calopin dimethyl ether. 
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3.4 EXPERIMENTAL SECTION 
3.4.1 Experiment of section 3.2 
3.4.1.1 One-pot reaction following ICR for preparation of enantioenriched Claisen adducts 
General one-pot procedure E for preparing of enantioenriched di(allyl)ethers with diethyl zinc 
addition and Pd(0)-catalyzed allylation: To a 0 oC solution of 1,7,7-trimethyl-3-
morpholinobicyclo [2.2.1]heptan-2-ol ((-)-MIB) (2 mol%, 0.02 mmol) in 2 ml of pentane or 
toluene was added Et2Zn (1.0 M in hexanes, 1.05 equiv., 1.05 mmol) via syringe. A solution of 
aldehydes (1.0 mmol) in 1 ml pentane or toluene was added slowly (0.33 M final concentration 
in aldehydes) and the reaction mixture was stirred at 0 oC until the reaction was complete as 
monitored by TLC (about 6 h). A solution of acetic acid (1.05 equiv.) in 2 ml THF was added via 
syringe dropwise and the solution was stirred 10 min. A solution of palladium acetate (5 mol%), 
PPh3 (25 mol%) and allyl acetate (1.5 equiv.) in anhydrous 10 ml THF was added and the 
reaction was heated at 60 oC for 12 h. The reaction mixture was cooled to ambient temperature 
and passed a short silica gel column to remove the salt, the solvent was removed in vacuo and 
the residue was purified as indicated. Enantioselectivity for the Et2Zn addition was determined 
for the allylic alcohol obtained by quenching the Et2Zn addition reaction with saturated NH4Cl 
solution and extracting the resulting mixture with Et2O (3x). The combined organic extracts were 
dried (MgSO4), concentrated and purified allylic alcohol was obtained using indicated method.  
 
1-((S,E)-3-(allyloxy)pent-1-enyl)benzene (31a): General procedure E was 
followed employing cinnamaldehyde (132 mg, 1.0 mmol), 4.8 mg (-)-MIB (0.02 
mmol), 1.05 ml Et2Zn (1.0 M in hexanes, 1.05 mmol), 0.069 ml HOAc (1.05 mmol), 11.2 mg 
O
Et Ph
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Pd(OAc)2 (0.05 mmol), 65.5 mg PPh3 (0.25 mmol) and 0.163 ml allyl acetate (1.5 mmol). The 
crude product was purified by flash chromatograph on silical gel (2 % EtOAc in hexanes) to 
yield 151 mg (75 %) of the title compound as light yellow oil. Separating the allylic alcohol 
(30a) enantiomers by chiral HPLC Daicel ChiracelTM OD-H column, flow rate 1.0 ml/min, 10 % 
i-PrOH, 90 % hexanes, Tr 13.4 (R) and 16.3 (S) provided the enantiomer ratio: 3R: 3S = 3.6: 
96.4 (93 % ee). 
 
2-((S,E)-3-(Allyloxy)pent-1-enyl)furan (31b) : General procedure E was 
applied to trans-3-(2-furyl)-acrolein (122 mg, 1.0 mmol). The crude product 
was purified by column chromatography on silical gel (2 % EtOAc in hexanes) to yield 152 mg 
(79 %) of the title compound as light yellow oil. [α] D = -76.1 (c 3.44, CHCl3). 1H NMR (300 
MHz, CDCl3): δ 7.36 (d, J = 1.8 Hz, 1H), 6.38 (dd, J = 3.3, 1.8 Hz, 1H), 6.37 (d, J = 15.9 Hz, 
1H), 6.25 (d, J = 3.2 Hz, 1H), 6.04 (dd, J = 15.9, 7.7 Hz, 1H), 5.95 (dddd, J = 17.2, 10.4, 6.0, 5.1 
Hz, 1H), 5.30 (dq, J = 17.2, 1.7 Hz, 1H), 5.18 (dq, J = 10.4, 1.5 Hz, 1H), 4.10 (ddt, J = 12.8, 5.1, 
1.5 Hz, 1H), 3.89 (ddt, J = 12.8, 6.0, 1.4 Hz, 1H), 3.78 (q, J = 6.8 Hz, 1H), 1.55-1.78 (m, 2H), 
0.96 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ 152.31, 144.81, 135.14, 129.14, 
120.20, 116.46, 111.17, 107.68, 81.01, 69.22, 28.58, 9.72 ppm; IR (liquid film): 2965, 2933, 
2875, 1647, 1489, 1462, 1152, 1073, 1013, 964, 927, 734 cm-1; MS (EI, 70 V): m/z 192 (M+.), 
163, 151, 135, 121, 109, 91, 81, 65, 57; HRMS m/z calcd for C12H16O2 (M+.): 192.1150. found 
192.1153. The allylic alcohol (S,E)-1-(furan-2-yl)pent-1-en-3-ol (30b) was purified by flash 
chromatography on silica gel (16 % ethyl acetate in hexanes). [α] D = -6.4 (c 1.74, CHCl3). 
Separation of the enantiomers by chiral HPLC Daicel ChiracelTM OD-H column, flow rate 0.5 
O
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ml/min, 5 % i-PrOH, 95 % hexanes, Tr 18.69 (R) and 20.52 (S) provided the enantiomer ratio: 
3R: 3S = 2.0: 96.6 (96 % ee).  
 
1-((S,1E,3E)-5-(Allyloxy)hepta-1,3-dienyl)benzene (31c): General 
procedure E was applied to (2E,4E)-5-phenylpenta-2,4-dienal89 (1.4 mmol, 
222 mg). The crude product was purified by column chromatography on silical gel (2 % EtOAc 
in hexanes) to yield 278 mg (87 %) of the title compound as a light yellow oil. [α] D = -77.7 (c 
2.33, CHCl3); 1H NMR (300 MHz, CDCl3): δ 7.22-7.45 (m, 5H), 6.82 (dd, J = 15.7, 10.5 Hz, 
1H), 6.58 (d, J = 15.7 Hz, 1H), 6.36 (dd, J = 15.3, 10.4 Hz, 1H), 5.96 (dddd, J = 17.2, 10.3, 6.0, 
5.2 Hz, 1H), 5.70 (dd, J = 15.3, 8.0 Hz, 1H), 5.31 (dq, J = 17.2, 1.7 Hz, 1H), 5.19 (dq, J = 10.3, 
1.5 Hz, 1H), 4.10 (ddt, J = 12.8, 5.2, 1.5 Hz, 1H), 3.89 (ddt, J = 12.8, 6.0, 1.4 Hz, 1H), 3.75 (q, J 
= 6.9 Hz, 1H), 1.55-1.78 (m, 2H), 0.96 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 
137.1, 135.2, 134.7, 132.6, 132.4, 128.6, 128.3, 127.5, 126.3, 116.5, 81.2, 69.2, 28.6, 9.8 ppm. 
MS (EI, 70 V): m/z 228 (M+.), 199, 187, 171, 157, 129, 115; HRMS m/z calcd for C16H20O (M+.): 
228.1514; found 228.1532. The allylic alcohol (S,4E,6E)-7-phenylhepta-4,6-dien-3-ol (30c) was 
purified by flash chromatography on silica gel (16 % ethyl acetate in hexanes). [α] D = +2.1 (c 
2.12, CHCl3). Separating the enantiomers by chiral HPLC Daicel ChiracelTM OD-H column, 
flow rate 1.0 ml/min, 10 % i-PrOH, 90 % hexanes, Tr 7.49 (R) and 9.57 (S) provided the 
enantiomer ratio: 3R: 3S = 3.5: 96.5 (93 % ee).  
O
Et Ph
 
(S,E)-3-(Allyloxy)dec-4-ene (31d): General procedure E was applied to (E)-O
Et C5H11
                                                 
89 Kim, D. D.; Lee, S. J.; Beak, P. J. Org. Chem. 2005, 70, 5376-5386. 
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oct-2-enal (1.0 mmol, 126 mg). The crude product was purified by column chromatography on 
silical gel (2 % EtOAc in hexanes) to yield 157 mg (80 %) of the title compound as light yellow 
oil. [α] D = -13.6 (c 3.77, CHCl3); 1H NMR (300 MHz, CDCl3): δ 5.85-5.98 (m, 1H), 5.58 (dt, J = 
15.4, 6.7 Hz, 1H), 5.22-5.30 (m, 2H), 5.15 (d, J = 10.3 Hz, 1H), 4.03 (ddt, J = 12.8, 5.2, 1.5 Hz, 
1H), 3.81 (ddt, J = 12.8, 6.0, 1.3 Hz, 1H), 3.56 (q, J = 7.1 Hz, 1H), 2.05 (q, J = 7.0 Hz, 2H), 1.48-
1.71 (m, 2H), 1.26-1.50 (m, 6H), 0.90 (t, J = 7.0 Hz, 3H), 0.89 (t, J = 7.4 Hz, 3H) ppm; 13C NMR 
(75 MHz, CDCl3): δ 135.4, 134.3, 130.5, 116.3, 81.8, 68.7, 32.7, 31.3, 28.9, 28.5, 22.5, 14.0, 9.9 
ppm; MS (EI, 70 V): m/z 167 (M+.-Et), 125, 97, 67, 55; HRMS m/z calcd for C11H19O (M+.-Et): 
167.1436; found 167.1442. The allylic alcohol (S,E)-dec-4-en-3-ol (30d) was purified by flash 
chromatography on silica gel (16 % ethyl acetate in hexanes). Then (S,E)-dec-4-en-3-ol (41d) 
(15.6 mg, 0.1 mmol), (R)-2-Methoxy-2-phenylacetic acid (18.3 mg, 0.11 mmol), 1,3-
dicyclohexylcarbodimide (DCC, 22.7 mg, 0.11 mmol), 4-(dimethylamino)pyridine (DMAP, 1.3 
mg, 0.01 mmol) was mixed in CH2Cl2 1 ml and stirred 12 h at ambient temperature, then remove 
the solvent and the crude product was purified by flash chromatograph on silical gel (4 % EtOAc 
in hexanes) to yield (2R)-(S,E)-dec-4-en-3-yl 2-methoxy-2-phenylacetate. Separating the 
diastereomer by chiral HPLC [Zorbax (4.6 mm X 25 cm) column, flow 0.8 ml/min, 2 % ethyl 
acetate, 98 % hexanes, Tr 10.01 (3R) and 9.17 (3S)] provided the diastereomer ratio: 3R: 3S = 
5.9: 94.1 (88 % ee).   
 
                                                
1-(((S,E)-4-(Allyloxy)hex-2-enyloxy)methyl)benzene (31e): General 
procedure E was followed employing (E)-4-(benzyloxy)but-2-enal90 (176 
mg, 1.0 mmol). The crude product was purified by flash chromatograph on silical gel (5 % 
O
Et
OBn
 
90  Kang, J.; Lim, G. J.; Yoon, S. K.; Kim, M. Y. J. Org. Chem. 1995, 60, 564-577. 
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EtOAc in hexanes) to yield 180 mg (73 %) of the title compound as light yellow oil. [α] D = -
26.9 (c 2.87, CHCl3). 1H NMR (300 MHz, CDCl3): δ 7.20-7.38 (m, 5H), 5.87-6.00 (m, 1H), 5.78 
(dt, J = 15.6, 5.6 Hz, 1H), 5.61 (dd, J = 15.6, 7.6 Hz, 1H), 5.29 (d, J = 17.2 Hz, 1H), 5.18 (d, J = 
10.4 Hz, 1H), 4.04-4.11 (m, 3H), 3.87 (ddt, J = 12.8, 5.9, 1.3 Hz, 1H), 3.69 (q, J = 6.8 Hz, 1H), 
1.50-1.76 (m, 2H), 0.94 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 138.16, 135.11, 
133.72, 129.24, 128.32, 127.66, 127.55, 116.46, 80.86, 71.98, 70.05, 69.13, 28.32, 9.75 ppm; 
MS (EI, 70 V): m/z 217 (M+.-Et), 199, 181, 169, 159, 143, 131, 125, 117, 105; HRMS m/z calcd 
for C14H17O2 (M+.-Et): 217.1229. found 217.1227. The allylic alcohol (S,E)-6-(benzyloxy)hex-4-
en-3-ol (30e) was purified by flash chromatography on silica gel (16 % ethyl acetate in hexanes). 
Separation of the enantiomers by chiral HPLC Daicel ChiracelTM OD-H column, flow rate 0.5 
ml/min, 5 % i-PrOH, 95 % hexanes, Tr 24.70 (R) and 26.93 (S) provided the enantiomer ratio: 
3R: 3S = 2.7: 71.7 (93 % ee). [α] D = +5.8 ° (c 3.89, CHCl3).  
 
1-((S,E)-3-(Allyloxy)-2-methylpent-1-enyl)benzene (31f): General procedure 
A was applied to (E)-2-methyl-3-phenylacrylaldehyde(1.0 mmol, 146 mmol). 
The crude product was purified by column chromatography on silical gel (2 % EtOAc in 
hexanes) to yield 181 mg (84 %) of the title compound as light yellow oil. [α] D = +9.3 (c 5.48, 
CHCl3); 1H NMR (300 MHz, CDCl3): δ 7.24-7.44 (m, 5H), 6.47 (s, 1H), 5.93-6.05 (m, 1H), 5.34 
(d, J = 17.2 Hz, 1H), 5.22 (d, J = 10.3 Hz, 1H), 4.06 (ddt, J = 12.8, 5.1, 1.4 Hz, 1H), 3.88 (ddt, J 
= 12.8, 6.1, 1.4 Hz, 1H), 3.75 (t, J = 6.9 Hz, 1H), 1.87 (d, J = 1.3 Hz, 3H), 1.55-1.84 (m, 2H), 
0.98 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 137.7, 137.4, 135.2, 128.9, 128.0, 
127.9, 126.3, 116.4, 86.9, 68.9, 26.6, 12.3, 10.3 ppm; IR (liquid film): 2963, 1446, 1327, 1074, 
918, 698 cm-1; MS (EI, 70 V): m/z 216 (M+.), 187, 159, 145, 129, 117, 105, 91, 77; HRMS m/z 
O
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calcd for C15H20O (M+.): 216.1514; found 216.1507. The allylic alcohol (S,E)-2-methyl-1-
phenylpent-1-en-3-ol (30f) was purified by flash chromatography on silica gel (16 % ethyl 
acetate in hexanes). Separation of the enantiomers by chiral HPLC Daicel ChiracelTM OD-H 
column, flow rate 0.6 ml/min, 3 % i-PrOH, 97 % hexanes, Tr 21.15 (R) and 23.40 (S) provided 
the enantiomer ratio:3R:3S = 0.8: 98.7 (98 % ee). [α] D = +37.6 (c 1.74, CHCl3). 
 
((1E)-3- ((S,E)-1-Phenylpent-1-en-3-yloxy)prop-1-enyl)trimethylsilane 
(37): General procedure E was applied to cinnamaldehyde (1.0 mmol, 132 
mg) and (E)-3-(trimethylsilyl)allyl acetate91 (1.5 mmol, 258 mg). The crude product was purified 
by column chromatography on silical gel (2 % EtOAc in hexanes) to yield 211 mg (77 %) of the 
title compound as a light yellow oil. [α] D = -71.3 (c 3.57, CHCl3); 1H NMR (300 MHz, CDCl3): 
δ 7.19-7.41 (m, 5H), 6.51 (d, J = 15.9 Hz, 1H), 6.11 (dt, J = 18.7, 4.8 Hz, 1H), 6.07 (dd, J = 15.9, 
8.0 Hz, 1H), 5.92 (dt, J = 18.7, 1.4 Hz, 1H), 4.12 (ddd, J = 13.2, 4.6, 1.6 Hz, 1H), 3.92 (ddd, J = 
13.2, 5.1, 1.4 Hz, 1H), 1.49-1.81 (m, 2H), 0.96 (t, J = 7.4 Hz, 3H), 0.08 (s, 9H) ppm; 13C NMR 
(75 MHz, CDCl3): δ 142.9, 136.7, 132.2, 131.4, 130.5, 128.5, 127.6, 126.4, 82.0, 71.3, 28.6, 9.9, 
-1.4 ppm; MS (EI, 70 V): m/z 274 (M+.), 259, 245, 216, 202, 171, 161, 145, 129, 115, 103, 91, 
75; HRMS m/z calcd for C15H20O (M+.): 274.1753; found 274.1766. 
O
Et Ph
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(E,2R,3S)-3-(furan-2-yl)-2-methylhept-4-enal (32b): General Procedure D 
was followed employing 2-((S,E)-3-(allyloxy)pent-1-enyl)furan (31b, 130 
mg, 0.68 mmol) and 1 mol% catalyst (3.1 mg Ir-dimer, 5,7 mg PCy3 and 2.3 
mg NaBPh4) in dichloroethane for 30 min. The reaction was heated at reflux for 16 h. (2R,3S): 
O
Et O
Me
H
 
91  Trost, B. B.; Self, C. R. J. Am. Chem. Soc. 1983, 105, 5942-5944. 
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(2S,3R) = 95 : 5. Purification by flash chromatograph on Iatrobeads neutral (pH = 7) silica gel 
(2.5 % ethyl ether in hexanes) to yield 97 mg (75 %) of the title compound as a colorless oil. 
Separating the enantiomers by chiral HPLC (Daicel ChiracelTM OD-H column, flow rate 0.8 
ml/min, 0.8% i-PrOH, 99.2% hexanes, Tr 8.45 (2S,3R) and 10.12 (2R,3S) provided the 
enantiomer ratio: (2R,3S):(2S, 3R) = 98:2 (96% ee). [α] D = +75.6 (c 0.66, CHCl3); 1H NMR (300 
MHz, CDCl3): δ 9.69 (d, J = 1.9 Hz, 1H), 7.33 (dd, J = 1.9, 0.9 Hz, 1H), 6.29 (dd, J = 3.2, 1.9 
Hz, 1H), 6.06 (dt, J = 3.2, 0.8 Hz, 1H), 5.65 (dt, J = 15.3, 5.9 Hz, 1H), 5.54 (ddt, J = 15.3, 8.2, 
1.2 Hz, 1H), 3.71 (dd, J = 8.2, 6.6 Hz, 1H), 2.78 (qdd, J = 7.0, 6.6, 1.9 Hz, 1H), 1.00 (d, J = 7.0 
Hz, 3H), 0.98 (t, J = 7.5 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 204.0, 155.0, 141.5, 136.8, 
125.9, 110.1, 106.3, 49.7, 43.8, 25.4, 13.5, 11.4 ppm; MS (EI, 70 V): m/z 192 (M+.), 163, 135, 
117; HRMS m/z calcd for C12H16O2 (M+.): 192.1150. found 192.1146.  
 
(E,2R,3S)-3-(furan-2-yl)-2-methylhept-4-en-1-ol (32b′): Diisobutyl 
aluminum hydride (1.0 ml, 1.0 M in hexanes, 1.0 mmol) reduction of  
aldehyde 32b (97 mg, 0.5 mmol) followed by purification by flash chromatography (16 % 
EtOAc/hexanes) gave 79 mg (81 %) of the title compound as a colorless oil. 1H NMR (300 MHz, 
CDCl3): δ 7.33 (dd, J = 1.8, 0.84 Hz, 1H), 6.30 (dd, J = 3.2, 1.8 Hz, 1H), 6.02 (dd, J = 3.2, 0.6 
Hz, 1H), 5.53-5.66 (m, 2H), 3.59 (dd, J = 11.0, 5.8 Hz, 1H), 3.50 (dd, J = 11.0, 5.9 Hz, 1H), 
3.37-3.42 (m, 1H), 1.98-2.14 (m, 3H), 1.56 (brs, 1H), 1.00 (t, J = 7.4 Hz, 3H), 0.87 (d, J = 6.9 
Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 156.82, 140.89, 134.24, 127.80, 109.95, 105.50, 
66.16, 45.24, 39.77, 25.46, 14.43, 13.62 ppm; IR (liquid film): 3358, 2963, 2932, 2875, 1590, 
1461, 1932, 1010, 971, 728 cm-1; MS (EI, 70 V): m/z 194 (M+.), 135, 117, 107, 91, 79, 65, 55; 
HRMS m/z calcd for C12H18O2 (M+.): 194.1307. found 194.1309.  
HO
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 (2R,3R,4E)-2-Methyl-3-styrylhept-4-enal (32c): General Procedure D 
was followed employing 1-((S,1E,3E)-5-(allyloxy)hepta-1,3-
dienyl)benzene (31c, 228 mg, 1.0 mmol) and 1 mol% catalyst (4.5 mg Ir-
dimer, 8.4 mg PCy3 and 3.4 mg NaBPh4) in dichloroethane for 10 min. The reaction was heated 
at reflux for 18 h. (2R,3R): (2S:3S) = 95 : 5. Purification by flash chromatograph on Iatrobeads 
neutral (pH7) silica gel (2.5 % ethyl ether in hexanes) to yields 176 mg (77 %) of the title 
compound as colorless oil. Separation of the enantiomers by chiral HPLC Daicel ChiracelTM OD-
H column, flow rate 0.8 ml/min, 1.0 % i-PrOH, 99.0 % hexanes, Tr 14.03 (2S, 3S) and 20.67 (2R, 
3R) provided the enantiomer ratio: (2S,3S): (2R,3R) = 3.7 : 96.3 (93% ee). 1H NMR (300 MHz, 
CDCl3): δ 9.69 (d, J = 2.3 Hz, 1H), 6.44 (d, J = 15.9 Hz, 1H), 6.12 (dd, J = 15.8, 8.1 Hz, 1H), 
5.60 (dt, J = 15.4, 6.1 Hz, 1H), 5.45 (dd, J = 15.4, 7.5 Hz, 1H), 3.22 (q, J = 7.5 Hz, 1H), 2.50 
(ddqd, J = 8.1, 7.5, 7.0, 2.3 Hz, 1H), 1.11 (d, J = 7.0 Hz, 3H), 0.99 (t, J = 7.4 Hz, 3H) ppm; 13C 
NMR (75 MHz, CDCl3): δ 204.7, 137.1, 134.7, 129.5, 128.5, 128.2, 127.3, 126.2, 50.4, 47.4, 
25.6, 13.7, 11.4 ppm; IR (liquid film): 2962, 1726, 1450, 969, 748, 694 cm-1; MS (EI, 70 V): m/z 
228 (M+.), 213, 199, 171, 143, 129, 115; HRMS m/z calcd for C16H20O (M+.): 228.1514. found 
228.1509.  
O
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(2R,3S)-3-((E)-But-1-enyl)-2-methyloctanal (32d): General Procedure D 
was followed employing (S,E)-3-(allyloxy)dec-4-ene (31d, 392 mg, 2.0 
mmol) and 1 mol% catalyst (9.0 mg Ir-dimer, 16.8 mg PCy3 and 6.8 mg 
NaBPh4) in dichloroethane for 10 min. The reaction was heated at reflux for 18 h. (2R,3R): 
(2S:3S) = 97 : 3. Purification by flash chromatograph on Iatrobeads neutral (pH = 7) silica gel 
O
Et C5H11
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(2.5 % ethyl ether in hexanes) yields 274 mg (70 %) of the title compound as colorless oil. 
Separating the enantiomers by chiral GC (Chiracel G-TA column (30 m x 0.25 mm), flow rate 
0.6 mL/min, method: 50 °C for 2.00 min, ramp @ 2.00 °C/min to 160 °C, hold for 20.00 min, Tr 
7.17 (2S,3R) and 9.22 (2R,3S) provided the enantiomer ratio: (2R,3S):(2S, 3R) = 93.5:6.5 (87 % 
ee). [α] D = +10.6 (c 0.71, CHCl3); 1H NMR (300 MHz, CDCl3): δ 9.64 (d, J = 2.2 Hz, 1H), 5.50 
(dt, J = 15.3, 6.4 Hz, 1H), 5.21 (ddt, J = 15.3, 8.9, 1.4 Hz, 1H), 2.21-2.38 (m, 2H), 1.97-2.07 (m, 
2H), 1.11-1.40 (m, 9H), 1.04 (d, J = 5.9 Hz, 3H), 0.97 (t, J = 7.4 Hz, 3H), 0.88 (t, J = 7.4 Hz, 3H) 
ppm; 13C NMR (75 MHz, CDCl3): δ 205.7, 134.4, 129.8, 50.7, 44.3, 31.7, 31.6, 26.8, 25.9, 22.5, 
14.0, 13.9, 11.0 ppm; IR (liquid film): 2930, 1727, 1460, 1378, 970, 723 cm-1; MS (EI, 70 V): 
m/z 196 (M+.), 167, 153, 139, 125, 97, 83, 73; HRMS m/z calcd for C13H24O (M+.): 196.1827; 
found 196.1825.  
 
(E,2R,3S)-3-((Benzyloxy)methyl)-2-methylhept-4-enal (32e): General 
Procedure D was followed employing 1-(((S,E)-4-(allyloxy)hex-2-
enyloxy)methyl)benzene (31e, 123 mg, 0.5 mmol) and 1 mol% catalyst (2.3 
mg Ir-dimer, 4.2 mg PCy3 and 1.7 mg NaBPh4) in dichloroethane for 10 min. The reaction was 
heated at reflux for 18 h. (2R,3S) : (2S:3S) = 96 : 4. Purification by flash chromatograph on 
Iatrobeads neutral (pH = 7) silica gel (2.5 % ethyl ether in hexanes) yields 74 mg (60 %) of the 
title compound as colorless oil. Separation of the enantiomers by chiral HPLC Daicel ChiracelTM 
OD-H column, flow rate 0.8 ml/min, 0.8 % i-PrOH, 99.2 % hexanes, Tr 20.27 (2S, 3R) and 24.71 
(2R, 3S) provided the enantiomer ratio: (2S,3R): (2R,3S)= 4.1: 95.9 (92 % ee). [α] D = +53.6 (c 
1.51, CHCl3). 1H NMR (300 MHz, CDCl3): δ 9.70 (d, J = 1.2 Hz, 1H), 7.27-7.61 (m, 5H), 5.60 
(dt, J = 15.4, 6.3 Hz, 1H), 5.35 (dd, J = 15.4, 8.3 Hz, 1H), 4.48 (s, 2H), 3.50 (dd, J = 9.3, 5.8 Hz, 
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1H), 3.45 (dd, J = 9.3, 7.9 Hz, 1H), 2.79-2.87 (m, 1H), 2.48-2.56 (m, 1H), 2.03 (qd, J = 7.4, 6.3 
Hz, 2H), 1.06 (d, J = 6.9 Hz, 3H), 0.98 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 
204.7, 138.2, 135.3, 128.4, 127.6 (3C, overlap), 126.6, 73.2, 70.7, 47.9, 44.2, 25.7, 13.7, 9.9 
ppm; MS (EI, 70 V): m/z 246 (M+.), 188, 158, 125, 105, 91, 81, 65; HRMS m/z calcd for 
C16H22O2 (M+.): 246.1620 found 246.1622. 
 
(((S,E)-4-((E)-Prop-1-enyloxy)hex-1-enyloxy)methyl)benzene (31e′):  
The compound is isolated 19 mg, 15 % as the by-product with compound 
32e. 1H NMR (300 MHz, CDCl3): δ 7.30-7.65 (m, 5H), 6.37 (d, J = 12.6 Hz, 1H), 6.08 (dq, J = 
12.3, 1.5 Hz, 1H), 4.81-4.94 (m, 2H), 4.67 (s, 2H), 3.45-3.53 (m, 1H), 2.13-2.19 (m, 2H), 1.55 
(dd, J = 6.7, 1.4 Hz, 3H), 1.49-1.65 (m, 2H), 0.91 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 147.51, 146.03, 137.12, 128.45, 127.84, 127.53, 100.41, 100.16, 81.95, 71.02, 31.99, 
26.10, 12.51, 9.53 ppm. 
Et
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 (E,2R,3R)-2,4-Dimethyl-3-phenylhept-4-enal (32f): General Procedure D was 
followed employing 1-((S,E)-3-(allyloxy)-2-methylpent-1-enyl)benzene (31f, 
432 mg, 2.0 mmol) and 1 mol% catalyst (9.0 mg Ir-dimer, 16.8 mg PCy3 and 
6.8 mg NaBPh4) in dichloromethane for 10 min. After the initial reaction time, 
triphenylphosphine (15.2 mg, 3 mol%) was added, the solvent was evaporated, and the residue 
was dissolved in 5 ml dry toluene. The resulting solution was heated at reflux for 18 h; (2RE, 
3RE): (2SE, 3SE): ZC4-5 = 76.4: 6.6: 17.0. Purification by flash chromatograph on Iatrobeads 
neutral (pH7) silica gel (2.5 % ethyl ether in hexanes) yields 350 mg (81 %) as colorless oil. 
Separating the enantiomers by chiral HPLC (Daicel ChiracelTM OD-H column, flow rate 0.8 
O
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ml/min, 0.8% i-PrOH, 99.2% hexanes, Tr 7.90 (2S,3S) and 11.4 (2R,3R) provided the enantiomer 
ratio: (2R,3R):(2S, 3S) = 98.5:1.5 (97% ee). [α]D = -36.5 (c 6.23, CHCl3). 1H NMR (300 MHz, 
CDCl3): δ 9.58 (d, J = 3.9 Hz, 1H), 7.18-7.34 (m, 5H), 5.43 (t, J = 7.0 Hz, 1H), 3.34 (d, J = 11.4 
Hz, 1H), 2.90-3.01 (m, 1H), 2.05-2.18 (m, 2H), 1.59 (s, 3H), 1.04 (t, J = 7.4 Hz, 2H), 0.98 (d, J = 
6.8 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 204.3, 140.6, 135.1, 129.5, 128.6, 128.4, 128.3, 
128.1, 126.6, 56.1, 47.7, 21.1, 15.0, 14.0, 13.4 ppm; MS (EI, 70 V): m/z 216 (M+.), 201, 187, 
173, 159, 143, 131, 117, 105, 91; HRMS m/z calcd for C15H20O (M+.): 216.1514 found 216.1502. 
 
(E,2R,3S)-2- ((Trimethylsilyl)methyl)-3-phenylhe 
pt-4-en-1-ol (38′): General Procedure D was 
followed employing ((1E)-3-((S,E)-1-phenylpent-1-
en-3-yloxy)prop-1-enyl)trimethylsilane (48, 137 mg, 0.5 mmol) and 1 mol% catalyst (2.3 mg Ir-
dimer, 4.2 mg PCy3 and 1.7 mg NaBPh4) in dichloroethane for 20 h. The reaction was heated at 
reflux for 12 h to afford (E,2R,3S)-2- ((trimethylsilyl)methyl)-3-phenylhe pt-4-en-1-al (38); 
(2R,3S): (2R,3R) = 95 : 5. Due to the sensitivity of aldehydes 38 toward epimerization, 
Diisobutylaluminum hydride (1.0 ml, 1.0 M in hexanes, 1.0 mmol) reduction of 38 followed by 
purification by flash chromatography (16 % EtOAc/hexanes) gave 70 mg (50 %) of the title 
compound as a colorless oil. Separating the enantiomers by chiral HPLC (Daicel ChiracelTM OD-
H column, flow rate 0.5 ml/min, 5.0% i-PrOH, 95.0% hexanes, Tr 7.08 (2S,3R) and 8.68 (2R,3S) 
provided the enantiomer ratio: (2R,3S):(2S, 3R) = 95.5:4.5 (91% ee). [α] D = +39.1 (c 2.20, 
CHCl3); 1H NMR (300 MHz, CDCl3): δ 7.19-7.34 (m, 5H), 5.71 (dd, J = 15.3, 8.6 Hz, 1H), 5.62 
(dt, J = 15.3, 5.7 Hz, 1H), 3.73 (dd, J = 11.1, 3.7 Hz, 1H), 3.55 (dd, J = 11.1, 5.6 Hz, 1H), 3.29 (t, 
J = 8.4 Hz, 1H), 2.03-2.08 (m, 3H), 1.60 (brs, 1H), 0.43-0.52 (m, 2H), -0.03 (s, 9H) ppm; 13C 
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NMR (75 MHz, CDCl3): δ 144.0, 133.1, 131.7, 128.4, 128.2, 126.1, 65.5, 54.3, 42.3, 25.5, 16.1, 
13.7, -0.8 ppm; MS (EI, 70 V): m/z 243 (M+.-H2O-Me), 218, 145, 131, 117, 91, 75, 73. 
 
(2R,3S,E)-2-Ethyl-3-phenylhept-4-en-1-ol (41′): General 
procedure E was applied to cinnamaldehyde (2.0 mmol, 264 
mg) and crotyl acetate (3.0 mmol, 346 mg). The crude 
product was purified by column chromatography on silical gel (2 % EtOAc in hexanes) to yield 
260 mg (60 %) of a mixture of di(allyl) ether (39 and 40, ratio 1: 2). Then general procedure D 
was followed employing a mixture of  (39 and 40, 216 mg, 1.0 mmol) and 1 mol% catalyst (4.5 
mg Ir-dimer, 8.4 mg PCy3 and 3.4 mg NaBPh4) in dichloroethane for 1.5 h. The reaction was 
heated at reflux for 12 h to afford (2R,3S,E)-2-Ethyl-3-phenylhept-4-en-1-al (41); (2R, 3S): (2R, 
3R) = 95: 5. Due to the poor separation of desired product from by-products, the DIBAL-H (1.0 
M in hexanes, 2.0 ml, 2.0 mmol) reduction of aldehyde 41 at –78 oC and crude product was 
purified by flash chromatograph on silical gel (16 % EtOAc in hexanes) to yield 43 mg (20 %) of 
the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.18 (m, 5H), 5.55-5.72 (m, 
2H), 3.65-3.80 (m, 2H), 3.24 (t, J = 8.9 Hz, 1H), 1.98-2.07 (m, 2H), 1.69-1.83 (m, 1H), 1.19-1.39 
(m, 2H), 0.96 (t, J = 7.4 Hz, 3H), 0.84 (t, J = 7.4 Hz, 3H) ppm.  
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3.4.1.2 One pot reaction from alkenyl zinc addition 
General Procedure F: Preparation of di(allyl) ethers from terminal alkynes:  Cyclohexene 
(2.0 equiv.) was added to a solution of BH3.THF (1.0 M in THF, 1.0 equiv.) at 0 oC and stirred 3 
h. Then the alkyne (1.0 equiv.) was added to a suspension of dicyclohexylborane at 0 oC and 
stirred 15 min. The resulting suspension was warmed directly to ambient temperature, stirred for 
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1 h and THF was removed in vacuo. Then pentane was added (1.0 M solution) and cooled to -78 
oC. Diethylzinc (1.0 M in hexanes, 1.05 equiv.) and catalyst (-)-MIB (2 mol%) was added at -78 
oC and stirred 30 min and warmed to 0 oC. Then benzaldehyde (0.9 equiv.) in pentane (1.0 M 
solution) was added over 10 min and stirred 3 h. Then acetic acid (1.05 equiv.) in THF (1.0 M 
solution) was added and continually stirred for 10 min then added via syringe to a solution of 
palladium acetate (5 mol%), PPh3 (25 mol%), allyl acetate (1.5 equiv.) in 10 ml anhydrous THF, 
The reaction was stirred for 12 h at 60 oC oil bath whereupon the solvent was removed in vacuo 
and the residue purified as indicated. To get enantiomer excess value, same reaction condition 
without Pd-catalyzed allylation was applied, and saturated NH4Cl solution was added to quench 
the reaction after alkenylzinc addition. The solution was extracted with Et2O (3x) and the 
combined organic extracts were dried (MgSO4). The solvent was removed in vacuo and the 
residue purified as indicated. 
 
1-((S,E)-1-(Allyloxy)oct-2-enyl)benzene (42a): General procedure F was 
applied to 1-heptyne (2.0 mmol, 192 mg) and benzaldehyde (1.8 mmol, 191 
mg). The crude product was purified by column chromatography on silical gel (2 % EtOAc in 
hexanes) to yield 302 mg (62 %) of the title compound as light yellow oil. [α] D = +25.3 (c 2.74, 
CHCl3); 1H NMR (300 MHz, CDCl3): δ 7.24-7.44 (m, 5H), 5.87-6.01 (m, 1H), 5.69 (dt, J = 15.3, 
6.4 Hz, 1H), 5.56 (dd, J = 15.3, 7.1 Hz, 1H), 5.27 (d, J = 17.2 Hz, 1H), 5.16 (d, J = 10.4 Hz, 1H), 
4.76 (d, J = 7.0 Hz, 1H), 4.00 (dd, J = 12.8, 5.5 Hz, 1H), 3.93 (dd, J = 12.8, 5.5 Hz, 1H), 2.04 (q, 
J = 7.0 Hz, 2H), 1.27-1.43 (m, 6H), 0.87 (t, J = 7.2 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 
141.8, 134.9, 133.7, 130.6, 128.3, 127.3, 126.7, 116.6, 81.8, 68.9, 32.2, 31.3, 28.7, 22.4, 14.0 
ppm; IR (liquid film): 3064, 2927, 2856, 1452, 1070, 971, 920, 748, 699 cm-1; MS (EI, 70 V): 
O
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m/z 244 (M+.), 203, 186, 173, 161, 143, 129, 117, 105, 99, 91, 84; HRMS m/z calcd for C17H24O 
(M+.): 244.1827; found 244.1816. The allylic alcohol (S,E)-1-phenyloct-2-en-1-ol (42a′) was 
purified by flash chromatography on silica gel (16 % ethyl acetate in hexanes). Separation of the 
enantiomers by chiral HPLC Daicel ChiracelTM OD-H column, flow rate 0.5 ml/min, 5.0 % i-
PrOH, 95.0 % hexanes, Tr 14.53 (R) and 18.27 (S) provided the enantiomer ratio: 1R: 1S = 5.7: 
78.8 (87 % ee), [α] D = +26.4 (c 2.26, CHCl3).  
 
1-((S,E)-1-(Allyloxy)-4,4-dimethylpent-2-enyl)benzene (42b): General 
procedure F was applied to 3,3-dimethylbut-1-yne (2.0 mmol, 164 mg) and 
benzaldehyde (1.8 mmol, 191 mg). The crude product was purified by column chromatography 
on silical gel (2 % EtOAc in hexanes) to yield 290 mg (63 %) of the title compound as light 
yellow oil. [α] D = +38.6 (c 2.07, CHCl3). 1H NMR (300 MHz, CDCl3): δ 7.40-7.62 (m, 5H), 
6.10 (ddt, J = 17.2, 10.4, 5.6 Hz, 1H), 5.87 (dd, J = 15.6, 0.9 Hz, 1H), 5.62 (dd, J = 15.6, 7.4 Hz, 
1H), 5.43 (dq, J = 17.2, 1.7 Hz, 1H), 5.33 (dq, J = 10.4, 1.4 Hz, 1H), 4.91 (d, J = 7.4 Hz, 1H), 
4.15 (ddt, J = 12.9, 5.5, 1.3 Hz, 1H), 4.08 (ddt, J = 12.9, 5.6, 1.3 Hz, 1H), 1.17 (s, 9H) ppm; 13C 
NMR (75 MHz, CDCl3 ): δ 144.62, 141.94, 135.03, 128.30, 127.30, 126.76, 125.40, 116.76, 
82.01, 68.90, 33.00, 29.44 ppm; MS (EI, 70 V): m/z 230 (M+.), 188, 173, 157, 147, 131, 115, 
105; HRMS m/z calcd for C16H22O (M+.): 230.1671. found 230.1671. The allylic alcohol (S,E)-
4,4-dimethyl-1-phenylpent-2-en-1-ol (53b′) was purified by flash chromatography on silica gel 
(16 % ethyl acetate in hexanes). Separation the enantiomers by chiral HPLC Daicel ChiracelTM 
OD-H column, flow rate 0.8 ml/min, 5.0 % i-PrOH, 95.0 % hexanes, Tr 9.3 (R) and 11.8 (S) 
provided the enantiomer ratio: 1R: 1S = 4.0: 96.0 (92 % ee).  
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(E,2S,3R)-2-Methyl-3-styryloctanal (43a): General Procedure D was 
followed employing 1-((S,E)-1-(allyloxy)oct-2-enyl)benzene (42a, 244 mg, 
1.0 mmol) and 1 mol% catalyst (4.5 mg Ir-dimer, 8.4 mg PCy3 and 3.4 mg 
NaBPh4) in dichloromethane for 10 min. The reaction was heated at reflux for 16 h. (2S,3R): 
(2R:3R) = 95 : 5. Purification by flash chromatograph on Iatrobeads neutral (pH7) silica gel (2.5 
% ethyl ether in hexanes) yields 195 mg (80 %) of the title compound as colorless oil. Separation 
of the enantiomers by chiral HPLC Daicel ChiracelTM OD-H column, flow rate 1.0 ml/min, 0.8 
% i-PrOH, 99.2 % hexanes, Tr 10.05 (2R,3S) and 15.14 (2S,3R) provided the enantiomer ratio: 
(2R, 3S): (2S, 3R)=  7.0 : 88.7 (86% ee). [α] D = -27.6 (c 2.54, CHCl3); 1H NMR (300 MHz, 
CDCl3): δ 9.73 (d, J = 1.9 Hz, 1H), 7.23-7.50 (m, 5H), 6.44 (d, J = 15.8, 1H), 6.06 (dd, J = 15.8, 
9.0 Hz, 1H), 2.43-2.60 (m, 2H), 1.25-1.49 (m, 6H), 1.14 (d, J = 6.8 Hz, 3H), 0.90 (t, J = 7.4 Hz, 
3H) ppm; 13C NMR (75 MHz, CDCl3): δ 204.8, 137.1, 131.8, 131.2, 128.5, 127.2, 126.1, 50.7, 
44.7, 31.7, 31.6, 27.0, 22.4, 14.0, 11.0 ppm; MS (EI, 70 V): m/z 244 (M+.), 187, 173, 145, 129, 
115, 104, 91; HRMS m/z calcd for C17H24O (M+.): 244.1827; found 244.1826.  
O
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(E,2S,3R)-3-tert-Butyl-2-methyl-5-phenylpent-4-enal (43b): General 
Procedure D was followed employing 1-((R,E)-1-(allyloxy)-4,4-dimethylpent-2-
enyl)benzene (42b, 125 mg, 0.5 mmol) and 1 mol% catalyst (2.3 mg Ir-dimer, 
4.2 mg PCy3 and 1.7 mg NaBPh4) in dichloroethane for 10 min. The reaction was heated at 
reflux for 24 h. (2S,3R): (2R:3R) = 92: 8. Purification by flash chromatograph on Iatrobeads 
neutral (pH7) silica gel (2.5 % ethyl ether in hexanes) yields 100 mg (80 %) of the title 
compound as colorless oil.stirred 30 min at dichloroethane. Separation of the enantiomers by 
chiral HPLC Daicel ChiracelTM OD-H column, flow rate 0.8 ml/min, 0.8 % i-PrOH, 99.2 % 
O
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hexanes, Tr 12.7 (2R,3S) and (2S,3R) provided the enantiomer ratio: (2R,3S): (2S,3R)=  3.6 : 96.4 
(93 % ee).  [α] D = +19.1 (c 1.02, CHCl3); 1H NMR (300 MHz, CDCl3): δ 9.87 (d, J = 3.9 Hz, 
1H), 7.30-7.48 (m, 5H), 6.53 (d, J = 15.6 Hz, 1H), 6.33 (dd, J = 15.6, 10.7 Hz, 1H), 2.90 (qdd, J 
= 7.0, 3.9, 2.6 Hz, 1H), 2.15 (dd, J = 10.7, 2.6 Hz, 1H), 1.22 (d, J = 7.0 Hz, 3H), 1.09 (s, 9H) 
ppm; 13C NMR (75 MHz, CDCl3): δ 205.4, 137.2, 133.8, 128.6, 127.4, 127.2, 126.3, 59.2, 47.2, 
34.2, 28.6, 15.6 ppm; MS (EI, 70 V): m/z 215 (M+.-Me), 188, 173, 147, 105, 77; HRMS m/z 
calcd for C15H19O(M+.-Me): 215.1436; found 215.1439.  
3.4.2 Experiment of se
                                                
ction 3.3 
(E)-3-(2,3-Dimethoxy-4-methylphenyl)acrylaldehyde 92  (46): Solution 
of n-butyl lithium (1.6 M in hexanes, 20 ml, 32 mmol) was added to a 
solution of diisopropylamine (4.5 ml, 32 mmol) in 100 ml dry THF at -78 
oC. The solution was stirred for 10 min then acetaldehyde N-tert-butylamine (2.1 ml, 16 mmol) 
was added and the solution stirred for 30 min. Diethyl chlorophosphate (2.3 ml, 16 mmol) was 
added and the solution stirred at -78 oC for 2 h, then allowed to warm to -10 oC over 3 h and 
recooled to -78 oC. Solution of 2,3-dimethoxy-4-methylbenzaldehyde93 (1.93 g, 10.7 mmol) in 
10 ml THF was added to the resulting yellow solution and the reaction allowed to warm slowly 
to ambient temperature overnight. Add oxalic acid (2.88 g, 32 mmol) in 100 ml water and 100 ml 
benzene, stirred 3 h, extracted with ethyl ether (2 X 100 ml), washed with 5 % oxalic acid, 
saturated NaHCO3 and brine. Solvent was evaporated and the residue oil was purified with 
column chromatography (15 % ethyl acetate in hexanes) to afford yellow solid 1.44 g, 65 %. 1H 
O
H
MeMeO
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92 Mann, S.; Carillon, S.; Breyne, O.; Marquet, A. Chem. Eur. J. 2002, 8, 439. 
93 Comins, D. L.; Brown, J. D. J. Org. Chem. 1984, 49, 1078-1083. 
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NMR (300 MHz, CDCl3): δ 9.70 (d, J = 7.8 Hz, 1H), 7.77 (d, J = 16.1 Hz, 1H), 7.24 (d, J = 8.0 
Hz, 1H), 6.96 (d, J = 8.0 Hz, 1H), 6.72 (dd, J = 16.1, 7.8 Hz, 1H), 3.92 (s, 3H), 3.85 (s, 3H), 2.30 
(s, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 193.9, 152.2, 151.5, 141.4, 136.4, 128.5, 126.1, 
126.0, 122.3, 60.9, 59.8, 16.0 ppm. IR: 2937, 2813, 2738, 1671, 1490, 1409, 1270, 1176, 1075, 
1022, 822, 787, 768 cm-1.  MS (EI, 70 V): m/z 206 (M+.), 191, 175, 160, 147, 135, 91; HRMS 
m/z calcd for C12H14O3 (M+.): 206.0943; found 206.0936. 
 
(S,E)-1- (3-(Allyloxy)pent-1-enyl)-2,3-dimethoxy-4-methylbenzene 
(50): The General Procedure E (one-pot addition and allylation) was 
applied to (E)-3-(2,3-dimethoxy-4-methylphenyl)acrylaldehyde (46, 
1.53 mg, 7.4 mmol). The crude product was purified by column chromatography on silical gel (2 
% ethyl acetate in hexanes) to yield 1.86 mg (90 %) of the title compound as light yellow oil. [α] 
D = -53.7 (c 10.4, CHCl3); 1H NMR (300 MHz, CDCl3): δ 7.17 (d, J = 8.0 Hz, 1H), 6.89 (d, J = 
8.0 Hz, 1H), 6.80 (d, J = 16.1 Hz, 1H), 6.06 (dd, J = 16.1, 8.1 Hz, 1H), 5.90-6.02 (m, 1H), 5.30 
(d, J = 17.2 Hz, 1H), 5.19 (d, J = 10.4 Hz, 1H), 4.13 (dd, J = 12.8, 5.1 Hz, 1H), 3.92 (dd, J = 
12.8, 5.9 Hz, 1H), 3.91 (q, J = 7.0 Hz, 1H), 3.86 (s, 6H), 2.28 (s, 3H), 1.59-1.82 (m, 2H), 0.98 (t, 
J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 151.6, 150.6, 135.2, 131.7, 130.8, 128.9, 
126.5, 125.7, 120.9, 116.4, 81.9, 69.1, 60.6, 60.0, 28.6, 15.7, 9.8 ppm. IR(liquid film) 2963, 
2933, 2859, 1460, 1407, 1277, 1074, 1029, 916, 805, 734 cm-1. MS (EI, 70 V): m/z 276 (M+.), 
247, 235, 219, 205, 191, 175, 165; HRMS m/z calcd for C17H24O3 (M+.) 276.1725; found 
276.1722. The allylic alcohol (S,E)-1-(2,3-dimethoxy-4-methylphenyl)pent-1-en-3-ol (50′) was 
purified by column chromatography on silica gel (16 % EtOAc in hexanes). 1H NMR (300 MHz, 
CDCl3): δ 7.12 (d, J = 8.0 Hz, 1H), 6.87 (d, J = 8.0 Hz, 1H), 6.81 (d, J = 16.1 Hz, 1H), 6.19 (dd, J 
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= 16.1, 7.0 Hz, 1H), 4.21 (q, J = 6.5 Hz, 1H), 3.84 (s, 3H), 3.83 (s, 3H)， 2.25 (s, 3H), 1.61-1.76 
(m, 2H), 0.97 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 151.50, 150.56, 132.77, 
131.64, 128.97, 125.73, 124.66, 120.95, 74.65, 60.64, 60.03, 30.13, 15.76, 9.71 ppm; MS (EI, 70 
V): m/z 236 (M+.), 207, 179, 165, 152; HRMS m/z calcd for C14H20O3 (M+.) 236.1412; found 
236.1410. Separating the enantiomers by chiral HPLC Daicel ChiracelTM OD-H column, flow 
rate 1.0 ml/min, 5 % i-PrOH, 95 % hexanes, Tr 8.84 (R) and 9.76 (S) provided the enantiomer 
ratio: (R) : (S) = 5.2 : 94.8 (90 % ee).  
 
(2S,3R,E)-3- (2,3-Dimethoxy-4-methylphenyl)-2-methylhept-4-en-1-
ol (52): General Procedure D was followed employing (S,E)-1-(3-
(allyloxy)pent-1-enyl)-2,3-dimethoxy-4-methylbenzene (50, 1.93 g, 7 
mmol) and stirred 30 min at dichloroethane. Then added PPh3 (55 mg, 
0.21 mmol) and refluxed in oil bath for 12 h to afford (2S,3R,E)-3-(2,3-Dimethoxy-4-
methylphenyl)-2-methylhept-4-en-1-al (51); (2S,3R) : (2R,3R) = 94 : 6. 1H NMR (300 MHz, 
CDCl3): δ 9.76 (d, J = 3.3 Hz, 1H), 6.98 (d, J = 7.9 Hz, 1H), 6.87 (d, J = 7.9 Hz, 1H), 5.60-5.75 
(m, 2H), 3.94 (s, 3H), 3.90 (s, 3H), 3.85-3.95 (m, 1H), 2.78-2.84 (m, 1H), 2.33 (s, 3H), 2.02-2.12 
(m, 2H), 1.03 (t, J = 6.9 Hz, 3H), 0.98 (d, J = 7.4 Hz, 3H) ppm. Then cooled to -78 oC and 
DIBAL-H (1.0 M in hexanes, 10.5 ml, 10.5 mmol) was added into aldehyde 51 dropwise. After 
warm to ambient temperature, saturated saturated sodium tartrate solution salt solution was 
added to the reaction to quench the reaction and extracted with ethyl ether. After solvent 
Vaporation the oil was purified by flash chromatograph on silical gel (16 % ethyl acetate in 
hexanes) to yield 1.55 g (80 %) of the title compound as colorless oil. [α] D = -9.9 (c 11.9, 
CHCl3); 1H NMR (300 MHz, CDCl3): δ 6.89 (d, J = 8.0 Hz, 1H), 6.82 (d, J = 8.0 Hz, 1H), 5.70 
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(dd, J = 15.2, 8.2 Hz, 1H), 5.60 (dt, J = 15.2, 5.5 Hz, 1H), 3.85 (s, 3H), 3.83 (s, 3H), 3.62-3.77 
(m, 2H), 3.37-3.52 (m, 1H), 2.37 (s, 1H), 2.25 (s, 3H), 0.97 (t, J = 7.4 Hz, 3H), 0.73 (t, J = 6.9 
Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 151.27, 150.70, 134.40, 132.82, 131.38, 129.72, 
125.60, 123.23, 66.57, 60.57, 59.82, 43.47, 40.28, 25.46, 15.50, 13.89, 13.60. IR(liquid film): 
3444, 2962, 2933, 2874, 2246, 1461, 1408, 1277, 1066, 1027, 910, 805, 734 cm-1; MS (EI, 70 
V): m/z 278 (M+.), 219, 204, 188, 175; HRMS m/z calcd for C17H26O3 (M+.) 278.1882; found 
278.1883. 
 
1-((2S,3R,E)-1- (Benzyloxy)-2-methylhept-4-en-3-yl)-2,3-dimethoxy-
4-methylbenzene (53): To a suspention of sodium hydride (360 mg, 15 
mmol) in 10 ml anhydrous THF added  solution of alcohol 52 (1.39 g, 
5.0 mmol) in THF, stirred 30 min, then benzyl bromide (1.71 g, 10.0 
mmol) was added dropwise and warmed to 60 oC for 12 h, then saturated NH4Cl solution was 
added to quench the reaction and extracted with ethyl ether (3 X 30 ml). After solvent 
Vaporation the oil was purified with silica gel (2 % ethyl acetate in hexanes) to afford the title 
product 1.66 g (90 %) as colorless oil. [α] D = +16.6 (c 14.3, CHCl3); 1H NMR (300 MHz, 
CDCl3): δ 7.33-7.43 (m, 5H), 6.93 (d, J = 8.0 Hz, 1H), 6.87 (d, J = 8.0 Hz, 1H), 5.61 (dd, J = 
15.9, 8.2 Hz, 1H), 5.53 (dt, J = 15.9, 5.7 Hz, 1H), 4.60 (d, J = 12.1 Hz, 1H), 4.54 (d, J = 12.1 Hz, 
1H), 3.89 (s, 3H), 3.88 (s, 3H), 3.69 (dd, J = 9.5, 3.6 Hz, 1H), 3.58 (dd, J = 9.5, 8.5 Hz, 1H), 3.39 
(dd, J = 8.8, 7.4 Hz, 1H), 2.30 (s, 3H), 2.10-2.20 (m, 1H), 1.99-2.08 (m, 2H), 0.99 (t, J = 7.4 Hz, 
3H), 0.91 (d, J = 6.9 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 151.42, 150.90, 138.90, 
135.98, 132.63, 131.60, 129.50, 128.20, 127.44, 127.28, 125.54, 122.70, 74.18, 72.98, 60.34, 
59.79, 45.34, 37.84, 25.49, 16.20, 15.61, 13.71 ppm; IR(liquid film): 3029, 2961, 2931, 1461, 
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1408, 1278, 1070, 1028, 969, 910, 734, 698 cm-1. MS (EI, 70 V): m/z 368 (M+.), 287, 277, 262, 
247, 219, 188, 175, 91; HRMS m/z calcd for C24H32O3 (M+.): 368.2351; found 368.2348. 
 
(2S,3R)-4- (Benzyloxy)-2-(2,3-dimethoxy-4-methylphenyl)-3-methylbuta 
nal (54): To a suspention of olefin 53 (368 mg, 1.0 mmol) in tBuOH-H2O (1 
: 1) 5 ml added OsO4 (2.5 % wt. in tBuOH, 0.655 ml, 0.05 mmol) and N-
methyl-morpholine oxide (176 mg, 1.5 mmol) and stirred 12 h at 23 oC, 
then added Na2SO3 (1.5 g, 12 mmol) and stirred 1 h, extracted with ether, dried and removed 
solvent to afford the crude diol compound as a mixture of diastereomers. To a solution of the diol 
residue in 5 ml MeCN-H2O (1 : 1) added NaIO4 (214 mg, 1.0 mmol) and stirred 6 h, extracted 
with ethyl ether, dried and removed solvent. The residue oil was purified by column 
chromatography on silical gel (5 % ethyl acetate in hexanes) to yield 267 mg (78 %) of the title 
compound as a light yellow oil, (2S,3R): (2R,3R) = 93: 7. [α] D = -67 (c 6.8, CHCl3); 1H NMR 
(300 MHz, CDCl3): δ 9.71 (d, J = 2.8 Hz, 1H), 7.21-7.40 (m, 5H), 6.90 (d, J = 7.9 Hz, 1H), 6.80 
(d, J = 7.9 Hz, 1H), 4.54 (d, J = 12.2 Hz, 1H), 4.48 (d, J = 12.2 Hz, 1H), 3.84 (s, 3H), 3.81 (s, 
3H0, 3.77-3.81 (m, 1H), 3.52 (dd, J = 9.3, 5.0 Hz, 1H), 3.39 (dd, J = 9.3, 7.3 Hz, 1H), 2.66-2.77 
(m, 1H), 2.26 (s, 3H), 0.76 (d, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 200.5, 151.7, 
151.5, 138.2, 131.8, 128.3, 127.6, 127.5, 127.0, 125.7, 124.6, 74.1, 73.0, 60.5, 59.7, 56.3, 34.1, 
15.7, 14.6 ppm; IR (liquid film): 2934, 2718, 1721, 1489, 1409, 1278, 1069, 1025, 916, 814, 737, 
699 cm-1. MS (EI, 70 V): m/z 342 (M+.), 312, 314, 204, 191, 173, 163, 148, 133, 103; HRMS m/z 
calcd for C21H26O4 (M+.): 342.1831; found 342.1825; HRMS m/z calcd for C20H26O3 (M+.-CO): 
314.1882; found 314.1876. 
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 (2S,3R,4R,E)-1- (Benzyloxy)-3-(2,3-dimethoxy-4-methylphen 
yl)-2-methylundec-5-en-4-ol 94  (55): To a suspention of 
bis(cyclopentadienyl)zirconium(IV) chloride hydride (Schwartz’ 
reagent, 260 mg, 1.0 mmol) added 1-heptyne (96 mg, 1.0 mmol) and stirred 30 min, cooled to -
78 oC and Et2Zn (1.0 M in hexane, 1.0 ml, 1.0 mmol) was added dropwise over 5 min, then 
stirred 30 min and warmed to 0 oC, Aldehyde 54 (274 mg, 0.8 mmol) in 2 ml toluene was added 
over 10 min, stirred 5 h. Saturated NH4Cl solution was added to quench the reaction and filtrated 
through silica plug, solvent was evaporated and the residue oil was purified by column 
chromatography on silica gel (20 % ethyl acetate in hexanes) to yield 236 mg (67 %) of the title 
compound as a light yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.29-7.37 (m, 5H), 6.83 (d, J = 
8.0 Hz, 1H), 6.72 (d, J = 8.0 Hz, 1H), 5.46 (dt, J = 15.3, 6.6 Hz,1 H), 5.29 (dd, J = 15.3, 7.0 Hz, 
1H), 4.58 (d, J = 11.8 Hz, 1H), 4.52 (d, J = 11.8 Hz, 1H), 4.40 (t, J = 7.2 Hz, 1H), 3.82 (s, 3H), 
3.79 (s, 3H), 3.59 (dd, J = 9.4, 5.8 Hz, 1H), 3.45 (dd, J = 9.4, 5.3 Hz, 1H), 3.19-3.25 (m, 1H), 
3.07 (s, 1H), 2.25-2.35 (m, 1H), 2.24 (s, 3H), 1.78-1.94 (m, 2H), 1.04-.129 (m, 6H), 0.86 (t, J = 
6.9 Hz, 3H), 0.85 (d, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 151.7, 151.3, 138.2, 
132.5, 132.3, 131.1, 129.9, 128.3, 127.7, 127.6, 125.1, 124.0, 74.6, 74.1, 73.2, 60.2, 59.8, 35.3, 
32.1, 31.1, 28.7, 22.4, 16.3, 15.6, 14.2, 13.9 ppm; IR (liquid film): 3423, 2929, 1491, 1408, 1278, 
1070, 1027, 909, 734 cm-1; MS (ESI): m/z 463 (M+.+Na); HRMS m/z calcd for C28H40O4Na 
(M+.+Na): 463.2824; found 463.2780. 
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94 Wipf, P.; Xu, W. Tetrahedron. Lett. 1994, 35, 5197. 
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dimethoxy-4-methylphenyl)-4-methylpentanal (57): To a solution of alcohol 55 (220 mg, 0.5 
mmol) in DMF 2 ml added imidazole (66 mg, 1 mmol) and TBSCl (90 mg, 0.6 mmol) and the 
reaction was stirred 3 h at 80 oC. The reaction was diluted with water and extracted with ethyl 
ether. After solvent evaporation, the oil was purified by column chromatography on silica gel (2 
% ethyl acetate in hexanes) to yield ((2S,3R,4R,E)-1-(benzyloxy)-3-(2,3-dimethoxy-4-
methylphenyl)-2-methylundec-5-en-4-yloxy)(tert-butyl)dimethylsilane (56) as colorless oil. 
Then solved the oil in 20 ml methanol and cooled to -78 oC, the solution was bubbled with ozone 
until blue colour lasting 10 min. Dimethyl sulfide 0.4 ml was added to the reaction mixture and 
stirred overnight from -78 oC to ambient temperature. The solvent was evaporated and the oil 
was purified by column chromatography (5 % ethyl acetate in hexanes) to yield 194 mg (72 %) 
of the title compound as yellow oil over two steps. [α]D = -11.7 (c 0.65, CHCl3); 1H NMR (300 
MHz, CDCl3): δ 9.49 (d, J = 1.2 Hz, 1H), 7.42-7.23 (m, 5H), 6.89 (d, J = 8.0 Hz, 1H), 6.84 (d, J 
= 8.0 Hz, 1H), 4.47 (d, J = 11.9 Hz, 1H), 4.39 (d, J = 11.9 Hz, 1H), 4.16 (dd, J = 4.7, 1.2 Hz, 
1H), 3.84 (s, 3H), 3.80 (s, 3H), 3.68 (dd, J = 9.0, 4.6 Hz, 1H), 3.42 (dd, J = 9.2, 4.6 Hz, 1H), 3.37 
(dd, J = 9.2, 5.5 Hz, 1H), 2.37-2.50 (m, 1H), 2.48 (s, 3H), 0.92 (s, 9H), 0.88 (d, J = 6.9 Hz, 3H), -
0.01 (s, 3H), -0.12 (s, 3H) ppm; IR(liquid film): 2930, 2857, 1736, 1462, 1408, 1279, 1254, 
1159, 1071, 1027, 838, 778, 698 cm-1; MS (EI, 70 V): 457 (M+.-CHO), 429, 349, 337, 321, 207, 
165, 105, 91; HRMS m/z calcd for C27H41O4Si (M+.-CHO): 457.2774; found 457.2761. 
 
(3S,4R,5S)-4- (2,3-Dimethoxy-4-
methylphenyl -3-hydroxy-5-methyl-
tetrahydropyran-2-one (44): A solution 
of the compound 57 (100 mg, 0.2 mmol) in ethyl acetate 10 ml and 5 % Pd/C (10 mg) was 
Me
Me
O
O
Me
Me
O
O
OTBS OH
OMe
OMe
OMe
OMe
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placed under an atmosphere of H2 and strirred overnight to afford lactol (58). After filtration 
through a Celite plug and washed with ethyl ether, the solvent was evaporated and the resulting 
oil lactol (58) was solved in 10 ml CH2Cl2, 4-methylmorpholine N-oxide (34 mg, 0.3 mmol) and 
4 Å MS (100 mg) was added. Tetrapropylammonium perruthenate (TPAP, 3.5 mg, 0.01 mmol) 
was added in portion to the reaction mixture. After 2 h, the solution was filtered through a silica 
plug and washed with CH2Cl2. After solvent evaporation, the TBS protected δ-lactone 
(3R,4R,5R)-3-(tert-Butyldimethylsilyloxy)-4-(2,3-dimethoxy-4-methylphenyl)-5-methyl-
tetrahydropyran-2-one (59) 68 mg was obtained, the compound was used directly without further 
purification. [α] D = -36.5 (c 0.46, CHCl3); 1H NMR (300 MHz, CDCl3): δ 6.84 (d, J = 7.9 Hz, 
1H), 6.79 (d, J = 7.9 Hz, 1H), 4.49 (dd, J = 11.1, 5.1 Hz, 1H), 4.38 (d, J = 6.2 Hz, 1H), 4.04 (dd, 
J = 11.1, 9.6 Hz, 1H), 3.85 (s, 3H), 3.78 (s, 3H), 3.26 (dd, J = 9.6, 6.2 Hz, 1H), 2.42-2.55 (m, 
1H), 2.25 (s, 3H), 0.96 (d, J = 6.9 Hz, 3H), 0.74 (s, 9H), 0.00 (s, 3H), -0.24 (s, 3H) ppm. Then 
protected lactone (59, 38 mg, 0.1 mmol) in DMF 1 ml was added tris(dimethylamino)sulfonium 
difluorotrimethylsilicate (TASF, 55 mg, 0.2 mmol) at 23 oC. After 3 h, the solution was diluted 
with ethyl ether 10 ml and the resulting mixture was washed with brine, dried over MgSO4, after 
solvent Vaporation, the oil was purified by column chromatography (50 % ethyl acetate in 
hexanes) to afford 25 mg (81 % over three steps) the title product as colorless oil. [α] D = +42 (c 
0.3, CHCl3); 1H NMR (300 MHz, CDCl3): δ 6.87 (d, J = 7.8 Hz, 1H), 6.70 (d, J = 7.8 Hz, 1H), 
4.62 (dd, J = 10.0, 5.1 Hz, 1H), 4.32 (dd, J = 11.5, 5.1 Hz, 1H), 4.12 (t, J = 11.5 Hz, 1H), 3.88 (s, 
3H), 3.80 (s, 3H), 3.59 (dd, J = 9.7, 7.9 Hz, 1H), 2.27-2.32 (m, 1H), 2.25 (s, 3H), 1.06. (d, J = 6.9 
Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 175.03, 151.47, 150.98, 131.97, 130.14, 125.47, 
124.19, 77.20, 70.81, 66.72, 60.21, 59.76, 36.34, 16.40, 15.74 ppm; IR (liquid film): 3467, 2927, 
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1740, 1463, 1409, 1277, 1071, 1028 cm-1; MS (EI, 70 V): m/z 280 (M+.), 251, 205, 165, 91; 
HRMS m/z calcd for C15H20O5 (M+.): 280.1311; found 280.1311. 
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4.0  STEREOSELECTIVE QUATERNARY CARBON CONSTRUCTION 
ENABLED BY OLEFIN ISOMERIZATION-CLAISEN REARRANGEMENT 
REACTIONS 
Asymmetric construction of quaternary carbon stereocenters continues to pose a special 
challenge in organic synthesis. In particular, methods accessing quaternary carbons wherein the 
attendant substituents are not limited by the requirement for specially derivatized or activated 
reaction components remain especially valuable. The [3,3]-sigmatropic rearrangements are 
among the well-established methods affording general access to all-carbon stereocenters Ven in 
architecturally complex settings.95 Ireland enolate Claisen rearrangements, the most versatile and 
widely utilized variant of the [3,3] sigmatropic rearrangement, howVer, is limited in this context 
by the poor E/Z selectivity commonly associated with the enolization of simple α,α–
disubstituted esters (Figure 30). After the [3,3] sigmatropic rearrangement via a critical chair-like 
transition state, a mixture of two diastereomers is formed.  
                                                 
95 For selected examples, see: (a) Ziegler, F. E.; Klein, S. I.; Pati, U. K.; Wang, T.-F. J. Am. Chem. Soc. 1985, 107, 2730-2737. (b) 
Ziegler, F. E.; Nangia, A.; Schulte, G. J. Am. Chem. Soc. 1987, 109, 3987-3991. (c) Corey, E. J.; Guzman-Perez, A. Angew. 
Chem. Int. Ed. 1998, 37, 388-401. (d) Boeckman, R. K. Jr., del Rosario Rico Ferreira, M.; Mitchell, L. H.; Shao, P. J. Am. Chem. 
Soc. 2002, 124, 190-191. 
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Figure 30. Constructing quaternary carbon stereocenters with Ireland Claisen rearrangements 
Some special esters, such as chelated and/or cyclic enolates, provide good control of 
enolate geometry for α,α-disubstituted esters in advance of Ireland-Claisen rearrangements.96 
For example, α-amino substituted esters afford enolates of high Z selectivity because of a strong 
chelating effect. Highly diastereoselective [3,3]-sigmatropic products have been obtained 
(Scheme 35).97
O
Y
O NHBoc
R1
LDA, ZnCl2
O
X Y
O NBoc
R1 O
X Y
OH
R1
NHBoc
Zn
[3,3]
X  
Scheme 35.  Ireland –Claisen rearrangement of allyl α-aminoacetate 
                                                 
96 For a review, see: (a) Quaternary Stereocenters (Eds.: J. Christoffers, A. Baro), Wiley-VCH, Weinheim, 2005, pp. 120-131. 
For other selected examples, see: (b) Ireland, R. E.; Wipf, P.; Armstrong, III, J. D. J. Org. Chem. 1991, 56, 650-657. (c) 
Echavarren, A. M.; de Mendoza, J.; Prados, P.; Zapata, A. Tetrahedron Lett. 1991,32, 6421-6424. (d) Gilbert, J. C.; Selliah, R. D. 
Tetrahedron 1994, 50, 1651-1664. (e) Enders, D.; Knopp, M.; Tetrahedron 1996, 52, 5805-5818. (f) Calad, S. A.; Woerpel, K. A. 
J. Am. Chem. Soc. 2005, 127, 2046-2047. 
97 (a) Kazmaier, U. Angew. Chem. Int. Ed. Eng. 1994, 33, 998-999. (b) Kazmaier, U.; Krebs, A. Angew. Chem. Int. Ed. Eng. 1995, 
34, 2012-2014. (c) Kazmaier, U.; Mues, H.; Krebs, A. Chem. Eur. J. 2002, 8, 1850-1855. 
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4.1 CONSTRUCTION OF QUATERNARY CARBON CENTERS USING THE ICR 
REACTION 
Based on the olefin isomerization-Claisen rearrangement (ICR) developed before, the ICR 
strategy, in which highly stereoselective construction of quaternary carbon stereocenters are 
obtained from chemo- and stereoselective Ir(I)-catalyzed isomerization of 2-substituented and 
2,3-disubstituented allylic ethers and in situ [3,3] sigmatropic rearrangement of the formed allyl 
vinyl ethers, are desired (Figure 31). 
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H R2
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Figure 31. ICR-based strategy for quaternary carbon construction 
Rigorous coupling of substrate olefin geometry and transition state organization with 
reaction stereoselectivity is a defining characteristic of [3,3] sigmatropic rearrangements. Highly 
stereoselective ICR-based Claisen rearrangements are predicted on controlling vinyl ether 
geometry during the initial olefin isomerization event. Limited energetic differentiation of the 
putative E or Z trisubstituted vinyl ethers constitutes a considerable liability for controlling olefin 
isomerization and Claisen stereoselectivity. As a result, documenting the capacity of metal-
catalyzed isomerization of 2-substituented (60a, eq 16) and 2,3-disubstituented (60b, eq 17) 
allylic ethers was an essential component of these investigations. Moreover, enantioselective 
reaction variants would be predicated on the 2,2-disubstituted vinyl ether moieties causing 
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limited disruption of chair-like transition states responsible for efficient transfer of substrate 
chirality during bond reorganization. 
4.1.1 ICR of 1,1-disubstituted allyl ethers for preparing aldehydes with quaternary 
carbon center 
Preliminary efforts addressing these issues employed ethers 60a/b as representative test 
substrates for assaying olefin isomerization. Each reaction produced only a single Z/E vinyl 
isomer (61a/b) even after long reaction time (eq 16 and 17).  
TBDPSO
Bu
2 % Ir(PCy3)3BPh4
Me
TBDPSO
Bu
39 oC, 6 h
H
60a 61a
(16)
1 2
1
2
3
 
MeTBDPSO
Me 2 % Ir(PCy3)3BPh4
70 oC, 6 h MeTBDPSO
Me
H
60b 61b
(17)
1
2 1 23
 
Based on the transition state shown in Figure 32, we assumed that vinyl ether 61a is the Z 
isomer and 61b is the E isomer. The non-bonding relationship between huge Ir(PCy3)n with OR 
makes Ir(I) coordinate with the olefin and insert into the allylic C-H bond from the side opposite 
from the OR group. Although the isomerization of 2-substituted or 2,3-disubstituted allyl ethers 
requires more catalyst-loading and longer time at higher temperature than that of simple allyl 
ethers described before, only one isomer was observed. The result indicated that the E-Z vinyl 
ether transformation is not observed in these reactions. 
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Figure 32. Stereoselectivity of isomerization 
Based on this initial result, treating the di(allyl) ether (E)-(3-(2-methylenehexyloxy)prop-
1-ene-1,3-diyl)dibenzene (62a) with 2 mol% Ir(PCy3)3BPh4 at 75 oC elicited a highly selective 
isomerization and concomitant [3,3] sigmatropic rearrangement to directly generate the 2,2-
disubstituted pentenal derivatives 64a (d.r. = 97:3). Converting this aldehyde to the 
semicarbazide derivative (64a′) indicated that the aldehyde 64a is the 2,3-anti isomer (Figure 
33). This result confirmed our assumation that the (Z)-vinyl ether intermediate (63a) was offered 
from the isomerization. 
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Figure 33. Structure of semicarbazide derivative of Claisen rearrangement product 64a 
More 2-substituted di(allyl) ethers (62a-n) were prepared to observe the isomerization 
reactivity of this new ICR protocol. Some methods were applied to prepare the 2-substituted allyl 
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alcohols. A two-step sequence from diethyl malonate with alkylation and reduction offered 
substituted allyl alcohols (Scheme 36).98
O O
EtO OEt
NaH
nBuBr
O O
EtO OEt
nBu
OH
nBu
LAH
NaH
PBr3 Br
nBu
60 %70 %  
Scheme 36. Allyl alcohol from diethyl malonate 
The CuI-catalyzed Grignard reagent addition to propargyl alcohol afforded 2-substituted 
allyl alcohols in a single step. 99  The first equivalent of Grignard reagent deprotonate the 
propargyl alcohol and the second equivalent of Grignard reagent (forming RCuMgBrI) attack the 
triple bond in the presence of copper salt to produce a five-member ring intermediate.100 The 2-
substituted allyl alcohols are obtained after aqueous work-up (eq 18).  
OH
2.5 eq RMgX
10 mol % CuI
R
OH
(18)
 
With the substituted allyl alcohol at hand, di(allyl) ether (62) was prepared. Generally, 
the di(allyl) ethers are obtained from the etherification of allyl bromide and sodium alkoxide. In 
some cases, the strong bases caused side reactions. For example, when R was a benzyl group (in 
the reaction for preparing 62e, Scheme 37), the base partially deprotonated the benzyl carbon 
atom and caused an olefin shift to afford a by-product with a conjugated structures (62e′). It was 
difficult to directly isolate these two ethers. However when the mixture was treated under ICR 
conditions, the di(allyl) ether 62e′ had no ICR; but the di(allyl) ether 62e afforded an aldehyde 
under ICR conditions. Finally, the ether 62e′ and the aldehyde 64e were isolated. The Pd(0)-
catalyzed O-allylation prepared the pure di(allyl) ether 62e.  
                                                 
98 Yadav, J. S.; Satyanarayana Reddy, P.; Jolly, R. S. Indian J. Chem. Sect. B. 1986, 25, 294-295. 
99 Duboudin J. Organomet. Chem. 1979, 168, 1-11.  
100 Pd(0)-catalyzed coupling of this five-member ring intermediate affords disubstituted allyl alcohols, see: (a) Tessier, P. E.; 
Penwell, A. J.; Souza, F. E. S.; Fallis, A. G. Org. Lett. 2003, 5, 2989-2992. (b) Lu, Z.; Ma, S. J. Org. Chem. 2005, 71, 2655-2660. 
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Scheme 37. O-allylation of benzyl substituted allyl bromide 
The ICR of di(allyl) ethers 62 offered modest to high yields of aldehydes 64. The results 
are listed in Table 6. The isomerization proceeded smoothly for most substrates (R = Me, Et, 
nBu, Bn and Cy). The Claisen rearrangement of the benzyl-substituted allylic ethers 62d/e served 
to highlight that olefin isomerization is highly regioselective even when the formation of a 
resonance-stabilized styrene system is a possible competing pathway (Scheme 38).  
Req R1
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O
Req R1
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Req R1
Me
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[3,3]
O
Req R1
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H
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Scheme 38. ICR of benzyl substituted di(allyl) ether 
Due to the large A1,2 strain between R2 and the alkoxy group, the isomerization process is 
retarded and no isomerization was observed when allyl ether (R2 is tBu, 60c) was treated in 10 
mol% catalyst loading at 80 oC for 24 h (eq 19). The same explaination accounts for the poor 
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isomerization of substrates 62f/g with branched R2 (cyclohexyl): the isomerization of 62f/g 
requires more catalyst loading, a higher temperature and a longer reaction time.  
tBu
RO
60c
10 mol % Ir(PCy3)3
80 oC, 24 h
starting material
R = allyl or TBS
(19)
 
Table 6. ICR of 1,1-Disubstituted Allyl Ethers 62 
O
Req R1
2 mol % Ir(PCy3)3 O
Req39 or 75 oC
O
Req R1
62 64
R2
Me
R2
R1
R2
Me
H
63  
entry Req R1 R2 anti: syn % yield 
a Ph Ph nBu 97:3 90 
b Ph Me nBu 93:7 93 
nBu Me nBu 88:6.2 (6.2% Z isomers) 71 c 
nBu Me Bn 95:3 (2% Z isomers) 75 d 
e Et 2-furyl Bn 96:4 76 
f Et Ph Cy 87:13 70 
nBu Me Cy 93:7 50ag 
h Et Ph Et 90:6 (4% Z isomer) 66 
tert-Bu Me Me NA 85 i 
j Et Ph Cl  0 
k Et Ph Ph  0 
a. The initial reaction time 24 h at ambient temperature, starting material remained. 
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Some substrates had not isomerization in the Table 6. Stabilized conjugated styrene 
structure caused no isomerization in entry 62k (R2 is Ph). Coordinations between Cl atom and 
Ir(I) made the isomerization of entry 62j (R2 is Cl) to be impossible.  
Because there is no epimerization in these α-quaternary center aldehydes (64a-i) and the 
Ir(I)-catalyzed isomerization process is relatively slow at ambient temperature, the direct heating 
of the reaction mixtures also afforded ideal result. But this convenient procedure afforde good 
result only in some examples (e.g. Req = Me, Ph, iPr and cyclohexyl). When Req was Et or nBu, a 
side reaction, which is named post-rearrangement olefin isomerization of Claisen adduct (64e), 
produced a difficultly isolated by product (65e) (Scheme 39). To avoid the by product, the lower 
isomerization temperature and the additive PPh3 were necessary. 
O
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O
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Me O
O
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Me
Me
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62e
Me
ICR
Me
64e 65e
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H H
+
 
Scheme 39. Post-rearrangement olefin isomerization 
 
4.1.2 ICR of 2,3-disubstituted allyl ether  
Based on the ICR of 2-substituted allyl ethers, the ICR of 2,3-disubstituted allyl ethers (66) was 
examined. Suggested from the transition state in Figure 35, the (E)-vinyl ethers (67) were 
generated from the isomerization of 2,3-disubstituted allyl ethers 66. Finaly, 2,3-syn aldehydes 
68 were obtained followed by Claisen rearrangement.  
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2,3-Disubstituted allyl ethers were prepared from a convenient sequence: the 2-methyl 
allyl alcohol was treated with phosphrous bromide to afford a mixture of primary and secondary 
allylic bromides (about 3 : 1 to 4 : 1). Then sodium alkoxides attacked the mixture through SN2 
or SN2′ reaction to afford the single non-branched di(allyl) ethers with different Z/E selectivity 
(66, Scheme 40). 
OH
Me
R
PBr3
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,
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Req R2 O
Req R2NaH
66
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Scheme 40. Preaparation of trisubstituted allyl ethers 
The ICR of di(allyl) ethers 66 offered modest to high yields of 2,3-syn aldehydes 68. The 
results are listed in Table 7. This isomerization is more difficult and slower than that of 2-
substituted allyl ethers 62. Generally, isomerization temperatures were as high as 75 oC. Upon 
treatment under ICR conditions, entries 66a-c (R= Me or CH2CH2Ph) afforded syn-α-quaternary 
pentenals 68a-c with good diastereoselectivity and yield. No desired aldehyde was afforded from 
the ICR of entry d (R = cyclohexyl) due to the large cyclohexyl retarding the Ir(I) complex 
coordination with the olefin and insertion into the allylic C-H bond. 
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Table 7.  ICR of 2,3-disubstituted allyl ethers 66 
O
Req R1
cat Ir(PCy3)3 O
Req75 oC
O
Req R1
66 68
Me Me
R1
Me
HR R
R
67  
entry Req R1 R syn:anti Yield % 
nBu Me Me 96:4 75 a 
nBu Me CH2CH2Bn 94:6 71 b 
ca Et Ph Me  60 
nBu Me Cy  0 d 
a. The post-rearrangement olefin isomerization always afforded about 10 % by product in entry c (eq 20), but not 
obviously found in entry a and b. The possible reason is that the Claisen rearrangement of entry c is much easier than that 
of in entry a and b.  
Et Ph
O
Me
Me
Ph
O
H
Me
Et
Me
4 mol% Ir(PCy3)3
66c 68c
80 oC, 24 h Ph
O
H
Me
Et
Me
68c'
+
88: 12
(20)
 
The Overall ICR stereoselectivity was suggestive of Claisen diastereoselection 
originating from kinetically controlled allyl ether isomerization via the η3-allyl IrIII intermediates 
69a or 69b (Figure 34). Kinetic control of vinyl ether geometry is inferred from the eroded olefin 
stereoselectivity that accompanies extended isomerization reaction times. Moreover, ICR 
reorganization of 62h and 66c afford the diastereomeric Claisen products 64h and 68c, 
respectively (both two diastereomers are different in NMR spectra and HPLC coinjection), 
indicative of bond reorganization proceeding through stereochemically unique intermediates. 
Olefin isomerization subject to thermodynamic control would lead to stereoconvergent reactions 
of vinyl ethers 63h/67c via interconversion of the kinetically-formed η3-allyl complexes. Claisen 
rearrangements are characterized by the well-established relationships existing between substrate 
chirality, olefin geometry, and rearrangement stereoselectivity. Given the regioisomeric 
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relationship existing between 62h and 66c, these results correlate, for the first time, substrate 
regiochemistry, rather than stereochemistry, with the stereochemical outcome of the [3,3] 
sigmatropic rearrangement. 
Et Ph
O Me
Et Ph
O
Et
Et Ph
O Me
Et
Et Ph
O Et
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O Me
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[Ir]H
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H
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Me
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× Ir(I)+
Me
Ir(I)+
67c 63h  
Figure 34. Correlating ICR substrate regiochemistry and Claisen diastereoselectivity 
 
4.1.3 ICR reaction for enantioenriched aldehyde with quaternary center 
Among the defining characteristics of these ICR reactions is the flexibility they offer in devising 
enantioselective reaction variants. First, enantioenriched ICR substrates were prepared in a single 
step by an amino alcohol-catalyzed asymmetric Et2Zn-aldehyde addition and in situ zinc 
alkoxide allylation under Pd(0) catalysis (Scheme 41). Under the ICR reaction conditions, the 
enantioenriched 1,1-disubstituted allylic ethers 62e/f afforded the 2,2-disubstituted-4-pentenals 
64e/f with near perfect chirality transfer.  
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Scheme 41. Catalytic asymmetric di(allyl) ether synthesis 
Alternatively, enantioenriched allyl homoallyl ethers as ICR substrates were prepared by 
asymmetric aldehyde C-allylation followed by O-alkylation (81% ee, Scheme 42). 101  
Enantioenriched allyl homoallyl ether 70 participated in stereoselective tandem olefin 
isomerization to the corresponding (E,Z)-allyl vinyl ether 71 and in situ [3,3] sigmatropic 
rearrangement to afford the 2,3-anti-pentenal derivative 72 (81% ee) with near perfect chirality 
transfer.  
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98:2 anti:syn
Ph Me
O Bn
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Scheme 42. ICR of asymmetric allyl homoallyl ether for aldehyde with quaternary carbon center 
                                                 
101 The enantioenriched homoallylic alcohol was prepared according to the published procedure, see: Brown, H. C.; Randad, R. 
S.; Bhat, K. S.; Zaidlewicz, M.; Racherla, U. S.  J. Am. Chem. Soc. 1990, 112, 2389-2392. The enantioselectivity of the allylation 
reaction was not optimized. 
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Finally, an enantioenriched α,α-disubstituted aldehyde lacking β stereocenter (75) was 
prepared by ICR of an enantioenriched di(allyl) ether 73, which was prepared by enzyme- 
catalyzed kinetic resolution of racemic 5-phenylpent-1-en-3-ol102 followed by O-allylation. The 
reaction proceeded without competing terminal olefin isomerization and delivered an aldehyde 
75 with faithful chirality transfer but only modest yield (95% ee, 50%, Scheme 43). 103 However, 
under Pd(II) catalysis (5 mol% (i-BuCN)PdCl2, i-BuCN/tol), the isolated allyl vinyl ether 74 
undergoes bond reorganization with chirality transfer equal to the thermal reaction, albeit with 
opposite induction, to generate aldehyde ent-75 in excellent yield (84%).104
O nBu O
H
nBu
Me
Conditions: (a) 75 °C; 95% ee (50% + 8% Z olefin)
(b) 5 mol % (iBuCN)PdCl2; 93% ee (84% ent -75)
(99% ee)
O
Me
nBu
2 mol% Ir(PCy3)3
39 °C
Ph
73 75
Ph Ph
74
Conditions
 
Scheme 43. Thermal and Pd(II)-catalyzed Claisen rearrangement for different enantiomers 
In conclusion, the olefin isomerization-Claisen rearrangement reaction provides  
convenient access to stereodefined all-carbon stereocenters and vicinal quaternary-tertiary 
stereocenter relationships. The success of these reactions enables a variety of easily accessed 
strategies for achiVing enantioselective quaternary carbon installation. 
                                                 
102 Takagi, Y.; Teramoto, J.; Kihara, H.; Itoh, T.; Tsukube, H. Tetrahedron Lett. 1996, 37, 4991-4992. 
103 Remaining material is unreacted starting material resulting from incomplete olefin isomerization. 
104 Pd(II)-catalyzed Claisen rearrangements employing nitrile additives suppress the competing vinyl cleavage noted in prVious 
attempts at Pd(II)-catalyzed Claisen rearrangement of α-unsubstituted vinyl ethers; see: Van der Baan, J. L.; Bickelhaupt, F. 
Tetrahedron Lett. 1986, 27, 6267-6270. 
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4.2 ICR OF DI(ALLYL) ETHER BEARING AN ENOL ETHER-QUATERNARY 
CENTER WITH OXYGEN 
Based on the result of constructing highly stereodefined all carbon quaternary centers with the 
ICR protocol, we sought to extend this methodology to prepare stereodefined quaternary α-
hydroxy-pent-4-enals (Figure 35). 
O
Req R1
ICR O
Req R1
O
Req R1
OP
OP
Me
Me
OP
H
[3,3]
 
Figure 35. ICR of 2-alkoxy allyl ethers 
Some precedents for preparing α-siloxy-pent-4-enals have been reported. The enolates of 
α-allyoxy ketones (76) were trapped with TMSCl to produce allyl vinyl ether intermediates (77). 
The subsequent Claisen rearrangement of 77 afforded α-siloxy-pent-4-enals (78) in good yield 
(70- 92 %).105 However no aldehyde data, especially diastereoselectivity, were reported. It was 
suggested that the enolization of 76 afforded the Z/E mixture of silyl vinyl ethers (77) and caused 
the poor diastereoselectivity of the [3,3] products. Another problem of the strategy was a 
competing [2,3] Wittig rearrangement, which afforded by-product α-hydroxycarbonyl 
compounds 79 (Figure 36).106
                                                 
105 (a) Kachinski, J. L. C.; Salomon, R. G. Tetrahedron Lett. 1977, 37, 3235-3238. (b) Kachinsky, J. L. C.; Salomon, R. G. J. Org. 
Chem. 1986, 51, 1393-1401. 
106 (a) Mikami, K.; Takahashi, O.; Tabei, T.; Nakai, T. Tetrahedron Lett.1986, 27, 4511-4514. (b) Nakai, T.; Mikami, K.; Taya, 
S.; Kimura, Y.; Mimura, T. Tetrahedron Lett.1981, 22, 69-72. 
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Figure 36. Competing [3,3] and [2,3] rearrangement of 76 
Wood has reported a Rhodium carbenoid-initiated Claisen rearrangement for 
enantioselective synthesis of quaternary center with hydroxyl group (eq 21). 107  High chiral 
transfer was obtained from this reaction. Another example for preparing Claisen product with 
quaternary center with hydroxyl group is a Pd(II)-catalyzed ICR of a di(allyl) ether bearing an 
enol ether (eq 22).108  
Me
N2
O O
OMe
Me
OH
Rh2(OAc)4 Me
O
COOMeHO
Me
[3,3]
Me
O
COOMe
HO
Me (21)
 
EtO
Ph
O O Me
OEt
[3,3]
OEt
Me
Ph
OPdCl2
toluene
110 oC
Ph
(22)
 
The ICR protocol was focused on preparing α-hydroxy quaternary carbon center with 
better diastereoselectivity, substrate generality and operational simplicity. Di(allyl) ethers (81) 
                                                 
107 Wood, J. L.; Moniz, G. A.; Pflum, D. A.; Stoltz, B. M.; Holubec, A. A.; Dietrich, H. J. J. Am. Chem. Soc. 1999, 121, 1748-
1749. 
108 Nevado, C.; Echavarren, A. M. Tetrahedron 2004, 60, 9735-9744. 
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were prepared by methylidenation of corresponding alkoxy acetate esters (80) with Tebbe’s 
reagent (eq 23).109  
O
Req R1
O
Req R1
O
OR OR
80 81
Ti
Cl
Al
Me
Me
(23)
 
First, upon treatment under ICR conditions, the isomerization of di(allyl) ether 81a at 
ambient temperature gave a mixture of 1: 1 Z/E isomer of by-product (81a'). The conjugation 
was overcome to form vinyl ether (81a′). No desired allyl vinyl ether (82a) or aldehyde (83a) 
was observed. The result indicated that the isomerization of 2-alkoxy allyl ether is even more 
difficult than that of the conjugated cinnamyl ether (eq 24). As a result, more elaborate 
conditions were required for the desired isomerization. 
O
Ph
2 mol% Ir(PCy3)3
23 oC, 24 h,CH2Cl2
O
81a 81a'
Z/E = 1:1
OMe
Ph
OMe
50 % conversion
O
Ph
no 82a
Me
OMe+ O
Ph
no 83a
Me
OMe
+
H
(24)
 
The ICR of substrate 82b afforded 100 % conversion of rearrangement products (83b) 
with good diastereoselectivity (about 20 : 1). But the post-rearrangement olefin isomerization of 
83b afforded a difficultly isolated aldehydes mixture (83b′, about 50%, Figure 37). Considering 
this high temperature, slow isomerization rate and fast Claisen rearrangement rate, the post-
rearrangement olefin isomerization is an essential problem for realizing successful ICR protocol. 
                                                 
109 1.0 equivalent of bis(cyclopentadienyl)titanium (IV) dichloride and 2.0 equivalents of AlMe3 in toluene stir in ambient 
temperature. See: (a) Pine, S. H.; Kim, G.; Lee, V. Org. Syn. 1990, 69, 72. Review of Titanium reagents for alkylidenation of 
carboxylic acid and carbonic acid derivatives, see: Hartley, R. C.; McKiernan, G. J. J. Chem. Soc., Perkin Trans. 1, 2002, 2763. 
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Figure 37. ICR and post-rearrangement olefin isomerization of di(allyl) ether 
For minimizing the post-rearrangement olefin isomerization, milder condition was 
employed. The reaction afforded 50 % conversion of Claisen product (83b/c) with good 
diastereoselectivity in 48 h at 40 oC, with unreacted starting material and a small amount of post-
rearrangement olefin isomerization aldehyde (83b’/c’, eq 25).  
5 mol% Ir(PCy3)3
40 oC, 48 h, DCE
O
Et Ph
O
Et Ph
Me
OROR
81b/c 83b/c
entry b R = CH2CH2TMS
         c R = Me
50 % conversion
H
(25)
 
Based on the above observation, the slow isomerization, the fast [3,3]-sigmatropic 
rearrangement and the high temperature with the ICR protocol will bring post-rearrangement 
olefin isomerization products. To overcome this conflict, Req should be chosen from groups, in 
which no post-rearrangement olefin isomerization in the Claisen product (83). Methyl and some 
aryls and branched alkyls, for example, Ph, iPr, tBu and cyclohexyl, are good choices. Thus, the 
substrate 81d (Req = Me) was subjected in 5 mol% catalyst loading at 75 oC for 48 h to give 
product 83d with good yield and diastereoselectivity (anti:syn = 94: 6) (eq 26). There is no post-
rearrangement olefin isomerization in this case. 
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OMe Ph
5 mol% Ir(PCy3)3
75 oC, 48 h, DCE
58 %
O
Me Ph
Me
OCH2CH2SiMe3OCH2CH2SiMe3
81d 83d
H
(26)
 
In general, stereoselective quaternary all-carbon stereocenter construction is often not 
easily achieved from methodologies developed primarily for accessing less substituted 
stereogenic carbons. Olefin isomerization-Claisen rearrangement (ICR) reactions offer a strategy 
for recruiting the venerable Claisen rearrangement for asymmetric quaternary carbon 
construction. Several complementary strategies for enantioselective quaternary carbon synthesis 
derive directly from the ICR reaction design. 
4.3 EXPERIMENTAL SECTION 
4.3.1 Experiment of section 4.1 
4.3.1.1 ICR for 2-substituted allyl ethers 
(E)-(3-(2-Methylenehexyloxy)prop-1-ene-1,3-diyl)dibenzene (62a): General 
Procedure C (concentrated H2SO4 catalyzed etherification) was followed 
employing (E)-1,3-diphenyl-2-propen-1-ol (0.489 g, 2.33 mmol) and 2-
methylenehexan-1-ol110 (0.474 ml, 3.49 mmol) in anhydrous THF (1 ml). The crude product was 
purified by MPLC on silica gel (0-5% EtOAc in hexanes) to afford 0.490 g (69%) of the title 
compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 0.90 (t, J = 7.2 Hz, 3H), 1.26-1.29 (m, 
O
Ph Ph
nBu
                                                 
110 Yadav, J. S.; Joshi, B.; Sahasrabubhe, A. Synth. Comm. 1985, 15, 797-805. 
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4H), 2.09 (m, 2H), 3.97 (s, 2H), 4.93 (s, 1H), 4.96 (d, J = 7.1 Hz, 1H), 5.06 (s, 1H), 6.30 (dd, J = 
16, 7.0 Hz, 1H), 6.62 (d, J = 16 Hz, 1H), 7.20-7.45 (m, 10H) ppm; 13C NMR (75 MHz, CDCl3): 
δ 13.9, 22.4, 29.8, 32.9, 71.0, 81.3, 111.1, 126.5, 126.8, 127.5, 127.6, 128.4, 128.5, 130.3, 131.2, 
136.6, 141.2, 146.3 ppm; MS (EI, 70 V): m/z 306 (M+.), 288, 262, 206, 193, 181, 165, 158, 143, 
129, 115, 105, 91, 77, 65; HRMS m/z calcd for C22H26O (M+.): 306.1984; found: 306.1984. 
 
(E)-(1-(2-Methylenehexyloxy)but-2-enyl)benzene (62b): General Procedure A 
was followed employing 1.00 g of (E)-1-phenylbut-2-en-1-ol (6.75 mmol) in 
THF. The crude product was purified by silica gel (2% EtOAc in hexanes) to 
afford 1.57 g (95%) of the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 0.89 
(m, 3H), 1.25-1.46 (m, 4H), 1.71 (d, J = 5.7 Hz, 3H), 2.06 (m, 2H), 3.88 (s, 2H), 4.72 (d, J = 6.7 
Hz, 1H), 4.89 (s, 1H), 5.01 (s, 1H), 5.59 (ddd, J = 15, 6.6, 0.9 Hz, 1H), 5.69 (dq, J = 15, 6.2 Hz, 
1H), 7.22-7.35 (m, 5H) ppm; 13C NMR (75 MHz, CDCl3): δ 13.8, 17.6, 22.4, 32.9, 70.7, 81.4, 
110.9, 126.7, 127.2, 127.8, 128.2, 132.3, 132.4, 141.8, 146.4 ppm; MS (EI, 70 V): m/z 244 (M+.), 
229, 147, 131, 119, 115, 105, 91, 77, 55; HRMS m/z calcd for C17H24O (M+.): 244.1827; found: 
244.1821. 
O
Ph Me
nBu
 
(E)-4-(2-Methylenehexyloxy)oct-2-ene (62c): General Procedure A was 
followed employing 0.961 g of (E)-oct-2-en-4-ol 111  (6.75 mmol) in THF. 
Purification by MPLC on silica gel(0-5 % ethyl acetate in hexanes) afforded 
1.20 g (71 %) of the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 0.89 (m, 
3H), 0.91 (m, 3H), 1.20-1.65 (m, 10H), 1.71 (dd, J = 6.4, 1.6 Hz, 3H), 2.04 (m, 2H), 3.58 (dt, J = 
O
nBu Me
nBu
                                                 
111 Chamberlin, A, R.; Mulholland, R. L. Jr.  Tetrahedron 1984, 40, 2297.  
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8.1, 6.3 Hz, 1H), 3.72 (d, J = 13 Hz, 1H), 3.93 (d, J = 13 Hz, 1H), 4.85 (s, 1H), 4.97 (s, 1H), 5.29 
(ddq, J = 14, 6.6, 1.6 Hz, 1H), 5.58 (dqd, J = 15, 6.5, 0.6 Hz, 1H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 13.9, 14.0, 17.6, 22.5, 22.7, 27.7, 29.8, 33.0, 35.5, 70.5, 80.0, 110.5, 128.1, 132.4, 
146.9 ppm; MS (EI, 70 V): m/z 224 (M+.), 229, 167, 139, 127, 111, 97, 85, 69, 55; HRMS m/z 
calcd for C15H28O (M+.): 224.2140. Found: 224.2141. 
 
1-(2-((E)-Oct-2-en-4-yloxy)methyl)allyl)benzene (62d): General Procedure 
A was followed employing (E)-oct-2-en-4-ol (256 mg, 2.0 mmol) and 1-(2-
(bromomethyl)allyl)benzene112 (630 mg, 3.0 mmol) in THF.  The crude product 
was purified by flash chromatography on silica gel (2% EtOAc in hexanes) to yield 397 mg 
(77%) of the title compound as light yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.18-7.53 (m, 
5H), 5.51 (dq, J = 15.2, 6.5 Hz, 1H), 5.28 (ddq, J = 15.2, 8.2, 1.4 Hz, 1H), 5.09 (s, 1H), 4.89 (s, 
1H), 3.91 (d, J = 12.6 Hz, 1H), 3.70 (d, J = 12.6 Hz, 1H), 3.58 (dt, J = 8.2, 6.2 Hz, 1H), 3.40 (s, 
2H), 1.69 (dd, J = 6.5, 1.4 Hz, 3H), 1.30-1.76 (m, 6H), 0.92 (t, J = 7.4 Hz, 3H) ppm; 13C NMR 
(75 MHz, CDCl3): δ 146.1, 139.3, 132.2, 129.0, 128.3, 128.1, 126.0, 112.9, 79.9, 69.7, 40.0, 
35.4, 27.7, 22.6, 17.6, 14.0 ppm; IR (liquid film): 2932, 2859, 1651, 1495, 1453, 1073, 969, 902, 
740, 699 cm-1; MS (EI, 70 V): m/z 258 (M+.), 240, 201, 131, 91, 70; HRMS m/z calcd for 
C18H26O (M+.): 258.1984; found: 258.1988. 
O
nBu Me
Bn
 
(S,E)-2-(3-(2-Benzylallyloxy)pent-1-enyl)furan (62e): General 
Procedure D was applied to (E)-3-(2-furyl)acrolein (611 mg, 5.0 mmol) O
Bn
Me O
                                                 
112 1-(2-(Bromomethyl)allyl)benzene was prepared by by reacting 2-benzylprop-2-en-1-ol with PBr3 in hexanes. 
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and 2-benzylallyl acetate (950 mg, 5.0 mmol)113.  The crude product was purified by column 
chromatography on silica gel (2% EtOAc in hexanes) to yield 765 mg (54%) of the title 
compound as light yellow oil.  [α] D = −89.7 (c 5.12, CHCl3); 1H NMR (300 MHz, CDCl3): δ 
7.27-7.41 (m, 6H), 6.43 (dd, J = 3.2, 1.9 Hz, 1H), 6.34 (d, J = 15.9 Hz, 1H), 6.28 (d, J = 3.2 Hz, 
1H), 6.07 (dd, J = 15.9, 7.7 Hz, 1H), 5.19 (s, 1H), 4.99 (s, 1H), 4.04 (d, J = 12.5 Hz, 1H), 3.84 (d, 
J = 12.5 Hz, 1H), 3.77 (q, J = 6.9 Hz, 1H), 3.48 (s, 2H), 1.60-1.90 (m, 5H), 1.04 (t, J = 7.3 Hz, 
3H) ppm; 13C NMR (75 MHz, CDCl3): δ 152.30, 145.90, 141.78, 139.17, 129.00, 128.21, 
126.03, 120.32, 113.13, 111.16, 107.70, 80.87, 70.24, 40.00, 28.61, 9.84 ppm; IR (liquid film): 
3027, 2964, 2931, 1651, 1494, 1453, 1030, 1013, 963, 736, 699 cm-1; MS (EI, 70 V): m/z 282 
(M+.), 253, 225, 200, 191, 151, 148, 135, 131, 123, 115; HRMS m/z calcd for C19H22O2 (M+.) 
282.1620; found: 282.1608.  The allylic alcohol (S,E)-1-(furan-2-yl)pent-1-en-3-ol was purified 
by column chromatography on silica gel (2% EtOAc in hexanes); [α]D = −6.4 (c 1.74, CHCl3).  
Separating the enantiomers by chiral HPLC [Daicel ChiracelTM OD-H column, flow rate 0.5 
mL/min, 5% i-PrOH, 95% hexanes, Tr 18.69 (R) and 20.52 (S)] provided the enantiomer ratio: 
3R: 3S = 2.0: 98.0 (96% ee).  
 
(S,E)-(3-(2-Cyclohexylallyloxy)pent-1-enyl)benzene (62f): General 
Procedure D was followed employing cinnamaldehyde (2.0 mmol, 264 mg) 
and 2-cyclohexylallyl acetate (2.4 mmol, 437 mg).114  The crude product 
was purified by flash chromatography on silica gel (2% EtOAc in hexanes) to yield 341 mg 
(60%) of the title compound as light yellow oil.  [α] D = −63.4 (c 4.51, CHCl3); 1H NMR (300 
MHz, CDCl3): δ 7.20-7.40 (m, 5H), 6.58 (d, J = 15.9 Hz, 1H), 6.14 (dd, J = 15.9, 8.0 Hz, 1H), 
O
Ph
Me
                                                 
113 2-Benzylallyl acetate was prepared by reacting 2-benzylprop-2-en-1-ol with acetic anhydride. 
114 2-Cyclohexylallyl acetate was prepared by reacting 2-cyclohexylprop-2-en-1-ol with acetic anhydride. 
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5.09 (s, 1H), 4.96 (s, 1H), 4.14 (d, J = 12.8 Hz, 1H), 3.91 (d, J = 12.8 Hz, 1H), 3.84 (q, J = 6.9 
Hz, 1H), 1.98-2.08 (m, 1H), 1.15-1.98 (m, 12H), 1.03 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 
MHz, CDCl3): δ 151.73, 136.71, 132.06, 130.66, 128.49, 127.51, 126.37, 109.05, 81.39, 70.27, 
41.10, 32.35, 32.11, 28.71, 26.72, 26.33, 9.90 ppm; IR (liquid film): 2926, 2852, 1449, 1093, 
967, 891, 747, 692 cm-1; MS (EI, 70 V): m/z 284 (M+.), 255, 193, 145, 129, 115, 91; HRMS m/z 
calcd for C20H28O (M+.): 284.2140; found: 284.2147.  The allylic alcohol (S,E)-1-phenylpent-1-
en-3-ol was purified by flash chromatography on silica gel (2% EtOAc in hexanes).  Separating 
the allylic alcohol enantiomers by chiral HPLC [Daicel ChiracelTM OD-H column, flow rate 1.0 
mL/min, 0.5% i-PrOH, 99.5% hexanes, Tr 13.4 (R) and 16.3 (S)] provided the enantiomer ratio: 
3R: 3S = 3.5:96.5 (93% ee). 
 
(3-((E)-Oct-2-en-4-yloxy)prop-1-en-2-yl)cyclohexane (62g): General 
Procedure A was followed employing (E)-oct-2-en-4-ol (256 mg, 2.0 mmol) 
and (3-bromoprop-1-en-2-yl)cyclohexane (447 mg, 2.2 mmol)115 in THF.  The 
crude product was purified by flash chromatography on silica gel (2% EtOAc in hexanes) to 
yield 355 mg (71%) of the title compound as a light yellow oil.  1H NMR (300 MHz, CDCl3): δ 
5.58 (dq, J = 15.3, 6.5 Hz, 1H), 5.30 (ddq, J = 15.3, 8.2, 1.5 Hz, 1H), 4.97 (s, 1H), 4.85 (s, 1H), 
3.98 (d, J = 12.8 Hz, 1H), 3.75 (d, J = 12.8 Hz, 1H), 3.60 (dt, J = 8.2, 6.4 Hz, 1H), 1.95 (t, J = 
11.1 Hz, 1H), 1.72 (dd, J = 6.5, 1.5 Hz, 3H), 1.07-1.83 (m, 16 H), 0.90 (t, J = 7.4 Hz, 3H) ppm; 
13C NMR (75 MHz, CDCl3): δ 152.1, 132.5, 128.3, 109.0, 80.1, 69.9, 41.2, 35.6, 32.5, 32.2, 27.8, 
26.9 (overlap of 2 C), 26.5, 22.8, 17.8, 14.2 ppm; MS (EI, 70 V): m/z 250 (M+.), 209, 193, 137, 
O
nBu Me
                                                 
115 (3-Bromoprop-1-en-2-yl)cyclohexane was prepared by reacting 2-cyclohexylprop-2-en-1-ol with PBr3 in hexanes 
 148 
123, 109, 111, 95, 86, 83, 69, 67, 55; HRMS m/z calcd for C17H30O (M+.): 250.2297; found: 
250.2306. 
 
(E)-(3-(2-Methylenebutoxy)pent-1-enyl)benzene (62h): General 
Procedure A was followed employing (E)-1-phenylpent-1-en-3-ol (324 mg, 
2.0 mmol) and 2-(bromomethyl)but-1-ene (447 mg, 3.0 mmol) in DMF.  The crude product was 
purified by flash chromatography on silica gel (2 % EtOAc in hexanes) to yield 360 mg (78%) of 
the title compound as light yellow oil.  1H NMR (300 MHz, CDCl3): δ 7.27-7.49 (m, 5H), 6.59 
(d, J = 16.0 Hz, 1H), 6.15 (dd, J = 16.0, 8.0 Hz, 1H), 5.10 9s, 1H), 4.97 (s, 1H), 4.10 (d, J = 12.5 
Hz, 1H), 3.91 (d, J = 12.5 Hz, 1H), 3.84 (q, J = 7.4 Hz, 1H), 2.17 (q, J = 7.3 Hz, 2H), 1.62-1.91 
(m, 2H), 1.14 (t, J = 7.4 Hz, 3H), 1.04 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 
148.11, 136.68, 132.09, 130.55, 128.48, 127.50, 126.36, 109.84, 81.29, 71.08, 28.67, 25.96, 
11.99, 9.85 ppm; MS (EI, 70 V): m/z 230 (M+.), 201, 161, 145, 133, 117, 91; HRMS m/z calcd 
for C16H22O (M+.): 230.1671; found: 230.1668. 
O
Ph
Et
Me
 
(E)-5,5-Dimethyl-4-(2-methylallyloxy)hex-2-ene (62i): General procedure A 
was followed employing (E)-2,2-dimethylhex-4-en-3-ol (640 mg, 5.0 mmol) and 
3-chloro-2-methylprop-1-ene (675 mg, 7.5 mmol). The crude product was 
purified by flash chromatograph on silical gel (2 % EtOAc in hexanes) to yield 819 mg (90 %) of 
the title compound as a light yellow oil. 1H NMR (300 MHz, CDCl3): δ 5.54 (dq, J = 15.3, 6.4 
Hz, 1H), 5.31 (ddq, J = 15.3, 8.6, 1.4 Hz, 1H), 4.92 (s, 1H), 4.81 (s, 1H), 3.87 (d, J = 12.7 Hz, 
1H), 3.62 (d, J = 12.7 Hz, 1H), 3.17 (d, J = 8.6 Hz, 1H), 1.72 (dd, J = 6.4, 1.5 Hz, 3H), 1.71 (s, 
3H), 0.89 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3): δ 143.09, 129.70, 129.09, 111.08, 88.03, 
71.98, 34.62, 26.24, 19.74, 17.77 ppm. 
O
tBu Me
Me
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 (E)-(3-(2-Chloroallyloxy)pent-1-enyl)benzene (62j): General procedure A 
was followed employing (E)-1-phenylpent-1-en-3-ol (810 mg, 5.0 mmol) and 
2,3-dichloroprop-1-ene (833 mg, 7.5 mmol). The crude product was purified 
by flash chromatograph on silical gel (2 % EtOAc in hexanes) to yield 1.06 g (90 %) of the title 
compound as a light yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.20-7.42 (m, 5H), 6.53 (d, J = 
15.9 Hz, 1H), 6.05 (dd, J = 15.9, 8.1 Hz, 1H), 5.48 (q, J = 1.3 Hz, 1H), 5.35 (q, J = 1.0 Hz, 1H), 
4.12 (ddd, J = 14.1, 1.4, 1.1 Hz, 1H), 3.98 (ddd, J = 14.1, 1.2, 0.9 Hz, 1H), 3.82 (q, J = 7.0 Hz, 
1H), 1.57-1.84 (m, 2H), 0.97 (t, J = 7.4 Hz, 3H) ppm. 
O
Ph
Cl
Me
 
1-(1-((E)-1-Phenylpent-1-en-3-yloxy)prop-2-en-2-yl)benzene (62k): 
General procedure A was followed employing (E)-1-phenylpent-1-en-3-ol 
(486 mg, 3 mmol) and 1-(1-bromoprop-2-en-2-yl)benzene116 (870 mg, 4.5 
mmol). The crude product was purified by flash chromatograph on silical gel (2 % EtOAc in 
hexanes) to yield 667 mg (80 %) of the title compound as a light yellow oil. 1H NMR (300 MHz, 
CDCl3): δ 7.35-7.65 (m, 10H), 6.70 (d, J = 16.0 Hz, 1H), 6.26 (dd, J = 16.0, 8.0 Hz, 1H), 5.68 (s, 
1H), 5.53 (d, J = 1.3 Hz, 1H), 4.64 (d, J = 12.9 Hz, 1H), 4.42 (d, J = 12.9 Hz, 1H), 4.02 (q, J = 
6.9 Hz, 1H), 1.68-1.93 (m, 2H), 1.05 (d, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 
144.7, 139.0, 136.1, 132.3, 130.4, 128.6, 128.2, 127.6, 126.4, 126.2, 114.0, 81.5, 69.9, 28.7, 9.9 
ppm; MS (EI, 70 V): m/z 278 (M+.), 249, 231, 220, 205, 187, 145, 131, 116, 103; HRMS m/z 
calcd for C20H22O (M+.) 278.1671. found 278.1675. 
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116 1-(1-bromoprop-2-en-2-yl)benzene was prepared by reacting 2-phenylprop-2-en-1-ol with PBr3 in hexanes 
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anti-2-((E)-1,3-Diphenylallyl)-2-methylhexanal (64a): General Procedure D 
was followed employing 0.477 g of (E)-3-(2-methylenehexyloxy)-1,3-
diphenylprop-1-ene (62a, 6.21 mmol) in CH2Cl2 at 23 °C.  Purifying the crude 
product mixture by MPLC (0-10% EtOAc in hexanes) afforded 0.430 g (90%) of the title 
compound as colorless oil (anti: syn > 97:3).  1H NMR (300 MHz, CDCl3): δ 0.87 (m, 3H), 1.12 
(s, 3H), 1.25 (m, 4H), 1.47-1.77 (m, 2H), 3.68 (d, J = 8.7 Hz, 1H), 6.47 (d, J = 16 Hz, 1H), 6.56 
(dd, J = 16, 8.7 Hz, 1H), 7.17-7.39 (m, 10H), 9.61 (s, 1H); 13C NMR (75 MHz, CDCl3): δ 13.9, 
16.0, 23.3, 26.3, 34.6, 52.7, 55.7, 126.3, 126.8, 127.4, 127.8, 128.3, 128.5, 129.0, 133.0, 137.1, 
140.2, 206.4; MS (EI, 70 V): m/z 306 (M+.), 250, 193, 178, 165, 115, 91; HRMS m/z calcd for 
C22H26O (M+.): 306.1984; found: 306.1986. 
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anti-(1E)-1-((E)-2-Butyl-2-methyl-3,5-diphenylpent-4-enylidene)semi 
carbazide (64a′): Semicarbazide hydrochloride (1.11 g, 10 mmol) and dry 
sodium acetate (1.23 g, 15 mmol) were ground together in a mortar. 
Ethanol (10 mL) was added and the resulting mixture was heated to boiling.  The hot solution 
was filtered and then cooled to ambient temperature anti-2-((E)-1,3-diphenylallyl)-2-
methylhexanal (64a, 153 mg, 0.5 mmol) was added and the mixture was heated at 40 °C for 2.5 
h.  Water (20 mL) was added and the resulting mixture was extracted with ethyl ether (3 × 20 
mL).  evaporating the solvent gave 181 mg of the desired product (100 %) that was recrystallized 
from ethanol to provide crystals suitable for X-ray diffraction analysis. 1H NMR (300 MHz, 
DMSO-d6): δ 9.77 (s, 1H), 6.70 (dd, J = 15.6, 10.1 Hz, 1H), 6.43 (d, J = 15.6 Hz, 1H), 6.02 (s, 
2H), 3.51 (d, J = 9.9 Hz, 1H), 3.33 (s, 1H), 1.10-1.45 (m, 7H), 1.05 (s, 3H), 0.79 (t, J = 7.4 Hz, 
3H) ppm; 13C NMR (75 MHz, DMSO-d6): δ 156.71, 148.56, 141.41, 137.04, 131.47, 129.86, 
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129.20, 128.50, 127.80, 127.18, 126.15, 126.10, 57.69, 43.66, 37.06, 25.91, 22.88, 19.21, 13.97 
ppm; MS (EI, 70 V): m/z 363 (M+.), 246, 233, 193, 178, 165, 127, 115, 91; HRMS m/z calcd for 
C23H29ON3 (M+.): 363.2311; found: 363.2237.  See Appendix A for X-ray diffraction data. 
 
anti-2-Methyl-2-((E)-4-phenylbut-3-en-2-yl)hexanal (64b): General 
Procedure D (CH2Cl2 at 40 °C) was followed employing 0.491 g of 1-((E)-1-
(2-methylenehexyloxy)but-2-enyl)benzene (62b). Purifying the crude product 
mixture by MPLC (0-10% gradient EtOAc in hexanes) afforded 454 mg (93%) of the title 
compound as a colorless oil (anti : syn = 93 :7).  Separating the steoisomers by GLC [Varian CP 
Wax 52CB column (30 m x 0.25 mm), flow rate 0.6 mL/min, method: 80 °C for 2.00 min, ramp 
@ 5.00 °C/min to 250 °C, hold for 20.00 min, Tr = 55.4 (ANTI), 55.8 (SYN) min] provided the 
diastereomer ratio: 93:7.  1H NMR (300 MHz, CDCl3): δ 0.87 (m, 3H), 1.01 (d, J = 5.8 Hz, 3H), 
1.03 (s, 3H), 1.03-1.25 (m, 4H), 1.43-1.63 (m, 2H), 2.61 (m, 1H), 6.08 (dd, J = 16, 9.0 Hz, 1H), 
6.43 (d, J = 16 Hz, 1H), 7.21-7.40 (m, 5H), 9.50 (s, 1H); 13C NMR (75 MHz, CDCl3): δ 13.6, 
13.9, 16.0, 23.3, 26.1, 34.9, 41.8, 52.2, 126.1, 127.2, 128.5, 130.4, 131.3, 137.2, 206.8; MS (EI, 
70 V): m/z 244 (M+.), 188, 131, 115, 104, 91, 77, 70, 65, 55; HRMS m/z calcd for C17H24O (M+.): 
244.1827; found: 244.1827. 
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anti-(E)-2-Butyl-2,3-dimethylnon-4-enal (64c): General Procedure D (1,2-
DCE, at 80 οC) was followed employing 0.477 g of (E)-4-(2-
methylenehexyloxy)oct-2-ene (62c). Purification by MPLC (0-10% 
EtOAc/hexanes) afforded 0.338 g (71 %) of the title compound as a colorless oil (anti : syn : Z = 
88 : 6.2 : 6.2). 1H NMR (300 MHz, CDCl3): δ 0.86 (m, 3H), 0.90 (m, 3H), 0.93(s, 3H), 1.00-1.57 
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(m, 10H), 2.00 (m, 2H), 2.36 (dq, J = 8.5, 6.9, 1H), 5.25 (ddt, J = 15, 8.7, 1.2 Hz, 1H), 5.45 (dt, J 
= 15, 6.7 Hz, 1H), 9.43 (s, 1H); 13C NMR (75 MHz, CDCl3): δ 13.5, 13.8, 16.1, 22.1, 23.3, 26.1, 
31.6, 32.2, 34.8, 41.2, 51.8, 130.0, 132.3, 207.2; MS (EI, 70 V): m/z 224 (M+.), 168, 153, 114, 
111, 95, 81, 69, 55; HRMS m/z calcd for C15H28O (M+.): 224.2140. Found: 224.2143. 
 
anti-(E)-2-Benzyl-2,3-dimethylnon-4-enal (64d): General Procedure D was 
followed employing 1-(2-(((E)-oct-2-en-4-yloxy)methyl)allyl)benzene (62d, 
258 mg, 1.0 mmol) and 2 mol% of the Ir(I)-derived catalyst (9.0 mg 
[IrCl(C8H14)2]2, 16.8 mg PCy3, and 6.8 mg NaBPh4) and stirred 60 h at 75 °C using 1,2-
dichloroethane as solvent.  Purifying the crude product mixture by flash chromatography on 
silica gel (2.5% Et2O in hexanes) yielded 194 mg (75%) of the title compound as a colorless oil 
(anti : syn : Z = 95 : 3 : 2).  Separating the stereoisomers by GLC [Varian CP Wax 52CB column 
(30 m x 0.25 mm), flow rate 0.6 mL/min, method: 80 °C for 2.00 min, ramp @ 5.00 °C/min to 
250 °C, hold for 20.00 min, Tr = 50.4, 50.6, 53.0 and 53.4 min] provided the diastereomer ratio: 
Z: syn: anti = 2.6:2.9:94.5.  1H NMR (300 MHz, CDCl3): δ 9.61 (s, 1H), 7.04-7.28 (m, 5H), 5.56 
(dt, J = 15.2, 6.7 Hz, 1H), 5.38 (ddt, J = 15.2, 8.8, 1.2 Hz, 1H), 3.01 (d, J = 13.8 Hz, 1H), 2.70 (d, 
J = 13.8 Hz, 1H), 2.49 (dq, J = 8.6, 7.0 Hz, 1H), 2.06-2.13 (m, 2H), 1.36-1.42 (m, 4H), 0.99 (d, J 
= 6.9 Hz, 3H), 0.95 (t, J = 7.4 Hz, 3H), 0.93 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 207.0, 
137.2, 133.2, 130.2, 129.9, 128.1, 126.4, 53.3, 41.8, 41.4, 32.3, 31.6, 22.2, 16.4, 13.9, 13.7 ppm; 
MS (EI, 70 V): m/z 258 (M+.), 240, 201, 131, 91, 70; HRMS m/z calcd for C18H26O (M+.): 
258.1984; found: 258.1988. 
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(2S,3S,E)-2-Benzyl-3-(furan-2-yl)-2-methylhept-4-enal (64e): General 
Procedure D was followed employing di(allyl) ether 62e (141 mg, 0.5 
mmol) and 4 mol% catalyst (9.0 mg [IrCl(C8H14)2]2, 16.8 mg PCy3, and 
6.8 mg NaBPh4) using 1,2-dichloroethane as solvent at 35 °C and an initial reaction time of 12 h. 
After addition of 15.6 mg PPh3, the reaction was heated at 80 °C for 16 h; (2R,3R):(2S,3R) = 
96:4.  Purifying the crude product mixture by flash chromatography on silica gel (2.5% Et2O in 
hexanes) yielded 107 mg (76%) of the title compound as a light yellow oil.  [α] D = +25.0 (c 
2.71, CHCl3); 1H NMR (300 MHz, CDCl3): δ 9.75 (s, 1H), 7.05-7.40 (m, 6H), 6.32 (dd, J = 3.1, 
1.9 Hz, 1H), 6.10 (d, J = 3.1 Hz, 1H), 5.61-5.76 (m, 2H), 3.72 (d, J = 8.2 Hz, 1H), 3.07 (d, J = 
13.7 Hz, 1H), 2.75 (d, J = 13.7 Hz, 1H), 2.15 (qd, J = 7.4, 5.0 Hz, 1H), 1.06 (t, J = 7.4 Hz, 3H), 
0.99 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 205.87, 154.44, 141.49, 137.40, 136.72, 
130.38, 128.11, 126.48, 123.71, 110.11, 107.33, 53.28, 48.55, 41.05, 25.64, 15.98, 13.64 ppm; 
IR (liquid film): 2965, 2932, 1723, 1497, 1454, 1148, 1013, 973, 733, 701 cm-1; MS (EI, 70 V): 
m/z 282 (M+.), 253, 225, 200, 191, 151, 148, 135, 131, 123, 115; HRMS m/z calcd for C19H22O2 
(M+.): 282.1620; found: 282.1608. 
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(2S,3S,E)-2-Benzyl-3-(furan-2-yl)-2-methylhept-4-en-1-ol (64e′): 1 M 
hexanes solution of iBu2AlH (0.5 mL, 0.5 mmol) was added to a −78 °C 
solution of aldehyde 64e (70 mg, 0.25 mmol) in CH2Cl2.  After stirring 30 
min at −78 °C, a saturated aqueous sodium tartrate solution (2 mL) was added and the mixture 
was warmed to ambient temperature and stirred until two homogeneous phases formed (~1 h).  
The mixture was extracted with Et2O (3×) and the combined organic extracts were dried 
(MgSO4), concentrated, and the resulting crude oil was purified by flash chromatography on 
HO
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silica gel (16% EtOAc in hexanes) to yield 56 mg (80%) of the title compound as a light yellow 
oil.  Separating the enantiomers by chiral HPLC [Daicel ChiracelTM OD-H column, flow rate 0.5 
mL/min, 5.0% i-PrOH, 95.0% hexanes, Tr 10.06 (2R, 3R) and 11.12 (2S, 3S)] provided the 
enantiomer ratio: 64e′(2R,3R): 64e′(2S,3S) = 2.4:97.6 (95.2 % ee).  [α]D = +18.1 (c 5.37, 
CHCl3); 1H NMR (300 MHz, CDCl3): δ 7.37 (dd, J = 1.7, 0.6 Hz, 1H), 7.20-7.35 (m, 5H), 6.36 
(dd, J = 3.1, 1.7 Hz, 1H), 6.12 (d, J = 3.1 Hz, 1H), 5.80 (dd, J = 15.2, 9.5 Hz, 1H), 5.66 (dt, J = 
15.2, 6.0 Hz, 1H), 3.61 (d, J = 9.5 Hz, 1H), 3.19 (d, J = 11.5 Hz, 1H), 3.06 (d, J = 11.5 Hz, 1H), 
2.87 (d, J = 13.2 Hz, 1H), 2.63 (d, J = 13.2 Hz, 1H), 2.14 (qd, J = 7.4, 6.0 Hz, 2H), 1.06 (t, J = 
7.4 Hz, 3H), 0.73 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 156.34, 140.78, 138.58, 135.81, 
130.80, 127.81, 125.89, 125.42, 110.22, 106.52, 66.05, 48.63, 42.86, 40.73, 25.70, 17.70, 13.76 
ppm; IR (liquid film): 3590, 3461, 2964, 2247, 1496, 1454, 1147, 1032, 973, 910, 731, 703 cm-1; 
MS (EI, 70 V): m/z 284 (M+.), 193, 148, 135, 121, 117, 107, 91, 79; HRMS m/z calcd for 
C19H24O2 (M+.): 284.1776; found: 284.1787. 
 
(2S,3S,E)-2-Cyclohexyl-2-methyl-3-phenylhept-4-enal (64f): General 
Procedure C was followed employing di(allyl) ether 62f (142 mg, 0.5 mmol) 
and 4 mol% catalyst (9.0 mg [IrCl(C8H14)2]2, 16.8 mg PCy3, and 6.8 mg 
NaBPh4) in 1,2-dichloroethane solvent at 50 °C and an initial reaction time of 12 h.  After 
addition of 15.6 mg PPh3, the reaction was heated at 80 °C for 16 h; (2R,3S):(2S,3S) = 87:13.  
Purifying the crude product mixture by flash chromatography on silica gel (2.5% Et2O in 
hexanes) yielded 100 mg (70%) of the title compound as light yellow oil.  Stereoisomer ratios 
were determined for corresponding primary alcohol (see below).  [α] D = +17 (c 0.78, CHCl3); 
1H NMR (300 MHz, CDCl3): δ 9.66 (s, 1H), 7.20-7.40 (m, 5H), 5.66 (dd, J = 15.1, 9.5 Hz, 1H), 
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5.56 (dt, J = 15.1, 5.8 Hz, 1H), 3.70 (d, J = 9.5 Hz, 1H), 1.98-2.13 (m, 2H), 1.12-1.80 (m, 13 H), 
0.99 (s, 3H), 0.98 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 208.33, 141.08, 
135.33, 128.99, 128.21, 127.22, 126.49, 54.40, 52.91, 40.99, 28.36, 27.19, 26.80, 26.64, 26.49, 
25.63, 13.71, 13.51 ppm; IR (liquid film): 2927, 2853, 1722, 1451, 969, 746, 702 cm-1; MS (EI, 
70 V): m/z 284 (M+.), 255, 193, 145, 129, 115, 91; HRMS m/z calcd for C20H28O (M+.): 
284.2140; found: 284.2145. 
 
(2S,3S,E)-2-Cyclohexyl-2-methyl-3-phenylhept-4-en-1-ol (64f′): A 1 M 
hexanes solution of iBu2AlH (0.5 mL, 0.5 mmol) was added to a −78 °C 
solution of aldehyde 64f (70 mg, 0.25 mmol) in CH2Cl2.  After stirring 30 
min at −78 °C, a saturated aqueous sodium tartrate solution (2 mL) was added and the mixture 
was warmed to ambient temperature and stirred until two homogeneous phases formed (~1 h).  
The mixture was extracted with Et2O (3×) and the combined organic extracts were dried 
(MgSO4), concentrated, and the resulting crude oil was purified by flash chromatography on 
silica gel (16% EtOAc in hexanes) to yield 59 mg (85%) of the title compound as a light yellow 
oil.  Separating the stereoisomers by GLC [Varian CP Wax 52CB column (30 m x 0.25 mm), 
flow rate 0.6 mL/min, method: 80 °C for 2.00 min, ramp @ 5.00 °C/min to 250 °C, hold for 
20.00 min, Tr = 69.8 (syn, E), 70.1 (anti, E), and 70.4 (anti, Z), min] provided the diastereomer 
ratio: 12.8: 89.4: 3.8.  Separating the enantiomers by chiral HPLC Daicel ChiracelTM OD-H 
column, flow rate 0.5 ml/min, 4.0% i-PrOH, 96.0% hexanes, Tr 10.6 (2S,3S) and 14.1 (2R,3R) 
provided the enantiomer ratio: (2S,3S): (2R,3R) 3.6: 96:4 (92 % ee). [α] D = +11.2 (c 2.51, 
CHCl3); 1H NMR (300 MHz, CDCl3): δ 7.18-7.32 (m, 5H), 5.90 (ddt, J = 15.1, 10.0, 1.2 Hz, 
1H), 5.50 (dt, J = 15.1, 6.3 Hz, 1H), 3.61 (d, J = 10.0, 1H), 3.46 (dd, J = 11.6, 5.6 Hz, 1H), 3.36 
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(dd, J = 11.6, 6.7 Hz, 1H), 2.05 (qd, J = 7.4, 6.3 Hz, 2H), 1.10-1.80 (m, 11H), 0.99 (t, J = 7.4 Hz, 
3H), 0.84 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 143.37, 134.17, 129.23, 128.77, 128.19, 
126.17, 66.90, 52.40, 43.44, 42.97, 27.98, 27.87, 27.50, 27.40, 26.88, 25.82, 16.82, 13.91 ppm; 
IR (liquid film): 3467, 2959, 1738, 1451, 1375, 1265, 1032, 973, 739, 704 cm-1; MS (EI, 70 V): 
m/z 268 (M+.−H2O), 255, 146, 123, 117; HRMS m/z calcd for C20H28 (M+.−H2O): 268.2191; 
found 268.2197. 
 
anti-(E)-2-Cyclohexyl-2,3-dimethylnon-4-enol (64g′): 
General Procedure C was followed employing 1-(2-(((E)-
oct-2-en-4-yloxy)methyl)allyl)benzene 62g (250 mg, 1.0 
mmol) and 2 mol% catalyst (9.0 mg [IrCl(C8H14)2]2, 16.8 mg PCy3, and 6.8 mg NaBPh4) and an 
initial reaction time of 24 h at 23 °C.  After addition of 15.6 mg PPh3, the reaction was heated at 
80 °C for 16 h.  The reaction was cooled to ambient temperature and the crude product mixture 
was dissolved in CH2Cl2 (2 mL).  The reaction was cooled to −78 °C and a solution of iBu2AlH 
(1.0 M in hexanes, 2.0 mL, 2.0 mmol) was added.  After stirring 30 min at −78 °C, a saturated 
aqueous sodium tartrate solution (8 mL) was added and the mixture was warmed to ambient 
temperature and stirred until two homogeneous phases formed (~1 h).  The mixture was 
extracted with Et2O (3×) and the combined organic extracts were dried (MgSO4), concentrated, 
and the resulting crude oil was purified by flash chromatography on silica gel (16% EtOAc in 
hexanes) to yield 126 mg (50%, anti : syn= 93 : 7) of the title compound as a light yellow oil.  1H 
NMR (300 MHz, CDCl3): δ 5.49 (dd, J = 15.4, 7.6 Hz, 1H), 5.39 (dt, J = 15.4, 5.9 Hz, 1H), 3.54 
(d, J = 11.5 Hz, 1H), 3.46 (d, J = 11.5 Hz, 1H), 2.39 (dq, J = 7.6, 7.0 Hz, 1H), 2.01 (q, J = 6.4 Hz, 
2H), 1.04-1.78 (m, 15H), 1.01 (d, J = 7.0 Hz, 3H), 0.90 (t, J = 7.4 Hz, 3H), 0.69 (s, 3H) ppm; 13C 
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NMR (75 MHz, CDCl3): δ 133.3, 130.6, 66.7, 41.9, 41.8, 40.4, 32.5, 31.8, 28.0, 27.4 (overlap of 
3C), 26.9, 22.2, 16.7, 15.9, 14.0 ppm; MS (EI, 70 V): m/z 252 (M+.), 227, 193, 181, 169, 127, 
109, 95, 67, 57; HRMS m/z calcd for C17H32O (M+.): 252.2453; found: 252.2460. 
 
anti-(E)-2-Ethyl-2-methyl-3-phenylhept-4-enal (64k): General Procedure 
C was followed employing (E)-(3-(2-methylenebutoxy)pent-1-enyl)benzene 
(62k, 115mg, 0.5 mmol) and 4 mol% catalyst (9.0 mg [IrCl(C8H14)2]2, 16.8 
mg PCy3 and 6.8 mg NaBPh4), and stirred 12 h at 50 °C in 1,2-dichloroethane solvent.  At this 
time, 15 mg of PPh3 was added at the reaction was heated at 80 °C for an additional 12 h.  
Purifying the crude product mixture by flash chromatography on silica gel (2.0% EtOAc in 
hexanes) yielded 76 mg (66%) of the title compound as colorless oil.  1H NMR (300 MHz, 
CDCl3): δ 9.58 (s, 1H), 7.27-7.47 (m, 5H), 5.80 (dd, J = 15.2, 9.8 Hz, 1H), 5.61 (dt, J = 15.1, 6.2 
Hz, 1H), 3.48 (d, J = 9.7 Hz, 1H), 1.95-2.09 (m, 2H), 1.45-1.80 (m, 2H), 1.04 (s, 3H), 1.01 (t, J = 
7.5 Hz, 3H), 0.82 (t, J = 7.6 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 207.0, 140.9, 135.8, 
129.3, 128.2, 126.6, 126.5, 55.3, 52.7, 27.2, 25.6, 15.3, 13.6, 8.5; MS (EI, 70 V): m/z 230 (M+.), 
201, 145, 131, 117, 91, 77, 69, 57; HRMS m/z calcd for C16H22O (M+.): 230.1671; found 
230.1668.  
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anti-(E)-2-Ethyl-2-methyl-3-phenylhept-4-enol (64k′): A 1 M hexanes 
solution of iBu2AlH (0.5 mL, 0.5 mmol) was added to a −78 °C solution of 
aldehyde 64k (57 mg, 0.25 mmol) in CH2Cl2.  After stirring 30 min at −78 °C, a saturated 
aqueous sodium tartrate solution (2 mL) was added and the mixture was warmed to ambient 
temperature and stirred until two homogeneous phases formed (~1 h).  The mixture was 
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extracted with Et2O (3×) and the combined organic extracts were dried (MgSO4), concentrated, 
and the resulting crude oil was purified by flash chromatography on silica gel (16% EtOAc in 
hexanes) to yield 40 mg (70%) of the title compound as a light yellow oil.  Separating the 
isomers by GLC [Varian CP Wax 52CB column (30 m x 0.25 mm), flow rate 0.6 mL/min, 
method: 80 °C for 2.00 min, ramp @ 5.00 °C/min to 250 °C, hold for 20.00 min, Tr = 52.9, 53.2, 
and 53.7 min] provided the diastereomer ratio: 6 (syn): 4 (Z): 90 (anti).  1H NMR (300 MHz, 
CDCl3): δ 7.21-7.40 (m, 5H), 5.94 (ddt, J = 15.1, 10.1, 1.4 Hz, 1H), 5.59 (ddt, J = 15.1, 10.1, 1.4 
Hz, 1H), 3.52 (d, J = 11.3 Hz, 1H), 3.41 (d, J = 11.3 Hz, 1H), 3.35 (d, J = 10.1 Hz, 1H), 1.98-
2.10 (m, 2H), 1.20-1.65 (m, 2H), 0.99 (t, J = 7.5 Hz, 3H), 0.82 (t, J = 7.5 Hz, 3H), 0.82 (s, 3H) 
ppm; 13C NMR (75 MHz, CDCl3): δ 142.7, 134.3, 129.3, 128.6, 127.9, 126.1, 67.2, 54.9, 41.1, 
27.1, 25.7, 18.2, 13.7, 8.0 ppm; IR (liquid film): 3392, 2963, 2930, 1601, 1492, 1453, 1376, 
1034, 970, 702 cm-1; MS (EI, 70 V): m/z 232 (M+.), 201, 145, 129, 117; HRMS m/z calcd for 
C16H24O (M+.): 232.1827; found 232.1835. 
 
(E)-2,2,3,6,6-Pentamethylhept-4-enal (64i): General Procedure D was followed 
employing di(allyl) ether (62i, 182 mg, 1.0 mmol) and 2 mol% catalyst (9.0 mg 
Ir-dimer, 16.8 mg PCy3 and 6.8 mg NaBPh4) and stirred 60 h at 80 oC in 
dichloroethane solvent. Purification by flash chromatograph on silical gel (2.5 % ethyl ether in 
hexanes) to yield 155 mg (85 %) of the title compound as a colorless oil. 1H NMR (300 MHz, 
CDCl3): δ 9.43 (s, 1H), 5.46 (d, J = 15.6 Hz, 1H), 5.13 (dd, J = 15.6, 8.8 Hz, 1H), 2.29 (dq, J = 
8.8, 7.0 Hz, 1H), 0.96 (s, 9H), 0.95 (s, 3H), 0.94 (s, 3H), 0.90 (d, J = 7.0 Hz, 3H) ppm; 13C NMR 
(75 MHz, CDCl3): δ 206.9, 143.5, 124.8, 48.7, 41.8, 33.0, 29.7, 19.5, 17.9, 15.6 ppm. 
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4.3.1.2 ICR for 2,3-disubstituted allyl ethers 
(2E)-4-((E)-2-Methylbut-2-enyloxy)oct-2-ene (66a): General Procedure A 
was followed employing (E)-oct-2-en-4-ol (384 mg, 3.0 mmol) and (E)-1-
bromo-2-methylbut-2-ene (671 mg, 4.5 mmol) in THF. The crude product 
was purified by flash chromatography on silica gel (2% EtOAc in hexanes) to yield 235 mg 
(40%) of the title compound as a light yellow oil.  1H NMR (300 MHz, CDCl3): δ 5.57 (dq, J = 
15.3, 6.4 Hz, 1H), 5.45 (q, J = 6.7 Hz, 1H), 5.29 (ddq, J = 15.3, 8.2, 1.5 Hz, 1H), 3.87 (d, J = 
11.2 Hz, 1H), 3.66 (d, J = 11.3 Hz, 1H), 3.55 (q, J = 7.0 Hz, 1H), 1.71 (dd, J = 6.4, 1.5 Hz, 3H), 
1.63 (s, 3H), 1.61 (s, 3H), 1.25-1.46 (m, 6H), 0.89 (t, J = 6.8 Hz, 3H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 133.4, 132.5, 128.0, 121.8, 79.6, 73.8, 35.5, 27.7, 22.7, 17.6, 14.0, 13.8, 13.1 ppm; 
MS (EI, 70 V): m/z 196 (M+.), 181, 139, 110, 81, 71, 69; HRMS m/z calcd for C13H24O  
(M+.)196.1827. found 196.1832. 
O
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1-((3E)-5-((E)-Oct-2-en-4-yloxy))-4-methylpent-3-enyl)benzene (66b): 
General Procedure A was followed employing (E)-oct-2-en-4-ol (256 mg, 
2.0 mmol) and a mixture of 1-((E)-5-bromo-4-methylpent-3-enyl)benzene 
and 1-(3-bromo-4-methylpent-4-enyl) benzene (~4:1, 714 mg, 3.0 mmol)117 in THF.  The crude 
product was purified by flash chromatography on silica gel (2% EtOAc in hexanes) to yield 372 
mg (65%) of the title compound as light yellow oil.  1H NMR (300 MHz, CDCl3): δ 7.18-7.53 
(m, 5H), 5.55 (dq, J = 15.3, 6.4 Hz, 1H), 5.44 (t, J = 6.8 Hz, 1H), 5.30 (ddq, J = 15.3, 8.2, 1.5 Hz, 
1H), 3.89 (d, J = 11.5 Hz, 1H), 3.69 (d, J = 11.5 Hz, 1H), 3.55 (q, J = 7.0 Hz, 1H), 2.69 (t, J = 7.8 
Hz, 2H), 2.39 (q, J = 7.4 Hz, 2H), 1.73 (dd, J = 6.2, 1.0 Hz, 3H), 1.63 (s, 3H), 1.24-1.50 (m, 4H), 
O
nBu
Me
Me
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117 The mixture of 1-((E)-5-bromo-4-methylpent-3-enyl)benzene and 1-(3-bromo-4-methylpent-4-enyl)benzene was prepared 
by reacting 2-methyl-5-phenylpent-1-en-3-ol with PBr3 in hexanes. 
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0.91 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 142.1, 133.3, 132.4, 128.4, 128.2, 
128.1, 126.6, 125.7, 79.4, 73.6, 35.7, 35.4, 31.6, 29.6, 27.7, 22.7, 17.7, 14.1 ppm; MS (EI, 70 V): 
m/z 286 (M+.), 229, 195, 181, 175, 160, 143, 127; HRMS m/z calcd for C16H21O (M+.−C4H9) 
229.1592; found: 229.1594. 
 
((E)-3-((E)-2-Methylbut-2-enyloxy)pent-1-enyl)benzene (66c): General 
Procedure A was followed employing (E)-1-phenylpent-1-en-3-ol (324 mg, 
2.0 mmol) and (E)-1-bromo-2-methylbut-2-ene (447 mg, 3.0 mmol) in DMF.  
The crude product was purified by flash chromatography on silica gel (2% EtOAc in hexanes) to 
yield 320 mg (70%) of the title compound as light yellow oil.  1H NMR (300 MHz, CDCl3): δ 
7.21-7.53 (m, 5H), 6.62 (d, J = 16.0 Hz, 1H), 6.18 (dd, J = 16.0, 7.9 Hz, 1H), 5.61 (q, J = 5.7 Hz, 
1H), 4.07 (d, J = 11.2 Hz, 1H), 3.88 (d, J = 11.2 Hz, 1H), 3.83 (q, J = 7.0 Hz, 1H), 1.79 (s, 3H), 
1.75 (d, J = 5.7 Hz, 3H), 1.61-1.91 (m, 2H), 1.07 (t, J = 6.9 Hz, 3H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 136.76, 133.19, 131.90, 130.77, 128.50, 127.49, 126.36, 122.12, 80.95, 74.31, 28.67, 
13.75, 13.13, 9.94 ppm; IR (liquid film): 2965, 2931, 2859, 1493, 1450, 1063, 968, 747, 693 cm-
1; MS (EI, 70 V): m/z 230 (M+.), 201, 161, 145, 133, 117, 91; HRMS m/z calcd for C16H22O  
(M+.): 230.1671; found 230.1668. 
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1-((1E)-3- ((E)-3-Cyclohexyl-2-methylallyloxy)pent-1-enyl)benzene 
(66d): General procedure A was followed employing (E)-1-phenylpent-1-
en-3-ol (486 mg, 3.0 mmol) and mixture of 1-((E)-5-bromo-4-
methylpent-3-enyl)benzene and 1-(3-bromo-4-methylpent-4-enyl) benzene (about 4: 1, 1.3 g, 6.0 
mmol). The crude product was purified by flash chromatograph on silical gel (2 % EtOAc in 
O
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hexanes) to yield 715 mg (80 %) of the title compound as a light yellow oil. 1H NMR (300 MHz, 
CDCl3): δ 7.20-7.46 (m, 5H), 6.49 (d, J = 16.0 Hz, 1H), 6.07 (dd, J = 16.0, 8.0 Hz, 1H), 5.23 (d, J 
= 9.1 Hz, 1H), 3.95 (d, J = 11.5 Hz, 1H), 3.76 (d, J = 11.5 Hz, 1H), 3.71-3.75 (m, 1H), 2.12-2.28 
(m, 1H), 1.26-1.80 (m, 12H), 1.68 (d, J = 1.1 Hz, 3H), 0.95 (t, J = 7.4 Hz, 3H) ppm; 13C NMR 
(75 MHz, CDCl3): δ 136.7, 134.3, 132.0, 130.7, 130.3, 128.5, 127.5, 126.3, 80.6, 74.4, 36.6, 
33.1, 32.9, 28.7, 26.0, 25.94, 25.91, 14.0, 10.04 ppm; MS (EI, 70 V): m/z 298 (M+.), 269, 240, 
226, 161, 145, 133, 117, 95, 81; HRMS m/z calcd for C21H30O (M+.) 298.2297. found 298.2305. 
 
syn-(E)-2-Ethyl-2,3-dimethylnon-4-enal (68a): General Procedure C was 
followed employing (2E)-4-((E)-2-methylbut-2-enyloxy)oct-2-ene (66a, 196 
mg, 1.0 mmol) and 2 mol% catalyst (9.0 mg [IrCl(C8H14)2]2, 16.8 mg PCy3, and 
6.8 mg NaBPh4) and stirred 60 h at 75 °C in 1,2-dichloroethane solvent.  Purifying the crude 
product mixture by flash chromatography on silica gel (2.5% Et2O in hexanes) yielded 147 mg 
(75%) of the title compound as a colorless oil (syn:anti= 96:4).  1H NMR (300 MHz, CDCl3): δ 
9.45 (s, 1H), 5.43 (dt, J = 15.2, 6.4 Hz, 1H), 5.27 (dd, J = 15.2, 8.4 Hz, 1H), 2.39 (dq, J = 8.4, 6.9 
Hz, 1H), 2.34-2.44 (m, 1H), 1.94-2.00 (m, 2H), 1.27-1.73 (m, 6H), 0.97 (d, J = 6.9 Hz, 3H), 0.94 
(s, 3H), 0.88 (t, J = 7.4 Hz, 3H), 0.80 (t, J = 7.5 Hz, 3H) ppm; 13C (75 MHz, CDCl3): 207.3, 
132.0, 130.9, 51.9, 41.6, 32.2, 31.6, 26.6, 22.1, 14.8, 14.2, 13.9, 8.4 ppm; MS (EI, 70 V): m/z196 
(M+.), 181, 139, 110, 81, 71, 69; HRMS m/z calcd for C13H24O (M+.): 196.1827; found 196.1820. 
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syn-(E)-2-Ethyl-2,3-dimethylnon-4-enol (68a’): A 1 M hexanes solution of 
iBu AlH (0.5 mL, 0.5 mmol) was added to a −78 °C solution of aldehyde 68a 
(49 mg, 0.25 mmol) in CH Cl .  After stirring 30 min at −78 °C, a saturated 
2
2 2
nBu Me
HO
MeEt
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aqueous sodium tartrate solution (2 mL) was added and the mixture was warmed to ambient 
temperature and stirred until two homogeneous phases formed (~1 h).  The mixture was 
extracted with Et O (3×) and the combined organic extracts were dried (MgSO ), concentrated, 
and the resulting crude oil was purified by flash chromatography on silica gel (16% EtOAc in 
hexanes) yielded 29 mg (60 %) of the title compound as a light yellow oil. 
2 4
1H NMR (300 MHz, 
CDCl ): δ 5.41-5.45 (m, 2H), 3.41 (s, 2H), 2.11-2.21 (m, 1H), 1.97-2.01 (m, 2H), 1.37 (q, J = 7.6 
Hz, H), 1.26-1.36 (m, 4H), 0.97 (d, J = 6.9 Hz, 3H), 0.94 (s, 3H), 0.88 (t, J = 7.4 Hz, 3H), 0.80 (t, 
J = 7.5 Hz, 3H) ppm; 
3
13C NMR (75 MHz, CDCl ): δ 133.2, 130.5, 68.0, 41.4, 39.7, 32.3, 31.8, 
27.5, 22.2, 17.4, 15.2, 13.9, 7.9 ppm; MS (EI, 70 V): m/z 198 (M
3
+.), 180, 167, 111, 83, 69; 
HRMS m/z calcd for C H O (M13 26 +.): 198.1984; found 198.1975. 
 
syn-(E)-2,3-Dimethyl-2-(3-phenylpropyl)non-4-enal (68b): General 
Procedure C was followed employing 1-((3E)-5-((E)-oct-2-en-4-yloxy)-4-
methylpent-3-enyl)benzene (66b, 143 mg, 0.5 mmol) and 2 mol% catalyst  (4.5 
mg [IrCl(C8H14)2]2, 8.4 mg PCy3 and 3.4 mg NaBPh4) and stirred 60 h at 75 °C in 1,2-
dichloroethane solvent.  Purifying the crude product mixture by flash chromatography on silica 
gel (2.5% Et2O in hexanes) yielded 102 mg (71%) of the title compound as a colorless oil 
(syn:anti = 95:5).  Separating the stereoisomers by GLC [Varian CP Wax 52CB column (30 m x 
0.25 mm), flow rate 0.6 mL/min, method: 80 °C for 2.00 min, ramp @ 5.00 °C/min to 250 °C, 
hold for 20.00 min, Tr = 60.1 and 61.0 min] provided the diastereomer ratio: anti: syn = 5.8:94.2.  
1H NMR (300 MHz, CDCl3): δ 9.45 (s, 1H), 7.15-7.31 (m, 5H), 5.42 (dt, J = 15.2, 6.5 Hz, 1H), 
5.26 (dd, J = 15.2, 8.5 Hz, 1H), 2.57-2.61 (m, 2H), 2.24-2.48 (m, 2H), 1.93-1.98 (m, 3H), 1.24-
1.75 (m, 6H), 0.96 (s, 3H), 0.96 (d, J = 7.0 Hz, 3H), 0.89 (t, J = 7.1 Hz, 3H) ppm; 13C NMR (75 
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MHz, CDCl3): δ 207.1, 142.0, 132.2, 130.7, 128.32, 128.25, 125.8, 51.6, 41.8, 36.5, 33.7, 32.2, 
31.6, 29.7, 25.9, 22.1, 14.9, 13.9 ppm; MS (EI, 70 V): m/z 286 (M+.), 258, 256, 245, 229, 192, 
163, 145, 117, 111, 104, 91, 69; HRMS m/z calcd for C20H30O (M+.); 286.2297; found 286.2288. 
 
syn-(E)-2,3-Dimethyl-2-(3-phenylpropyl)non-4-enol (68b′): A 1 M hexanes 
solution of iBu2AlH (0.5 mL, 0.5 mmol) was added to a −78 °C solution of 
aldehyde 68b (72 mg, 0.25 mmol) in CH2Cl2.  After stirring 30 min at −78 °C, a 
saturated aqueous sodium tartrate solution (2 mL) was added and the mixture was warmed to 
ambient temperature and stirred until two homogeneous phases formed (~1 h).  The mixture was 
extracted with Et2O (3×) and the combined organic extracts were dried (MgSO4), concentrated, 
and the resulting crude oil was purified by flash chromatography on silica gel (16% EtOAc in 
hexanes) yielded 65 mg (90 %) of the title compound as a light yellow oil.  Separating the 
stereoisomers by GLC [Varian CP Wax 52CB column (30 m × 0.25 mm), flow rate 0.6 mL/min, 
method: 80 °C for 2.00 min, ramp @ 5.00 °C/min to 250 °C, hold for 20.00 min, Tr = 64.6 and 
68.9 min] provided the diastereomer ratio: anti: syn = 3.7:96.3; 1H NMR (300 MHz, CDCl3): δ 
7.15-7.31 (m, 5H), 5.39-5.41 (m, 2H), 3.41 (d, J = 11.4 Hz, 1H), 3.37 (d, J = 11.4 Hz, 1H), 2.58 
(t, J = 7.7 Hz, 2H), 2.12-2.19 (m, 1H), 1.95-2.05 (m, 2H), 1.52-1.74 (m, 3H), 1.26-1.46 (m, 6H), 
0.90 (d, J = 6.9 Hz, 3H), 0.89(t, J = 7.4 Hz, 3H), 0.75 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3): 
δ 143.0, 133.4, 130.9, 128.7, 128.6, 126.0, 68.8, 42.0, 40.1, 37.2, 35.5, 32.6, 32.1, 25.8, 22.5, 
18.4, 15.5, 14.2 ppm; MS (EI, 70 V): m/z 288 (M+.), 270, 257, 176, 159, 145, 117, 104, 91; 
HRMS m/z calcd for C20H32O (M+.): 288.2453; found 288.2459. 
nBu Me
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syn-(E)-2-Ethyl-2-methyl-3-phenylhept-4-enal (68c): General Procedure 
D was followed employing ((E)-3-((E)-2-methylbut-2-enyloxy)-pent-1-
enyl)benzene (66c, 115mg, 0.5 mmol) and 4 mol% catalyst (9.0 mg 
[IrCl(C8H14)2]2, 16.8 mg PCy3 and 6.8 mg NaBPh4), and stirred 24 h at 80 °C in 1,2-
dichloroethane solvent.  The crude product mixture contained aldehyde 68c and aldehyde syn-
(E)-2-ethyl-2-methyl-3-phenylhept-5-enal 68c″ resulting from post-rearrangement olefin 
isomerization as a 90:10 mixture.  Purifying the crude product mixture by flash chromatography 
on silica gel (2.0% EtOAc in hexanes) yielded 68 mg (60%) of the title compound as colorless 
oil.  1H NMR (300 MHz, CDCl3): δ 9.58 (s, 1H), 7.27-7.47 (m, 5H), 5.81 (dd, J = 15.2, 9.3 Hz, 
1H), 5.60 (dt, J = 15.2, 6.2 Hz, 1H), 3.52 (d, J = 9.3 Hz, 1H), 1.95-2.09 (m, 2H), 1.45-1.80 (m, 
2H), 1.05 (s, 3H), 1.00 (t, J = 7.5 Hz, 3H), 0.78 (t, J = 7.6 Hz, 3H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 205.8, 140.4, 135.6, 129.3, 128.2, 127.2, 126.7, 55.0, 53.1, 27.6, 25.6, 14.4, 13.6, 8.3 
ppm;  MS (EI, 70 V): m/z 230 (M+.), 201, 145, 131, 117, 91, 77, 69, 57; HRMS m/z calcd for 
C16H22O 230 (M+.): 230.1671; found 230.1668. 
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syn-(E)-2-Ethyl-2-methyl-3-phenylhept-4-enal (68c’): A 1 M hexanes 
solution of iBu2AlH (0.5 mL, 0.5 mmol) was added to a −78 °C solution of 
aldehyde 68c (57 mg, 0.25 mmol) in CH2Cl2.  After stirring 30 min at −78 °C, a saturated 
aqueous sodium tartrate solution (2 mL) was added and the mixture was warmed to ambient 
temperature and stirred until two homogeneous phases formed (~1 h).  The mixture was 
extracted with Et2O (3×) and the combined organic extracts were dried (MgSO4), concentrated, 
and the resulting crude oil was purified by flash chromatography on silica gel (16% EtOAc in 
hexanes) to yield 40 mg (70%) of the title compound as a light yellow oil.  Separating the 
Ph
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isomers by GLC [Varian CP Wax 52CB column (30 m x 0.25 mm), flow rate 0.6 mL/min, 
method: 80 °C for 2.00 min, ramp @ 5.00 °C/min to 250 °C, hold for 20.00 min, Tr = 53.7, 54.6 
min] provided the stereoisomer ratio: syn: anti = 88:12.  1H NMR (300 MHz, CDCl3): δ 7.21-
7.40 (m, 5H), 5.91 (ddt, J = 15.1, 10.1, 1.4 Hz, 1H), 5.57 (ddt, J = 15.1, 10.1, 1.4 Hz, 1H), 3.35 
(d, J = 11.2 Hz, 1H), 3.35 (d, J = 10.1 Hz, 1H), 3.27 (d, J = 11.2 Hz, 1H), 1.98-2.10 (m, 2H), 
1.20-1.65 (m, 2H), 0.98 (t, J = 7.5 Hz, 3H), 0.86 (t, J = 7.5 Hz, 3H), 0.80 (s, 3H) ppm; 13C NMR 
(75 MHz, CDCl3): δ 142.5, 134.1, 129.4, 128.9, 127.9, 126.0, 67.1, 54.9, 41.1, 27.3, 25.6, 18.0, 
13.7, 7.9 ppm; IR (liquid film): 3392, 2963, 2930, 1601, 1492, 1453, 1376, 1034, 970, 702 cm-1; 
MS (EI, 70 V): m/z 232 (M+.), 201, 145, 129, 117; HRMS m/z calcd for C16H24O (M+.): 
232.1927; found 232.1835.  
 
Diastereomers Proof for Claisen Adducts 64h and 68c: The relative stereochemistry for 64h 
and 68c was determined for the corresponding primary alcohols 64h′ and 68c′. HPLC analysis of 
the 64h′ and 68c′ racemates provided the retention times 6.6/7.1 (50:50) and 7.0/8.4 min (50:50), 
respectively (Daicel ChiracelTM OD-H column, flow rate 0.8 ml/min, 4.0% i-PrOH, 96.0% 
hexanes).  HPLC analysis of a 1:1 mixture of (±)-64h′ and (±)-68c′ was separated using the same 
method (Daicel ChiracelTM OD-H column, flow rate 0.8 ml/min, 4.0% i-PrOH, 96.0% hexanes) 
to afford the retention times 6.6, 7.2, and 8.6 min peaks in a ratio of 25:50:25 indicating that 64h′ 
and 68c′ are unique diastereomers.   
4.3.1.3 Asymmetric quaternary ICR reaction 
1-(2-(((R)-1-Phenylbut-3-enyloxy)methyl)allyl)benzene (70): General 
Procedure A was followed employing (R)-1-phenylbut-3-en-1-ol (81% ee, 296 O
Ph
Bn
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mg, 2.0 mmol)118 and (2-(bromomethyl)allyl)benzene (630 mg, 3.0 mmol) in THF. The crude 
product was purified by flash chromatography on silica gel (2% EtOAc in hexanes) to yield 450 
mg (81%) of the title compound as light yellow oil. +10.8 (c 1.07, CHCl3); 1H NMR (300 MHz, 
CDCl3): δ 7.27-7.46 (m, 10H), 5.88-6.04 (m, 1H), 5.07-5.22 (m, 3H), 5.00 (s, 1H), 4.39 (dd, J = 
7.4, 5.8 Hz, 1H), 3.94 (d, J = 12.4 Hz, 1H), 3.76 (d, J = 12.4 Hz, 1H), 3.54 (d, J = 15.0 Hz, 1H), 
3.47 (d, J = 15.0 Hz, 1H), 2.62-2.82 (m, 1H), 2.48-2.60 (m, 1H) ppm; 13C NMR (75 MHz, 
CDCl3): δ; IR (liquid film): 3027, 2908, 2856, 1642, 1601, 1494, 1453, 1087, 913, 699 cm-1; MS 
(EI, 70 V): m/z 278 (M+.), 237, 147, 131, 129, 115, 107; HRMS m/z calcd for C20H22O (M+.): 
278.1671; found 278.1675. 
 
(2S,3R,E)-2-Benzyl-2,3-dimethyl-5-phenylpent-4-enal (72): General 
Procedure D was followed employing 1-(2-(((R)-1-phenylbut-3-
enyloxy)methyl)allyl)benzene 70 (81 % ee, 139 mg, 0.5 mmol) and 2 mol% 
catalyst Ir(PCy3)3BPh4 (4.5 mg [IrCl(C8H14)2]2, 8.4 mg PCy3, and 3.4 mg NaBPh4) and stirred 60 
h at 60 °C in 1,2-dichloroethane solvent.  The crude product mixture was purified by flash 
chromatography on silica gel (2.5% Et2O in hexanes) to yield 101 mg (73%) of the title 
compound as colorless oil: anti: syn > 98: 2).  Separating the enantiomers by chiral HPLC Daicel 
ChiracelTM OD-H column, flow rate 0.8 mL/min, 0.8% i-PrOH, 99.2% hexanes, Tr 30.55 (2R, 3S) 
and 36.09 (2S, 3R) provided the enantiomer ratio: (2R,3S) : (2S,3R) = 9.1:89.4 (82% ee).  [α] D = 
−74.6 (c 5.09, CHCl3); 1H NMR (300 MHz, CDCl3): δ 9.68 (s, 1H), 7.06-7.42 (m, 10H), 6.53 (d, 
J = 15.8 Hz, 1H), 6.19 (dd, J = 15.8, 9.1 Hz, 1H), 3.09 (d, J = 13.8 Hz, 1H), 2.77 (d, J = 13.8 Hz, 
Ph
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118 The enantioenriched homoallylic alcohol was prepared according to the published procedure, see: Brown, H. C.  J. Am. 
Chem. Soc. 1990, 112, 2389.  The enantioselectivity of the allylation reaction was not optimized. 
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1H), 2.74 (dq, J = 9.1, 6.9 Hz, 1H), 1.11 (d, J = 6.9 Hz, 3H), 1.02 (s, 3H) ppm; 13C NMR (75 
MHz, CDCl3): δ 206.6, 137.0, 136.8, 132.0, 130.2, 128.6, 128.1, 127.4, 126.5, 126.2, 53.4, 42.3, 
41.8, 16.2, 14.0 ppm; MS (EI, 70 V): m/z 278 (M+.), 263, 249, 187, 146, 131, 115, 105, 91, 77, 
65; HRMS m/z calcd for C20H22O (M+.): 278.1671; found 278.1662.  
 
ol (6.21 mmol, >99%
 (S,E)-2-Butyl-2-methyl-7-phenylhept-4-en-1-al (75): General 
Procedure D was followed employing di(allyl) ether (73, 258 mg, 1.0 
mmol) and 2 mol% catalyst (9.0 mg [IrCl(C8H14)2]2, 16.8 mg PCy3, and 6.8 mg NaBPh4) and 
                                                
1-((S)-3-(2-Methylenehexyloxy)pent-4-enyl)benzene (73): General 
Procedure A was followed employing 1.01 g of (S)-5-phenylpent-1-en-3-
 ee).119  Purifying the crude product mixture by flash chromatography 
(flushing with 400 mL of hexanes then eluting with 2.5% EtOAc in hexanes) afforded 1.39 g 
(86%) of the title compound as colorless oil.  Separating the enantiomers by chiral HPLC (Daicel 
ChiracelTM OD-H column, flow rate 1.0 mL/min, 0.5% i-PrOH, 95.5% hexanes, Tr 8.3 (S) and 
11.0 (R) provided only one enantiomer (>99% ee).  [α]D = +1.73 (c 6.57, CHCl3); 1H NMR (300 
MHz, CDCl3): δ 0.91 (t, J = 7.2 Hz, 3H), 1.27-1.50 (m, 4H), 1.74-2.02 (m, 2H), 2.07 (m, 2H), 
2.72 (m, 2H), 3.68 (dt, J = 5.8, 7.4 Hz, 1H), 3.75 (d, J = 13 Hz, 1H), 3.97 (d, J = 13 Hz, 1H), 4.88 
(s, 1H), 5.01 (s, 1H), 5.17 (m, 1H), 5.22 (m, 1H), 5.72 (m, 1H), 7.15-7.30 (m, 5H); 13C NMR (75 
MHz, CDCl3): δ 13.8, 22.4, 29.8, 31.6, 33.0, 37.1, 71.0, 79.7, 110.7, 116.8, 125.6, 128.2, 128.4, 
139.0, 142.1, 146.6; MS (EI, 70 V): m/z 258 (M+.− H), 235, 229, 215, 187, 171, 161, 144, 129, 
117, 105, 97, 91, 55; HRMS m/z calcd for C18H27O (M+.): 259.2062; found: 259.2061. 
 
O
nBu
Ph
H
 
119 Takagi, Y.; Teramoto, J.; Kihara, H.; Itoh, T.; Tsukube, H. Tetrahedron Lett. 1996, 37, 4991-4992. 
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stirred 60 h at 80 °C i
flash chromatography 
butyl-2-methyl-7-phen
 (65 mg, 0.25 mmol) in CH2Cl2 was added iBu2AlH 
(1.0 M in hexanes, 0.5 mL, 0.5 mmol).  After stirring 30 min at −78 °C, a 
d
ambient temperature a
extracted with Et2O (
n 1,2-dichloroethane solvent.  The crude product mixture was purified by 
on silica gel (2.5% EtOAc in hexanes) to yield 129 mg (50%) of (S,E)-2-
ylhept-4-en-1-al (75) and 21 mg (8%) of (S,Z)-2-butyl-2-methyl-7-
phenylhept-4-en-1-al (Z-75)as an inseperable mixture.  1H NMR (300 MHz, CDCl3): δ 9.42 (s, J 
= 2.4 Hz, 1H), 7.17-7.35 (m, 5H), 5.50 (dt, J = 15.2, 6.6 Hz, 1H), 5.31 (dt, J = 15.1, 7.3 Hz, 1H), 
2.68 (t, J = 7.3 Hz, 2H), 2.34 (dt, J = 7.6, 7.1 Hz, 2H), 2.08-2.22 (m, 2H), 1.07-1.55 (m, 6H), 
0.97 (s, 3H), 0.90 (t, J = 7.3 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 206.6, 141.7, 133.4, 
128.4, 128.2, 125.7, 125.1, 49.1, 38.5, 35.8, 34.9, 34.2, 26.1, 23.3, 18.3, 13.9 ppm; MS (EI, 70 
V): m/z 258 (M+.), 240, 202, 183, 167, 154, 98, 91; HRMS m/z calcd for C18H26O (M+.): 
258.1984. found: 258.1979. 
 
(S,E)-2-Butyl-2-methyl-7-phenylhept-4-en-1-ol (75′): To a −78 °C 
solution of aldehyde 75HO
saturated aqueous so ium tartrate solution (2 mL) was added and the mixture was warmed to 
nd stirred until two homogeneous phases formed (~1 h).  The mixture was 
3×) and the combined organic extracts were dried (MgSO4), concentrated, 
and the resulting crude oil was purified by flash chromatography on silica gel (16% EtOAc in 
hexanes) to yield 46 mg (70%) of the title compound as a light yellow oil.  Separating the 
isomers by GLC [Varian CP Wax 52CB column (30 m × 0.25 mm), flow rate 0.6 mL/min, 
method: 80 °C for 2.00 min, ramp @ 5.00 °C/min to 250 °C, hold for 20.00 min, Tr = 65.7, 66.1 
min] provided the isomer ratio: E:Z = 93.7:6.3.  Separating the enantiomers by chiral HPLC 
[Daicel ChiracelTM AD column, flow rate 1.0 mL/min, 2.0% i-PrOH, 98.0% hexanes, Tr 11.1 (R) 
Ph
nBu
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and 12.2 (S)] provided the enantiomer ratio: (R):(S) = 2.3:97.7 (95% ee). [α]D = +2.0 (c 2.32, 
CHCl3); 1H NMR (300 MHz, CDCl3): δ 7.17-7.35 (m, 5H), 5.50 (dt, J = 15.2, 5.6 Hz, 1H), 5.43 
(dt, J = 15.2, 6.0 Hz, 1H), 3.28 (s, 2H), 2.70 (t, J = 7.6 Hz, 2H), 2.33-2.43 (m, 2H), 1.95 (d, J = 
6.0 Hz, 2H), 1.19-1.30 (m, 6H), 0.92 (t, J = 7.4 Hz, 3H) 0.80 (s, 3H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 141.9, 132.1, 128.4, 128.3, 127.2, 125.7, 69.8, 40.1, 37.9, 36.3, 36.0, 34.3, 25.6, 23.6, 
21.5, 14.1 ppm; MS (EI, 70 V): m/z 260 (M+.), 242, 229, 185, 162, 151, 146, 138, 131, 117, 114, 
104, 97, 91; HRMS m/z calcd for C18H28O (M+.): 260.2140; found: 260.2127. 
4.3.2 Experiment of section 4.2 
Methyl 2-(cinnamyloxy)acetate (81a′): General procedure G for methyl 
(E)-3-phenylprop-2-en-1-ol (1.34 g, 10 mmol, 1.0 equiv.) in 
NaH (1.2 g, 50 mmol, 5.0 equiv.) slurry in THF (10 ml, 1.0 M), and 2-chloroacetic 
acid (945 mg
o
ether 20 ml X
O
O
allyoxyacetate: Add 
,10 mmol, 1.0 equiv.) in THF (10 ml, 0.5 M at last) was added dropwise at 0 oC. 
 reflux 6 h. Add water 20 ml dropwise to quench the reaction and extracted with 
 3, then extracted organic phase with water 20 ml X 2, combine water phase and 
add 1.0 M HCl to acidify the solution to pH = 2. Extracted the solution with ether 20 ml X 3, 
combine the organic phase and drying with MgSO
Then warm t
4. After solvent evaporation afford crude 2-
(cinnamyloxy)acetic acid. The acid can by purified with chromatography on silica (50 % ethyl 
acetate in hexanes) or using directly without purification. To a solution of 2-(cinnamyloxy)acetic 
acid (768 mg, 4.0 mmol), K2CO3 (2.76 g, 20 mmol) in DMF (10 ml) add methyl iodide (1.7 g, 
12.0 mmol) and stir 12 h at ambient temperature. Add water 50 ml and extracted with ether 20 
ml X 3, combine the organic phase, the solvent was evaporated and the crude product mixture 
Ph
OMe
 170 
was purified by flash chromatography on silica gel (10% EtOAc in hexanes) to yield 600 mg (72 
%) of the title compound as a light yellow oil. 
 
(E)-(3-(2-Methoxyallyloxy)prop-1-enyl)benzene (81a): General procedure H for 
methylidenation with Tebbe’s reagent: To a −40 °C solution of ester (81a′, 515 
m
reaction mixtu
(E)-2-(Trimethylsilyl)ethyl 2-(1-phenylpent-1-en-3-
yloxy)acetate (81b′): General procedure G for esterfication with 
p t
mmol) added DCC (1030 mg,
                                                
mg, 2.5 mmol) in 10 ml THF-pyridine (4:1) was added Tebbe’s reagent (2.5 
mol, 12.6 mL of 0.5 M toluene solution).equiv., 6.3 120  Once addition was complete, the 
re was warmed to ambient temperature and stirred for 16 h. The reaction mixture 
was cooled to 0 °C and quenched by dropwise addition of 0.5 M aq. NaOH. The resulting 
mixture was filtered through a celite pad, washing the filter cake with Et2O. The solvents were 
Vaporated and the crude oil was purified by column chromatography on basic alumina (10% 
Et2O in hexanes) to give 332 mg of the title product (65%) as colorless oil. 1H NMR (300 MHz, 
C6D6): δ 6.99-7.21 (m, 5H), 6.53 (d, J = 16.0 Hz, 1H), 6.16 (dt, J = 16.0, 5.7 Hz, 1H), 4.34 (s, 
1H), 3.99 (dd, J = 5.7, 1.5 Hz, 2H), 3.99 (s, 1H), 3.95 (s, 2H), 3.21 (s, 3H) ppm; 13C NMR (75 
MHz, C6D6): δ 161.11, 137.31, 132.06, 128.74, 127.68, 126.78, 126.69, 82.21, 71.03, 70.40, 
54.40 ppm.  
 
DCC and DMAP. To a 2 ml CH2Cl2 solution of (E)-2-(1-
ic acid (880 mg, 4.0 mmol), 2-(trimethylsilyl)ethanol (472 mg, 4.0 
 5.0 mmol) and DMAP (43 mg, 0.4 mmol). Stirred 24 h at ambient 
henylpent-1-en-3-yloxy)ace
 
120 For the in situ preparation of Tebbe’s reagent: Pine, S. H.; Kim, G.; Lee, V. Org. Syn. 1990, 69, 72. 
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temperature, after Vaporation of solvent, the crude product was purified by flash chromatograph 
on silical gel (10 % ethyl acetate in hexanes) to yield 1024 mg (80 %) of the title compound as a 
light yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.21-7.38 (m, 5H), 6.51 (d, J = 16.0 Hz, 1H), 
6.03 (dd, J = 16.0, 8.3 Hz, 1H), 4.20 (dd, J = 9.5, 8.7 Hz, 1H), 4.08 (d, J = 16.4 Hz, 1H), 4.02 (d, 
J = 16.4 Hz, 1H), 3.86 (q, J = 7.1 Hz, 1H), 1.57-1.92 (m, 2H), 0.97 (t, J = 7.4 Hz, 3H), 0.96 (t, J 
= 9.0 Hz, 2H), 0.02 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3): δ 170.72, 136.15, 133.18, 129.06, 
128.37, 127.65, 126.33, 83.07, 65.50, 62.69, 28.36, 17.12, 9.64 ppm; IR (liquid film): 2933, 
2119, 1752, 1250, 1115, 837, 749, 693 cm-1; MS (EI, 70 V): m/z 292 (M+.-CH2=CH2), 263, 219, 
161, 233, 145, 129, 115, 73; HRMS m/z calcd for C16H24O3Si (M+.-CH2=CH2): 292.1495. found 
292.1498. 
  
(E)-Trimethyl (2-(3-(1-phenylpent-1-en-3-yloxy)prop-1-en-2-
yloxy) ethyl)silane (81b): General procedure H was followed 
a
the title product 239 mg (75
O
employing ester 81b′ (320 mg, 1 mmol), the crude product was 
tography at basic alumina gel (10 % ethyl ether in hexanes) to give 
 %) as colorless oil. 
purified by column chrom
1H NMR (300 MHz, C6D6): δ 7.03-7.23 (m, 5H), 
6.45 (d, J = 16.0 Hz, 1H), 6.05 (dd, J = 16.0, 7.8 Hz, 1H), 4.43 (t, J = 0.69 Hz, 1H), 4.17 (d, J = 
7.3 Hz, 1H), 4.09 (d, J = 1.5 Hz, 1H), 3.94 (d, J = 7.3 Hz, 1H), 3.78 (q, J = 7.0 Hz, 1H), 3.74 (t, J 
= 7.8 Hz, 2H), 1.76-1.99 (m, 2H), 0.97 (t, J = 7.4 Hz, 3H), 0.93 (t, J = 7.8 Hz, 3H), 0.14 (s, 9H) 
ppm; 13C NMR (75 MHz, C6D6): δ 160.70, 137.16, 132.55, 130.86, 128.73, 126.85, 111.86, 
82.25, 81.97, 68.95, 64.77, 29.20, 17.33, 10.03, -1.36 ppm; IR (liquid film): 2957, 1662, 1250, 
1067, 837, 748, 693 cm-1; MS (EI, 70 V): m/z 290 (M+.-CH2=CH2), 217, 205, 145, 129, 115, 91, 
Et Ph
OCH2CH2SiMe3
 172 
79; HRMS m/z calcd for C19H30O2Si (M+) 318.2016, found 318.2031; and C17H26O2Si  (M+.-
CH2=CH2): 290.1702. found 290.1706. 
 
anti-(E)-2- Methyl-3-phenyl-2-(2-
followed employing 83b (145 mg, 0.5 mmol) and 5 mol%
(M+.-CH2OH) 289.1988, found 289.1989. 
H
(trimethylsilyl)ethoxy) hept-4-enol 
(83b′): General Procedure D was 
 catalyst (11.3 mg Ir-dimer, 21.0 mg 
PCy3 and 8.5 mg NaBPh4) and stirred 48 h at 40 oC in dichloroethane solvent to afford anti-(E)-
2-methyl-3-phenyl-2-(2-(trimethylsilyl)ethoxy)hept-4-enal 83b (syn: anti = 96: 4). the crude 
product was purified by flash chromatograph on silical gel (5 % Et2O in hexanes) to yield 64 mg 
(44 %) of the title compound as a colorless oil. 1H NMR (300 MHz, CDCl3): δ 9.73 (s, 1H), 5.93 
(ddt, J = 15.3, 9.4, 1.6 Hz, 1H), 5.48 (dt, J = 15.3, 6.1 Hz, 1H), 3.54 (td, J = 9.0, 6.4 Hz, 1H), 
3.40 (td, J = 9.0, 6.9 Hz, 1H), 1.98-2.05 (m, 2H), 1.10 (s, 3H), 0.95 (t, J = 6.9 Hz, 3H), 0.87-0.96 
(m, 2H), 0.02 (s, 9H) ppm. Then DIBAL-H reduction procedure was followed employing 
aldehydes 83b (64 mg, 0.2 mmol), the crude product was purified by flash chromatograph on 
silical gel (16 % Et2O in hexanes) to yield 51 mg (80 %) of the title compound as a colorless oil. 
1H NMR (300 MHz, CDCl3): δ 7.21-7.40 (m, 5H), 6.05 (ddt, J = 15.3, 8.9, 1.4 Hz, 1H), 5.64 (dt, 
J = 15.3, 6.3 Hz, 1H), 3.45-3.65 (m, 5H), 2.09-2.19 (m, 2H), 2.01 (s, 1H), 1.22 (s, 3H), 1.07 (t, J 
= 7.5 Hz, 3H), 0.99 (td, J = 8.5, 2.8 Hz, 3H),  0.13 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3): δ 
141.79, 134.50, 129.43, 128.19, 127.92, 126.26, 79.01, 66.07, 59.12, 54.66, 25.72, 18.85, 17.64, 
13.64, -1.27 ppm; IR (liquid film): 3454, 2958, 1453, 1248, 1053, 971, 837, 701 cm-1; MS (EI, 
70 V): m/z 289 (M+.-CH2OH), 261, 218, 171, 145, 131, 101, 73; HRMS m/z calcd for C18H29OSi 
O
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 (E)-Methyl 2-(1-phenylpent-1-en-3-yloxy)acetate (81c’): General 
procedure G was followed employing (E)-1-phenylpent-1-en-3-ol (3.24 g, 20 
r
1H NMR (300 MH
yallyloxy)pent-1-enyl)benzene (81c): General procedure H 
was followed employing ester 81c’ (585 mg, 2.5 mmol), the crude product was 
 
7.00-7.21 (m, 5H
1-
ol (83c’): General Procedure D was followed 
 
and 8.5 mg NaBPh4) and stirred 48 h a
O
O
mmol). the crude product was purified by column chromatography at silica gel 
 in hexanes) to give the title product 2.34 g (50 %) in two steps as colorless oil. 
z, CDCl
(10 % ethyl ethe
3): δ 7.27-7.44 (m, 5H), 6.56 (d, J = 16.0 Hz, 1H), 6.07 (dd, J = 16.0, 
8.3 Hz, 1H), 4.18 (d, J = 16.4 Hz, 1H), 3.89 (d, J = 16.4 Hz, 1H), 3.74 (s, 3H), 1.59-1.99 (m, 
2H), 1.01 (t, J = 7.4 Hz, 3H) ppm. 
 
(E)-(3-(2-Methox
purified by column chromatography at basic alumina gel (10 % ethyl ether in 
the title product 435 mg (75 %) as colorless oil. hexanes) to give 1H NMR (300 MHz, C6D6): δ 
), 6.43 (d, J = 16.0 Hz, 1H), 6.02 (dd, J = 16.0, 7.8 Hz, 1H), 4.39 (s, 1H), 4.12 
(d, J = 13.0 Hz, 1H), 3.99 (d, J = 1.8 Hz, 1H), 3.89 (d, J = 13.0 Hz, 1H), 3.74 (q, J = 6.8 Hz, 1H), 
3.21 (s, 3H), 1.53-1.80 (m, 2H), 0.94 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, C6D6): 
161.64, 137.14, 132.54, 130.79, 128.73, 126.84, 81.98, 81.89, 68.60, 54.35, 29.17, 10.00 ppm. 
 
anti-(E)-2- Methoxy-2-methyl-3-phenylhept-4-en-
employing (E)-(3-(2-Methoxyallyloxy)pent-1-
and 5 mol% catalyst (11.3 mg Ir-dimer, 21.0 mg PCyenyl)benzene (81c, 116 mg, 0.5 mmol) 3 
t 40 oC in dichloroethane solvent to afford anti-(E)-2-
Et Ph
OMe
O
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methoxy-2-methyl-3-phenylhept-4-en-1-ol 83c (syn : anti = 96 : 4). DIBAL-H reduction 
procedure was followed, the crude product was purified by flash chromatograph on silical gel 
(16 % Et2O in hexanes) to yield 68 mg (58 %) of the title compound as a colorless oil. 1H NMR 
(300 MHz, C6D6): δ 7.20-7.29 (m, 5H), 5.94 (ddt, J = 15.3, 8.9, 1.5 Hz, 1H), 5.56 (dt, J = 15.3, 
6.3 Hz, 1H), 3.57 (d, J = 8.8 Hz, 1H), 3.39-3.53 (m, 2H), 3.30 (s, 3H), 2.01-2.11 (m, 2H), 1.12 (s, 
3H), 0.98 (t, J = 7.4 Hz, 3H) ppm. 
 
(E)-2- (Trimethylsilyl)ethyl-2-(4-phenylbut-3-en-2-yloxy)acetate 
(81d′): To a solution of (E)-2-(4-phenylbut-3-en-2-yloxy)acetic acid 
w
and the reaction was stirred
yloxy)ethyl)silane (81d): To a −40 °C solution of ester (81d′, 612 
                                                
OCH2CH2TMS
(824 mg, 4.0 mmol)121  and 2-(trimethylsilyl)ethanol (472 mg, 4.0 
as added DCC (1.030 g, 5.0 mmol) and DMAP (43 mg, 0.4 mmol) 
 for 24 h. The solvent was Vaporated and the crude product mixture 
was purified by flash chromatography on silica gel (10% EtOAc in hexanes) to yield 980 mg 
(80%) of the title compound as a light yellow oil. 
O
Me
O
Ph
mmol) in CH2Cl2 (2 mL) 
1H NMR (300 MHz, CDCl3): δ 7.30-7.40 (m, 
5H), 6.53 (d, J = 16.0 Hz, 1H), 6.10 (dd, J = 16.0, 8.0 Hz, 1H), 4.23 (t, J = 8.5 Hz, 2H), 4.13 (dq, 
J =8.0, 6.3 Hz, 1H), 4.10 (d, J = 16.5 Hz, 1H), 4.08 (d, J = 16.5 Hz, 1H), 1.42 (d, J = 6.3 Hz, 3H), 
0.98 (t, J = 8.5 Hz, 2H), 0.04 (s, 9H) ppm; MS (EI, 70 V): m/z 278 (M+.-C2H4), 263, 219, 105, 
147, 131, 117, 91, 73; HRMS m/z calcd for C15H22O3Si (M+.−C2H4): 278.1338; found: 278.1330. 
 
(E)- Trimethyl(2-(3-(4-phenylbut-3-en-2-yloxy)prop-1-en-2-OCH2CH2TMS
 
O
121 Prepared by reacting (E)-4-phenylbut-3-en-2-ol (1.0 equiv.) with NaH (5.0 equiv.), and 2-chloroacetic acid (1.0 equiv.) in 
THF at reflux. 
Me Ph
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mg, 2.0 mmol) in 10 mL T
10 mL of 0.5 M toluenes
warmed to ambient temper
ethoxy)hex-4-
enal (83d): General Procedure D was followed employing di(allyl) 
[IrCl(C8H14)2]2, 16.8 mg P
dichloroethane solvent; an
                                                
HF-pyridine (4:1) was added Tebbe’s reagent (2. 5 equiv, 5.0 mmol, 
olution).122 Once addition was complete, the reaction mixture was 
ature and stirred for 16 h.  The reaction mixture was cooled to 0 °C 
and quenched by dropwise addition of 0.5 M aq. NaOH. The resulting mixture was filtered 
through a celite pad, washing the filter cake with Et2O. The solvents were Vaporated and the 
crude oil was purified by column chromatography on basic alumina (10% Et2O in hexanes) to 
give 460 mg of the title product (75%) as colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.12-7.31 
(m, 5H), 6.53 (d, J = 16.0 Hz, 1H), 6.17 (dd, J = 16.0, 7.5 Hz, 1H), 4.53 (d, J = 0.5 Hz, 1H), 4.19 
(s, 1H), 4.22 (d, J = 12.8 Hz, 1H), 4.04 (d, J = 12.8 Hz, 1H), 4.10 (dq, J = 7.5, 6.3 Hz, 1H), 3.83 
(t, J = 7.8 Hz, 2H), 1.41 (d, J = 6.3 Hz, 3H), 1.02 (t, J = 7.8 Hz, 2H), 0.04 (s, 9H) ppm; 13C NMR 
(75 MHz, CDCl3): δ 159.7, 136.6, 131.5, 131.2, 128.4, 127.5, 126.3, 82.5, 76.0, 68.6, 64.7, 21.6, 
17.1, -1.5 ppm; IR (liquid film): 2954, 1663, 1250, 1071, 837, 749, 693 cm-1; MS (EI, 70 V): m/z 
276 (M+.-C2H4), 219, 186, 157, 147, 131, 115, 91, 84, 73; HRMS m/z calcd for C16H24O2Si 
(M+.−C2H4): 276.1546; found: 276.1548. 
 
anti-(E)-2- Methyl-3-phenyl-2-(2-(trimethylsilyl)
ether (81d, 152 mg, 0.5 mmol) and 4 mol% catalyst (9.0 mg 
Cy3, and 6.8 mg NaBPh4) and stirred 60 h at 80 oC in 1,2-
ti:syn = 94:6. Purifying the crude product mixture by flash 
chromatography on silica gel (2.5% Et2O in hexanes) yielded 88 mg (58%) of the title compound 
as a light yellow oil. 1H NMR (300 MHz, CDCl3): δ 9.77 (s, 1H), 6.00 (ddq, J = 15.2, 9.4, 1.6 
 
122 For the in situ preparation of Tebbe’s reagent: Pine, S. H.; Kim, G.; Lee, V. Org. Syn. 1990, 69, 72. 
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Hz, 1H), 5.47 (dq, J = 15.2, 6.5 Hz, 1H), 3.57 (td, J = 9.1, 6.4 Hz, 1H), 3.43 (td, J = 9.1, 6.7 Hz, 
1H), 3.39 (d, J = 9.4 Hz, 1H), 1.68 (dd, J = 6.4, 1.6 Hz, 3H), 1.13 (s, 3H), 0.96-1.08 (m, 2H), 
0.07 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3): δ 208.0, 140.2, 129.3, 129.2, 128.0, 127.9, 126.7, 
84.0, 61.8, 56.8, 18.9, 17.9, 16.7, −1.3 ppm; IR (liquid film): 2953, 1732, 1452, 1378, 1249, 
1056, 970, 860, 837, 700 cm-1. MS (EI, 70 V): m/z, 276 (M+.−C2H4), 219, 186, 157, 147, 131, 
115, 91, 84, 73; HRMS m/z calcd for C16H24O2Si (M+.): 276.1546; found: 276.1548. 
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5.0  LEWIS ACID-PROMOTED CLAISEN REARRANGEMENT AND 
CASCADE REACTIONS BASED ON ICR 
Reactivity in the thermal Claisen rearrangement, which depends on the structure of allyl vinyl 
ether substrates, was poor in some cases. Thus, additives or catalysts were required for 
promoting the rearrangement. In general, there are two kinds of chemicals used to promote 
Claisen rearrangement: late transition metals 123  and hard Lewis acids. They have different 
activation mechanisms to produce products with different stereoselectivities. Late transition 
metal (such as Pd, Au, Hg) complexes coordinate the allyl olefin first and allow the vinyl ether 
nucleophile to attack the activated olefin to complete the Claisen rearrangement via a boat 
transition state. The (iBuCN)PdCl2-catalyzed Claisen rearrangement for preparing high 
stereoselectivity 2,3-anti disubstituted aldehydes was developed in Nelson group (Figure 38).124  
                                                 
123 Palladium-catalyzed Claisen rearrangement of allyl vinyl ether, see: (a) J. L. Van der Baan, F. Bickelhaupt, Tetrahedron Lett. 
1986, 27, 6267-6270; (b) Mikami, K.; Takahashi, K.; Nakai, T. Tetrahedron Lett. 1987, 28, 5879; (c) Hayashi, T.; Yamamoto, A.; 
Ito, Y. Synth. Commun., 1989, 19, 2109; Au-catalyzed Claisen rearrangement of propargyl vinyl ethers, see: (d) Sherry, B. D.; 
Toste, F. D. J. Am. Chem. Soc. 2004, 126, 15978-15979. 
124 Nelson, S. G.; Kerrigen, N.; Bungard, C. J. unpublished result. 
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Figure 38. Pd(II)-catalyzed ICR reactions 
The hard Lewis acid-mediated Claisen rearrangement may be via a concerted or an 
ionicic intermediate mechanism.125 In the concerted mechanism, Lewis acids coordinate with 
oxygen to decrease the the activated energy for the Claisen rearrangement, so the reaction 
becomes much easier. In the ionic intermediate mechanism, the carbon-oxygen bond cleavage to 
form an allyl carbonium ion and a vinyl oxide anion, so two regioisomers are formed after 
recombination: one is a normal [3,3] product and the other is a [1,3] rearrangement product.126 
But the [1,3] rearrangement can also be explained as an allyl ether migration followed by [3,3] 
rearrangement (Figure 39). In general, Lewis acids coordinate the Claisen products carbonyl 
groups much stronger than the Claisen starting material allyl vinyl ethers. As a result, it is 
difficult to remove the Lewis acid from the Claisen product to the starting material and start a 
new catalytic cycle. In most conditions, excess Lewis acids are required for promoting Claisen 
rearrangement.127  
                                                 
125 (a) Nonoshita, K.; Banno, H.; Maruoka, K.; Yamamoto, H. J. Am. Chem. Soc. 1990, 112, 316-322. (b) Nonoshita, K.; 
Maruoka, K.; Yamamoto, H. Bull. Chem. Soc. Jpn. 1992, 65, 541-545. (c) Takai, K.; Mori, I.; Oshima, K.; Nozaki, H. 
Tetrahedron Lett. 1981, 22, 3985-3988. (d) Chiral Lewis acid-mediated asymmetric Claisen rearrangement, see: Maruoka, K.; 
Saito, S.; Yamamoto, H. J. Am. Chem. Soc. 1995, 117, 1165-1166. 
126 Cu(OTf)2 catalyzed [1,3] rearrangement of allyl vinyl ether, see: Nasveschuk, C. G.; Rovis, T. Org. Lett. 2005, 7, 2173-2176. 
127 Lewis acid Cr(TPP)Cl-catalyzed Claisen rearrangement, see: Takanami, T.; Hayashi, M.; Iso, K.; Nakamoto, H.; Suda, K. 
Tetrahedron 2006, 62, 9467-9474. 
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Figure 39. Lewis acid-promoted [3,3] and [1,3] rearrangement 
5.1 ORGANOALUMINUM-PROMOTED CLAISEN REARRANGEMENT 
In general, the Lewis acid-promoted Claisen rearrangement affords the same diastereoselectivity 
as the thermal Claisen rearrangement. Thus when the thermal Claisen rearrangement is sluggish, 
the Lewis acid-promoted reaction may promote it. As we know, the Claisen rearrangement of 
allyl vinyl ethers bearing an alkene group in am ring seems difficult in common thermal 
conditions because the reaction is via a boat transition state.128 For example, the thermal Claisen 
rearrangement of 3-(vinyloxy)cyclohex-1-ene requires 190 oC (eq 27).129  
                                                 
128 (a) Ireland, R. E.; Daub, J. P. J. Org. Chem. 1981, 46,479-485. (b) Bartlett, P. A.; Pizzo, C. F. J. Org. Chem. 1981, 46. 3896-
3900. 
129 Dulcere, J. P.; Rodriguez, J. Synthesis 1993, 4, 399-405. 
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O
190 oC, 90 min O
[3,3] CHO
(27)
 
 
Microwave oven-promoted reactions help us realize these conditions. The cyclic (E)-allyl 
vinyl ether 86a was easily obtained from selective isomerization of di(allyl) ether 85a with 1 
mol% Ir(PCy3)3BPh4; the internal ring olefin is not isomerized. After addition of 3 mol% PPh3, 
thermolysis of the crude (E)-allyl vinyl ether (86a) at 150 oC in a microwave oven in DCE for 1 
h affords 40 % conversion of aldehydes (87a, syn : anti = 1 : 1) and 60 % of unreacted allyl vinyl 
ether 86a, which becomes a mixture of Z and E isomers (ratio 1:1). Considering the perhaps side 
reactions caused by residue of iridium salts, the crude allyl vinyl ether 86a was purified by short 
Florisil plug. Thermolysis of the purified (E)-allyl vinyl in 180 oC microwave oven for 2 h give 
excellent conversion to aldehydes (87a) with good diastereoselectivity (anti : syn = 90 : 10); only 
trace starting materials remain (Scheme 44). This result indicates that the residue of iridium salt 
still erodes selectivity at high temperature even it is quenched with PPh3.  
O O
Me
1. PPh3
O
Me
CHO
Me
+
87a, 40 %,
syn: anti = 1: 1
86a, 60 %, 
Z: E = 1: 1Purification
O
Me
86a, purified
microwave oven
180 oC, 2h, DCE CHO
87a, syn: anti = 95: 5
85a 86a, crude
Me
Ir(PCy3)3
2. microwave oven
    150 oC, 1h, DCE
 
Scheme 44. Thermal Claisen rearrangement of allyl vinyl ether 86a 
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Because the thermal Claisen rearrangement of the allyl vinyl ether 86a required elaborate 
conditions, the Lewis acid condition was examined. Treat the 86a with 1.5 equivalent Me2AlCl 
at -40 oC, after some minutes, the starting material disappeared to afford aldehyde 87a with a 
poor diastereoselective (anti: syn = 6: 1, depending on the reaction time). The one of possible 
reasons for poor diastereoselectivity is that strong Lewis acid epimerize Claisen adduct 87a. As a 
result, the formed aldehyde should be trapped in situ to avoid epimerization. Therefore, we try to 
use DIBAL-H to promote the Claisen rearrangement and reduce the formed aldehyde to primiary 
alcohol. The alcohol 88a (anti : syn = 96 : 4) was obtained with good yield and 
diastereoselectivity. Considering purified allyl vinyl ether is not necessary for this cascade 
reaction, but acetone as a co-solvent of isomerization reaction consumes the DIBAL-H. T`he 
solvent was removed in vacuum and add fresh CH2Cl2 before treated with DIBAL-H, the same 
result was obtained (Scheme 45).  
O
Me
CHO
crude
DIBAL-H
-78 - 23 oC
Me
88a syn: anti = 95: 5
95%
86a
Me2AlCl
OH
Me
87a syn: anti = 6: 1
-40 oC, 5 min
 
Scheme 45. Organoaluminum-promoted Claisen rearrangement of allyl vinyl ether 86a 
The Claisen products of substrates 89 have α-quaternary carbon center, so the 
organoaluminum-promoted ICR reaction afforded good result (Table 8). First, the Ir(I)-catalyzed 
isomerization of di(allyl) ethers 89 afforded allyl vinyl ethers 90. Then treatment the crude allyl 
vinyl ethers (90, solvent was changed to pure CH2Cl2) with Me2AlCl (1.0 equivalent, −40 °C) 
afforded aldehydes 91 with good diastereoselectivity. Diisobutylaluminum hydride proved to be 
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an equally efficient Lewis acid promoter, generating the alcohols 92 with good 
diastereoselectivity, thereby affording direct entry to alcohol-containing Claisen adducts without 
resorting to a separate aldehyde reduction step. 
Table 8. Lewis acid-promoted ICR for preparing quaternary carbon 
O
R1
R2
H
O
R1
OH
R1
 Me2AlCl, −40 °C
2 mol %Ir(PCy3)3
2) iBu2AlH
−78 °C → 23 °C
•
•
R2
89
91
92
R2
O
R1
R2
90
 
entry R1 R2 d.r. yield (compound) 
a Me nC6H13 100:0 57 (91) 
b Me nC6H13 98:2 71 (92) 
c Et nC5H11 94:6 62 (92) 
d Me H NA 70 (91) 
e Me H NA 76 (92) 
 
Next the organoaluminum-promoted ICR reactions of 6,6-disubstituted-di(allyl) ether 93 
was examined. The thermal Claisen rearrangements of corresponding allyl vinyl ether 94 
required elaborate conditions. For example, the thermal Claisen rearrangement of 94a required 
reflux in toluene for long time, but only modest conversion was observed and the 
diastereoselectivity was in the long reaction time (eq 28). The thermal Claisen rearrangement of 
allyl vinyl ether 94b required a temperature as high as 150 oC in a microwave oven (eq 29). In 
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addition, purified allyl vinyl ethers are recommended in thermal Claisen rearrangement to avoid 
epimerization. As a result, the thermal Claisen was not convenient for these reactions.  
OMe
Me
Me
Me
H
O Me
Me
Me
O Me
Ph
Ir(PCy3)3
O
Me
Ph
Me
O
H
Me
Ph
Me
O Me
Me
Me
Me
 Ir(PCy3)3
93a 94a
toluene
reflux, 24 h
95a (syn: anti = 87: 13)
(28)
93b 94b
150 oC, 2h
microwave oven
95b (syn: anti = 19: 1)
purified vinyl ether
(29)
 
Treatment of the crude allyl vinyl ether (94b) with DIBAL-H offered a good 
stereoselective alcohol 96b (eq 30).130  However, poorer selectivity was observed in eq 31: a 
mixture of alcohols 96c was obtained. Two major isomers were observed from the GC-trace; 
maybe they were diastereomers or E/Z isomers or a combination of both. A high yield of alcohol 
with a 2,3-bisquaternary center 96d was observed from the ICR reaction of the di(allyl) ether 
93d (eq 32). 
OHMe
Me
Me
Me
O Me
Me
Me
2) iBu2AlH
−78 °C → 23 °C93b 96b (syn: anti = 90: 10)
1) 1 mol % Ir(PCy3)3 (30)
 
                                                 
130 The ratio and following ratio are determined from crude proton NMR and the GC trace. 
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Me
Me
OH
Me
Me
Et
Me
Me
MeO
Et
1) 1 mol % Ir(PCy3)3
2) iBu2AlH
−78 °C → 23 °C
93c 96c (isomer ratio = 78: 22)
(31)
 
MeMe
OHMe
Me
Me
O Me
Me
Me
Me
1) 2 mol % Ir(PCy3)3
2) iBu2AlH
−78 °C → 23 °C93d 96d
(32)
 
Three other substrates with good thermal Claisen reactivity were examined in this 
ICR/reduction procedure. Poor selectivity was observed from substrates 93e/f (eq 33, 34), and 
good diastereoselectivity was afforded to substrates 93g (eq 35). As a comparison, the thermal 
Claisen rearrangement of these substrates always showed far better diastereoselectivity. 
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Me OH
Me
Bu
O
MeBu
1) 1 mol % Ir(PCy3)3
2) iBu2AlH
−78 °C → 23 °C
93e 96e (isomer ratio = 40: 40: 10: 10)
(33)
 
Me
O
PhEt
OH
Me
Et
Ph
Me
1) 1 mol % Ir(PCy3)3
2) iBu2AlH
−78 °C → 23 °C
93f 96f (isomer ratio = 42: 29: 16: 13)
(34)
 
O
Me
Me
Me
OH
Me
Me
Me
Me1) 1 mol % Ir(PCy3)3
2) iBu2AlH
−78 °C → 23 °C
93g 96g (syn: anti = 95: 5)
(35)
 
The DIBAL-H promoted cascade Claisen rearrangement/reduction reaction of acyclic 
substrates did not offer products with good diastereoselectivity, but no [1,3] rearrangement 
products were observed in these cases. 
5.2 CASCADE REACTION BASED ON ICR REACTION 
5.2.1 Cascade Claisen/ene reaction 
The DIBAL-H reduction trapping the formed aldehyde was discussed in the previous section. 
Besides this strategy, the Lewis acid-mediated ene reaction traps the formed Claisen adducts in 
some cases to provide synthetically valuable compounds in single step. Stoltz has reported a 
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cascade Claisen rearrangement/ene reaction of a vinyl ether, derived from geraniol, with good 
yield and diastereoselectivity (Scheme 46).131  
N
O
N
Ph
Me Me
Me
Rh2(OAc)4 O
Me
Me
O H
Me Me
Me
Ph
H
Me
Ph
OH Me
Ph
Me2AlCl
Me2AlCl
dr > 20: 1
Ph
 
Scheme 46. Cascade Claisen/ene reaction 
The Stoltz’s conditions were followed employing our allyl vinyl ether substrates, which 
were derived from isomerization of di(allyl) ethers. This Me2AlCl-mediated cascade Claisen/ene 
reaction of vinyl ethers (94b-d) derived from olefin isomerization of easily prepared di(allyl) 
ether (93b-d) was examined. Treatment of the allyl vinyl ether (94b) with 1.1 equivalents of 
Me2AlCl at -40 oC caused the Claisen/ene cascade reaction (Figure 40). But the stereoselectivity 
was very poor (Two major isomers 97b1: 97b2 = 66 %: 22 % were derived from 2,3-syn 
aldehyde 95b1; another two minor isomers 9 % 97b3 and 2 % 97b4  were derived from 2,3-anti 
aldehyde 95b2). The reason for obtaining the poorer stereoselectivity in our reaction than in the 
precedent (Scheme 46) was that two transition states (route a and b) existed in the ene reaction 
for the major diastereomer of the Claisen adduct (95b1). There was not much energy difference 
between these two transition states (route a and route b) where the α-Me assumed in the axial or 
equtorial position. But in the Scheme 46, due to the large energy difference between two possible 
                                                 
131 (a) May, J. A.; Stoltz, B. M. J. Am. Chem. Soc. 2002, 124, 12426-12427. The aldehyde was derived from Ireland Claisen 
rearrangement followed by reduction and oxidation, then the aldehyde was treated with Lewis acid condition. see: (b) Corey, E. J.; 
Roberts, B. E.; Dixon, B. R. J. Am. Chem. Soc. 1995, 117, 93-196. The cascade oxy-cope/Claisen/ene reaction, see: (c) Sauer, E. 
L. O.; Barriault, L. J. Am. Chem. Soc. 20024, 126, 8569-8575. 
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transition states where α-Ph assumed in the axial or equtorial position, a better selectivity (20:1) 
was obtained.  
O
Me
Me
Me O Me
Me Me
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O Me
Me Me
Me
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MeMe
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MeMe
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O H
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Figure 40. Me2AlCl promoted ICR-ene reaction 
Then two substrates with similar structure (Scheme 47/48) were subjected to same 
conditions. Both of the reactions afforded very poor selectivity. In Scheme 47, a cascade 
isomerization-Claisen rearrangement-ene reaction of di(allyl) ether 93c afforded four major 
isomers in a ratio of 46: 30: 16: 8 (according to the GC trace and proton NMR spectrum). The 
two major isomers 97c1 and 97c2 were derived from the major Claisen product 95c1. In Scheme 
48, although the ICR of di(allyl) ether 93d produced only one Claisen product 95d, the 
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diastereoselectivity of the ene reaction was very poor between two isomers of cyclohexanol 
(97d1 and 97d2) in a ratio of 33: 67. Although poor selectivity was obtained in this cascade 
isomerization/Claisen/ene reaction, polyfunctionallized cyclohexanols were prepared in a single 
operation from simple starting materials. The procedure could be useful in organic synthesis 
upon optimization. 
O
Me
Me
Et
Me
MeMe
HO
Et
Me
Me
HOMe
Et
+
2. Me2AlCl
93c
97c1, 46 % 97c2, 30 %
1. Ir(PCy3)3
Me
O Me
Me Me
Me
H
95c1
Et +
ene + other isomers
other isomers
 
Scheme 47. Isomerization-Claisen/ene reaction of di(allyl) ether 93c 
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Scheme 48. Isomerization-Claisen/ene reaction of di(allyl) ether 93d 
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5.2.2 Cascade isomerization/Claisen/Wittig/Cope reaction 
Another cascade reaction discussed here is cascade isomerization-Claisen-Wittig-Cope reactions. 
Due to the formed α-chiral aldehyde tend to epimerize in high temperature, Wittig reaction was 
desired to trap the formed aldehyde to avoid epimerization. Heating the mixture of crude allyl 
vinyl ether 86a with Ph3PCHCOOMe at 180 oC in microwave oven afforded high 
diastereoselective Wittig product 98a (anti: syn = 91: 9) (Scheme 49). When Ph3PCHCHO 
instead Ph3PCHCOOMe was used in this reaction, no any enal but simple aldehyde 87a (anti: 
syn = 50: 50) was observed, the possible reason for no desired product is the decomposition of 
Ph3PCHCHO in high temperature. 
O
86a
crude
 Ph3PCHCOOMe,
180 oC, 
microwave oven
87a
Me
O
H
Me
COOMe
Wittig
98a, anti: syn = 91: 9
Me
[3,3]O
85a
isomerization
 
Scheme 49. Cascade isomerization/Claisen/Wittig reaction of di(allyl) ether 85a 
When the allyl vinyl ether 86b was treated in the same condition, the unexpected product 
99b, which was formed via the Cope rearrangement of the Wittig products α,β-unsaturated ester 
98b, was observed (Scheme 50). 132  
                                                 
132 The Cope rearrangement of α,β-unsaturated ester was reported, see: (a) Davies, H. M.; Jin, Q. J. Am. Chem. Soc. 2004, 126, 
10862-10863. (b) Davies, H. M.; Beckwith, R. E. J. Org. Chem. 2004, 69, 9241-9247. (c) Davies, H. M.; Jin, Q. Proc. Natl. Acad. 
Sci. U.S.A. 2004, 101, 5472-5475.  
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Scheme 50. Cascade isomerization-Claisen-Wittig-Cope reaction of di(allyl) ether 85b 
Treatment of the acyclic allyl vinyl ether 94b under the above conditions afforded Cope 
rearrangement product 99c along with Wittig product 98c (the ratio is 80:20, eq 36). From the 
above two examples, an equilibrium exists in the Cope rearrangement between two isomers. It is 
suggested that the β-quaternary center in unconjugated esters (98b/c) is an important driving 
force for the Cope rearrangement to get more thermodynamic favored conjugated 99b/c. Further 
studies will let us know the optimized conditions and the limitations of this cascade reaction. The 
procedure could be useful in organic synthesis upon optimization. 
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5.2.3 Cascade tetrahydropyran rings formation  
Besides Claisen rearrangement, some other reactions for vinyl ethers are useful in organic 
synthesis. Nucleophilic electron-rich vinyl ethers take part in many reactions to form C-C bonds. 
Recently, Rychnovsky has reported a cascade tetrahydropyran ring formation through a 
Mukaiyama-Michael cascade reaction. 133  The reaction uses a vinyl ether as a nucleophilic 
reagent to attack an unsaturated carbonyl compound which is activated by TiBr4. After [3,3] 
sigmatropic rearrangement and cyclization, tetrahydropyran rings are formed with highly 
stereoselectivity (Figure 41). 
                                                 
133 Bolla, M. L.; Patterson, B.; Rychnovsky, S. D. J. Am. Chem. Soc. 2005, 127, 16044-16045. 
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Figure 41. Cascade reaction to form tetrahydropyran rings from homoallyl vinyl ether 
Our isomerization protocol is a useful reaction to obtain the substituted homoallyl vinyl 
ethers. Subsequent treatment of the homoallyl vinyl ethers under the cascade reaction conditions 
(methyl vinyl ketone, TiBr4, and 2,6-di-tert-butyl-4-methylpyridine (DTBMP) in CH2Cl2 at -78 
oC) should afford more substituted tetrahydropyran rings. Treating the homoallyl vinyl ether 
101a under the cascade reaction conditions  afforded a mixture of epimers (102a, 81: 19, Scheme 
51). 
O 1 mol % Ir(PCy3)3 O
Me O
Me
Me
+
100a
15 min
101a 100 : 0
O
O
Me
O
Me
TiBr4, DTBMP
-78 oC, CH2Cl2
70 %
H
H Me
102a (4: 1)  
Scheme 51. Tetrahydropyran rings fromation 
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Another di(allyl) ethyl (100b) was treated under the same condition. After isomerization 
and a cascade reaction, a poorer ratio (102b, ratio 58: 42, eq 37) was obtained. There was no 
selectivity for the vinyl ether addition to vinyl methyl ketone. Other Lewis acids, bases, ligands 
or reaction conditions should optimize this cascade reaction for obtaining highly complex 
products with good yield and stereoselectivity in a single step from simple starting materials. 
O
O
Me
O
Me
TiBr4, DTBMP
-78 oC, CH2Cl2
63 %
HH
Cy
H
O
Me
Cy
Me
101b 102b (58: 42)
O
Me
Cy
100b
Ir(PCy3)3
60 %
(37)
 
Some reactions were discussed in this chapter. First, the Me2AlCl or DIBAL-H were used 
to promote the Claisen rearrangement. Next, some ICR based cascade reactions were discussed. 
All of these reactions require more work to be optimized and applied in organic synthesis. 
 
5.3 EXPERIMENTAL SECTION 
5.3.1 Experim
 
                                                
ent of section 5.1 
(E)-3-(Prop-1-enyloxy)cyclohex-1-ene (86a): General Procedure D was followed 
employing 3-(allyloxy)cyclohex-1-ene134 (85a, 552 mg, 4.0 mmol) and 0.5 mol% 
catalyst (9.0 mg Ir-dimer, 16.8 mg PCy3 and 6.8 mg NaBPh4) in dichloromethane 
for 30 min. Add pentane 5 ml and pass the solution to a short Florisil plug, after solvent 
O
Me
 
134 Ghosh, S.; Raychaudhuri, S. R.; Salomon, R. G. J. Org. Chem. 1987, 52, 83-90. 
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evaporation, 496 mg (90 %) of the title compound as a colorless oil was yielded. 1H NMR (300 
MHz, CDCl3): δ 6.12 (dq, J = 12.3, 1.5 Hz, 1H), 5.89 (dt, J = 10.1, 1.2 Hz, 1H), 5.75 (d, J = 10.1 
Hz, 1H), 4.90 (dd, J = 12.3, 6.9 Hz, 1H), 4.17-4.20 (m, 1H), 1.90-2.10 (m, 2H), 1.60-1.85 (m, 
4H), 1.54 (dd, J = 6.9, 1.5 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 144.93, 131.60, 126.66, 
100.73, 73.06, 28.45, 24.96, 18.89, 12.48 ppm; IR (liquid film): 2936, 1725, 1674, 1655, 1160, 
728 cm-1.  
 
anti-2-(Cyclohex-2-enyl)propanal (87a): A solution of purified (E)-3-(prop-1-
enyloxy)cyclohex-1-ene (86a, 138 mg, 1.0 mmol) in 2 ml anhydrous 
dichloroethane in seal tube was heated at 180 oC in microwave oven for 2 h to afford aldehydes 
(anti: syn = 90 : 10). Purification by flash chromatograph on Iatrobeads neutral (pH7) silica gel 
(2.5 % ethyl ether in hexanes) yield 124 mg (90 %) of the title compound as colorless oil. 1H 
NMR (300 MHz, CDCl3): δ 9.67 (d, J = 1.59 Hz, 1H), 5.77 (dq, J = 10.2, 3.3 Hz, 1H), 5.50 (d, J 
= 10.2 Hz, 1H), 2.51-2.59 (m, 1H), 2.29-2.40 (m, 1H), 1.94-2.03 (m, 2H), 1.69-1.77 (m, 2H), 
1.47-1.57 (m, 1H), 1.23-1.36 (m, 1H), 1.04 (d, J = 7.0 Hz, 3H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 205.34, 129.46, 127.74, 50.55, 36.07, 26.67, 24.93, 21.65, 10.08 ppm; IR (liquid film): 
2930, 1726, 1455, 1070, 723 cm-1; MS (EI, 70 V): m/z 138 (M+.), 123, 109; HRMS m/z calcd for 
C9H14O (M+.): 138.1045; found 138.1041. 
 
anti-2-(Cyclohex-2-enyl)propanal (88a): General Procedure I for DIBAL-H 
promoted cascade Claisen rearrangement/reduction reaction: A solution of 
crude allyl vinyl ether (E)-3-(prop-1-enyloxy)cyclohex-1-ene (86a), which is obtained from 
di(allyl) ether (85a, 138 mg, 1.0 mmol) as general procedure D, in 2 ml dichloromethane and add 
Me
H
O
Me
OH
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DIBAL-H (1.0 M in hexanes, 1.5 ml, 1.5 mmol) dropwise at -78 oC, slow warm the solution to 
ambient temperature for 12 h. Add saturated sodium tartrate solution 6 ml to quench the reaction 
and extraction with ether. Purification by flash chromatograph on silica gel (16 % ethyl ether in 
hexanes) yield 132 mg (95 %) of the title compound as colorless oil (anti: syn = 95: 5). 1H NMR 
(300 MHz, CDCl3): δ 5.71 (dq, J = 10.2, 3.3 Hz, 1H), 5.55 (d, J = 10.2 Hz, 1H), 3.60 (dd, J = 
10.6, 5.2 Hz, 1H), 3.44 (dd, J = 10.6, 6.9 Hz, 1H), 2.17-2.25 (m, 1H), 1.91-1.98 (m, 2H), 1.46-
1.79 (m, 5H), 0.88 (d, J = 6.9 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 129.55, 128.15, 
65.94, 39.90, 37.30, 26.24, 25.26, 22.22, 13.70 ppm; IR (liquid film): 3332, 2928, 1447, 1037, 
721 cm-1; MS (EI, 70 V): m/z 140 (M+.), 122, 107; HRMS m/z calcd for C9H16O (M+.): 140.1201; 
found 140.1208. 
 
                                                
(E)-3-(2-Methyloct-2-enyloxy)cyclohex-1-ene (89a): General Procedure 
A was followed employing 0.49 g of cyclohex-2-enol (5.0 mmol), 240 mg 
NaH (10.0 mmol) and 1.03 g of a 4:1 mixture of (E)-1-bromo-2-methyloct-
2-ene and 3-bromo-2-methyloct-1-ene (5.0 mmol) 135  in THF.  Purifying the crude product 
mixture by flash chromatography (2% EtOAc in hexanes) gave 440 mg (40%) of the title 
compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 5.83 (d, J = 10.1 Hz, 1H), 5.75 (d, J = 
10.1 Hz, 1H), 5.41 (t, J = 6.8 Hz, 1H), 3.93 (d, J = 11.4 Hz, 1H), 3.87 (d, J = 11.4 Hz, 1H), 3.83-
3.87 (m, 1H), 1.90-2.03 (m, 4H), 1.29-1.79 (m, 10H), 1.65 (s, 3H), 0.88 (t, J = 7.4 Hz, 3H) ppm; 
13C NMR (300 MHz, CDCl3): δ 132.44, 130.47, 128.21, 128.06, 74.32, 71.27, 31.53, 29.13, 
28.33, 27.63, 25.20, 22.53, 19.27, 14.02, 13.92 ppm; MS (EI, 70 V): m/z 222 (M+.), 207, 179, 
127, 107, 97, 81, 69; HRMS m/z calcd for C15H26O (M+.): 222.1984; found: 222.1978. 
O
Me
C5H11
 
135 The mixture of (E)-1-bromo-2-methyloct-2-ene and 3-bromo-2-methyloct-1-ene was prepared by reacting 2-methyloct-1-
en-3-ol with PBr3 in hexanes. 
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3-(2-Ethylhept-2-enyloxy)cyclohex-1-ene (89c): General Procedure A was 
followed employing 0.20 g of cyclohex-2-enol (2.0 mmol), 144 mg NaH (6.0 
mmol), and 715 mg of a mixture of (E/Z)-3-(bromomethyl)oct-3-ene and 4-
bromo-3-methyleneoctane (3.0 mmol)136 in THF.  Purifying the crude product mixture by flash 
chromatography (2% EtOAc/hexanes) gave 176 mg (40%) of the title compound as a mixture of 
E and Z isomers (E:Z = 1: 3).  1H NMR (300 MHz, CDCl3): δ 5.83 (dt, J = 10.2, 3.5 Hz, 1H), 
5.76 (d, J = 10.2 Hz, 1H), 5.38 (t, J = 7.2 Hz, 1H), 3.97 (d, J = 11.6 Hz, 1H), 3.89 (d, J = 11.6 
Hz, 1H), 1.20-2.10 (m, 14H), 0.90 (t, J = 7.4 Hz, 3H), 1.01 (t, J = 7.4 Hz, 3H) ppm; MS (EI, 70 
V): m/z 222 (M+.), 124, 95, 85, 81, 69; HRMS m/z calcd for C15H26O (M+.): 222.1984; found 
222.1978. 
O
Et
C4H9
 
3-(2-Methylallyloxy)cyclohex-1-ene (89d): General Procedure A was followed 
employing 0.98 g of cyclohex-2-enol (10.0 mmol), 480 mg NaH (20.0 mmol) and 
1.8 g 3-chloro-2-methylprop-1-ene (20.0 mmol). Purification by flash 
chromatography (2 % EtOAc/hexanes) gave 1.42 g (94 %) of the title compound as colorless oil. 
1H NMR (300 MHz, CDCl3): δ 5.84 (dtd, J = 10.1, 3.4, 1.2 Hz, 1H), 5.76 (d, J = 10.1 Hz, 1H), 
4.97 (s, 1H), 4.86 (s, 1H), 3.96 (d, J = 12.6 Hz, 1H), 3.90 (d, J = 12.6 Hz, 1H), 3.84 -3.86 (m, 
1H), 1.74 (s, 3h), 1.69-1.81 (m, 6H) ppm; 13C NMR (300 MHz, CDCl3): δ 142.41, 130.19, 
127.59, 111.33, 71.64, 71.52, 28.01, 24.87, 19.15, 18.90 ppm; IR (liquid film): 2937, 1654, 1451, 
1087, 899, 729 cm-1; MS (EI, 70 V): m/z 152 (M+.), 137, 100; HRMS m/z calcd for C10H16O 
(M+.): 152.1201; found 152.1207. 
O
Me
 
136 The mixture of (E/Z)-3-(bromomethyl)oct-3-ene and 4-bromo-3-methyleneoctan was prepared by reacting 3-
methyleneoctan-4-ol with PBr3 inhexanes. 
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 syn-2-(Cyclohex-2-enyl)-2-ethylheptanal (91a): General Procedure D was 
followed employing (E)-3-(2-methyloct-2-enyloxy)cyclohex-1-ene (89a, 111 
mg, 0.5 mmol) and 4 mol% catalyst (9.0 mg [IrCl(C8H14)2]2, 16.8 mg PCy3, and 6.8 mg NaBPh4) 
and stirred 48 h at 80 °C in 1,2-dichloroethane.  After cooling the reaction mixture to ambient 
temperature, the solvent was evaporated and the resulting residue was dissolved in 1,2-
dichloroethane (2 mL) and cooled to −40 °C.  A 1.0 M hexanes solution of Me2AlCl (1.0 mL, 1.0 
mmol) was added and the reaction was stirred for 10 min.  A saturated sodium tartrate solution (4 
mL) was added and the mixture was warmed to ambient temperature and stirred until two 
homogeneous phases resulted (~1 h).  The mixture was extracted with Et2O (3×) and the 
combined organic extracts were dried over anhydrous MgSO4.  Purifying the crude product 
mixture by flash chromatography on silica gel (2.5% ethyl ether in hexanes) yielded 63 mg 
(57%, 100% de) of the title compound as a light yellow oil.  Analysis of the crude product 
mixture by 1H NMR and GLC [Varian CP Wax 52CB column (30 m x 0.25 mm), flow rate 0.6 
mL/min, method: 80 °C for 2.00 min, ramp @ 5.00 °C/min to 250 °C, hold for 20.00 min, Tr = 
38.9 min] provided Vidence of only one diastereomer.  1H NMR (300 MHz, CDCl3): δ 9.49 (s, 
1H), 5.81 (dq, J = 10.3, 3.1 Hz, 1H), 5.59 (dt, J = 10.3, 3.5 Hz, 1H), 2.38-2.48 (m, 1H), 1.82-2.10 
(m, 2H), 1.20-1.90 (m,1 3H), 0.97 (s, 3H), 0.88 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 207.1, 130.0, 126.2, 40.4, 33.8, 31.6, 30.0, 25.1, 24.5, 24.0, 22.6, 22.3, 14.8, 14.1 
ppm; MS (EI, 70 V) m/z 222 (M+.), 207, 193, 179, 142, 137, 81; HRMS m/z calcd for C15H26O 
(M+.): 222.1984; found 222.1977. 
Me nC6H13
O
H
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syn-2-(Cyclohex-2-enyl)-2-methyloctan-1-ol (92b): General Procedure D 
was followed employing di(allyl) ether 89a (111 mg, 0.5 mmol) and 4 mol% 
catalyst (9.0 mg [IrCl(C8H14)2]2, 16.8 mg PCy3, and 6.8 mg NaBPh4) and stirred 48 h at 80 °C in 
1,2-dichloroethane solvent.  After cooling the reaction mixture to ambient temperature the 
solvent was Vaporated and the resulting residue was dissolved in dichloromethane (2 mL) and 
cooled to −78 °C.  A 1.0 M hexanes solution of i-Bu2AlH (1.0 mL, 1.0 mmol) was added and the 
reaction was warmed to ambient temperature and stirred 12 h.  A saturated sodium tartrate 
solution (4 mL) was added and the mixture was stirred 1 h.  The mixture was extracted with Et2O 
(3×) and the combined organic extracts were dried over anhydrous MgSO4.  Purifying the crude 
product mixture by flash chromatography on silica gel (16% EtOAc in hexanes) yielded 78 mg 
(71%) of the title compound as a light yellow oil.  Separating the stereoisomers by GLC [Varian 
CP Wax 52CB column (30 m x 0.25 mm), flow rate 0.6 mL/min, method: 80 °C for 2.00 min, 
ramp @ 5.00 °C/min to 250 °C, hold for 20.00 min, Tr = 47.1 and 50.0 min] provided the 
diastereomer ratio: syn:anti = 1.0:99.0.  1H NMR (300 MHz, CDCl3): δ 5.69-5.81 (m, 2H), 3.54 
(d, J = 11.1 Hz, 1H), 3.39 (d, J = 11.1 Hz, 1H), 2.15-2.25 (m, 1H), 1.90-2.00 (m, 2H), 1.65-1.88 
(m, 2H), 1.20-1.62 (m, 13H), 0.89 (t, J = 6.5 Hz, 3H), 0.85 (s, 3H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 128.70, 128.64, 68.21, 40.39, 39.70, 35.18, 31.89, 30.35, 25.22, 23.84, 23.35, 22.83, 
22.69, 19.23, 14.09 ppm; MS (EI, 70 V): 224 (M+.), 206, 193, 143, 121, 109; HRMS m/z calcd 
for C15H28O (M+.) 224.2140, found: 224.2131. 
Me nC6H13
OH
 
syn-2-(Cyclohex-2-enyl)-2-ethylheptanal (92c): General Procedure C was 
followed employing di(allyl) ether 89c (67 mg, 0.3 mmol) and 4 mol% 
catalyst (5.4 mg [IrCl(C8H14)2]2, 10.1 mg PCy3, and 4.1 mg NaBPh4) and stirred 48 h at 80 °C in 
Et nC5H11
OH
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1,2-dichloroethane solvent.  After cooling the reaction mixture to ambient temperature, the 
solvents were evaporated and the resulting residue was dissolved in dichloromethane (2 mL).  
The reaction mixture was cooled to −78 °C and a 1.0 M hexanes solution of i-Bu2AlH (0.6 mL, 
0.6 mmol) was added and the reaction was warmed to ambient temperature and stirred for 12 h.  
A saturated sodium tartrate solution (4 mL) was added and the mixture was warmed to ambient 
temperature and stirred for 1 h.  The mixture was extracted with Et2O (3×) and the combined 
organic extracts were dried over anhydrous MgSO4.  Purifying the crude product mixture by 
flash chromatography on silica gel (16% EtOAc in hexanes) yielded 42 mg (62%) of the title 
compound as a light yellow oil.  Separating the stereoisomers by GLC [Varian CP Wax 52CB 
column (30 m x 0.25 mm), flow rate 0.6 mL/min, method: 80 °C for 2.00 min, ramp @ 5.00 
°C/min to 250 °C, hold for 20.00 min, Tr = 46.3 and 48.8 min] provided the diastereomer ratio: 
anti: syn = 3.8:96.2.  1H NMR (300 MHz, CDCl3): δ 5.86 (d, J = 10.4 Hz, 1H), 5.75 (dq, J = 
10.4, 3.2 Hz, 1H), 3.59 (d, J = 11.1 Hz, 1H), 3.39 (d, J = 11.1 Hz, 1H), 2.15-2.25 (m, 1H), 1.95-
2.05 (m, 2H), 1.72-1.89 (m, 3H), 1.21-1.67 (m, 12H), 0.89 (t, J = 7.5 Hz, 3H), 0.84 (t, J = 7.5 Hz, 
3H) ppm; 13C NMR (75 MHz, CDCl3): δ 129.30, 128.69, 67.19, 42.18, 39.94, 32.94, 31.79, 
31.58, 25.34, 24.26, 23.99, 22.96, 22.79, 14.12, 7.92 ppm; MS (EI, 70 V): 224 (M+.), 206, 195, 
193, 177, 163, 153, 149, 143, 142, 135, 125, 109, 95, 83, 69, 55; HRMS m/z calcd for C15H28O 
(M+.): 224.2140; found: 224.2138. 
 
2-(Cyclohex-2-enyl)-2-methylpropanal (91d): Same Procedure as preparation 
of compound 91a was followed employing 3-(2-methylallyloxy)cyclohex-1-ene 
(89d, 152 mg, 1 mmol), Purifying the crude product mixture by flash chromatography on silica 
gel (5 % EtOAc in hexanes) yielded 106 mg (70 %) of the title compound as a light yellow oil. 
CHO
Me Me
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1H NMR (300 MHz, CDCl3): δ 9.52 (s, 1H), 5.80 (dq, J = 10.3, 3.4 Hz, 1H), 5.49 (d, J = 10.3 Hz, 
1H), 2.35-2.42 (m, 1H), 1.97-1.98 (m, 2H), 1.24-1.57 (m, 4H), 1.03 (s, 6H) ppm; MS (EI, 70 V): 
m/z 152 (M+.), 137, 123,; HRMS m/z calcd for C10H16O (M+.): 152.1201; found 152.1208. 
 
 
2-(Cyclohex-2-enyl)-2-methylpropan-1-ol (92e): General Procedure D was 
followed employing 3-(2-methylallyloxy)cyclohex-1-ene (89d, 152 mg, 1 
mmol) and 2 mol% catalyst loading, the initial reaction time is 6 h at 40 oC. After DIBAL-H (1.0 
M in hexanes, 1.5 ml, 1.5 mmol) promoted reaction. Purification by flash chromatograph on 
silica gel (16 % ethyl ether in hexanes) yield 117 mg (76 %) of the title compound as colorless 
oil. 1H NMR (300 MHz, CDCl3): δ 5.71-5.80 (m, 1H), 5.68 (dt, J = 10.4, 1.5 Hz, 1H), 3.45 (d, J 
= 10.9 Hz, 1H), 3.39 (d, J = 10.9 Hz, 1H), 2.05-2.15 (m, 1H), 1.85-1.97 (m, 2H), 1.69-1.82 (m, 
2H), 1.65 (brs, 1H), 1.38-1.55 (m, 1H), 1.19-1.35 (m, 1H), 0.88 (s, 3H), 0.86 (s, 3H) ppm; 13C 
NMR (300 MHz, CDCl3): δ 128.6, 128.5, 70.3, 41.3, 37.5, 25.1, 24.0, 22.7, 22.1, 21.5 ppm; MS 
(EI, 70 V): m/z 154 (M+.), 136, 123, 107, 81, 73, 67, 55; HRMS m/z calcd for C10H18O (M+.): 
154.1358; found 154.1362.  
Me Me
OH
(E)-(4-(allyloxy)but-2-en-2-yl)benzene (93a): The General Procedure A  was 
applied to (E)-3-phenylbut-2-en-1-ol (1.48 g, 10.0 mmol). The crude product was 
purified by column chromatography on silical gel (2 % ethyl acetate in hexanes) to yield 1.80 g 
(95 %) of the title compound as light yellow oil. 1H NMR (300 MHz, CDCl3): δ 7.23-7.54 (m, 
5H), 6.02-6.15 (m, 2H), 5.43 (d, J = 17.2 Hz, 1H), 5.32 (d, J = 10.4 Hz, 1H), 4.32 (d, J = 6.5 Hz, 
2H), 4.15 (d, J = 5.7 Hz, 2H), 2.18 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 142.85, 138.20, 
134.81, 128.16, 127.12, 125.71, 124.24, 117.13, 71.20, 67.05, 16.13 ppm.  
O
Ph
Me
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syn-2,3-Dimethyl-3-phenylpent-4-enol (96a): General 
procedure D was followed employing (E)-(4-(allyloxy)but-2-
en-2-yl)benzene (116a, 188 mg, 1.0 mmol) and 1 mol% catalyst (4.5 mg Ir-dimer, 8.4 mg PCy3 
and 3.4 mg NaBPh4) in dichloromethane and an initial reaction time of 30 min before quenched 
with 7.8 mg PPh3 (0.03 mmol).  Dichloromethane was removed and add 5 ml dry toluene and 
reflux 24 h to afford syn-2,3-dimethyl-3-phenylpent-4-enal 95a (syn: anti = 87: 13). General 
Diisobutylaluminum hydride (2.0 ml, 1.0 M in hexanes, 2.0 mmol) reduction of 95a followed by 
purification by flash chromatography (15 % EtOAc/hexanes) gave 158 mg (85 %) of the title 
compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.20-7.37 (m, 5H), 6.18 (dd, J = 17.5, 
10.9 Hz, 1H), 5.20 (dd, J = 10.9, 0.9 Hz, 1H), 5.12 (dd, J = 17.5, 0.9 Hz, 1H), 3.74 (dd, J = 10.6, 
4.2 Hz, 1H), 3.33 (dd, J = 10.6, 8.3 Hz, 1H), 2.20-2.31 (m, 1H), 1.58 (s, 1H), 1.36 (s, 3H), 0.85 
(d, J = 6.7 Hz, 3H) ppm.  
O
Ph
Me
Me
HO
Ph
Me
Me
 
(E)-3,7-Dimethyl-1-((E)-prop-1-enyloxy)octa-2,6-diene (94b): General  
Procedure D was followed employing (E)-1-(allyloxy)-3,7-dimethylocta-
2,6-diene137 (93b, 785 mg, 4.0 mmol) and 0.5 mol% catalyst (9.0 mg Ir-
dimer, 16.8 mg PCy3 and 6.8 mg NaBPh4) in dichloromethane for 30 min. Add pentane 5 ml, 
pass the solution to a short Florisil plug and evaporate the solvent to yield 706 mg (90 %) of the 
title compound as a colorless oil. 1H NMR (300 MHz, CDCl3): δ 6.24 (dq, J = 12.5, 1.5 Hz, 1H), 
5.38 (tq, J = 6.7, 1.2 Hz, 1H), 5.08-5.12 (m, 1H), 4.80 (dq, J = 12.6, 6.7 Hz, 1H), 4.19 (d, J = 6.7 
Hz, 1H), 2.02-2.13 (m, 4H), 1.69 (s, 6H), 1.61 (s, 3H), 1.56 (dd, J = 6.7, 1.5 Hz, 3H) ppm; 13C 
O
Me
Me
 
137 Vyglazov, O. G.; Chuiko, V. A.; Izotova, L. V. Russ. J. Gen. Chem. En. 2003, 73, 933-939. 
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NMR (300 MHz, CDCl3): δ 146.2, 140.6, 131.6, 123.8, 119.7, 98.6, 65.7, 39.4, 26.2, 25.3, 17.6 
16.4, 12.5 ppm; IR (liquid film): 2925, 1657, 1443, 1178, 931 cm-1. 
 
syn-2,3,7-Trimethyl-3-vinyloct-6-enal (95b): A solution of purified (E)-
3,7-dimethyl-1-((E)-prop-1-enyloxy)octa-2,6-diene (94b, 196 mg, 1.0 
mmol) in 2 ml anhydrous dichloroethane in seal tube was heated at 150 
oC in microwave oven for 2 h to afford aldehydes (anti: syn = 95: 5). 1H NMR (300 MHz, 
CDCl3): δ 9.71 (d, J = 2.5 Hz, 1H), 5.88 (dd, J = 17.5, 10.9 Hz, 1H), 5.18 (dd, J = 10.9, 1.1 Hz, 
1H), 5.03 (dd, J = 17.5, 1.1 Hz, 1H), 5.03-5.13 (m, 1H), 2.34 (qd, J = 6.9, 2.5 Hz, 1H), 2.03-2.11 
(m, 2H), 1.85-1.93 (m, 2H), 1.67 (s, 3H), 1.58 (s, 3H), 1.02 (s, 3H), 1.01 (d, J = 6.9 Hz, 3H) 
ppm. 
O
Me
Me
MeMe
H
 
syn-2,3,7-Trimethyl-3-vinyloct-6-enol (96b): General Procedure I was 
followed employing di(allyl) ether (93b, 785 mg, 4.0 mmol) and 0.5 
mol% catalyst (9.0 mg Ir-dimer, 16.8 mg PCy3 and 6.8 mg NaBPh4) in dichloromethane for 30 
min. Then and DIBAL-H (1.0 M in hexanes, 6.0 ml, 6.0 mmol). Purification by flash 
chromatograph on silica gel (16 % ethyl ether in hexanes) yields 705 mg (90 %) of the title 
compound as colorless oil. Separating the stereoisomers by GLC [Varian CP Wax 52CB column 
(30 m x 0.25 mm), flow rate 0.6 mL/min, method: 80 °C for 2.00 min, ramp @ 5.00 °C/min to 
250 °C, hold for 20.00 min, Tr = 39.2 and 39.9 min] provided the diastereomer ratio: syn: anti = 
89.5: 10.5. 1H NMR (300 MHz, CDCl3): δ 5.75 (dd, J = 17.6, 10.9 Hz, 1H), 5.00-5.08 (m, 1H), 
5.04 (dd, J = 10.9, 1.4 Hz, 1H), 4.93 (dd, J = 17.6, 1.4 Hz, 1H), 3.68 (dd, J = 10.6, 4.2 Hz, 1H), 
3.23 (dd, J = 10.6, 8.3 Hz, 1H), 2.30 (brs, 1H), 1.83 (q, J = 7.9 Hz, 1H), 1.65 (s, 3H), 1.55 (s, 
HO
Me
Me
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3H), 1.16-1.39 (m, 3H), 0.91 (d, J = 6.8 Hz, 3H), 0.88 (s, 3H) ppm; 13C NMR (300 MHz, 
CDCl3): δ 146.28, 131.04, 124.76, 112.52, 65.17, 43.28, 41.30, 39.51, 25.57, 22.36, 17.56, 17.47, 
11.75 ppm; MS (EI, 70 V): m/z 165 (M+.-CH2OH), 153, 137, 121, 109, 95; HRMS m/z calcd for 
C12H21 (M+.-CH2OH): 165.1643; found 165.1640. 
 
 
 w
(E)-8-(Allyloxy)-2,6-dimethyldeca-2,6-diene (93c): General Procedure 
A was followed employing 0.91 g of (E)-5,9-dimethyldeca-4,8-dien-3-
ol (5.0 mmol), 240 mg NaH (10.0 mmol) and 0.75 ml allyl bromide 
(10.0 mmol).  Purification by flash chromatography (2 % EtOAc/hexanes) gave 1.0 g (90 %) of 
the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 5.91 (dddd, J = 15.3, 12.8, 
6.2, 5.1 Hz, 1H), 5.27 (dq, J = 15.3, 1.7 Hz, 1H0, 5.07-5.16 (m, 2H), 5.01 (d, J = 9.2 Hz, 1H), 
4.01 (ddt, J = 12.8, 5.1, 1.3 Hz, 1H), 3.89 (q, J = 6.9 Hz, 1H), 3.80 (ddt, J = 12.8, 6.2, 1.3 Hz, 
1H), 2.01-2.12 (m, 4H), 1.68 (s, 3H), 1.64 (d, J = 1.3 Hz, 3H), 1.61 (s, 3H), 1.34-1.51 (m, 2H), 
0.87 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (300 MHz, CDCl3): δ 139.0, 135.7, 131.4, 126.2, 124.0, 
116.2, 76.4, 68.5, 53.6, 39.7, 28.6, 26.3, 25.6, 17.6, 16.5, 9.7 ppm; IR (liquid film): 2966, 2929, 
1450, 1377, 1071, 920 cm-1; MS (EI, 70 V): 193 (M+.-C2H5), 164, 135, 123, 99, 81, 69, 57. 
O Me
Et
(2S,3R,E)-3-(But-1-enyl)-2,3,7-trimethyloct-6-en-1-ol (96c): General 
Procedure I as followed employing (E)-8-(allyloxy)-2,6-dimethyldeca-
2,6-diene (93c, 222 mg, 1 mmol), 1 mol% catalyst loading and DIBAL-H (1.0 M in hexanes, 2 
ml, 2 mmol). Purification by flash chromatograph on silica gel (16 % ethyl ether in hexanes) 
yield 165 mg (75 %) of the title compound as colorless oil. Separating the stereoisomers by GLC 
[Varian CP Wax 52CB column (30 m x 0.25 mm), flow rate 0.6 mL/min, method: 80 °C for 2.00 
HO
Me
Me
Et
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min, ramp @ 5.00 °C/min to 250 °C, hold for 20.00 min, Tr = 41.8, 41.9, 42.3 and 42.8 min] 
provided the diastereomer ratio: 2.4: 0.5: 75.8: 21.4. Data of the major isomer. 1H NMR (300 
MHz, CDCl3): δ 5.30-5.45 (m, 2H), 5.08 (t, J = 6.5 Hz, 1H), 3.72 (dd, J = 10.7, 4.8 Hz, 1H), 3.29 
(dd, J = 10.7, 7.7 Hz, 1H), 2.00-2.07 (m, 2H), 1.87 (q, J = 7.9 Hz, 2H), 1.67 (s, 3H), 1.58 (s, 3H), 
1.22-1.40 (m, 2H), 1.49-1.60 (m, 1H), 0.98 (t, J = 7.6 Hz, 3H), 0.89 (s, 3H) ppm; 13C NMR (300 
MHz, CDCl3): δ 137.1, 135.9, 131.1, 130.1, 125.0, 65.8, 65.3, 44.2, 43.8, 40.3, 40.2, 40.1, 39.1, 
34.6, 31.6, 25.9, 25.7, 22.6, 22.5, 20.5, 18.2, 17.5, 14.2, 14.1, 12.3, 11.9 ppm. 
 
(E)-3,7-Dimethyl-1-(2-methylallyloxy)octa-2,6-diene (93d): General 
methylprop-1-ene (20.
2,2,3,7-Tetramethyl-3-vinyloct-6-en-1-ol (96d): General Procedure I 
g
Procedure A was followed employing 1.54 g of (E)-3,7-dimethylocta-2,6-
dien-1-ol (10.0 mmol), 480 mg NaH (20.0 mmol) and 1.8 g 3-chloro-2-
0 mmol).  Purification by flash chromatography (2 % EtOAc/hexanes) 
gave 1.87 g (90 %) of the title compound as colorless oil.1H NMR (300 MHz, CDCl ): δ 5.36 (d, 
J = 6.7 Hz, 1H), 5.09 (d, J = 6.3 Hz, 1H), 4.95 (s, 1H), 4.88 (s, 1H), 3.95 (d, J = 6.8 Hz, 2H), 3.87 
(s, 2H), 1.95-2.12 (m, 4H), 1.74 (s, 3H), 1.67 (s, 3H), 1.66 (s, 3H), 1.60 (s, 3H) ppm; 
3
13C NMR 
(300 MHz, CDCl ): δ 142.4, 139.9, 131.5, 123.9, 120.9, 112.0, 73.8, 66.2, 39.5, 26.3, 25.6, 19.4, 
17.6, 16.3 ppm; MS (EI, 70 V): 208 (M
3
+.), 193, 136, 123, 109, 93, 81, 69, 55; HRMS m/z calcd 
for C H O (M14 24 +.): 208.1827; found 208.1835. 
 
O Me
Me
was followed employing di(allyl) ether (93d, 208 mg, 1 mmol) and 2 
, the initial reaction time is 6 h at 40 mol% catalyst loadin oC. After DIBAL-H (1.0 M in 
hexanes, 2.0 ml, 2 mmol) promoted reaction. Purification by flash chromatograph on silica gel 
HO
MeMe
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(16 % ethyl ether in hexanes) yield 154 mg (74 %) of the title compound as colorless oil. 1H 
NMR (300 MHz, CDCl3): δ 5.89 (dd, J = 17.6, 10.9 Hz, 1H), 5.12 (dd, J = 10.9, 1.6 Hz, 1H), 
5.08 (t, J = 7.1 Hz, 1H), 4.95 (dd, J = 17.6, 1.6 Hz, 1H), 3.52 (d, J = 11.1 Hz, 1H), 3.38 (d, J = 
11.1 Hz, 1H), 1.67 (s, 3H), 1.57 (s, 3H), 1.71-1.81 (m, 4H), 1.28-1.47 (m, 2H), 0.98 (s, 3H), 0.91 
(s, 3H), 0.85 (s, 3H) ppm; 13C NMR (300 MHz, CDCl3): δ 144.8, 131.1, 125.1, 113.6, 69.5, 43.9, 
40.7, 34.7, 25.7, 23.0, 20.4, 20.1, 17.6, 16.4 ppm; MS (EI, 70 V): 210 (M +.), 195, 179, 167, 137, 
123, 109, 95, 81, 69, 55; HRMS m/z calcd for C14H26O (M +.): 210.1984, found 210.1990. 
 
5.3.2 Experiment of section 5.2 
5.3.2.1 Cascade isomerization-Claisen rearrangement-ene reaction 
b1): 
(E)-1-(allyloxy)-3,7-
2β,3β-dimethyl-6β-(prop-1-en-2-yl)-3α-vinylcyclohex-β-anol (97
General Procedure J for cascade olefin isomerization/Claisen 
rearrangement/ene reaction: General Procedure D was followed employing 
dimethylocta-2,6-diene (93b, 194 mg, 1.0 mmol) with 1 mol% catalyst 
(iridium dimer 4.5 mg, PCy3 8.4 mg and NaBPh4 3.4 mg), after isomerization, remove the 
solvent in vacuum. A solution of crude allyl vinyl ether (94b) in dichloromethane (0.5 M) was 
added Me2AlCl (1.0 M in hexanes, 1.5 ml, 1.5 mmol) dropwise at -40 oC, allow the reaction 
warm to ambient temperature over 12 h. Add saturated sodium tartrate solution 6 ml to quench 
the reaction and extraction with ether. After drying with MgSO4 and solvent Vaporation, crude 
proton NMR show three isomers ratio is 64: 29: 7. Separating the stereoisomers in crude mixture 
products by GLC [Varian CP Wax 52CB column (30 m x 0.25 mm), flow rate 0.6 mL/min, 
method: 80 °C for 2.00 min, ramp @ 5.00 °C/min to 250 °C, hold for 20.00 min, Tr = 28.2, 28.9, 
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29.5 and 31.2 min] provided the diastereomer ratio: 22 (97b2): 9 (97b3): 2 (97b4): 66 (97b1). 
The purification by flash chromatograph on silica gel (3 % ethyl acetate in hexanes) yields 95 mg 
(49 %) of the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 6.02 (dd, J = 17.5, 
11.1 Hz, 1H), 4.87 (s, 1H), 4.90 (s, 1H), 5.03 (dd, J = 17.5, 1.3 Hz, 1H), 5.09 (dd, J = 11.1, 1.3 
Hz, 1H), 3.29 (t, J = 10.1 Hz, 1H), 2.04 (ddd, J = 12.3, 10.2, 4.3 Hz, 1H), 1.25-1.79 (m, 5H), 
1.72 (s, 3H), 1.06 (s, 3H), 1.01 (d, J = 6.7 Hz, 3H) ppm; 13C NMR (300 MHz, CDCl3): δ 146.9, 
141.5, 113.6, 113.0, 71.9, 54.8, 47.6, 40.8, 39.1, 27.3, 25.6, 19.0, 11.6 ppm; IR (liquid film): 
3462, 3079, 2974, 2934, 1639, 1456, 1373, 1075, 909 cm-1; MS (EI, 70 V): m/z 194 (M+.), 179, 
176, 161, 147, 135, 123, 111, 107, 95, 81, 68, 55; HRMS m/z calcd for C13H22O (M+.): 194.1671; 
found 194.1676. 
 
2α,3α-dimethyl-6β-(prop-1-en-2-yl)-3β-vinylcyclohex-β-anol (97b2): The 
= 17.6, 10.9 Hz, 1H
eM
purified 97b2 is isolated as minor product with 97b1. yields 30 mg (15 %) of 
the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ5.80 (dd, J 
), 4.93 (dd, J = 10.9, 1.3, 1H), 4.92 (s, 1H), 4.87 (dd, J = 17.6, 1.3 Hz, 1H), 
4.87 (s, 1H), 3.94 (dd, J = 10.9, 4.8 Hz, 1H), 2.16 (td, J = 10.8, 5.8 Hz, 1H), 1.84 (qd, J = 7.1, 4.8 
Hz, 1H), 1.75 (s, 3H), 1.46-1.73 (m, 3H), 1.12 (s, 3H), 0.86 (s, 3H) ppm; 13C NMR (300 MHz, 
CDCl3): δ 148.8, 146.7, 113.1, 109.9, 68.8, 47.1, 42.3, 40.4, 28.0, 25.6, 24.9, 19.0, 9.0 ppm; IR 
(liquid film): 3462, 3079, 2974, 2934, 1639, 1456, 1373, 1075, 909 cm-1; MS (EI, 70 V): m/z 194 
(M+.), 179, 176, 161, 147, 135, 123, 111, 107, 95, 81, 68, 55; HRMS m/z calcd for C13H22O 
(M+.): 194.1671; found 194.1676. 
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(E)-3α- (But-1-enyl) -2β, 3β-dimethyl-6β-(prop-1-en-2-yl) cyclohexanol 
(97c1): General Procedure J for cascade olefin isomerization/Claisen 
rearrangement/ene reaction was followed employing (E)-8-(allyloxy)-2,6-
dimethyldeca-2,6-diene (93c, 222 mg, 1.0 mmol), 1 mol% catalyst loading and Me2AlCl (1.0 M 
in hexanes, 1.5 ml, 1.5 mmol). Separating the stereoisomers by GLC [Varian CP Wax 52CB 
column (30 m x 0.25 mm), flow rate 0.6 mL/min, method: 80 °C for 2.00 min, ramp @ 5.00 
°C/min to 250 °C, hold for 20.00 min, Tr = 32.5, 33.5, 35.7 and 36.9 min] provided the 
diastereomer ratio: 30.6 (97c2): 16.0, 7.6: 45.8 (97c1). Purification by flash chromatograph on 
silica gel (16 % ethyl ether in hexanes) yields 85 mg (38 %) of the title compound as colorless 
oil. 1H NMR (300 MHz, CDCl3): δ 5.58 (d, J = 15.8 Hz, 1H), 5.44 (dt, J = 15.8, 6.2 Hz, 1H), 
4.90 (s, 1H), 4.87 (s, 1H), 3.29 (t, J = 10.1 Hz, 1H), 1.98-2.10 (m, 3H), 1.73 (s, 3H), 1.22-1.68 
(m, 5H), 1.03 (s, 3H), 0.99 (t, J = 7.4 Hz, 3H), 0.99 (d, J = 6.6 Hz, 3H) ppm; MS (EI, 70 V): 222 
(M+.), 207, 204, 193, 189, 165, 139, 123, 109, 96, 81, 68; HRMS m/z calcd for C15H26O (M+.): 
222.1984, found 222.1077. 
Me
MeMe
HO
Et
 
(E)-3β- (But-1-enyl)-2α,3α-dimethyl-6β-(prop-1-en-2-yl)cyclohexanol 
(97c2): The title compound is isolated 55 mg (25 %) as second major 
NMR (300 MHz, CDCl
MeEt
product with 97c1. H 1 3): δ 5.37 (d, J = 15.7 Hz, 1H), 5.29 (dt, J = 15.7, 
5.3 Hz, 1H), 4.91 (s, 1H), 4.87 (s, 1H), 3.93 (dd, J = 10.8, 4.7 Hz, 1H), 2.15 (td, J = 10.7, 7.9 Hz, 
1H), 2.05 (qd, J = 7.5, 5.5 Hz, 2H), 1.75 (s, 3H), 1.53-1.85 (m, 5H), 1.10 (s, 3H), 0.98 (t, J = 7.4 
Hz, 3H), 0.85 (d, J = 7.1 Hz, 3H) ppm. 
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2α,2β,3β- Trimethyl-6β-(prop-1-en-2-yl)-3α-vinyl 
cyclohexanol (97d1) and 2α,2β,3α-Trimethyl-6β-
(prop-1-en-2-yl)-3β-vinylcyclohexanol (97d2): 
General Procedure J for cascade olefin isomerization/Claisen rearrangement/ene reaction was 
followed employing (E)-3,7-Dimethyl-1-(2-methylallyloxy)octa-2,6-diene (93d , 104 mg, 0.5 
mmol) and 2 % catalyst (iridium dimer 4.5 mg, PCy3 8.4 mg and NaBPh4 3.4 mg) at 40 oC for 2 
h. Then treated in Me2AlCl (1.0 M in hexanes, 0.8 ml, 0.8 mmol). Purification by flash 
chromatograph on silica gel (3 % ethyl ether in hexanes) yields 83 mg (80 %) of the title 
compound as colorless oil. Separating the stereoisomers by GLC [Varian CP Wax 52CB column 
(30 m x 0.25 mm), flow rate 0.6 mL/min, method: 80 °C for 2.00 min, ramp @ 5.00 °C/min to 
250 °C, hold for 20.00 min, Tr = 31.4 and 32.5 min] provided the diastereomer ratio: 33 (97d2): 
67 (97d1). The major isomer (97d1) data: 1H NMR (300 MHz, CDCl3): δ 5.95 (dd, J = 17.5, 
11.0 Hz, 1H), 5.01(dd, J = 11.0, 1.5 Hz, 1H), 4.95 (dd, J = 17.5, 1.5 Hz, 1H), 4.90 (d, J = 1.5 Hz, 
1H), 4.86 (d, J = 1.5 Hz, 1H), 3.57 (d, J = 10.8 Hz, 1H), 2.19 (td, J = 11.3, 5.6 Hz, 1H), 1.75 (s, 
3H), 1.37-1.69 (m, 3H), 1.25 (t, J = 6.5 Hz, 1H), 1.06 (s, 3H), 0.98 (s, 3H), 0.88 (s, 3H) ppm; 13C 
NMR (300 MHz, CDCl3): δ 147.3, 145.9, 113.2, 112.0, 73.5, 49.2, 42.7, 40.3, 32.5, 25.8, 21.9, 
19.7, 18.9, 16.5 ppm; IR (liquid film): 3493, 2976, 1635, 1459, 1372, 1080, 910 cm-1; MS (EI, 
70 V): m/z 208 (M+.), 193, 190, 175, 165, 147, 135, 121, 109, 93, 81, 68, 55; HRMS m/z calcd 
for C13H22O (M+.): 208.1827; found 208.1835. The minor isomer (97d2) data: 1H NMR (300 
MHz, CDCl3): δ 6.25 (dd, J = 17.4, 1.1 Hz, 1H), 5.06 (dd, J = 11.1, 1.5 Hz, 1H), 5.03 (dd, J = 
17.4, 1.5 Hz, 1H), 4.90 (d, J = 1.5 Hz, 1H), 4.86 (d, J = 1.5 Hz, 1H), 3.50 (d, J = 10.8 Hz, 1H), 
1.83 (td, J = 12.7, 5.4 Hz, 1H), 1.72 (s, 3H), 1.37-1.69 (m, 3H), 1.21 (t, J = 6.4 Hz, 1H), 0.98 (s, 
Me
MeMe
MeHO and
Me
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3H), 0.97 (s, 3H), 0.94 (s, 3H) ppm; 13C NMR (300 MHz, CDCl3): δ 147.3, 143.4, 113.2, 113.0, 
73.7, 49.0, 43.0, 40.6, 33.9, 25.8, 22.4, 19.7, 18.8, 15.9 ppm. 
 
5.3.2.2 Cascade isome
 
rization-Claisen-Wittig-Cope reaction 
(4S,E)-methyl 4-(cyclohex-2-enyl)pent-2-enoate (99a): General 
Procedure of cascade ICR-Wittig reaction: General Procedure D was 
followed employing 3-(allyloxy)cyclohex-1-ene (95a, 72 mg, 0.5 mmol) 
and 1 % catalyst loading in DCE, after 30 min at ambient temperature, the solvent was removed 
in vacuum. The crude allyl vinyl ether (96a) and Ph3PCHCOOMe (211 mg, 0.63 mmol) in 3 ml 
toluene was added in sealed tube and heated in microwave oven at 180 oC for 2 h (anti: syn = 90: 
10). Remove the solvent and chromatography with silica gel (5 % ethyl acetate in hexanes) 
yields 72 mg (72 %) of the title compound as colorless oil. 1H NMR (300 MHz, CDCl3): δ 6.93 
(dd, J = 15.7, 7.5 Hz, 1H), 5.78 (dd, J = 15.7, 1.3 Hz, 1H), 5.68-5.75 (m, 1H), 5.55 (d, J = 10.2 
Hz, 1H), 3.71 (s, 3H), 2.30 (hex, J = 6.6 Hz, 1H), 2.08-2.20 (m, 1H), 1.90-1.99 (m, 2H), 1.64-
1.78 (m, 2H), 1.40-1.56 (m, 1H), ,1.17-1.31 (m, 1H), 1.06 (d, J = 6.7 Hz, 3H) ppm; 13C NMR 
(300 MHz, CDCl3): δ 167.1, 153.4, 129.0, 128.8, 120.0, 51.3, 40.9, 26.2, 25.1, 21.6, 16.0 ppm; 
IR (liquid film): 2932, 1725, 1655, 1435, 1314, 1197, 1174, 722 cm-1. 
Me
COOMe
3-(Allyloxy)-1-methylcyclohex-1-ene (95b): General Procedure A was followed 
employing 1.12 g of 3-methylcyclohex-2-enol (10.0 mmol), 480 mg NaH (20.0 
mmol) and 1.5 ml allyl bromide (20.0 mmol).  Purification by flash 
chromatography (2 % EtOAc/hexanes) gave 1.37 g (90 %) of the title compound as colorless oil. 
1H NMR (300 MHz, CDCl3): δ 5.91 (ddt, J = 17.2, 10.3, 5.6 Hz, 1H), 5.47-5.52 (m, 1H), 5.25 
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(dq, J = 17.2, 1.7 Hz, 1H), 5.12 (dq, J = 10.3, 1.4 Hz, 1H), 4.03 (ddt, J = 12.7, 5.5, 1.4 Hz, 1H), 
3.97 (ddt, J = 12.7, 5.7, 1.4 Hz, 1H), 3.81-3.89 (m, 1H), 1.48-2.00 (m, 6H), 1.66 (s, 3H) ppm; 13C 
NMR (75 MHz, CDCl3): δ 138.7, 135.4, 122.0, 116.2, 72.5, 69.0, 30.1, 27.9, 23.6, 19.2 ppm; MS 
(EI, 70 V): m/z 111 (M+.-C3H5); HRMS m/z calcd for C7H11O (M+.-C3H5): 111.0810; found 
111.0848. 
 
 
(E)-1-Methyl-3-(prop-1-enyloxy)cyclohex-1-ene (96b): General Procedure D 
was followed employing 3-(allyloxy)-1-methylcyclohex-1-ene (95b, 304 mg, 2.0 
mmol) and 1 mol% catalyst (9.0 mg Ir-dimer, 16.8 mg PCy3 and 6.8 mg NaBPh4) 
in dichloromethane for 30 min. Add pentane 5 ml and pass the solution to a short Florisil plug to 
yield 270 mg (90 %) of the title compound as a colorless oil. 1H NMR (300 MHz, CDCl3): δ 6.13 
(dq, J = 12.3, 1.6 Hz, 1H), 5.49-5.53 (m, 1H), 4.90 (dq, J = 12.3, 6.7 Hz, 1H), 4.16-4.19 (m, 1H), 
1.70 (s, 3H), 1.54 (dd, J = 6.7, 1.6 Hz, 3H), 1.20-1.90 (m, 6H) ppm; 13C NMR (75 MHz, CDCl3): 
δ 145.1, 140.0, 121.0, 100.5, 73.7, 30.0, 28.1, 23.7, 19.0, 12.5 ppm. 
Me
O
Me
 (E)-Methyl 2-(3-methylcyclohex-2-enyl)pent-3-
enoate (99b) and (E)-Methyl 4-(1-
methylcyclohex-2-enyl)pent-2-enoate (98b): 
General Procedure of cascade ICR-Wittig reaction was followed employing 3-(allyloxy)-1-
methylcyclohex-1-ene (96b, 152 mg, 1.0 mmol) and Ph3PCHCOOMe (422 mg, 1.26 mmol) 
heated in microwave oven at 180 oC for 2 h, the ratio of 99b: 98b is 57: 43. Continuing heating 
at 200 oC for another 2 h, The ratio of 99b: 98b increased to 69: 31. Data for 99b: 1H NMR (300 
Me
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O
MeO
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Meand
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MHz, CDCl3): δ 5.20-5.50 (m, 2H), 5.12 (s, 1H), 3.69 (s, 3H), 1.60-1.90 (m, 6H), 1.68 (dd, J = 
6.3, 1.4 Hz, 3H), 1.63 (s, 3H) ppm.  
 
5.3.2.3 Cascade t
(E)-Methyl 5,9-dimethyl-2-
((E)-prop-1-enyl) deca-4,8-
dienoate (99c) and (E)-Methyl 
4,5,9-trimethyl-5-vinyldeca-2,8-dienoate (98c): General Procedure of cascade ICR-Wittig 
reaction was followed employing (E)-1-(allyloxy)-3,7-dimethylocta-2,6-diene (94b, 194 mg, 1 
mmol) and Ph3PCHCOOMe (422 mg, 1.26 mmol) at 160 oC for 2 h at microwave oven. The 
ratio of 99c : 98c = 80: 20. Data for 99c:  1H NMR (300 MHz, CDCl3): δ 5.35-5.65 (m, 2H), 
5.03-5.10 (m, 2H), 3.67 (s, 3H), 2.99 (q, J = 7.5 Hz, 1H), 2.35-2.50 (m, 1H), 2.15-2.30 (m, 1H), 
1.91-2.07 (m, 4H), 1.58-1.70 (m, 12 H) ppm. 
Me
Me
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MeO
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and
etrahydropyran formation 
(E)-1-Allyl-1-(prop-1-enyloxy)cyclohexane (101aa): General procedure D 
was followed employing 1-allyl-1-(allyloxy)cyclohexane (100a, 180 mg, 1.0 
mmol) and 1 mol% catalyst loading for 15 min at ambient temperature. Add the PPh3 and pass it 
to Florisil plug to yield 160 mg (90 %) of the title compound as the colorless oil. 1H NMR (300 
MHz, CDCl3): δ 6.19 (dq, J = 12.0, 1.5 Hz, 1H), 5.80 (ddt, J = 17.2, 10.6, 7.2 Hz, 1H), 4.98-5.08 
(m, 3H), 2.25 (dt, J = 7.2, 1.2 Hz, 2H), 1.55 (dd, J = 6.8, 1.5 Hz, 3H), 1.20-1.90 (m, 10H) ppm. 
O
Me
 
1-((3R,6R)- 6-Allyl-(2,2-cyclohexyl)-5-methyl-tetrahydro-2H-pyran-3-
yl)ethanone (102a): General Procedure of tetrahydropyran rings 
O
HO
Me
H
Me
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formation: A solution of methyl vinyl ketone (mg, 2.0 mmol, 2.2 equiv), homoallyl vinyl ether 
(101a, 160 mg, 0.9 mmol) and 2,6-di-tert-butyl-4-methylpyridine (DTBMP, 310 mg, 1.5 mmol, 
1.6 equiv) in CH2Cl2 (0.1 M) was cooled to -78 oC, A solution of TiBr4 (0.4 M in CH2Cl2, 736 
mg, 2.0 mmol, 2.2 equiv) was added dropwise via syringe. The reaction mixture was then stirred 
at -78 oC for 1 h. Then saturated sodium bicarbonate solution was added at -78 oC and the 
mixture was allowed to warm to ambient temperature. Purification by flash chromatograph on 
silica gel (5-20 % ethyl acetate in hexanes) yields 155 mg (70 %) of the title compound as 
colorless oil (4: 1 mixture). Separating the stereoisomers by GLC [Varian CP Wax 52CB column 
(30 m x 0.25 mm), flow rate 0.6 mL/min, method: 80 °C for 2.00 min, ramp @ 5.00 °C/min to 
250 °C, hold for 20.00 min, Tr = 43.3 and 46.6 min] provided the diastereomer ratio: 19 (102a1): 
81 (102a2). Major isomer: 1H NMR (300 MHz, CDCl3): δ 5.75-6.00 (m, 1H), 5.08 (d, J = 17.2 
Hz, 1H), 5.02 (d, J = 10.2 Hz, 1H), 3.60 (ddd, J = 8.5, 5.4, 2.7 Hz, 1H), 2.78 (dd, J = 13.5, 3.4 
Hz, 1H), 2.17 (s, 3H), 1.20-2.20 (m, 15H), 0.96 (d, J = 7.0 Hz, 3H) ppm; MS (EI, 70 V): m/z 250 
(M+.), 190, 152, 109, 94, 84; HRMS m/z calcd for C16H26O2 (M+.): 250.1933; found 250.1939. 
 
                                                
(E)-(1-(Prop-1-enyloxy)but-3-enyl)cyclohexane (101b): General procedure 
D was followed employing (1-(allyloxy)but-3-enyl)cyclohexane 138 (100b, 
388 mg, 2.0 mmol) and 1 mol% catalyst loading for 12 min at ambient 
temperature, the crude proton NMR show the ratio of 101b: 100b: allyl vinyl ether = 84: 12: 4. 
Quenched catalyst in 20 min, the ratio is 74: 26: 0. Add the PPh3 and pass it to Florisil plug to 
yield 240 mg (60 %) of the title compound as the colorless oil. 1H NMR (300 MHz, CDCl3): δ 
6.06 (d, J = 12.2 Hz, 1H), 5.83 (ddt, J = 17.1, 10.2, 7.0 Hz, 1H), 5.24 (d, J = 10.2 Hz, 1H), 5.23 
O
Me
 
138  Schmit, B. J. Chem. Soc. Perkin Trans 1, 1999, 18, 2627-2638. 
 213 
(d, J = 17.2 Hz, 1H), 4.87 (dq, J = 12.2, 6.7 Hz, 1H), 3.53 (q, J = 5.8 Hz, 1H), 2.40-2.50 (m, 2H), 
1.54 (d, J = 6.7 Hz, 3H), 1.00-1.90 (m, 11H) ppm. 
 
1-((2S,3R,6R)-6- Allyl-2-cyclohexyl-5-methyl-tetrahydro-2H-pyran-3-
yl)ethanone (102b): General Procedure of tetrahydropyran rings 
formation was followed employing (E)-(1-(prop-1-enyloxy)but-3-
enyl)cyclohexane (101b, 240 mg, 1.2 mmol, 1.0 equiv). Purification by flash chromatograph on 
silica gel (5-20 % ethyl acetate in hexanes) yields 200 mg (63 %) of the title compound as 
colorless oil (1: 1 mixture). Separating the stereoisomers by GLC [Varian CP Wax 52CB column 
(30 m x 0.25 mm), flow rate 0.6 mL/min, method: 80 °C for 2.00 min, ramp @ 5.00 °C/min to 
250 °C, hold for 20.00 min, Tr = 45.9 and 46.7 min] provided the diastereomer ratio: 42 (102b1): 
58 (102b2). MS (EI, 70 V): m/z 264 (M+.), 223,205, 181, 152, 111, 94; HRMS m/z calcd for 
C17H28O2 (M+.): 264.2089; found 264.2092. 
O
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APPENDIX A 
X-RAY STRUCTURE OF SEMICARBAZIDE DERIVED 64A′ FROM ANTI-2-((E)-1,3-
DIPHENYLALLYL)-2-METHYLHEXANAL  
Ph Ph
H
N
nBu
Me
H
N
O
H2N
 
 
Empirical formula  C23H29N3O 
Formula weight  363.49 
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Temperature  295(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.440(2) Å α= 114.083(4)°. 
 b = 14.165(3) Å β= 105.058(4)°. 
 c = 16.869(4) Å γ = 92.317(4)°. 
Volume 2168.6(8) Å3 
Z 4 
Density (calculated) 1.113 Mg/m3 
Absorption coefficient 0.069 mm-1 
F(000) 784 
Crystal size 0.15 x 0.08 x 0.08 mm3 
Theta range for data collection 1.60 to 25.00°. 
Index ranges -12<=h<=12, -16<=k<=16, -20<=l<=20 
Reflections collected 15885 
Independent reflections 7644 [R(int) = 0.0905] 
Completeness to theta = 25.00° 99.8 %  
Absorption correction None 
Max. and min. transmission 0.9945 and 0.9897 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7644 / 0 / 511 
Goodness-of-fit on F2 1.111 
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Final R indices [I>2sigma(I)] R1 = 0.1411, wR2 = 0.2873 
R indices (all data) R1 = 0.2571, wR2 = 0.3305 
Largest diff. peak and hole 0.272 and -0.229 e.Å-3 
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